Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGRP,Agouti-related protein,42754,0.255097655868206,0.00480824709999859,0.245673491552208,0.264521820184203,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN1,CCN family member 1,42569,0.336081921290695,0.00692411753763302,0.322510650916934,0.349653191664456,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,0.088584671234927,0.00210647912849239,0.0844559721430819,0.0927133703267721,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LDLR,Low-density lipoprotein receptor,42644,0.385060896292628,0.00403294318086683,0.377156327658129,0.392965464927127,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFGE8,Lactadherin,42611,0.209288482331475,0.00407585638108914,0.20129980382454,0.21727716083841,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPY,Pro-neuropeptide Y,42721,0.333810646723167,0.00592217183076083,0.322203189934876,0.345418103511458,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.13611062185679,0.0031803124182324,0.129877209517055,0.142344034196526,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GHR,Growth hormone receptor,40283,0.103517695191887,0.00272467471272922,0.0981773327549378,0.108858057628836,4.95481599128601e-297
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPL,Lipoprotein lipase,42636,-0.168958747606327,0.00453117870533684,-0.177839857868787,-0.160077637343867,1.11099357273639e-289
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,0.268133640671549,0.00727454341274946,0.25387553558256,0.282391745760538,6.15186536657521e-281
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F7,Coagulation factor VII,42671,0.108809062964637,0.00302585018961299,0.102878396592995,0.114739729336278,1.72776153896537e-270
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CES1,Liver carboxylesterase 1,42661,0.283639304676721,0.00790207534927085,0.26815123699215,0.299127372361292,1.51498150725521e-269
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCG,Pro-glucagon,42346,0.436022618274268,0.0123454193461753,0.411825596355765,0.460219640192772,3.8926252261434e-261
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FURIN,Furin,42679,0.112297664957672,0.0031873252475029,0.106050507472566,0.118544822442778,3.27811159137031e-260
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42721,0.111341426573902,0.00320996264666094,0.105049899786446,0.117632953361357,1.24570111031105e-252
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADIPOQ,Adiponectin,40539,-0.231416150719127,0.00672707321958526,-0.244601214229515,-0.21823108720874,8.92001195037719e-247
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF9,Protein turtle homolog A,40511,0.276362726987533,0.00807296644614607,0.260539712753087,0.292185741221979,1.7536120887482e-244
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROC,Vitamin K-dependent protein C,42663,0.0835085284344118,0.00246332879493607,0.0786804039963371,0.0883366528724865,8.10644202582237e-242
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,0.139406052235949,0.00414463278524035,0.131282571976878,0.14752953249502,3.03353730070129e-238
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INHBC,Inhibin beta C chain,42611,0.133939002181702,0.00402947019022835,0.126041240608854,0.141836763754549,6.94405253949803e-233
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC39A5,Zinc transporter ZIP5,42594,0.174704178161239,0.00529269592739636,0.164330494143542,0.185077862178936,8.53946074396403e-230
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRP1,Neuropilin-1,42705,-0.0895962710145481,0.00273171277455722,-0.0949504280526803,-0.084242113976416,4.37052749402583e-227
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TTR,Transthyretin,40424,0.081207899738988,0.00246787236728358,0.0763708698991122,0.0860449295788638,8.54200419612914e-227
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RARRES2,Retinoic acid receptor responder protein 2,42705,0.149804615520132,0.00462678921697872,0.140736108654854,0.158873122385411,1.47447852101636e-221
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD1,Mothers against decapentaplegic homolog 1,42346,0.255048054170492,0.00800004923303131,0.239367957673751,0.270728150667233,6.6279934173422e-215
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTH,Parathyroid hormone,40182,0.255713868352873,0.00802924910154897,0.239976540113837,0.271451196591909,5.61317797674329e-213
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL23,C-C motif chemokine 23,42676,0.131104707483554,0.0041346375026572,0.123000817978346,0.139208596988762,6.95865756291806e-213
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA5,Plasma serine protease inhibitor,40387,0.0980661357634179,0.00308841419219547,0.0920128439467148,0.104119427580121,6.11354357083123e-212
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL27,C-C motif chemokine 27,42636,0.182857909244232,0.0058085048802026,0.171473239679035,0.194242578809429,5.98854832292194e-210
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN3,Contactin-3,42611,0.0966016413218962,0.00307895810705867,0.0905668834320612,0.102636399211731,1.39093625447774e-208
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,0.24519805215598,0.00781738364705819,0.229875980207746,0.260520124104215,1.86615356057422e-208
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42587,0.266258802277335,0.00851652410355626,0.249566415034365,0.282951189520305,3.6664699963229e-207
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRAP1,Proline-rich acidic protein 1,40527,0.124910816969455,0.00408052707932305,0.116912983893982,0.132908650044928,8.47863184005762e-198
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCHE,Cholinesterase,40346,0.083796395035178,0.0027389796768099,0.0784279948686306,0.0891647952017254,1.84125112871289e-197
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APCS,Serum amyloid P-component,40419,0.102676521823066,0.00335840853828181,0.0960940410880334,0.109259002558098,2.97533674080324e-197
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,0.313598078540037,0.0103064519373358,0.293397432742859,0.333798724337216,1.08841193886766e-196
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,42477,0.447468199490242,0.0148192275635692,0.418422513465646,0.476513885514837,8.95606060269133e-194
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSG2,Desmoglein-2,42611,-0.0807675139302028,0.00269544546680625,-0.086050587045143,-0.0754844408152626,5.19923732741204e-191
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,0.100355885616943,0.00341347249538552,0.0936654795259872,0.107046291707898,3.2118854439366e-184
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA4,Kallistatin,40342,0.0697466201862716,0.00237572341508406,0.0650902022927068,0.0744030380798364,1.49307335143586e-182
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.170631726596649,0.00584928673958197,-0.18209632860623,-0.159167124587069,2.16191415600795e-181
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C9,Complement component C9,40532,-0.152794415103746,0.00522976356120552,-0.163044751683708,-0.142544078523783,5.52055836353474e-181
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFPI,Tissue factor pathway inhibitor,42618,0.0874303259007598,0.00307089410687803,0.0814113734512789,0.0934492783502407,3.58524918316134e-173
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42770,-0.337225826493035,0.0119354432499579,-0.360619295262952,-0.313832357723118,1.04697526521049e-170
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,0.053154337610431,0.00188235130467822,0.0494649290532616,0.0568437461676003,1.85818315653965e-170
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLTP,Phospholipid transfer protein,42752,-0.100331232398808,0.00356022249737214,-0.107309268493657,-0.0933531963039584,7.44824786899129e-170
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR37,Prosaposin receptor GPR37,42357,0.18952235689837,0.00678435227486615,0.176225026439632,0.202819687357108,6.98579064196095e-167
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AFM,Afamin,40539,0.0546177821903812,0.00197243567444409,0.0507518082684708,0.0584837561122916,2.27788894361129e-163
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,0.190679316796239,0.00691840529776852,0.177119242412613,0.204239391179865,1.07693956333718e-162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS15,Enteropeptidase,42587,0.249752154318259,0.0090650223766296,0.231984710460065,0.267519598176453,1.3974008755868e-162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42771,-0.169624647114208,0.0061670934354024,-0.181712150247597,-0.15753714398082,4.09591152443362e-162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL6,C-X-C motif chemokine 6,42754,0.20909690706242,0.00760496880403282,0.194191168206515,0.224002645918324,5.38528707281279e-162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD4,T-cell surface glycoprotein CD4,42570,0.0842626255775966,0.00308567794461669,0.0782146968061478,0.0903105543490453,7.9635542027682e-160
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHMP6,Charged multivesicular body protein 6,40511,0.151105975148031,0.00554079106715913,0.140246024656399,0.161965925639663,1.15898507829502e-158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,0.307115058441464,0.0112961899578536,0.284974526124071,0.329255590758857,1.72515392534707e-158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,0.218861729186994,0.00808462481632345,0.203015864547,0.234707593826988,4.11788894136742e-157
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,0.0529891851441854,0.00196868721055445,0.0491305582114987,0.0568478120768721,2.39659250688823e-155
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,0.156943280880824,0.0058809507073293,0.145416617494459,0.16846994426719,7.58879731210098e-153
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAMR1,Inactive serine protease PAMR1,42611,0.0710927236825701,0.00266553221285138,0.0658682805453814,0.0763171668197588,9.43471256489248e-153
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPM,Carboxypeptidase M,42655,0.0893906857818324,0.00335859454255641,0.0828078404784219,0.095973531085243,3.7526212497676e-152
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFP,Properdin,40539,0.0582439269130308,0.00221423170080018,0.0539040327794624,0.0625838210465991,4.46102138108851e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUSB,Beta-glucuronidase,42711,0.157871296414942,0.00604836838374748,0.146016494382797,0.169726098447087,1.45649771735388e-146
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFH,Complement factor H,39956,0.0585387033395072,0.00227165133689495,0.0540862667191931,0.0629911399598213,3.79906473997899e-142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNCA,Alpha-synuclein,40283,0.293845921294923,0.0114160171408949,0.271470527698769,0.316221314891077,5.87748563814302e-142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,0.185204679026212,0.00727266386540462,0.170950257850019,0.199459100202405,1.02037859939456e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUMB,Protein numb homolog,40199,0.206356817854729,0.00816476134424113,0.190353885620016,0.222359750089441,4.76512183173879e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERP44,Endoplasmic reticulum resident protein 44,42569,0.0640777757694532,0.00254447487982006,0.0590906050050059,0.0690649465339006,9.18503183594917e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,0.130030106972903,0.00517413291301011,0.119888806463403,0.140171407482402,3.00235659664433e-136
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAPIN,SNARE-associated protein Snapin,40482,0.144059712443752,0.00572385375954806,0.132840959075037,0.155278465812466,4.81457709310351e-136
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRIP2,Cysteine-rich protein 2,42495,0.0917448907497856,0.00366224691354988,0.0845668867992279,0.0989228947003434,2.25228286564694e-135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,P4HB,Protein disulfide-isomerase,42563,0.0955686596304083,0.00382120531185718,0.0880790972191683,0.103058222041648,5.86518933814767e-135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLKB1,Plasma kallikrein,40293,0.0614026733543042,0.00245376201666385,0.0565932998016431,0.0662120469069654,1.72051909903002e-134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGR3,Anterior gradient protein 3,42326,0.149113309648891,0.0059798694233315,0.137392765579161,0.16083385371862,3.90735363782984e-134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTA3,Glutathione S-transferase A3,42346,0.189798074622622,0.00762378750150481,0.174855451119673,0.204740698125572,1.01186298907282e-133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42794,-0.0848657571452256,0.00341111991359025,-0.0915515521758625,-0.0781799621145887,1.19092713170068e-133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MXRA8,Matrix remodeling-associated protein 8,40283,-0.0771985480452039,0.00310030076312228,-0.0832751375409236,-0.0711219585494843,3.22881066314598e-133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLI1,Friend leukemia integration 1 transcription factor,42346,0.271924941147373,0.0109643283232273,0.250434857633848,0.293415024660899,9.59711250512775e-133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLAT,Tissue-type plasminogen activator,42760,0.124993092246049,0.00504449586168535,0.115105880357145,0.134880304134952,1.33939235964765e-132
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENO3,Beta-enolase,40223,0.145421662688558,0.00586915137397188,0.133918125995573,0.156925199381543,6.1271457074865e-132
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFI,Complement factor I,40539,0.048110214879315,0.0019481936644987,0.0442917552968976,0.0519286744617325,3.41271420123533e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPIND1,Heparin cofactor 2,40516,0.0690322536930531,0.00279727237651681,0.0635495998350801,0.074514907551026,5.08877906891895e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300LG,CMRF35-like molecule 9,42611,-0.0946014529229785,0.00384883758960002,-0.102145174598595,-0.0870577312473625,1.58849902418326e-130
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD2,Mothers against decapentaplegic homolog 2,40451,0.169334642650954,0.00688767776435272,0.155834794232822,0.182834491069085,4.7205699314405e-130
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAT2,Linker for activation of T-cells family member 2,42587,0.301624629217328,0.0122998112299288,0.277516999206668,0.325732259227989,6.07660880147267e-130
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHBG,Sex hormone-binding globulin,40532,-0.121814078825499,0.00503235061077842,-0.131677486022625,-0.111950671628373,2.96211452867668e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINF1,Pigment epithelium-derived factor,40351,0.0643094042721016,0.002660330102608,0.0590951572709899,0.0695236512732132,7.06134032175238e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF21,Fibroblast growth factor 21,42689,0.282166631291351,0.0117231630829059,0.259189231648855,0.305144030933846,2.26733223570379e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LATS1,Serine/threonine-protein kinase LATS1,40199,0.202696460515872,0.00840331783847744,0.186225957552457,0.219166963479288,2.60188594038832e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,0.330053319893388,0.013778979390732,0.303046520287553,0.357060119499223,1.03013371782722e-123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F9,Coagulation factor IX,42663,0.0431205888856147,0.00180644499178373,0.0395799567017186,0.0466612210695108,2.22919073562068e-123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASGR1,Asialoglycoprotein receptor 1,42495,0.0729742994181671,0.00305791451670904,0.0669807869654174,0.0789678118709168,2.77104510478373e-123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTSS1,Protein MTSS 1,40449,0.265615768184826,0.0111299713365587,0.243801024365171,0.287430512004481,7.7408017184048e-123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATRN,"Attractin, Isoform 2",40539,0.0398882716362675,0.00167178212217524,0.036611578676804,0.0431649645957309,8.25387993319966e-123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KDR,Vascular endothelial growth factor receptor 2,42679,0.0588374226711427,0.00247213368374112,0.0539920406510101,0.0636828046912753,1.10475883375218e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.0892076477410169,0.00375641984955726,-0.0965702306461492,-0.0818450648358847,3.628672089949e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP4,Metalloproteinase inhibitor 4,42611,-0.0981970303220183,0.00413939082905453,-0.106310236346965,-0.0900838242970714,6.70343635160746e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDHR5,Cadherin-related family member 5,42636,0.0919207271917788,0.00387753148713283,0.0843207654769985,0.0995206889065591,9.68384029194248e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CKB,Creatine kinase B-type,40527,-0.143070006035828,0.0060265065464226,-0.154881958866816,-0.13125805320484,1.25677072373363e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYAP1,Synapse-associated protein 1,40283,0.134756345390931,0.00570201389932795,0.123580398148249,0.145932292633614,1.62868025243756e-120
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F10,Coagulation factor X,40532,0.0667413239808438,0.00283079355160966,0.0611929686196889,0.0722896793419988,5.00103022982835e-120
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLA,Alpha-galactosidase A,40267,0.0873549761221283,0.00371315189355623,0.080077198410758,0.0946327538334985,1.83644631477075e-119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL16,C-C motif chemokine 16,42794,0.122691504501593,0.00523051426383888,0.112439696544468,0.132943312458717,2.5902792032324e-119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRP,Gastrin-releasing peptide,40223,0.131291439205702,0.00560059396186612,0.120314275040444,0.142268603370959,1.22165477377857e-118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA1,Ephrin type-A receptor 1,42658,0.076832800533838,0.00330581974350164,0.0703533938365748,0.0833122072311013,3.44864755721128e-117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL2,Angiopoietin-related protein 2,42640,0.0932686312142887,0.0040198382644829,0.0853897482159022,0.101147514212675,8.41907347680429e-117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,0.157027382060446,0.00679977566559666,0.143699821755877,0.170354942365016,1.07271116179976e-115
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROS1,Vitamin K-dependent protein S,40539,0.060382565974812,0.00261183451880888,0.0552633703179466,0.0655017616316774,1.37139784231252e-115
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,0.0445855085646128,0.00193510766438468,0.0407926975424188,0.0483783195868068,2.95925026877495e-115
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAP29,Synaptosomal-associated protein 29,42679,0.209433741218343,0.0091268480721844,0.191545118996862,0.227322363439825,2.41330866655794e-114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.0729899078380189,0.00318157323784767,0.0667540242918375,0.0792257913842003,2.7183502536661e-114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YES1,Tyrosine-protein kinase Yes,42587,0.258702168265602,0.0113317811544186,0.236491877202942,0.280912459328263,3.3157558385332e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TJAP1,Tight junction-associated protein 1,42679,0.187942962489456,0.00823933193177655,0.171793871903174,0.204092053075738,4.90934850284051e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,0.220302711488406,0.00965937690133398,0.201370332761792,0.239235090215021,5.4450104007672e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAA80,N-alpha-acetyltransferase 80,40182,0.275203661739735,0.0120441435930712,0.251597140297315,0.298810183182154,6.1673365058182e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTYMK,Thymidylate kinase,40511,0.154527227739958,0.00678668243759147,0.141225330162279,0.167829125317637,3.01320689121612e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOMO1,Nodal modulator 1,42611,0.0524053247530972,0.00232085152918612,0.0478564557558924,0.0569541937503019,7.78591495589585e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL4A1,Collagen alpha-1(IV) chain,42636,-0.0904523421544391,0.00400654194175468,-0.0983051643602783,-0.0825995199485999,8.4318835659877e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORT1,Sortilin,42613,0.0833483232657578,0.00370247602504371,0.0760914702566722,0.0906051762748435,3.47100305292034e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EEF1D,Elongation factor 1-delta,40511,0.205816602683059,0.00913181768553675,0.187918240019407,0.223714965346711,4.52126254994906e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SARG,Specifically androgen-regulated gene protein,40456,0.243808914871459,0.0108547448589598,0.222533614947897,0.26508421479502,2.46336916098578e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FYB1,FYN-binding protein 1,42590,0.206195724504757,0.00920775556240775,0.188148523602438,0.224242925407076,4.4992702239092e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UPB1,Beta-ureidopropionase,40511,0.201152078597878,0.0089924843522729,0.183526809267423,0.218777347928333,1.74066061675777e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACY1,Aminoacylase-1,42636,0.134868472208872,0.00606204972693121,0.122986854744087,0.146750089673657,1.02596240271324e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,0.127164244198294,0.0057182743834508,0.11595642640673,0.138372061989857,3.26446733129775e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINF2,Alpha-2-antiplasmin,40317,0.029969231471,0.00135515652276933,0.0273131246863721,0.0326253382556279,4.30248760220449e-106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,0.0880059871186352,0.00399295663724135,0.0801797921096422,0.0958321821276283,8.88818491239016e-106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYH9,Myosin-9,40527,0.252672191263262,0.0114577847494355,0.230214933154368,0.275129449372155,1.47457006967727e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SKAP1,Src kinase-associated phosphoprotein 1,42476,0.162389743899623,0.0074036601075948,0.147878570088738,0.176900917710509,8.87670386670913e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABL1,Tyrosine-protein kinase ABL1,42587,0.146768417400299,0.00669358462734262,0.133648991530708,0.159887843269891,9.94398684527212e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTA1,Glutathione S-transferase A1,42611,0.180817627662174,0.00826175094983246,0.164624595800503,0.197010659523846,2.33443088840754e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELPLG,P-selectin glycoprotein ligand 1,42594,0.0604671652260535,0.00276340319428052,0.0550508949652637,0.0658834354868434,2.59223315683366e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,0.194723595915816,0.00893223177814239,0.177216421630657,0.212230770200975,1.49849440812759e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,0.21129911934698,0.00971267010142257,0.192262285948192,0.230335952745768,3.74759442210503e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BPIFB1,BPI fold-containing family B member 1,42573,-0.136558790270902,0.00627713646850891,-0.148861977749179,-0.124255602792624,3.76715570050111e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP1G2,AP-1 complex subunit gamma-like 2,40451,0.171587053806546,0.00790544654827965,0.156092378571918,0.187081729041174,2.27637120861131e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GH1,Somatotropin,42613,-0.373201908276296,0.017236173798431,-0.40698480892122,-0.339419007631371,3.22115111919587e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,0.0945195609271005,0.0043738227219885,0.0859468683920031,0.103092253462198,7.81678729089969e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,0.146708209271878,0.00679144692381989,0.133396973301191,0.160019445242565,2.24079742179608e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42594,0.228213832450145,0.0106097195831084,0.207418782067252,0.249008882833037,6.34867050147327e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MLN,Promotilin,42594,0.191651900900808,0.00892380040966151,0.174161252097871,0.209142549703744,1.27251057860681e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KYNU,Kynureninase,42754,0.0958599179955415,0.00446530258437512,0.0871079249301663,0.104611911060917,1.45975086676727e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCN2,Ficolin-2,42597,0.0885661176800432,0.00412680158044779,0.0804775865823656,0.0966546487777209,1.74740171346081e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HJV,Hemojuvelin,40482,0.0949824914983722,0.00442194452673957,0.0863154802259626,0.103649502770782,2.41682384949028e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,0.240047678948847,0.0111915253170743,0.218112289327382,0.261983068570313,4.90442212950937e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CES3,Carboxylesterase 3,42587,0.151301303560404,0.0070729013194849,0.137438416974214,0.165164190146595,7.41959476693049e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AXIN1,Axin-1,42594,0.202512994275801,0.00949828598696135,0.183896353741357,0.221129634810245,3.19837024487465e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MASP1,Mannan-binding lectin serine protease 1,42476,0.0501271377045681,0.00236116356121784,0.0454992571245811,0.054755018284555,2.16538779272594e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,0.0850202690411586,0.00400356085994177,0.0771732897556728,0.0928672483266445,3.63037328108309e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXLNA,Alpha-taxilin,42495,0.186686594776559,0.00881223194270597,0.169414620168855,0.203958569384263,5.42271084689919e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42733,0.0666398472834313,0.00316624359529425,0.0604340098366546,0.072845684730208,8.59086704355869e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTD,Biotinidase,40539,0.0435213422610848,0.00206518659525804,0.0394735765343791,0.0475691079877905,9.74933218549876e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPK9,Mitogen-activated protein kinase 9,42594,0.0891122504571139,0.00423848078847828,0.0808048281116965,0.0974196728025313,1.40699461938049e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFR2,Fibroblast growth factor receptor 2,42679,0.0471358008697475,0.00225009018780192,0.0427256241016558,0.0515459776378393,6.49344992017139e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,0.0452547816717181,0.00216726472036323,0.0410069428198062,0.0495026205236301,5.28853506796126e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,0.116128799795381,0.00557375392342548,0.105204242105467,0.127053357485295,7.04251869504812e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F11R,Junctional adhesion molecule A,42611,0.116174506923013,0.00557956989818072,0.105238549922579,0.127110463923448,8.67354461286288e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42721,0.168362128906961,0.00814393912302392,0.152400008225834,0.184324249588088,1.66960613660994e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,0.201838093675127,0.00975170760819655,0.182724746763062,0.220951440587192,1.94969721037031e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTSS2,Protein MTSS 2,40451,0.204398465954723,0.00987781580144874,0.185037946983883,0.223758984925562,2.17946305471754e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,0.0629889662613087,0.00304665013339103,0.0570175319998623,0.0689604005227552,3.11521777233138e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,0.110896193511557,0.00537420333819158,0.100362754968702,0.121429632054413,3.81152525245866e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,0.17212369663782,0.00833591577884697,0.15578530171128,0.188462091564361,5.58723069337264e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,0.166717611388204,0.00807599833337302,0.150888654654793,0.182546568121615,5.77771054916165e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KAZN,Kazrin,40449,0.215592993688338,0.0104450400439792,0.195120715202139,0.236065272174538,6.15350939686612e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.0488891274191363,0.00237273337948893,0.044238569995338,0.0535396848429346,6.69452675524134e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BECN1,Beclin-1,40223,0.1238232464845,0.00600701237500946,0.112049502229482,0.135596990739519,1.15327131081849e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOS3,"Nitric oxide synthase, endothelial",42311,0.11330539596978,0.00551599284776419,0.102494049988162,0.124116741951397,2.59535800468413e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL16,Pro-interleukin-16,42754,0.0851035281660335,0.00415526235768922,0.0769592139449627,0.0932478423871044,7.76996391681472e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD2AP,CD2-associated protein,42636,0.130644377236434,0.00639270330685681,0.118114678754995,0.143174075717874,1.93203845451112e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PON3,Serum paraoxonase/lactonase 3,42676,-0.0584672614990613,0.00286362706866873,-0.064079970553652,-0.0528545524444706,2.80717716783375e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAMDC4,Apical endosomal glycoprotein,40451,0.112389213456095,0.00552070000782045,0.101568641440767,0.123209785471423,1.66995363564419e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARF6,ADP-ribosylation factor 6,40449,0.218650691853536,0.0107456033339736,0.197589309318947,0.239712074388124,2.02891154025097e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,0.211514995734222,0.0104113482875591,0.191108753090606,0.231921238377838,2.13068128148682e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAB2,Stabilin-2,40527,0.0573012050642615,0.0028183914821702,0.0517771577592079,0.0628252523693151,2.75067477745997e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF8,Immunoglobulin superfamily member 8,42636,0.0625274094234753,0.00308480680043924,0.0564811880946144,0.0685736307523362,5.26692878564778e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLUL1,Clusterin-like protein 1,42621,-0.0915455523573818,0.00451863764772643,-0.100402082146926,-0.082689022567838,6.42687103067845e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YTHDF3,YTH domain-containing family protein 3,42370,0.17271978933394,0.00853452795964689,0.155992114533032,0.189447464134848,1.04530391086532e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A4,Protein S100-A4,42679,0.115801468055792,0.00572562858882518,0.104579236021694,0.127023700089889,1.24988493939517e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IKBKG,NF-kappa-B essential modulator,42594,0.184504260623196,0.00914367727358363,0.166582653166972,0.20242586807942,3.19353019636747e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,0.170393489603428,0.00843726778744303,0.15385644474004,0.186930534466817,4.34394613195265e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTN1,Dynactin subunit 1,42721,0.130989708541507,0.00649977647243851,0.118250146655527,0.143729270427486,5.11058510041046e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL13,C-X-C motif chemokine 13,42711,0.127131163010409,0.00631005390873204,0.114763457349294,0.139498868671523,5.71160189291371e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FN1,Fibronectin,40539,0.0539866700311583,0.00267691990777334,0.0487399070119225,0.059233433050394,6.7712413159584e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,0.145807676293832,0.0072439255469776,0.131609582221756,0.160005770365908,9.01392274484167e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP3S2,AP-3 complex subunit sigma-2,40483,0.096182292972915,0.00477771988647362,0.0868179619954267,0.105546623950403,1.39105409474171e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP85,Centrosomal protein of 85 kDa,42346,0.129210489856275,0.00643501118450306,0.116597867934649,0.141823111777901,2.34837663156512e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EHBP1,EH domain-binding protein 1,40511,0.149576180965853,0.00744801182753489,0.134978077783885,0.164174284147822,3.55954739608393e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.232269779419193,0.0116321398124537,-0.255068773451602,-0.209470785386784,1.92984730226407e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFC,Platelet-derived growth factor C,42346,0.0572529808734772,0.00287573779264893,0.0516165347998853,0.0628894269470691,6.45197978819276e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,0.131979376694998,0.00663936314491065,0.118966224930973,0.144992528459023,1.16796893507331e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TARBP2,RISC-loading complex subunit TARBP2,42311,0.155714550213812,0.0078578292825626,0.14031320481999,0.171115895607635,3.88607099518023e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP5,Retinol-binding protein 5,42587,0.111012054618322,0.00561508971519276,0.100006478776544,0.122017630460099,8.92721879375056e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPB2,Carboxypeptidase B2,40516,0.0441148735742922,0.00223187240113361,0.0397404036680703,0.0484893434805141,1.60738657796862e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPY30,Protein dpy-30 homolog,42651,0.119622699659812,0.00606825294727362,0.107728923883156,0.131516475436469,2.65956350391448e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEG1,Protein HEG homolog 1,40283,0.0534147997995449,0.00270799371271355,0.0481071321226264,0.0587224674764635,3.76826319143448e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFX1,Transcriptional repressor NF-X1,40116,0.134796659283561,0.00683406794094663,0.121401886119305,0.148191432447816,4.01056129817645e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,40462,0.169552592304449,0.00859894446646511,0.152698661150177,0.186406523458721,4.09097016791662e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,0.212125877021214,0.0107699180499739,0.191016837643265,0.233234916399162,6.15406255468257e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0503785879150753,0.00257455513544449,0.0453324598496041,0.0554247159805465,4.1829879798515e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R9B,Neurabin-2,42754,0.183982122355623,0.00941707807552405,0.165524649327596,0.20243959538365,7.52657880336914e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTN4R,Reticulon-4 receptor,42721,0.067748076268645,0.00347128667258672,0.060944354390375,0.074551798146915,1.1162803319244e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDLIM7,PDZ and LIM domain protein 7,42676,0.242375874377961,0.0124236266076517,0.218025566226964,0.266726182528959,1.29711511159633e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,0.0951795037414684,0.00488480370731506,0.0856052884751309,0.104753719007806,2.16096699716535e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCS1,Neuronal calcium sensor 1,42721,0.0567104705974075,0.00291583202017723,0.0509954398378601,0.0624255013569549,4.02886826568003e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,0.0577087776125115,0.00297005125680649,0.0518874771491707,0.0635300780758522,9.4790960396599e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YOD1,Ubiquitin thioesterase OTU1,40116,0.123996351633082,0.00638113106262381,0.111489334750339,0.136503368515824,1.02831912010311e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,40223,0.141140199306651,0.00727023863878634,0.12689053157463,0.155389867038672,1.40786578161575e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXNA4,Plexin-A4,42594,0.159486762161105,0.00825053058271517,0.143315722218984,0.175657802103227,3.89345295876755e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD63,CD63 antigen,42475,0.0995336664388192,0.00514902286774725,0.0894415816180346,0.109625751259604,3.97444206080684e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM20A,Pseudokinase FAM20A,40511,0.0549419605388418,0.0028434741178734,0.04936875126781,0.0605151698098737,7.23753411600759e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OXT,Oxytocin-neurophysin 1,42711,0.268918580386548,0.0139471368810662,0.241582192099659,0.296254968673438,9.6260048802822e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATG16L1,Autophagy-related protein 16-1,40449,0.163702874675387,0.00848132873599047,0.147079470352846,0.180326278997929,1.08160830724123e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAS6,Growth arrest-specific protein 6,42718,-0.0492598971448594,0.0025568421297776,-0.0542713077192234,-0.0442484865704953,1.2834377408664e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBIN,Erbin,42587,0.197359233583631,0.0102461461842021,0.177276787062595,0.217441680104667,1.42043562823711e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNIP1,TNFAIP3-interacting protein 1,40483,0.171581075797233,0.00891464395756317,0.154108373640409,0.189053777954057,2.96951677484644e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,0.142521124135597,0.00740397267355513,0.128009337695429,0.157032910575765,3.14588435219648e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCR,Breakpoint cluster region protein,42594,0.176039448808,0.00917064724420142,0.158064980209365,0.194013917406634,4.8787640779347e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,40451,0.217903697903619,0.0114100754225861,0.195539950075351,0.240267445731888,4.85276991546909e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORD,Sorbitol dehydrogenase,42658,0.128416132723144,0.0067351366191438,0.115215264949622,0.141617000496665,5.4016858117599e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,0.0641869227143136,0.00338082224532931,0.0575605111134681,0.070813334315159,2.46317553327809e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,0.20799512415169,0.0109451161239929,0.186542696548664,0.229447551754716,2.79419880279152e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,40511,0.127802122296781,0.00674315379477563,0.114585540859021,0.141018703734541,6.92515896971261e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42580,0.0391046615724721,0.00206714005698388,0.0350530670607837,0.0431562560841605,8.73262751867444e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPPC,C-type natriuretic peptide,42594,0.0957136466105149,0.00506358389688902,0.0857890221726125,0.105638271048417,1.1476454978737e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADH1B,All-trans-retinol dehydrogenase,40283,0.141434459160655,0.00747502880181312,0.126783402709101,0.156085515612208,1.31878169730246e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAXX,Protein PAXX,40283,0.0862304518348638,0.0045661884312337,0.0772807225096458,0.0951801811600819,2.57160833018223e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42674,0.138087847971287,0.00732652338182876,0.123727862142903,0.152447833799672,3.10329346773104e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CREG1,Protein CREG1,42445,0.0732022855109311,0.00388880057174672,0.0655802363903076,0.0808243346315547,4.99982610885102e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,0.195100427068185,0.0103695123876459,0.174776182788399,0.215424671347971,5.69610244219362e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLA2,Src-like-adapter 2,40482,0.196273912495077,0.010435893946011,0.175819560360896,0.216728264629259,1.00362143374022e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAB2,Disabled homolog 2,42721,0.205849282910822,0.0109876850610847,0.184313420191096,0.227385145630548,2.45801919643018e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,42346,0.0936163392296787,0.00499686778258648,0.0838224783758092,0.103410200083548,2.59612370567438e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42495,0.108660483546381,0.00580047185137493,0.0972915587176858,0.120029408375076,2.6233616615844e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAP23,Synaptosomal-associated protein 23,42636,0.163153033462534,0.00871955341784922,0.14606270876355,0.180243358161519,3.82329259253034e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB11FIP3,Rab11 family-interacting protein 3,40511,0.200910162053771,0.0107292996293661,0.179880734780214,0.221939589327329,4.46881161834419e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC1B,C-type lectin domain family 1 member B,42711,0.179436982852858,0.00959571627445774,0.160629378954921,0.198244586750795,4.65799709321097e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL17,C-X-C motif chemokine 17,42754,0.0765866342332067,0.00409639391376533,0.0685577021622266,0.0846155663041867,4.93899898042414e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPY,Pancreatic prohormone,42600,0.195491972527268,0.0104566552509142,0.174996928235476,0.21598701681906,5.12544781662951e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP20,Centrosomal protein 20,42346,0.140668723334248,0.00753942606691816,0.125891448243088,0.155445998425407,1.06441381247651e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOST,Sclerostin,42613,0.0732219345721651,0.00392959369246708,0.0655199309349296,0.0809239382094005,1.58498295529329e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,0.127825843649976,0.00686579597956496,0.114368883530029,0.141282803769924,2.19532047940721e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL22,C-C motif chemokine 22,42509,0.0995889136933598,0.00535046327668837,0.0891020056710506,0.110075821715669,2.33395375827479e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18R1,Interleukin-18 receptor 1,42754,0.0618817923976359,0.00332939505862194,0.0553561780827369,0.0684074067125349,3.642091464372e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ISM1,Isthmin-1,42594,0.0721841191613629,0.00388480122586773,0.0645699087586621,0.0797983295640636,4.11669828463438e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KHK,Ketohexokinase,40223,0.117416879441817,0.00631448583983163,0.105040487195747,0.129793271687887,5.10850898448895e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDHR2,Cadherin-related family member 2,42587,0.132091192953778,0.00711645367315527,0.118142943754393,0.146039442153162,5.90252227898023e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,0.138904287748431,0.00748865055525685,0.124226532660127,0.153582042836734,1.17677566409231e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAT5B,Signal transducer and activator of transcription 5B,42587,0.254660714176235,0.0137771481972264,0.227657503709671,0.281663924642798,2.38496287240514e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,0.12871823313074,0.00695822870197141,0.115080104874876,0.142356361386604,2.72743189828742e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,0.0545974946482054,0.00295696775381826,0.0488018378507216,0.0603931514456892,5.12959170998924e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TANK,TRAF family member-associated NF-kappa-B activator,42370,0.128854468953353,0.00699586810663955,0.115142567464339,0.142566370442366,8.06875955578854e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAK4,Serine/threonine-protein kinase PAK 4,42311,0.112781207079478,0.00612784300443041,0.100770634790795,0.124791779368162,1.04691875735466e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,40223,0.189741025561727,0.0103017581682521,0.169549579551953,0.209932471571501,1.22566966062086e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BACH1,Transcription regulator protein BACH1,42594,0.135181867825114,0.00736115239171448,0.120754009137353,0.149609726512874,2.07326682282179e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASAH2,Neutral ceramidase,42495,0.0993574634154585,0.00541324225466664,0.0887475085963119,0.109967418234605,2.50628329744456e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42594,0.205336591462997,0.0111967286855527,0.183391003239314,0.22728217968668,3.26218272508693e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTBS,Di-N-acetylchitobiase,40383,0.0494848833960288,0.002698497020654,0.0441958292355469,0.0547739375565106,4.9802031691655e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCK2,Cytoplasmic protein NCK2,42676,0.192732863299233,0.0105300753941152,0.172093915526767,0.213371811071699,6.13173456075264e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKK1,Dickkopf-related protein 1,42711,0.108272578416896,0.00591929815148443,0.0966707540399864,0.119874402793805,7.51191869253704e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.0403474067512778,0.00221005864018647,0.0360156918165123,0.0446791216860433,1.46682628006757e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42585,0.100137038456886,0.00548932789366871,0.0893779557852949,0.110896121128476,1.84888921032402e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,0.0678362063303775,0.00372594797687129,0.0605333482957098,0.0751390643650452,3.44684898872131e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCLY,Selenocysteine lyase,42674,0.0858701595072126,0.00471702570878209,0.0766247891179997,0.0951155298964254,3.58264937491256e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOK2,Docking protein 2,42636,0.220473125631538,0.0121112837055762,0.196735009568608,0.244211241694467,3.62586479118252e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CMIP,C-Maf-inducing protein,40451,0.151776998554325,0.00833164812795384,0.135446968223536,0.168107028885115,4.23202089393297e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,0.153368739478188,0.00841986176491117,0.136865810418962,0.169871668537414,4.34186777082181e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOXO1,Forkhead box protein O1,42594,0.155598461111962,0.00855221081153892,0.138836127921346,0.172360794302578,4.35976574488048e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPD52L2,Tumor protein D54,40283,0.196159299534901,0.0107678067052112,0.175054398392687,0.217264200677115,4.36496672148381e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STC1,Stanniocalcin-1,42711,0.0830171652437356,0.00456411178680378,0.0740715061416002,0.0919628243458711,4.67009856883291e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEFTY2,Left-right determination factor 2,42689,0.0912765745524463,0.00504798161488756,0.0813825305872667,0.101170618517626,3.1505121631163e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,0.19815427764803,0.0109472033108099,0.176697759158843,0.219610796137218,3.29862734901912e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OTUD7B,OTU domain-containing protein 7B,40482,0.11277396438826,0.00623537703962383,0.100552625390598,0.124995303385923,4.25023285558646e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MINK1,Misshapen-like kinase 1,40483,0.168655959949585,0.00933273820906092,0.150363793059826,0.186948126839344,5.50756720280057e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,0.173583837801039,0.00963247481902609,0.154704187155748,0.19246348844633,9.29342432158134e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,0.177921348530296,0.00987960474687126,0.158557323226429,0.197285373834164,1.13120349135888e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUGP1,SURP and G-patch domain-containing protein 1,40449,0.0722744255347668,0.00402496742912521,0.0643854893736814,0.0801633616958522,4.17275196097995e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMBP,Protein AMBP,42706,0.0379422988180321,0.00211620085045044,0.0337945451511492,0.0420900524849149,4.61692467418159e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FETUB,Fetuin-B,42663,0.0580111109283415,0.00324713405544094,0.0516467281796773,0.0643754936770057,1.42960680952385e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.0484848599567079,0.00273581167797461,0.0431226690678777,0.0538470508455381,1.75078453611828e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCBP2,Poly(rC)-binding protein 2,40482,0.128690082180667,0.00725462203652208,0.114471022989084,0.14290914137225,1.82867815513911e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AAMDC,Mth938 domain-containing protein,40223,0.0949631186663296,0.00535709766901598,0.0844632072350583,0.105463030097601,2.38415548378154e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM5,Tripartite motif-containing protein 5,42594,0.151786015383624,0.00860562717195187,0.134918986126598,0.168653044640649,7.53471465215454e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RLN2,Prorelaxin H2,40257,0.0886094178650578,0.00503090095852317,0.0787488519863524,0.0984699837437632,1.67770076586498e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,0.0981569710057934,0.00558078944664979,0.0872186236903598,0.109095318321227,1.85879458504857e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIT1,ARF GTPase-activating protein GIT1,40199,0.17168278262266,0.00975364962974319,0.152565629348364,0.190799935896957,2.05392320665697e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL5,C-X-C motif chemokine 5,42605,0.200776683423838,0.0114284801928102,0.17837686224593,0.223176504601746,2.51415470928599e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRPK2,SRSF protein kinase 2,42594,0.147640461361324,0.00841000310628757,0.131156855273,0.164124067449648,3.13653164737649e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,0.114228003476982,0.0065113338217837,0.101465789186286,0.126990217767678,4.01033582714239e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,0.181644733733062,0.0103463517065017,0.161365884388319,0.201923583077805,4.27887246068214e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,0.159023956240731,0.00906020263245634,0.141265959081116,0.176781953400345,4.5923136174114e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.0355062805093454,0.00202539879232366,0.031536498876391,0.0394760621422998,4.81213320081231e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD6,T-cell differentiation antigen CD6,42746,0.093353307770578,0.00533189757660665,0.082902788520429,0.103803827020727,6.88945598031117e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,0.135207501702987,0.00772648704353897,0.120063587097651,0.150351416308324,8.23743869735287e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,0.196472684801741,0.0112290724697355,0.17446370276106,0.218481666842423,8.71234515036921e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RABEP1,Rab GTPase-binding effector protein 1,40283,0.137039344878124,0.00786012859815646,0.121633492825738,0.152445196930511,3.52470507591045e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OPHN1,Oligophrenin-1,40483,0.187742916597664,0.0107698692729425,0.166633972822697,0.208851860372631,3.54904929814513e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,0.162536183487453,0.00934172319582231,0.144226406023641,0.180845960951264,4.71904673070552e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHACTR2,Phosphatase and actin regulator 2,40482,0.198670532035129,0.0114235767141829,0.176280321675331,0.221060742394928,7.12599859145976e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F13B,Coagulation factor XIII B chain,40479,0.045412997423527,0.00261571463682804,0.040286196735344,0.0505397981117099,1.17993715465547e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH2B3,SH2B adapter protein 3,42346,0.17040426129758,0.00982618825708692,0.15114493231369,0.189663590281471,1.25018777758435e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLIN1,Perilipin-1,42311,0.0612302858165979,0.00353230244978282,0.0543069730150235,0.0681535986181722,1.42576359255027e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,0.119899885566981,0.00691522219721413,0.106346050060441,0.13345372107352,1.82497448687772e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOP2B,DNA topoisomerase 2-beta,40199,0.13895593164046,0.00802159065824637,0.123233613950297,0.154678249330623,2.39504402482662e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PYY,Peptide YY,40116,0.179372125278458,0.0103588033067875,0.159068870797155,0.199675379759762,2.72912300521197e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCAM,Cell surface glycoprotein MUC18,42689,-0.0586780332108277,0.00339943000831031,-0.0653409160271159,-0.0520151503945395,4.71718873652646e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USO1,General vesicular transport factor p115,42587,0.156118501029389,0.00906699894940859,0.138347183088549,0.17388981897023,9.85529789012741e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMOT,Angiomotin,40283,0.0673128109568944,0.00390676627915703,0.0596555490497466,0.0749700728640422,1.13258718105665e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGCC,Regulator of cell cycle RGCC,40482,0.13077328294343,0.00760144805316425,0.115874444759228,0.145672121127632,1.69767924835288e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA3F,Semaphorin-3F,42636,0.0471145492120823,0.00274243690162187,0.0417393728849034,0.0524897255392611,1.87727523172315e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFC,Vascular endothelial growth factor C,42679,0.0963227609213256,0.0056076200129024,0.0853318256960369,0.107313696146614,1.9545704033738e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP43,Centrosomal protein 43,42255,0.119615832966373,0.00697340816590094,0.105947952961207,0.133283712971539,3.08120717962074e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUCB2,Nucleobindin-2,42683,0.0639607377384058,0.00373317786763336,0.0566437091178444,0.0712777663589672,4.10420614896883e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEXIM1,Protein HEXIM1,42594,0.139405731351003,0.00814041865856687,0.123450510780212,0.155360951921794,4.7381751600072e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,0.123360989145047,0.00719904127349821,0.109250868248991,0.137471110041104,5.34259804879824e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB6,DnaJ homolog subfamily B member 6,40183,0.144200837240323,0.00842680240595545,0.12768430452465,0.160717369955996,8.29672586209364e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL10,C-X-C motif chemokine 10,42676,0.11668435928621,0.00683536993842225,0.103287034206903,0.130081684365518,1.17113842036224e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,0.163306456973535,0.00957773072969214,0.144534104743339,0.182078809203732,1.67279081825766e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINH1,Serpin H1,40302,0.221874828864756,0.0130031038890008,0.196388745242315,0.247360912487198,1.841651085607e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GHRL,Appetite-regulating hormone,42636,0.146050819207038,0.00859088681458725,0.129212681050447,0.162888957363629,3.79586059527221e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLSCR3,Phospholipid scramblase 3,40457,0.0995428054396523,0.00584974232288919,0.0880773104867895,0.111008300392515,3.90391907079542e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELP,P-selectin,42689,0.096056878393076,0.00565199237986321,0.0849789733285441,0.107134783457608,4.13236890310043e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GASK1A,Golgi-associated kinase 1A,40116,0.0744267941089607,0.00437498971604882,0.065851814265505,0.0830017739524164,4.46945411467669e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,40451,0.0890025600445522,0.00523803894441022,0.0787360037135082,0.0992691163755962,5.92618432758276e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRAP,BRCA1-associated protein,40342,0.186598828523836,0.0109854264134527,0.165067392753469,0.208130264294204,6.61381522710458e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,0.180192172009574,0.0106105619986803,0.15939547049216,0.200988873526987,7.07853475606576e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNMBP,Dynamin-binding protein,42495,0.102842149473423,0.00606545221175946,0.090953863138374,0.114730435808471,8.20661083160355e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MVK,Mevalonate kinase,42370,0.136857371838299,0.00808399395544736,0.121012743685622,0.152701999990976,1.28261993836774e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,0.0871133125318667,0.00517873664442764,0.0769629887087885,0.0972636363549449,7.74570575928496e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP45,Rho GTPase-activating protein 45,40283,0.139537316462653,0.00829221979185066,0.123284565670626,0.155790067254681,9.19158154992276e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP3B1,AP-3 complex subunit beta-1,40449,0.129704591652619,0.00771170021187318,0.114589659237348,0.144819524067891,1.02682794819356e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.0561184592838101,0.00334254356946092,0.0495670738876667,0.0626698446799535,1.26567478838899e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELN,Elastin,40511,0.0622661622921597,0.00370680341620992,0.0550008275963882,0.0695314969879311,1.4462783280189e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,42346,0.106516329355401,0.00634950766597229,0.0940712943300952,0.118961364380707,1.6433610703609e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKT1S1,Proline-rich AKT1 substrate 1,42311,0.112898187079121,0.00673306740780209,0.0997013749598285,0.126094999198413,1.87629690398272e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,0.15954157825601,0.00953112150190357,0.140860580112279,0.178222576399741,2.99422087505588e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42587,0.14247156838424,0.00852689658410173,0.1257588510794,0.159184285689079,4.82306959239708e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNST,Consortin,42636,0.182656675171932,0.0109482567722796,0.161198091898264,0.2041152584456,7.21586794157812e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AZI2,5-azacytidine-induced protein 2,40482,0.0927977653602522,0.00555676154734399,0.081906512727458,0.103689017993046,7.22763476445217e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1S,Complement C1s subcomponent,40539,0.0350825374973763,0.00210242965036046,0.0309617753826698,0.0392032996120828,8.90916935495075e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42754,0.09247680673605,0.00555807147325992,0.0815829866484605,0.103370626823639,1.49828146039886e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.0794687260256235,0.00477678907988903,-0.088831232622206,-0.0701062194290411,1.5513622384675e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSNK2A1,Casein kinase II subunit alpha,40482,-0.0754454581600107,0.00453441295440524,-0.084332907550645,-0.0665580087693764,1.97450723967202e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PON2,Serum paraoxonase/arylesterase 2,42357,0.0588449017951622,0.00354328836521174,0.0519000565993472,0.0657897469909773,2.58669615555502e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAT,Linker for activation of T-cells family member 1,42754,0.126258075866454,0.00760587890879802,0.11135055320521,0.141165598527699,2.79873218589814e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42676,0.174498326177729,0.0105143873377815,0.153890126995678,0.195106525359781,3.00728063041503e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,0.13328627146429,0.00802677595788048,0.117553790586845,0.149018752341736,3.39092711662931e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,0.0830978272600351,0.00501001819257289,0.0732781916025922,0.092917462917478,4.74602137083284e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EZR,Ezrin,42711,0.0399765811825391,0.00241486449473125,0.0352434467728658,0.0447097155922123,5.92072887105032e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,METAP2,Methionine aminopeptidase 2,42689,0.0951993084169451,0.00575806861146556,0.0839134939384726,0.106485122895418,8.37550920941959e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCTN3,Tectonic-3,40511,0.0501523199246673,0.00303099182718543,0.0442115759433839,0.0560930639059508,8.76088510872325e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYTL4,Synaptotagmin-like protein 4,40511,0.123163731140471,0.00744407867072942,0.108573336945841,0.1377541253351,8.94892366026407e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,0.123922252220015,0.00749612429227351,0.109229848607159,0.138614655832871,1.1170991470149e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MITD1,MIT domain-containing protein 1,42495,0.159888368170416,0.00968223074936504,0.140911195901661,0.178865540439172,1.17497017743792e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEP,Leptin,42636,0.110701267418414,0.00670968316348492,0.097550288417984,0.123852246418845,1.47414151918311e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,0.174943781439458,0.0106085587225291,0.154151006343301,0.195736556535614,1.68742131122889e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM13A,Protein FAM13A,40449,0.111962188527826,0.00679342751402667,0.0986470706003336,0.125277306455318,2.55303092908611e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRAF2,TNF receptor-associated factor 2,42594,0.1153589282895,0.00701952489062639,0.101600659503872,0.129117197075127,4.22396954015559e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,0.0925268633323551,0.00564247941047524,0.0814676036878237,0.103586122976887,7.69531090146368e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAMBP,STAM-binding protein,42476,0.104881340277385,0.00639617599485502,0.0923448353274688,0.1174178452273,7.70657994747181e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRELD2,Protein disulfide isomerase CRELD2,42654,0.0858680882545658,0.00523929301855732,0.0755990739381934,0.0961371025709381,8.65038369801645e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,0.149515502196667,0.00911533821738253,0.131649439290597,0.167381565102737,9.02107932872136e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGRN,Agrin,42676,0.0603005606966927,0.00367995242584541,0.0530878539420357,0.0675132674513497,9.06224334785215e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,0.103780038968218,0.00633425840213795,0.0913648925000277,0.116195185436408,9.719863533169e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,0.177624624276137,0.0108605304955068,0.156337984504944,0.19891126404733,1.92751977450518e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,0.128442801229593,0.00785603575175068,0.113044971156162,0.143840631303024,2.09656739048442e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,0.116922119833437,0.00715259811692856,0.102903027524257,0.130941212142617,2.26210244745088e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42746,0.0628107087710691,0.00384918464108144,0.0552663068745495,0.0703551106675887,2.7025285461472e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSD,Cathepsin D,41747,0.0696706411415423,0.00426819736774397,0.0613049743007641,0.0780363079823205,2.75016047925289e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD5,Programmed cell death protein 5,42711,0.0948818429819051,0.00581952260213522,0.0834755786817201,0.10628810728209,3.38767667354564e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBCC,Tubulin-specific chaperone C,42495,0.132131635573575,0.00811156725932593,0.116232963745296,0.148030307401854,4.38377545358624e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,0.165217268852276,0.0101479581339333,0.145327270909767,0.185107266794785,4.97143746068972e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,0.0548981957001067,0.00337180841881987,0.0482894511992198,0.0615069402009937,6.66070025790786e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BID,BH3-interacting domain death agonist,42594,0.110325033974495,0.00679333095988241,0.0970101052931254,0.123639962655864,9.52772497922483e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,0.10791153148706,0.00665609851322004,0.0948655784011484,0.120957484572971,1.88020386212734e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,0.188649368025695,0.0116520873394537,0.165811276840366,0.211487459211025,2.11857218364693e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC27,Cell division cycle protein 27 homolog,42346,0.0985489438896619,0.00609012981917642,0.0866122894440761,0.110485598335248,2.47962866727205e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEC31A,Protein transport protein Sec31A,40223,0.125277764717358,0.00774192378810031,0.110103594092682,0.140451935342035,3.17060783507963e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HGF,Hepatocyte growth factor,42754,0.0569412481012652,0.00352402651820305,0.0500341561255872,0.0638483400769432,3.48212027804044e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,0.126374055133083,0.00781818416398552,0.111050414171671,0.141697696094495,4.04956936606541e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GMPR,GMP reductase 1,42754,0.0805655688123154,0.00499402633569665,0.07077727719435,0.0903538604302809,5.23322471569218e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NHLRC3,NHL repeat-containing protein 3,40013,0.0526225140793953,0.0032581003456952,0.0462366374018327,0.0590083907569579,5.29010655753276e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,40199,0.144908087028924,0.00898423652897944,0.127298983432124,0.162517190625724,7.3175318509788e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMN,Protein amnionless,42370,0.0768838684371558,0.00477176333764927,0.0675312122953633,0.0862365245789484,7.46547259272633e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NIT2,Omega-amidase NIT2,40462,0.11884449449815,0.00737607014565432,0.104387397012668,0.133301591983633,9.24212312937091e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STK11,Serine/threonine-protein kinase STK11,42357,0.117681053911038,0.00732037806831323,0.103333112897144,0.132028994924932,1.33145990967826e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,0.124260121192827,0.00773043652587833,0.109108465602106,0.139411776783549,1.34052784812719e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRKL,Crk-like protein,42636,0.169785577592878,0.0105648547659202,0.149078462251674,0.190492692934081,1.4048986262859e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOC1,Apolipoprotein C-I,40516,0.0600179679486717,0.0037330171038429,0.0527012544251396,0.0673346814722038,1.58438728932441e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX15,Sorting nexin-15,40283,0.0879616922559705,0.00547296107777703,0.0772346885435275,0.0986886959684135,1.78265984186337e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDLIM5,PDZ and LIM domain protein 5,40482,0.189342263440201,0.01178871037835,0.166236391098635,0.212448135781767,2.05714473638146e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1R2,Interleukin-1 receptor type 2,42600,0.0323204365822772,0.0020151183230762,0.0283708046690479,0.0362700684955066,2.33102448953442e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CMC1,COX assembly mitochondrial protein homolog,40511,0.146589708252059,0.00913583185280179,0.128683477820567,0.16449593868355,2.62655269384507e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBNL,Drebrin-like protein,42676,0.148322720571666,0.00925313494993734,0.130186576069788,0.166458865073543,2.69084287867071e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,0.143687737924154,0.00897313384565015,0.12610039558668,0.161275080261628,4.41246025792077e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,0.102827684748502,0.00642420962743885,0.0902362338787215,0.115419135618282,4.89112833075673e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.0533792085866279,0.00333907866737731,0.0468346143985684,0.0599238027746875,5.36628763441301e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,0.100131154502498,0.00625900771784142,0.0878634993755285,0.112398809629467,5.84879828252253e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEP1A,Meprin A subunit alpha,40449,0.117119510115215,0.00733153224004874,0.10274970692472,0.131489313305711,8.05531669495245e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINE1,Plasminogen activator inhibitor 1,42794,0.106477983653643,0.00667777073761051,0.0933895530079265,0.11956641429936,1.00511244825719e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDHD2,Phospholipase DDHD2,40482,0.105593207549494,0.00662313907682221,0.0926118549589225,0.118574560140066,1.31800246471169e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42692,0.0391378854872578,0.00245804836212984,0.0343201106974833,0.0439556602770323,1.45043953163319e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYN,Tyrosine-protein kinase Lyn,42587,0.134628973120123,0.00847396058663116,0.118020010370326,0.15123793586992,2.53207929591177e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,0.0374862803490916,0.00236144048271849,0.0328578570029633,0.0421147036952198,3.09905230193745e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CES2,Cocaine esterase,42587,0.0880553487390727,0.00555170403798628,0.0771740088246196,0.0989366886535258,3.82754153505567e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42590,0.0807820330629992,0.00509454681027397,0.0707967213148623,0.0907673448111362,4.09827062073506e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,0.0744641376995365,0.00469302809116034,0.0652658026408622,0.0836624727582108,4.43750019640145e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOLGA3,Golgin subfamily A member 3,40482,0.125503544376789,0.00791603247881159,0.109988120718318,0.141018968035259,5.2659977620344e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN2,CCN family member 2,42624,0.088318922034178,0.00557654633411228,0.0773888912193179,0.099248952849038,5.49811968773583e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCXR,L-xylulose reductase,42679,0.0841671653340842,0.00531728726508068,0.0737452822945261,0.0945890483736423,6.25827531709038e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMMD1,COMM domain-containing protein 1,40223,0.0966605386186462,0.00610238615812837,0.0846998617487145,0.108621215488578,6.81988152565018e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,0.101123014068894,0.00638606435850816,0.0886063279262179,0.11363970021157,7.09679813045453e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHSG,Alpha-2-HS-glycoprotein,40532,0.0434235710304858,0.00274492341821836,0.0380435211307778,0.0488036209301938,8.98794402782937e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBC1D23,TBC1 domain family member 23,42587,0.142728026351722,0.00903630571461404,0.125016867151079,0.160439185552366,1.07170097329734e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RL2,Interleukin-1 receptor-like 2,42370,0.0617739669133721,0.00391455175515959,0.0541014454732593,0.0694464883534849,1.36530807807833e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IST1,IST1 homolog,40375,0.157313092511064,0.00997014607814582,0.137771606197898,0.17685457882423,1.73531453655472e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGFR,Opioid growth factor receptor,42587,0.0517952085604807,0.00328959246333619,0.0453476073323418,0.0582428097886197,2.3233694091015e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAX1BP1,Tax1-binding protein 1,40483,0.100593182768301,0.00638834273780463,0.0880720310022041,0.113114334534398,2.8135790895514e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NIT1,Deaminated glutathione amidase,40223,0.0755494746874858,0.00479949072296097,0.0661424728704823,0.0849564765044893,3.1474915798688e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRELD1,Protein disulfide isomerase CRELD1,40283,0.0600713329170617,0.00382085104685915,0.0525824648652178,0.0675602009689056,4.20115646444574e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EREG,Proepiregulin,42476,0.128058866642226,0.00815698879942297,0.112071168595357,0.144046564689095,4.77621375655274e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL5,C-C motif chemokine 5,42689,0.157727508118431,0.0100723101004625,0.137985780321525,0.177469235915338,8.67722431955162e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLK1,Protein delta homolog 1,42794,0.0873033986498862,0.00557613757441712,0.0763741690040287,0.0982326282957438,8.99940808434895e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP10,Stromelysin-2,42608,-0.0932404163878811,0.00595682054404386,-0.104915784654207,-0.0815650481215552,9.70185287463733e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LBR,Delta(14)-sterol reductase LBR,42711,0.105301330500955,0.0067314061298828,0.0921077744863845,0.118494886515525,1.11272213424324e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THOP1,Thimet oligopeptidase,42571,0.0488219852766856,0.00312361581894173,0.0426996982715598,0.0549442722818114,1.38230238079691e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD1,Sushi domain-containing protein 1,42357,0.0779275847165063,0.00499112557451143,0.0681449785904639,0.0877101908425487,1.82070596716323e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPC5,Glypican-5,42495,0.0891039303379787,0.00571381753300114,0.0779048479732965,0.100303012702661,2.40220583966877e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,0.124226695907392,0.00797001006545841,0.108605476179094,0.139847915635691,2.68225948075481e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPL,N-acetylneuraminate lyase,40511,0.0717840328129597,0.00460894291012066,0.0627505047091232,0.0808175609167962,3.92284490337712e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP5,Fatty acid-binding protein 5,42678,0.106322002209867,0.00684790632155242,0.0929001058196241,0.11974389860011,6.74783006399928e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSIP1,PC4 and SFRS1-interacting protein,42594,0.101112644928477,0.00651412055495484,0.0883449686407651,0.113880321216188,7.23678689451726e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB27B,Ras-related protein Rab-27B,40511,0.129296895441242,0.00832301104016556,0.112983793802518,0.145609997079967,7.2400860497767e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NSFL1C,NSFL1 cofactor p47,42711,0.10172604879938,0.00656122585285867,0.0888660461277774,0.114586051470983,9.43709709688134e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,0.132887665008362,0.00856357815637737,0.116103051821862,0.149672278194861,9.66276763106528e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CIRBP,Cold-inducible RNA-binding protein,40449,0.14883072327352,0.00959678027348357,0.130021033937492,0.167640412609548,1.09185123036702e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,0.0826620090523819,0.00533386737778125,0.0722076289919306,0.0931163891128331,1.30932433711086e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42618,0.0429486309027102,0.00277523894913773,0.0375091625624002,0.0483880992430201,1.46875057133497e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST13,Hsc70-interacting protein,40283,0.0880540740814384,0.005693900693955,0.0768940287212866,0.0992141194415902,2.16619522409242e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSME1,Proteasome activator complex subunit 1,42480,0.0581387338413717,0.00376509688866493,0.0507591439395884,0.0655183237431549,2.49961310358894e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL17,C-C motif chemokine 17,42604,0.143180958789354,0.00927386689062615,0.125004179683726,0.161357737894981,2.56408030751633e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDUA,Alpha-L-iduronidase,42721,0.0724656761502957,0.00469456337411815,0.0632643319370241,0.0816670203635672,2.66399905759399e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOK1,Docking protein 1,40483,0.211748990990065,0.0137284822340789,0.184841165811271,0.23865681616886,3.92236227915343e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAG1,Dystroglycan,42676,0.0713406787296155,0.00463832682508687,0.0622495581524453,0.0804317993067858,6.20596004687284e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL3,C-X-C motif chemokine 3,42620,0.144931200397377,0.00942472618104426,0.12645873708253,0.163403663712224,6.51588299917284e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GTPBP2,GTP-binding protein 2,40182,0.125645818886729,0.0081660141546065,0.1096404311437,0.141651206629757,7.17216604969247e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MME,Neprilysin,42587,0.126054526221115,0.00822033994626458,0.109942659926437,0.142166392515794,1.2589639310817e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAGK,N-acetyl-D-glucosamine kinase,40209,0.0864196367252862,0.00563234984215602,0.0753802310346604,0.097459042415912,1.36880584853853e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIGYF2,GRB10-interacting GYF protein 2,40482,0.116418112788389,0.00760559750801121,0.101511141672687,0.131325083904091,2.30490477586149e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS8,Prostasin,42568,0.0649972043147491,0.00425262713293642,0.0566620551341937,0.0733323534953044,2.70218077775119e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.0509762873560337,0.0033429528448863,-0.0575284749320109,-0.0444240997800566,4.512698000857e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LSP1,Lymphocyte-specific protein 1,42594,0.0614213387642787,0.00402904939948572,0.0535244019412867,0.0693182755872707,4.8821982510146e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,40482,0.103378177395876,0.00678553578464184,0.0900785272579778,0.116677827533774,6.78125338417888e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APPL2,DCC-interacting protein 13-beta,40283,0.170604022529747,0.0111980810637526,0.148655783644792,0.192552261414702,6.9218623130104e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TWF2,Twinfilin-2,40527,0.127753075398498,0.00838796837937075,0.111312657374931,0.144193493422065,7.22785872162809e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXNB3,Plexin-B3,42597,0.0720676435723104,0.00473695812235035,0.0627832056525037,0.081352081492117,7.74581159901372e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSO,Cathepsin O,42754,0.0473673461294555,0.00311499383304942,0.0412619582166786,0.0534727340422323,8.59253463534895e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYDGF,Myeloid-derived growth factor,40511,0.151019661015736,0.00992522507773283,0.13156621986338,0.170473102168093,9.03324066626306e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGA,Protein O-GlcNAcase,40449,0.107647854575479,0.00708079784240104,0.0937694908043731,0.121526218346585,1.10366299143559e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,0.0736474979590362,0.00484895995000867,0.0641435364570192,0.0831514594610532,1.3701642359034e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAT2,Signal transducer and activator of transcription 2,40199,0.116639363046035,0.00768529934530666,0.101576176329234,0.131702549762836,1.66730065508563e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN2L,Ataxin-2-like protein,40482,0.074043380070701,0.00488326262726192,0.0644721853212677,0.0836145748201344,2.00257196385569e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTDH,Protein LYRIC,40199,0.143773377054745,0.00948828418454278,0.125176340053041,0.162370414056449,2.39288766959519e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS1BP3,HCLS1-binding protein 3,40223,0.135561738727955,0.0089494124362805,0.118020890352846,0.153102587103065,2.57794708151133e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBPL,FK506-binding protein-like,40449,0.0896858115344815,0.00592246677368061,0.0780777766580675,0.101293846410895,2.68218554457535e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINC1,Antithrombin-III,40516,0.0225443066502205,0.00149072712449606,0.0196224814862082,0.0254661318142328,3.60441500453901e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,0.125310443503552,0.00829591331541852,0.109050453405331,0.141570433601772,4.7384236605733e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DGKA,Diacylglycerol kinase alpha,40199,0.0835154565475586,0.00553060360965117,0.0726754734726423,0.0943554396224749,5.19775033000509e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,0.0666243083699139,0.00441989085445893,0.0579613222951744,0.0752872944446534,6.41475899274047e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGL1,Fibrinogen-like protein 1,40532,-0.100388572761837,0.0066575049294028,-0.113437282423466,-0.0873398631002075,6.92412431336001e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THPO,Thrombopoietin,42357,0.059489387987939,0.00395311292943849,0.0517412866462396,0.0672374893296384,9.29583492293853e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GORASP2,Golgi reassembly-stacking protein 2,40449,0.0715750720587323,0.00475420979583561,0.0622568208588945,0.0808933232585701,9.95443290313863e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPART,Spartin,40283,0.11634917517177,0.00773306202434206,0.101192373604059,0.13150597673948,1.16376318057792e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42594,0.0594430676070369,0.00395745869785633,0.0516864485592385,0.0671996866548353,1.38986206734342e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH2,Cadherin-2,42636,0.0540446865795065,0.00359931309158473,0.0469900329200004,0.0610993402390126,1.49775518852396e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAG4,BAG family molecular chaperone regulator 4,40199,0.0744189378453305,0.00495539208407091,0.0647063693605516,0.0841315063301095,1.77396193549342e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFB,Platelet-derived growth factor subunit B,42676,0.129510112196265,0.0086448362396574,0.112566233166537,0.146453991225994,2.47435473827824e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL32,Interleukin-32,42594,-0.067299866446313,0.00449437950622905,-0.0761088502785219,-0.0584908826141041,2.75916027241011e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT5,ADP-sugar pyrophosphatase,42611,0.0764144245334709,0.00511748156235842,0.0663841606712483,0.0864446883956934,5.14002855286846e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAVS,Mitochondrial antiviral-signaling protein,42346,0.137046534299745,0.00918471186430746,0.119044499045702,0.155048569553787,6.14644986891486e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F2,Prothrombin,40539,0.0224895976369779,0.00150723583247259,0.0195354154053316,0.0254437798686242,7.13292771314477e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS8,Galectin-8,42711,0.0901545249510229,0.00605839056199753,0.0782800794495078,0.102028970452538,1.08378854877899e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASHC3,WASH complex subunit 3,40483,0.112755505686507,0.00757171257707884,0.0979149490354325,0.127596062337582,1.10440533309107e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,-0.0489116440085098,0.00329697274325283,-0.0553737105852853,-0.0424495774317342,2.12302384288184e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,QDPR,Dihydropteridine reductase,42581,0.063740078008642,0.004301147579793,0.0553098287522477,0.0721703272650363,2.70040459262565e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT5,"Keratin, type II cytoskeletal 5",42311,0.0773268364696895,0.00521869413896324,0.0670981959573216,0.0875554769820575,2.83374758220335e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3GLB2,Endophilin-B2,40483,0.0999531627376239,0.00674994123469773,0.0867232779176163,0.113183047557631,3.7565833018546e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,0.086131998358605,0.00583492646700888,0.0746955424832676,0.0975684542339424,7.54128696865104e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GMPR2,GMP reductase 2,40283,0.100365909436966,0.00680140045797922,0.0870351645393272,0.113696654334606,8.08649219529493e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0552268007771479,0.0037503844645407,0.0478760472266481,0.0625775543276476,1.24558746231463e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,0.154628407711361,0.0105105332702892,0.134027762501594,0.175229052921128,1.29672907939717e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL13,C-C motif chemokine 13,42734,0.102921411297749,0.00700092847684389,0.0891995914831354,0.116643231112363,1.50043111978913e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPP,Lipoma-preferred partner,40116,0.0980160425812249,0.0066647930656058,0.0849530481726375,0.111079036989812,1.7003949693761e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PXN,Paxillin,42311,0.0762389412864284,0.00518890383713688,0.0660686897656401,0.0864091928072167,1.74289986732071e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,0.125645485190784,0.00855305539336059,0.108881496619797,0.142409473761771,1.80464971369648e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RILPL2,RILP-like protein 2,40511,0.143762462511164,0.00979882132803918,0.124556772708207,0.16296815231412,2.72611976138626e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,0.0653225335376524,0.00445601939435745,0.0565887355247118,0.0740563315505929,2.77484821370561e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL3,Angiopoietin-related protein 3,42652,0.0531274388271841,0.00362487552590854,0.0460226827964034,0.0602321948579649,2.88807479666566e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53,Cellular tumor antigen p53,42346,0.0639565843298796,0.00436505934653512,0.0554010680106708,0.0725121006490884,3.13981032404028e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.0619679271399137,0.00422971903373035,0.0536776778338022,0.0702581764460252,3.17773828977366e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,0.106442144194894,0.00727014542261104,0.0921926591665766,0.120691629223212,3.60145574079711e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,0.215204747298155,0.0147355573698724,0.186323054853205,0.244086439743105,7.20367904268634e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFRP4,Secreted frizzled-related protein 4,40283,0.0595621228820672,0.00407839288691149,0.0515684728237207,0.0675557729404137,7.32651831816096e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,0.114183347711912,0.00783150132182302,0.0988336051211392,0.129533090302685,8.87740206550965e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STIP1,Stress-induced-phosphoprotein 1,42586,0.095405170807746,0.00654995854209504,0.0825672520652397,0.108243089550252,1.07352439912401e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MGLL,Monoglyceride lipase,42654,0.126277668799929,0.00868313673255829,0.109258720804115,0.143296616795743,1.48657198364875e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLB1,Beta-galactosidase,42495,0.0610657481700907,0.00420089971943108,0.0528319847200057,0.0692995116201756,1.64863144573335e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,0.144355937442267,0.00994451652561988,0.124864685052052,0.163847189832482,2.22491524894323e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLG4,Disks large homolog 4,40483,0.102926258632931,0.00708999967587121,0.0890298592682234,0.116822657997639,2.51750193872658e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARSB,Arylsulfatase B,42587,0.0806438024218617,0.00556524918987074,0.0697359140097151,0.0915516908340084,3.16142503646157e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT18,"Keratin, type I cytoskeletal 18",42587,0.1183972189101,0.00817089051588047,0.102382273498974,0.134412164321226,3.18307775302583e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP3,Metalloproteinase inhibitor 3,42676,0.191014964310541,0.0131837909003398,0.165174734145875,0.216855194475207,3.23493647367349e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD36,Platelet glycoprotein 4,40199,0.0657698347128747,0.00453712757634151,0.0568770646632453,0.0746626047625041,3.49460872442481e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNPY4,Protein canopy homolog 4,42587,0.108240956781634,0.00748414904358073,0.0935720246562158,0.122909888907052,4.71463643125831e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,0.104391471839786,0.00721872841360841,0.0902427641491138,0.118540179530459,4.81449117269743e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGBP1,Immunoglobulin-binding protein 1,40482,0.089286307858154,0.00617501291492854,0.0771832825448941,0.101389333171414,5.75196573737911e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HYOU1,Hypoxia up-regulated protein 1,42794,0.0338598976527914,0.00234539744343138,0.0292629186636659,0.0384568766419169,6.74942569529593e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBM17,Splicing factor 45,40482,0.11158726020659,0.00773087632963434,0.0964347426005071,0.126739777812674,8.25124514323141e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM40,E3 ubiquitin ligase TRIM40,40182,0.104970624556135,0.00727542593081028,0.0907107897317464,0.119230459380523,9.20445463590499e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASC3,Protein CASC3,40182,0.0613130053932434,0.00425020395267903,0.0529826056459925,0.0696434051404943,9.49842256510392e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE4,Ribonuclease 4,40169,0.0427539628500659,0.00296459833212221,0.0369433501191064,0.0485645755810254,1.01226677425792e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,0.127798261700881,0.00886470317758067,0.110423443472823,0.145173079928939,1.0603639638218e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RWDD1,RWD domain-containing protein 1,42711,0.0916903023304989,0.00636851272404237,0.0792080173913758,0.104172587269622,1.1881178981756e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,0.0887860954476663,0.00616799997148254,0.0766968155035605,0.100875375391772,1.24391887735337e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIA1,Nucleolysin TIA-1 isoform p40,42190,0.176085514376302,0.0122344443366022,0.152106003476562,0.200065025276043,1.31360545132725e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP5,Microfibrillar-associated protein 5,42794,0.0600373107208121,0.00417490836841148,0.0518544903187257,0.0682201311228986,1.50489788190262e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,0.127750787024957,0.00888387866723629,0.110338384837174,0.145163189212741,1.53268513247373e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,0.0754744974729818,0.00524932230469543,0.0651858257557788,0.0857631691901849,1.83451585110211e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,0.159354962982033,0.0110923939359808,0.13761387086751,0.181096055096555,1.85861615313678e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADD1,Alpha-adducin,40283,0.103288705711938,0.00719151463646159,0.0891933370244736,0.117384074399403,2.31327074482619e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRP14,Signal recognition particle 14 kDa protein,42587,0.0860748170268525,0.00599986328359314,0.07431508499101,0.0978345490626951,2.48283793934972e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICA1,Islet cell autoantigen 1,42370,0.11428139220455,0.00797305816462811,0.0986541982018789,0.129908586207221,3.01091866264414e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,42311,0.0419066644633715,0.00292370781870209,0.0361761971387154,0.0476371317880276,3.0237372349081e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAMP8,Vesicle-associated membrane protein 8,40199,0.127478450531883,0.00890854631629545,0.110017699751944,0.144939201311822,4.92309930011396e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,0.0861086445495302,0.00602239140156116,0.0743047574024703,0.09791253169659,5.67924958295421e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,A1BG,Alpha-1B-glycoprotein,40539,0.0246329867153085,0.00172324655975142,0.0212554234581957,0.0280105499724213,5.92857500884694e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH2D1A,SH2 domain-containing protein 1A,42594,0.0836309547896759,0.00585596596198299,0.0721532615041893,0.0951086480751626,6.21542191836748e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGF,Placenta growth factor,42754,0.0385527297975316,0.00270031418943103,0.0332601139862468,0.0438453456088165,6.53590371109553e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDC,Nuclear migration protein nudC,42754,0.089570966194089,0.00627858045266837,0.077264948506859,0.101876983881319,7.63595702902261e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPHOSPH8,M-phase phosphoprotein 8,42357,0.108856048363619,0.00763641123178201,0.0938886823493267,0.123823414377912,9.15580473170129e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,0.109023292607791,0.00765881602334349,0.094012013202038,0.124034572013545,1.21224129675839e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESM1,Endothelial cell-specific molecule 1,42618,-0.049602160676269,0.00348846641757895,-0.0564395548547237,-0.0427647664978142,1.49726124404573e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTBDN,Retbindin,42587,0.0430930798045374,0.00303184084503588,0.0371506717482671,0.0490354878608078,1.61826540242878e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,0.115829697772721,0.00815903243102831,0.0998379942079057,0.131821401337537,2.36364067068991e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,0.0707372855276413,0.00498288237510055,0.0609708360724442,0.0805037349828384,2.43924230000978e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4A,C-type lectin domain family 4 member A,42594,-0.0506381900030983,0.00357428563235979,-0.0576437898425235,-0.0436325901636731,3.09329496188208e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42587,0.0805550358966836,0.00568835202041045,0.0694058659366791,0.0917042058566881,3.36418669834724e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIFBP,KIF-binding protein,42587,0.116874877350621,0.0082609167189062,0.100683480581565,0.133066274119677,4.06322279765137e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT4,Vascular endothelial growth factor receptor 3,42679,0.0473499119414302,0.00334817279580715,0.0407874932616482,0.0539123306212122,4.39196755109848e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD207,C-type lectin domain family 4 member K,42365,0.0570364675014306,0.00403436102740362,0.0491291198877195,0.0649438151151417,4.74978667311022e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA11,Annexin A11,42570,0.0954721926224718,0.00675819858660468,0.0822261233927266,0.108718261852217,5.46154477437932e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,42370,0.0860237031986636,0.00609411703870992,0.0740792338027921,0.097968172594535,6.44198626962091e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,0.10910241258025,0.00774209653136661,0.0939279033787714,0.124276921781728,8.85755975528386e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.0621076350609825,0.00440552464933244,0.0534728067482909,0.0707424633736741,9.44777223795622e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,0.121200755737332,0.00860974782867743,0.104325649993125,0.13807586148154,1.08856172935307e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELE,E-selectin,42794,0.0723859908846623,0.0051490193658875,0.0622939129275228,0.0824780688418018,1.40696773240294e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R2,Protein phosphatase inhibitor 2,42636,0.111960325349893,0.00796520484661749,0.0963485238505223,0.127572126849263,1.45950577918347e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GYS1,"Glycogen [starch] synthase, muscle",42357,0.131325116228056,0.00936167089560932,0.112976241272662,0.14967399118345,2.19396988747292e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKG1,cGMP-dependent protein kinase 1,40283,0.176467832190955,0.0125742721562701,0.151822258764666,0.201113405617245,2.31039690265173e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0858395757896818,0.00612206129600864,0.0738403356495049,0.0978388159298588,2.37400982900742e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBXN1,UBX domain-containing protein 1,40283,0.0970016682988616,0.00691396855188961,0.083450289937158,0.110553046660565,2.44983054976011e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOXJ3,Forkhead box protein J3,40199,0.0621431381263309,0.00442991776446152,0.0534604993079863,0.0708257769446755,2.52663435935033e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,0.117718056508147,0.00840212087680669,0.101249899589606,0.134186213426688,2.75323790073663e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,0.132238430027676,0.00943431769044797,0.113747167354398,0.150729692700954,2.89158155570307e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,0.0933814880337044,0.00666365587282916,0.0803207225229592,0.10644225354445,3.06386929975667e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.0537483500023679,0.00384368385781314,0.0462147296410542,0.0612819703636817,4.01185272334859e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHMP1A,Charged multivesicular body protein 1a,42495,0.111906736466373,0.00800581265988804,0.0962153436529926,0.127598129279754,4.34248227243288e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,0.11963651013648,0.00856586472674483,0.10284741527206,0.1364256050009,5.13462998535765e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUOM,Fucose mutarotase,40283,0.0895114919587215,0.00640586728613764,0.0769559920778917,0.102066991839551,5.34734737621859e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,40199,0.0803860916272591,0.00576419226073136,0.0690882747962256,0.0916839084582926,7.87319968691543e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,0.0639521894593385,0.00459108664681311,0.0549536596315848,0.0729507192870922,8.44344656938948e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,0.0539076123860279,0.00386784746130243,0.0463266313618751,0.0614885934101806,8.67282919733442e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGLN1,Egl nine homolog 1,42594,0.078335126577341,0.00562481105093312,0.067310496917512,0.0893597562371699,8.79942121863202e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEXN,Nexilin,40532,0.0972527256770337,0.00697881055849802,0.0835742569823776,0.11093119437169,8.85487951037786e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,0.0390168786293351,0.00280558458135096,0.0335179328498873,0.044515824408783,1.15447519459981e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNLR1,Interferon lambda receptor 1,42594,0.0512831228783477,0.00369751838477511,0.0440359868441884,0.0585302589125069,1.93190889853812e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOLM2,Protein GOLM2,42711,0.0324464346340499,0.00234203544049489,0.0278560451706799,0.0370368240974199,2.38144050368075e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YJU2,Splicing factor YJU2,40451,0.0455764348633481,0.00328776356337638,0.0391324182791304,0.0520204514475658,2.42717719138796e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD3,Mothers against decapentaplegic homolog 3,40451,0.0725249609029878,0.00523442293226043,0.0622654919557573,0.0827844298502182,2.67341729951803e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRADD,Death domain-containing protein CRADD,42476,0.105177189631296,0.00759645696584511,0.0902881339782393,0.120066245284352,2.70410483789251e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,0.136307422599443,0.00984067786721825,0.117019693979695,0.15559515121919,2.81598541153339e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRAP2,GRB2-related adapter protein 2,42636,0.177859031724196,0.0128580303266152,0.152657292284031,0.203060771164362,3.207073659537e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VNN1,Pantetheinase,40532,0.101981492107598,0.00737790394629552,0.0875208003728585,0.116442183842337,4.1649355280564e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42658,0.0978570513460559,0.00708788847093404,0.0839647899430252,0.111749312749087,4.59217324179734e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,0.144686491428465,0.01047606945094,0.124153395304623,0.165219587552308,4.95496317005415e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CETN3,Centrin-3,40449,0.10589018222695,0.00767155142669613,0.0908539414306254,0.120926423023274,5.47393445651979e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIAE,Sialate O-acetylesterase,42646,0.0640920817053356,0.00464924784126745,0.0549795559364514,0.0732046074742198,6.10338832076512e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.0588056701317516,0.00426633346362221,0.050443656543052,0.0671676837204511,7.12195629405101e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM24,Transcription intermediary factor 1-alpha,40287,0.0905791243417755,0.00657156600314575,0.0776988549756098,0.103459393707941,7.22194534912994e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH9,Protocadherin-9,40449,0.0482328556019901,0.00350002476142318,0.0413728070696007,0.0550929041343796,7.41375233477182e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,0.0969002392485218,0.00704497001431316,0.083092098020468,0.110708380476576,1.07928115341785e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,0.0683947595313158,0.00497895121949778,0.0586360151411001,0.0781535039215314,1.3617027657945e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED8,Protein TMED8,40449,0.14197717106122,0.0103372370252442,0.121716186491741,0.162238155630698,1.38936691950025e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDRKH,Tudor and KH domain-containing protein,42311,0.117769147850862,0.00858084554528342,0.100950690582106,0.134587605119617,1.42223264056209e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAX,Protein max,42311,0.145842342266493,0.0106308870134799,0.125005803720072,0.166678880812913,1.54142978498411e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOM,Apolipoprotein M,42663,0.0392755058316592,0.00286713802134346,0.033655915309826,0.0448950963534923,1.99407527427676e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP2B1,AP-2 complex subunit beta,40182,0.0671798383215473,0.00490233841570211,0.0575712550267712,0.0767884216163235,2.153049566607e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.0357295439318586,0.00260813079568701,0.0306176075723121,0.0408414802914052,2.27666925503227e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,0.110666483425596,0.00808266648764791,0.0948244571098064,0.126508509741386,2.52122360481712e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TADA3,Transcriptional adapter 3,40451,0.0546599876036391,0.00400754713459392,0.0468051952198351,0.0625147799874432,5.04379602305009e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUC13,Mucin-13,42311,0.0723244146681231,0.00530843269208303,0.0619198865916403,0.0827289427446058,5.53192378836466e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FIS1,Mitochondrial fission 1 protein,42624,0.103898856062965,0.00762981627910865,0.0889444161559125,0.118853295970018,5.98563763633925e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK10,Kallikrein-10,42636,0.0561207943614435,0.00412792160673559,0.0480300680122418,0.0642115207106453,8.05700905970641e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACYBP,Calcyclin-binding protein,40267,0.140196517201423,0.0103124310414473,0.119984152360186,0.16040888204266,9.28158745041857e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F12,Coagulation factor XII,40539,0.0572287205719529,0.00421027394619267,0.0489765836374153,0.0654808575064905,9.39573152609657e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD226,CD226 antigen,40199,0.0584465786848851,0.00430022284939135,0.050018141900078,0.0668750154696921,9.75902386659226e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,0.0610825945347785,0.00449881432223086,0.052264918463206,0.069900270606351,1.02816095807359e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,0.0544487181515861,0.00401116954907608,0.046586825835397,0.0623106104677752,1.06337307130732e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COCH,Cochlin,40511,0.0646114250255595,0.00475778653635763,0.0552861634142985,0.0739366866368204,1.11338551916235e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YWHAQ,14-3-3 protein theta,40283,0.100786671133351,0.00743252230169002,0.0862189274220386,0.115354414844663,1.47698818330199e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F11,Coagulation factor XI,40383,0.0414686730361326,0.00305898465108104,0.0354730631200137,0.0474642829522514,1.54527090434595e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EHD3,EH domain-containing protein 3,40223,0.161051215112273,0.0118890301867651,0.137748715946214,0.184353714278333,1.78968103226445e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH1A1,Retinal dehydrogenase 1,42611,0.0735871744374663,0.00544155196415697,0.0629217325877186,0.0842526162872139,2.13035433840369e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACE2,Angiotensin-converting enzyme 2,42357,0.0737009188328487,0.00545323169124889,0.0630125847180009,0.0843892529476965,2.40342098281907e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLG,Plasminogen,40285,0.0293678771251062,0.0021751978994708,0.0251044892421434,0.033631265008069,3.25178412608694e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB9,Serpin B9,42495,0.0450232910836662,0.00333942355773489,0.0384780209105058,0.0515685612568265,3.70120326115804e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN3,Ataxin-3,40483,0.0851451787494705,0.00631156647793503,0.0727745084527178,0.0975158490462232,3.71288523854481e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMPACT,Protein IMPACT,40483,0.0766454863693178,0.00568153925880587,0.0655096694220583,0.0877813033165773,3.71647117655823e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD99L2,CD99 antigen-like protein 2,42611,0.0331862052845201,0.00246473941471265,0.0283553160316833,0.0380170945373569,4.68082654943989e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,0.106503940776255,0.00792313353887334,0.0909745990400628,0.122033282512446,6.33158025636769e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRAS,Ras-related protein R-Ras,40182,0.176776396151486,0.0131422138165525,0.151017657071043,0.202535135231929,6.394093557059e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MOCS2,Molybdopterin synthase catalytic subunit,40283,0.0897211979778603,0.00669429543778323,0.0766003789198051,0.102842017035915,1.20812270237077e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,0.150573321984652,0.0112433962566594,0.1285362653216,0.172610378647704,1.24212346432232e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OTUD6B,Deubiquitinase OTUD6B,40449,0.0793034865087784,0.00593203777979012,0.0676766924603897,0.090930280557167,1.87454623772162e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DFFA,DNA fragmentation factor subunit alpha,42754,0.090406644648058,0.0067708496207679,0.0771357793913529,0.103677509904763,2.06560139580836e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAV3,Guanine nucleotide exchange factor VAV3,40136,0.1338868643684,0.0100375356045574,0.114213294583468,0.153560434153333,2.84501825347781e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBCB,Tubulin-folding cofactor B,42495,0.134647204293261,0.0101024459368218,0.11484641025709,0.154447998329431,2.87631093172039e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5E,5'-nucleotidase,42679,0.0766149783744774,0.00574881023560423,0.0653473103126931,0.0878826464362617,2.89421279453323e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,0.113816626379261,0.00853435728087373,0.0970892861087482,0.130543966649773,2.90629944426301e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.084151247055799,0.00632401481902209,0.0717561780105157,0.0965463161010823,4.29754470141528e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RFC4,Replication factor C subunit 4,40451,0.0284994372330612,0.00214388744737872,0.0242974178361989,0.0327014566299235,5.06499179794644e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB3A2,Secretoglobin family 3A member 2,42654,-0.117292097128731,0.00883881710635159,-0.13461617865718,-0.099968015600282,6.1473627794816e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BIN2,Bridging integrator 2,42611,0.121456172186124,0.00916222369655694,0.103498213740872,0.139414130631375,7.39761133175569e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRY2,Protein sprouty homolog 2,42370,0.123716870404293,0.00933630942008674,0.105417703940923,0.142016036867663,7.98728664945908e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNM3,Dynamin-3,40482,0.0737861849313781,0.00556993434753334,0.0628691136102127,0.0847032562525435,9.26698104705342e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,0.042898042140348,0.0032395730365871,0.0365484789886373,0.0492476052920587,1.00987154126825e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GZMA,Granzyme A,42754,0.0477537290536604,0.0036102172628805,0.0406777032184147,0.0548297548889062,1.07383044142201e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,0.0783235304779179,0.00592122941407212,0.0667179208263365,0.0899291401294993,1.07568892484756e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP25,Rho GTPase-activating protein 25,42346,0.0797799477462143,0.00603157723123336,0.0679580563729969,0.0916018391194316,1.09754203952709e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,0.0686102285363454,0.00518801437480297,0.0584417203617315,0.0787787367109592,1.13101697245395e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM172A,Cotranscriptional regulator FAM172A,40223,0.0817354433223818,0.00617896177230883,0.0696246782486565,0.0938462083961071,1.21094578232045e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42679,0.0812268898731964,0.00614600508495699,0.0691807199066807,0.0932730598397121,1.24736383154671e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42620,0.0660373792541025,0.00499717860206448,0.0562429091940561,0.0758318493141488,1.27156950035782e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,0.113892258436993,0.00861561011477798,0.0970056626120282,0.130778854261958,1.33637864855245e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUB1,NEDD8 ultimate buster 1,42594,0.111154575662208,0.0084238810047873,0.0946437688928248,0.127665382431591,1.64933407853273e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6AP2,Renin receptor,42346,0.0541281067844868,0.00410345877350418,0.0460853275884186,0.062170885980555,1.76403223188507e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPON2,Spondin-2,42562,-0.0480860872448428,0.00364579169251299,-0.0552318389621683,-0.0409403355275173,1.7794856400499e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA4D,Semaphorin-4D,42711,0.0400174387808615,0.00303477262687508,0.0340692844321863,0.0459655931295366,1.84348265428731e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDNF,Cerebral dopamine neurotrophic factor,42587,0.0450723116960627,0.0034188295754045,0.0383714057282699,0.0517732176638555,1.92104454245406e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,0.0769424875880308,0.00583975023667723,0.0654965771241434,0.0883883980519181,2.15706303321731e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UROD,Uroporphyrinogen decarboxylase,40283,0.0919401206197439,0.00697527962451438,0.0782685725556957,0.105611668683792,2.23532698483411e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANG,Angiogenin,42618,0.0447636084248071,0.00340848881436328,0.0380829703486551,0.0514442465009591,3.71469509213146e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,0.0709866391206386,0.00540585522930586,0.0603911628711991,0.0815821153700781,3.79500247906583e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TALDO1,Transaldolase,40499,0.0587168294895693,0.00447030626810543,0.0499550292040826,0.0674786297750559,4.01875116500471e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERP29,Endoplasmic reticulum resident protein 29,40283,0.157243373695603,0.0119745379469551,0.133773279319571,0.180713468071635,4.25299727314982e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOA2,Apolipoprotein A-II,40532,-0.0654763904342189,0.00499340967177995,-0.0752634733909076,-0.0556893074775302,5.35986171387576e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNCG,Gamma-synuclein,42495,0.0917592690644147,0.00700699602964121,0.0780255568463179,0.105492981282511,6.09198331965269e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATOX1,Copper transport protein ATOX1,42679,0.0924179519085022,0.00705854992639788,0.0785831940527623,0.106252709764242,6.23233436906667e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.120314967767899,0.0091892807026047,0.102303977590793,0.138325957945004,6.26043779538573e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,40223,0.0972690054052635,0.00743037663344293,0.0827054672037154,0.111832543606812,7.2455804103599e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,0.108254076983194,0.00828383138261141,0.0920177674732752,0.124490386493112,8.73458289230881e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP2,Caspase-2,42594,0.0891758919807211,0.00682991161835882,0.0757892652087378,0.102562518752704,1.00302350689153e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSC22D1,TSC22 domain family protein 1,40482,0.0863279705784292,0.00661295562885448,0.0733665775458744,0.0992893636109839,1.14283915825584e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,0.103226034866494,0.00791490383250839,0.0877128233547772,0.11873924637821,1.22766061129687e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMVK,Phosphomevalonate kinase,42303,0.14256814716007,0.0109700061097486,0.121066935184962,0.164069359135177,2.21983543957546e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF19,Fibroblast growth factor 19,42676,0.10234399375066,0.00787565134973651,0.086907717105176,0.117780270396143,2.22068549701647e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA5,Integrin alpha-5,42611,0.0330642945763308,0.00254439672297022,0.0280772769993091,0.0380513121533524,2.22759662568735e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,40539,-0.0352528931454993,0.00271524702141987,-0.0405747773074822,-0.0299310089835164,2.84946772631874e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINE2,Glia-derived nexin,40511,0.0845614706767878,0.00651560632851144,0.0717908822729053,0.0973320590806702,3.04398334428456e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42689,0.0542581356423652,0.00418754638398292,0.0460505447297587,0.0624657265549717,3.62090465948956e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD69,Early activation antigen CD69,42585,0.114910171218878,0.00886843044741147,0.0975280475419513,0.132292294895804,3.62652512997588e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTF1,Cardiotrophin-1,42357,0.110463318689485,0.00852771637215824,0.093748994600055,0.127177642778915,3.84145606556493e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK13,Kallikrein-13,42381,0.0606986264309342,0.00468613015001247,0.0515138113369097,0.0698834415249587,3.86852480311071e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VASP,Vasodilator-stimulated phosphoprotein,40532,0.094497056034081,0.00730531312529424,0.0801786423085043,0.108815469759658,5.27560451253295e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLOD4,Glyoxalase domain-containing protein 4,42602,0.0457859073793107,0.00354194593502672,0.0388436933466583,0.052728121411963,5.36088028900733e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,0.125105085010656,0.00968697918140978,0.106118605815093,0.14409156420622,6.25554706540601e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP7,Caspase-7,40483,0.10950442259246,0.00847601287739653,0.0928914373527626,0.126117407832157,6.49798343181529e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.0272213615584147,0.00210868647492646,-0.0313543870492706,-0.0230883360675589,6.70148334046313e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,0.129576007759781,0.0100467449122561,0.109884387731759,0.149267627787803,7.82481805063591e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGF,Pro-epidermal growth factor,42597,0.134238322407231,0.0104105653363674,0.113833614347951,0.154643030466511,8.11812277078319e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOXO3,Forkhead box protein O3,42346,0.124240854975942,0.00964155218130879,0.105343412700576,0.143138297251307,9.13496130778571e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.0382853338300699,0.00297340232311284,0.0324574652767687,0.0441132023833711,1.02116186053099e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCT5,T-complex protein 1 subunit epsilon,42346,0.0600125073247855,0.0046667635509128,0.0508656507649965,0.0691593638845746,1.28075893320646e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.036814730262317,0.00286464739116093,0.0312000213756415,0.0424294391489924,1.39945604397081e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUS,RNA-binding protein FUS,42336,0.0519064233080405,0.00404196874595614,0.0439841645659664,0.0598286820501145,1.60591037520379e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL3,C-C motif chemokine 3,42594,0.0749560596921365,0.00584459183759805,0.0635006596904443,0.0864114596938287,1.97525122743238e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,0.0961289875157996,0.0074940460686791,0.0814406572211886,0.110817317810411,2.12154431520438e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PF4,Platelet factor 4,40463,0.127658940766619,0.00995434611591003,0.108148422379436,0.147169459153803,2.18338494049827e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,0.0360614791724767,0.00281918869883478,0.0305358693227606,0.0415870890221929,3.02334698400191e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CETN2,Centrin-2,42311,0.0873729377442361,0.00683158958017622,0.0739830221670908,0.100762853321382,3.12949980561771e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THTPA,Thiamine-triphosphatase,40436,0.114046219944983,0.00891288659327421,0.0965769622221651,0.1315154776678,3.15176923974311e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL7,Interleukin-7,42594,0.0822918247789591,0.00644576724241371,0.0696581209838282,0.09492552857409,4.13318438569961e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB2,DnaJ homolog subfamily B member 2,40283,0.0696494446735679,0.00545365002920571,0.0589602906163247,0.0803385987308111,4.33428624374348e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC59,Leucine-rich repeat-containing protein 59,40511,0.0629075074539181,0.00493202137065982,0.0532407455674248,0.0725742693404113,5.26049453377415e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42711,0.0863547226036642,0.00678494523613283,0.0730562299408438,0.0996532152664845,6.78048770162466e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP10,Caspase-10,42311,0.0923774655681404,0.00726662022808883,0.0781348899210863,0.106620041215195,8.29958719145316e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PENK,Proenkephalin-A,40283,0.0422922662206095,0.00332651224393205,0.0357723022225027,0.0488122302187164,8.95870844809141e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,0.0612425545708983,0.00481938694296726,0.0517965561626825,0.0706885529791141,9.58235974333315e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESYT2,Extended synaptotagmin-2,40483,0.105934758795505,0.00834623368218727,0.089576140778418,0.122293376812592,1.15775355551334e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NACC1,Nucleus accumbens-associated protein 1,40451,0.0710582180643582,0.00560214050502509,0.0600780226745091,0.0820384134542074,1.28900384601881e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,0.0748219654302188,0.00590320311209684,0.0632516873305089,0.0863922435299286,1.33485858956955e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,0.0980771919173208,0.0077365418145468,0.0829135699608091,0.113240813873833,1.42402910619704e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,0.0836501925653736,0.00660393561497243,0.0707064787600277,0.0965939063707196,1.47803387414121e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ORM1,Alpha-1-acid glycoprotein 1,40483,0.0258557175945087,0.00204052582136876,0.0218562869846259,0.0298551482043914,1.51576429417682e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,0.0971649666911875,0.00768499080958475,0.0821023847044014,0.112227548677974,1.95829394138079e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,0.0938459240514203,0.00743029353657838,0.0792825487197266,0.108409299383114,2.34304742258992e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MICALL2,MICAL-like protein 2,40182,0.0882909886440815,0.00699169892397266,0.0745872587530951,0.101994718535068,2.64465316900238e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB14,DnaJ homolog subfamily B member 14,40449,0.0810846920330955,0.00642612246514727,0.0684894920014068,0.0936798920647841,2.95662109908818e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF3,Immunoglobulin superfamily member 3,42587,0.0463564664520926,0.0036760636000769,0.0391513817959419,0.0535615511082433,2.97501432965138e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CIAPIN1,Anamorsin,42679,0.0793214577770429,0.00629059965427159,0.0669918824546706,0.0916510330994152,2.99659580075365e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,0.0723941985439148,0.00574584568757872,0.0611323409962605,0.0836560560915691,3.40904170378291e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP2,Microtubule-associated protein 2,40483,0.0594488448016814,0.00471897679944203,0.050199650274775,0.0686980393285877,3.79815080319302e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42594,0.0743348192994235,0.00591248009581764,0.0627463583116209,0.0859232802872261,4.77629544184974e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,0.0829672774578205,0.00660734482469403,0.0700168816014202,0.0959176733142208,5.78850423412957e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB1,Leukocyte elastase inhibitor,42569,0.112995860495366,0.00900424518860604,0.095347539925698,0.130644181065034,6.3996350161824e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUGT1,Protein SGT1 homolog,42346,0.102000602699141,0.00813403943436247,0.0860578854077909,0.117943319990492,7.23498584992543e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,40223,0.116420713498901,0.00929095264618324,0.0982104463123822,0.134630980685421,8.90104977044327e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DYNLT1,Dynein light chain Tctex-type 1,40182,0.102534865150409,0.00818398378137949,0.0864942569389054,0.118575473361913,9.12400900827025e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17RB,Interleukin-17 receptor B,42416,-0.0680453914474232,0.00543726607552632,-0.0787024329554548,-0.0573883499393916,9.89556070019836e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,0.0586132792244859,0.00469624900022841,0.0494086311840382,0.0678179272649336,1.50796129726772e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD244,Natural killer cell receptor 2B4,42754,0.0347619416082654,0.00278547159816313,0.0293024172758657,0.0402214659406652,1.50966891009316e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4G,C-type lectin domain family 4 member G,42594,0.0420240460126898,0.00336945177640485,0.0354199205309363,0.0486281714944433,1.66911263629662e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,0.113001983297112,0.00906697239761868,0.095230717397779,0.130773249196444,2.02772791609464e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JPT2,Jupiter microtubule associated homolog 2,40449,0.109890127243489,0.00881916420670264,0.0926045653983522,0.127175689088627,2.10155608069995e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS2,Trypsin-2,42689,0.0706376646697309,0.00567918971205258,0.0595064528341078,0.0817688765053539,2.538446689631e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPARC,SPARC,42679,0.0883736364668732,0.00710627923169123,0.0744453291727584,0.102301943760988,2.60259390120917e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDC4,Syndecan-4,42636,0.0595639948572363,0.00478997303214652,0.0501756477142292,0.0689523420002435,2.63385536605238e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DIABLO,"Diablo homolog, mitochondrial",42603,0.136991297333946,0.0110369993965686,0.115358778516672,0.15862381615122,3.50968136694979e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMT,Catechol O-methyltransferase,42214,0.104735044092431,0.00843776895985937,0.0881970169311071,0.121273071253756,3.5282339901466e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GET3,ATPase GET3,40511,0.0681792006023347,0.0054908321952366,0.057417169499671,0.0789412317049985,3.58405545184984e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELOA,Elongin-A,42587,0.0673643437761394,0.00543678345205077,0.0567082482101199,0.0780204393421589,4.5799522296388e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGCT,Gamma-glutamylcyclotransferase,40500,0.0599260900541369,0.00483750660079522,0.0504445771165783,0.0694076029916956,5.13192532370735e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPI,Glucose-6-phosphate isomerase,40532,0.0589573380073927,0.00475994612052298,0.0496278436111676,0.0682868324036177,5.23076114859073e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42636,0.0838282936924141,0.0067797114769636,0.0705400591975655,0.0971165281872628,6.29056708062899e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPB1,Heat shock protein beta-1,42448,0.0849029415496875,0.00686646424829203,0.0714446716230351,0.0983612114763399,6.30690557163596e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,40283,0.107945110666195,0.0087256293370611,0.0908428771655554,0.125047344166835,6.37032965134827e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STXBP1,Syntaxin-binding protein 1,40482,0.096390645230082,0.00779498846621786,0.081112467836295,0.111668822623869,6.73777291061461e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB6,Serpin B6,42679,0.0725400308536802,0.0058734239274814,0.0610281199558167,0.0840519417515438,7.46477994574535e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FMNL1,Formin-like protein 1,42311,0.0777316955875833,0.00629412612399961,0.0653952083845441,0.0900681827906225,7.61826236424232e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,0.0547646429730705,0.00443502001211543,0.0460720037493242,0.0634572821968167,7.72686208478045e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,0.134859656720882,0.0109195137112571,0.113457409846818,0.156261903594946,8.1493658812196e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4E,Eukaryotic translation initiation factor 4E,40199,0.112991133608436,0.00914894284119846,0.0950592056396875,0.130923061577185,8.26111304960516e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,0.116442322440651,0.0094431069289483,0.0979338328599122,0.13495081202139,9.52669335096378e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MIF,Macrophage migration inhibitory factor,42586,0.0846036292356771,0.00687505661838995,0.0711285182636328,0.0980787402077214,1.29521468079019e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,0.0295288631253541,0.00240140561434046,0.0248221081212468,0.0342356181294614,1.44357235462009e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MESD,LRP chaperone MESD,42611,0.150103460825104,0.0122111117932161,0.1261696817104,0.174037239939808,1.52701978785848e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFA,Vascular endothelial growth factor A,42716,0.0730602535616176,0.00594723207960275,0.0614036786855962,0.084716828437639,1.67062591582939e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.132494128297611,0.0107869089520264,0.111351786751639,0.153636469843583,1.90519570424472e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERMAP,Erythroid membrane-associated protein,40199,0.0557899601671494,0.00454916203163868,0.0468736025851376,0.0647063177491612,2.37418124037639e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPB1,Carboxypeptidase B,42794,0.075587874975896,0.0061706439261062,0.0634934128807279,0.0876823370710642,2.5603231904088e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STK24,Serine/threonine-protein kinase 24,42311,0.0765318133878485,0.00624822105789348,0.0642853001143772,0.0887783266613197,2.63198233748342e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,0.0905071759801742,0.00739302034942105,0.076016856095309,0.104997495865039,3.04275267247854e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBC1D5,TBC1 domain family member 5,42594,0.0972800860606682,0.00796343932255448,0.0816717449884614,0.112888427132875,3.88586161994017e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB33A,Ras-related protein Rab-33A,40116,0.0814411126415822,0.00666939957434458,0.0683690894758668,0.0945131358072976,4.51785930860653e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,0.0659867467519786,0.00540789256577962,0.0553872773230505,0.0765862161809066,4.63375110509119e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,0.0619740087499145,0.00508153486640047,0.0520142004117696,0.0719338170880595,5.41356325658008e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.0452464437855072,0.00371294512378956,0.0379690713428797,0.0525238162281347,6.07189497775716e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,0.137075243987085,0.011265549340781,0.114994767279155,0.159155720695016,6.95917305108292e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,0.11409652699977,0.00938423632438488,0.095703423803976,0.132489630195565,7.86642133478696e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNDC9,Thioredoxin domain-containing protein 9,40483,0.0650395649742464,0.00534844650053652,0.0545566098331948,0.0755225201152979,8.21073347847286e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP1BB,Platelet glycoprotein Ib beta chain,40116,0.0853619062725036,0.00702203620083489,0.0715987153188672,0.09912509722614,8.77578810443724e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,0.115208602985674,0.00948709404019092,0.0966138986668996,0.133803307304448,9.34572707417065e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTD,Deoxycytidylate deaminase,40283,0.115745825748391,0.00952626191817236,0.0970743523887728,0.134417299108008,9.37672923878081e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GMFG,Glia maturation factor gamma,40511,0.0880916822773786,0.00725358332392564,0.0738746589624844,0.102308705592273,9.93510627754587e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYO9B,Unconventional myosin-IXb,42370,0.0814832794384952,0.0067126855543843,0.0683264157519019,0.0946401431250884,9.96870339483802e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPI,Mannose-6-phosphate isomerase,42587,0.103940467915761,0.00856437160415624,0.0871542995716146,0.120726636259907,1.01841212666015e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRGN,Neurogranin,40532,0.111815766702562,0.00920877633276783,0.093766565090337,0.129864968314787,1.02019593383772e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,0.0568725849447175,0.00468671700198804,0.0476866196208209,0.066058550268614,1.03363572324382e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2L1,Bcl-2-like protein 1,40483,0.122071349667181,0.0100586279914853,0.102356438803869,0.141786260530492,1.10330495747638e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL11,Eotaxin,42754,0.0452004092182028,0.00373134388287136,0.0378869752077749,0.0525138432286307,1.33247863712078e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATG4A,Cysteine protease ATG4A,42346,0.072445589183817,0.00598278159871515,0.0607193372503353,0.0841718411172987,1.42751634329453e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PARK7,Parkinson disease protein 7,42611,0.0636725983401954,0.0052629192722215,0.0533572765666413,0.0739879201137496,1.61044828906574e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REEP4,Receptor expression-enhancing protein 4,40482,0.0761423633227166,0.00629155139391169,0.0638109225906497,0.0884738040547835,1.65501149476645e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,0.0735882501642456,0.00608120773685983,0.0616690830000004,0.0855074173284909,1.69730889978939e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEPR,Leptin receptor,42636,-0.03833100911295,0.00316975534597086,-0.0445437295910529,-0.0321182886348471,1.72172018570392e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CERT,Ceramide transfer protein,42311,0.0750437391385864,0.00621426992618988,0.0628637700832542,0.0872237081939185,2.12569501844399e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS9,Galectin-9,42620,0.0395746951423795,0.003277506446169,0.0331507825078882,0.0459986077768707,2.14171791478743e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,0.0979193887766508,0.0081048449030513,0.0820338927666702,0.113804884786631,2.14911094047661e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53I3,Quinone oxidoreductase PIG3,40058,0.0650409116346983,0.00539426006038705,0.0544681619163396,0.0756136613530569,2.88916441400192e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,0.0816039177496178,0.00676859868135694,0.0683374643341582,0.0948703711650774,2.92275684037306e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAG6,Large proline-rich protein BAG6,42357,0.0435757268649336,0.00361819839733809,0.0364840580061509,0.0506673957237162,3.13785706866539e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,0.0599940461551669,0.00498208075459264,0.0502291678761653,0.0697589244341684,3.45175661606654e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOL1,Apolipoprotein L1,40532,0.0711477332044212,0.00591335854168843,0.0595575504627119,0.0827379159461305,3.85289099746328e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LACTB2,Endoribonuclease LACTB2,42636,0.0793770924774172,0.00660359377033044,0.0664340486875695,0.0923201362672648,4.10951598939797e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPPB,Natriuretic peptides B,42357,-0.172987121577564,0.0144281361755204,-0.201266268481584,-0.144707974673544,5.98233239331975e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,0.0589500940581167,0.00492382130397318,0.0492994043023293,0.0686007838139042,7.83072525193065e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCEMP1,Mast cell-expressed membrane protein 1,40199,0.110641795679912,0.00924732743748641,0.0925170339024383,0.128766557457385,8.68212287099343e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNRD2,Protein ZNRD2,40449,0.0847199012027656,0.00708431818030086,0.0708346375693759,0.0986051648361553,9.2219000000793e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BPIFB2,BPI fold-containing family B member 2,40473,0.0836158286854649,0.00700479681002444,0.069886426937817,0.0973452304331128,1.19443810454291e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,0.113941342197864,0.00955043556526449,0.095222488489946,0.132660195905783,1.29060909011673e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP3,Caspase-3,42794,0.104940948643687,0.00880562348498084,0.0876819266131244,0.122199970674249,1.39390644283059e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPA1,Carboxypeptidase A1,42794,0.0754990702617389,0.00635414087024115,0.0630449541560662,0.0879531863674115,2.12668902100653e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,0.122935680224432,0.0103438179745138,0.102661796994385,0.143209563454479,2.23346597028485e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,0.0635594682236005,0.00535139401590521,0.0530707359524263,0.0740482004947747,2.42594387718968e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42711,0.0381817938193198,0.00321763560534013,0.0318752280328531,0.0444883596057865,2.55925860847207e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LARP1,La-related protein 1,40451,0.0732209276671424,0.00622019181920798,0.0610293517014947,0.08541250363279,8.40832691735181e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.111075995669908,0.00946755626321569,0.0925195853940055,0.129632405945811,1.24140033848648e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMTN,Smoothelin,40460,0.109947349907626,0.00937551505126185,0.0915713404071524,0.128323359408099,1.41274233772589e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREH,Trehalase,40527,0.0885442689048268,0.00755714110027592,0.073732272348286,0.103356265461368,1.59170063180151e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TTF2,Transcription termination factor 2,40182,0.0583648870527273,0.00498097369546432,0.0486021786096172,0.0681275954958374,1.5951862937237e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX4,Syntaxin-4,42587,0.0705813640994231,0.0060339763390421,0.0587547704749005,0.0824079577239456,1.8706896625197e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKT2,RAC-beta serine/threonine-protein kinase,40482,0.149182656695862,0.0127664541266351,0.124160406607658,0.174204906784067,2.29049865160008e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC37,Hsp90 co-chaperone Cdc37,42679,0.0989084686475414,0.0084730737994639,0.0823012440005921,0.115515693294491,2.4699044982681e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPBP,Platelet basic protein,40471,0.0997086137496161,0.00854186571189246,0.0829665569543068,0.116450670544925,2.65246464000164e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JAM3,Junctional adhesion molecule C,40283,0.060006681119493,0.00514880376629413,0.0499150257375565,0.0700983365014295,3.30847643986734e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G4A,Cytosolic phospholipase A2,42676,0.102414951881728,0.00879318849377861,0.0851803024339216,0.119649601329534,3.34942837674553e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,0.0753675269822452,0.00648175669330395,0.0626632838633694,0.0880717701011209,4.2368973133079e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCA,Calcitonin,42476,0.0749484071508259,0.00644883603682609,0.0623086885186467,0.087588125783005,4.50325995768897e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C19orf12,Protein C19orf12,42311,0.0751159901071543,0.00647721298069938,0.0624206526649836,0.0878113275493251,6.04371526153054e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,40116,0.0814141683987901,0.0070188947125778,0.0676571347621376,0.0951712020354426,6.3057254072495e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42676,0.0463726636602655,0.00400617940070209,0.0385205520348894,0.0542247752856416,7.69202498057534e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.0305000906569521,0.00263599354374985,0.0253335433112024,0.0356666380027018,8.12473701764288e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKD2,Polycystin-2,40116,0.068684714954954,0.00593288185186217,0.0570562665253041,0.0803131633846038,8.15760319146559e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP170,Centrosomal protein of 170 kDa,40223,0.0907927288827103,0.00784512947969338,0.0754162751025112,0.106169182662909,8.49103757461688e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",40481,0.0466674563946714,0.00403310677942684,0.0387625671069948,0.054572345682348,8.61257535754001e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL7,C-C motif chemokine 7,42594,0.0696056603508853,0.00601861331051878,0.0578091782622685,0.0814021424395021,8.6723387643157e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,0.0666583509506665,0.00576644978785899,0.0553561093664629,0.0779605925348701,9.22352275095442e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKN3,Serine/threonine-protein kinase N3,40302,0.0879749533029823,0.00760743227409652,0.0730643860457531,0.102885520560211,9.36845690953338e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HPSE,Heparanase,40408,0.110157517347745,0.00952794731205276,0.0914827406161215,0.128832294079368,9.64155174738151e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,0.100639984760448,0.00871988889194894,0.0835490025322285,0.117730966988668,1.15048783292365e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA4,Protein disulfide-isomerase A4,40527,0.0702239070881772,0.00608318614368329,0.0583008622465579,0.0821469519297964,1.1753240175985e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.0665194429280901,0.00576905140737698,0.0552121021696312,0.0778267836865489,1.30264063482104e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,0.137888842481418,0.0119670320522465,0.114433459659015,0.161344225303822,1.41469705626974e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,0.040185888460424,0.0034952947297758,0.0333351107900634,0.0470366661307846,2.01572960664381e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,0.0710156408878126,0.00618252722399836,0.0588978875287758,0.0831333942468494,2.27185636011518e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RILP,Rab-interacting lysosomal protein,42674,0.0694143760727531,0.00605053139429779,0.0575553345399294,0.0812734176055767,2.50908709012199e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNMA1,Paraneoplastic antigen Ma1,40223,0.0650935367096627,0.00567341708432461,0.0539736392243865,0.0762134341949389,2.66478867516482e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAO1,Hydroxyacid oxidase 1,42721,0.145637319893293,0.0127123593041157,0.120721095657227,0.17055354412936,3.01263813901936e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SULT2A1,Bile salt sulfotransferase,42594,0.0653805932669793,0.00570831728667028,0.0541922913851055,0.076568895148853,3.11965880834064e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,0.034724667704519,0.00304505897035123,0.0287563521226306,0.0406929832864075,5.88980625615918e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA3,Annexin A3,42681,0.0804332433966973,0.00705947956715479,0.0665966634450739,0.0942698233483207,6.16362644120531e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C2,Complement C2,42663,0.0265706409040796,0.0023323318805479,0.0219992704182058,0.0311420113899535,6.26112302444851e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,0.077035481631689,0.00676426909524749,0.0637775142050039,0.090293449058374,6.58086349767513e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,0.0795394057097441,0.00698134291101614,0.0658559736041525,0.0932228378153357,6.6719450067545e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD5,T-cell surface glycoprotein CD5,42706,0.0418064165375098,0.00367174800076634,0.0346097904560078,0.0490030426190119,6.72196085907229e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,0.0350000798377499,0.0030758049805195,0.0289715020759317,0.0410286575995682,7.73661712478588e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,0.0666029132773027,0.00586537556953306,0.0551067771610179,0.0780990493935875,9.57071261852303e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFA,Platelet-derived growth factor subunit A,42794,0.0826115137349235,0.00728683191155935,0.0683293231882672,0.0968937042815798,1.1677141762915e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PQBP1,Polyglutamine-binding protein 1,42346,0.0657334985328396,0.00579766807801204,0.054370069099936,0.0770969279657432,1.16893771719344e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,0.0703116275315991,0.00619875935669531,0.0581620591924763,0.0824611958707219,1.17620693674006e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POMC,Pro-opiomelanocortin,40223,0.0807557371482024,0.00712404840162082,0.0667926022810256,0.0947188720153792,1.27410116650674e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,0.103823215940189,0.00916610845742183,0.0858576433636422,0.121788788516736,1.39374796068633e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBN1,Drebrin,40199,0.0575752157590998,0.0050830096934329,0.0476125167599713,0.0675379147582283,1.4060607088449e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,42357,0.125955713853597,0.0111297597104111,0.104141384821191,0.147770042886003,1.48007552735518e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,0.0736004231710171,0.00650186360734942,0.0608567705006123,0.086344075841422,1.51066094584798e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOD,Apolipoprotein D,40033,-0.0502584105397443,0.00443944596046512,-0.058959724622256,-0.0415570964572327,1.51515977446598e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST3,Cystatin-C,42659,0.0347582176252737,0.00307489393629058,0.0287314255101441,0.0407850097404032,1.70487931512336e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIP,Gastric inhibitory polypeptide,40223,0.0674940864308266,0.00597027028186747,0.0557923566783664,0.0791958161832869,1.79956783254256e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLMAP,Sarcolemmal membrane-associated protein,40449,0.0947863730615895,0.0083905019538751,0.0783409892319943,0.111231756891185,1.95824082720393e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASEH2A,Ribonuclease H2 subunit A,40482,0.0549798910029476,0.00487834465078824,0.0454183354874026,0.0645414465184925,2.64027366029285e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMEM106A,Transmembrane protein 106A,40451,0.0801570800034289,0.00711997644593663,0.0662019261693931,0.0941122338374647,3.0287159547896e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX8,Syntaxin-8,42594,0.0546996540777406,0.00486351215674534,0.0451671702505197,0.0642321379049615,3.24064655644728e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POSTN,Periostin,40527,-0.044185745086219,0.00392984033864618,-0.0518882321499655,-0.0364832580224724,3.55115003439518e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNAS,Neuroendocrine secretory protein 55,40482,0.0983436626580996,0.00874924821516646,0.0811951361563734,0.115492189159826,3.69453803493777e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MZT1,Mitotic-spindle organizing protein 1,42346,0.0589164547047246,0.00525480582914577,0.0486170352795989,0.0692158741298503,4.82617376576043e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL8,C-C motif chemokine 8,42706,0.0688910768133872,0.00615209099231715,0.0568329784684456,0.0809491751583288,5.59473728412948e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBI,Acyl-CoA-binding protein,42562,0.0868275244968019,0.00776154952654574,0.0716148874247722,0.102040161568832,6.35456395093815e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS1,Galectin-1,42636,0.0399118068875835,0.00356848860447888,0.0329175692228049,0.0469060445523621,6.51428151657895e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEBPB,CCAAT/enhancer-binding protein beta,42357,0.0433354848661128,0.00387537847686508,0.0357397430514572,0.0509312266807683,6.72179322604998e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPT1,Angiopoietin-1,42554,0.0951152651884321,0.00851752713656144,0.0784209120007716,0.111809618376092,7.93412591709807e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C3,Complement C3,39989,0.0533408962568221,0.00478468329498466,0.0439629169986522,0.0627188755149921,1.04734888652215e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,0.13442222121852,0.0120669111604646,0.110771075344009,0.15807336709303,1.07242999436878e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RASSF2,Ras association domain-containing protein 2,42346,0.064335844805387,0.00578164167517637,0.0530038271220413,0.0756678624887327,1.2357811422664e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,0.109956263287229,0.00988122958041944,0.0905890533096065,0.129323473264851,1.29310545569446e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP3,Stromelysin-1,42611,-0.0572475661171478,0.00514845260914325,-0.0673385332310686,-0.047156599003227,1.34637456653524e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBKS,Ribokinase,42317,0.0562551384452562,0.00506265034032593,0.0463323437782174,0.0661779331122951,1.47391684726963e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNDP1,Beta-Ala-His dipeptidase,42689,0.0520165905087437,0.00469877624659719,0.0428069890654132,0.0612261919520742,2.31695857028927e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYBB1,Beta-crystallin B1,40511,0.0718181059568033,0.00648610240251995,0.0591053452478642,0.0845308666657424,2.38160819114515e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL7,Angiopoietin-related protein 7,42721,0.0409699690827487,0.00370443304399891,0.0337092803165109,0.0482306578489866,2.6012008194439e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIPC3,PDZ domain-containing protein GIPC3,40449,0.109188382754906,0.00988196143578209,0.0898197383407731,0.128557027169039,3.08692449212835e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCN1,Ficolin-1,40515,0.0625902121185475,0.00566723362152774,0.0514824342203531,0.0736979900167419,3.25671565278673e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42794,0.0575461903161411,0.00521715736408951,0.0473205618825257,0.0677718187497565,3.5979990603556e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1R,Complement C1r subcomponent,40539,0.0218350291277383,0.00197884855181347,0.0179564859661839,0.0257135722892927,3.63392617064412e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,0.0608694741896657,0.00551809786232215,0.0500540023795143,0.0716849459998171,3.80779191472003e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,0.111111267719389,0.0100896125953577,0.0913356270324877,0.13088690840629,4.62412850720687e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F2R,Proteinase-activated receptor 1,42654,0.0625495350785892,0.00568617724646251,0.0514046276755227,0.0736944424816558,5.014356926445e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRG2,Bone marrow proteoglycan,40527,-0.0592554903384767,0.00538888305719286,-0.0698177011305747,-0.0486932795463787,5.53902153174941e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTRB1,Chymotrypsinogen B,42611,0.0646502388437884,0.00591218939145005,0.0530623476365463,0.0762381300510305,1.02548370177611e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,0.0646285060830164,0.00591179181811132,0.0530413941195182,0.0762156180465146,1.06468962260752e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.042654418566597,0.00391153511634736,0.0349878097385562,0.0503210273946378,1.4349766757233e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FRMD4B,FERM domain-containing protein 4B,40116,0.0779386775289529,0.00714400875896574,0.0639364203613801,0.0919409346965258,1.43784004278214e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,0.132542576880601,0.0121577635924404,0.108713360239418,0.156371793521784,1.47348814355788e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,42346,0.081976198449406,0.00751988458803203,0.0672372246568632,0.0967151722419488,1.4910693665087e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DXO,Decapping and exoribonuclease protein,40483,0.0506185494892559,0.00464497624364565,0.0415143960517104,0.0597227029268014,1.62418696750676e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA2,Integrin alpha-2,40283,0.0386242564898603,0.00354937103143972,0.0316674892682385,0.0455810237114822,1.93258270582254e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,0.0900481879823724,0.0082805833812533,0.0738182445551159,0.106278131409629,1.98255027799419e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL4,C-C motif chemokine 4,42642,0.0756403698033752,0.0069594838239388,0.0619997815084551,0.0892809580982952,2.11284281986075e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,0.0667295465570461,0.00614312683519132,0.0546890179600712,0.0787700751540211,2.27335116497926e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,0.0443858516264509,0.00408832934048557,0.0363727261190991,0.0523989771338026,2.52606724353667e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFAT5,Nuclear factor of activated T-cells 5,40199,0.0954771396658377,0.00880207251329184,0.0782250775397857,0.11272920179189,2.82733410087946e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LBP,Lipopolysaccharide-binding protein,42689,-0.0648175565665519,0.00598716598174596,-0.076552401890774,-0.0530827112423298,3.35004734303887e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD22,B-cell receptor CD22,42754,0.0480346958654912,0.00443967919023662,0.0393329246526274,0.056736467078355,3.5965866410336e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSZ,Cathepsin Z,42648,0.0354880207786329,0.00328083316640493,0.0290575877724792,0.0419184537847865,3.70800841877683e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACYP1,Acylphosphatase-1,40250,0.0719561102696487,0.00665387075296133,0.0589145235938445,0.0849976969454529,4.0306722177855e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BOLA2_BOLA2B,BolA-like protein 2,40223,0.0596136933842794,0.00551271852396263,0.0488087650773126,0.0704186216912461,4.0479639241622e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEMIP2,Cell surface hyaluronidase,40199,0.0378339529244385,0.00350683510879362,0.030960556111203,0.044707349737674,5.315669371254e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGACT,Gamma-glutamylaminecyclotransferase,40511,0.0769246198301987,0.00714086134897161,0.0629285315862143,0.0909207080741831,6.27272942252141e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSNAX,Translin-associated protein X,40116,0.0432824573555488,0.0040226184973626,0.0353981251007181,0.0511667896103795,7.26656644734278e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCG2,Secretogranin-2,42636,0.0374880694056113,0.00348775735363809,0.0306520649924806,0.044324073818742,7.74465331362163e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITPA,Inosine triphosphate pyrophosphatase,40116,0.0735306890600845,0.00683960961117134,0.0601250542221886,0.0869363238979803,8.00845915158388e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18,Interleukin-18,42566,0.0507511462981997,0.00472364629657857,0.0414927995569058,0.0600094930394937,8.13131247047634e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FEN1,Flap endonuclease 1,42346,0.0696345200680455,0.0064872657713865,0.0569194791561279,0.082349560979963,9.09378707209693e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WDR46,WD repeat-containing protein 46,40451,0.0392106145663808,0.00365766392560342,0.0320415932721981,0.0463796358605635,1.10143948431933e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBCA,Tubulin-specific chaperone A,40283,0.0918728482167928,0.00859894870997014,0.0750189087452513,0.108726787688334,1.6240738795919e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAG3,BAG family molecular chaperone regulator 3,42475,0.0442216685868813,0.00414145222207262,0.0361044222316189,0.0523389149421436,1.6559043262175e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,0.034474804815928,0.00324136170099128,0.0281217358819851,0.0408278737498709,2.58089894046468e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.0565510417153821,0.00532844724721892,0.046107285110833,0.0669947983199311,3.2917701289364e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,40223,-0.0655274890580482,0.00617611288620662,-0.0776326703150132,-0.0534223078010833,3.58616505262068e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCS,Copper chaperone for superoxide dismutase,42495,0.0513897354043035,0.00484625528080159,0.0418910750539324,0.0608883957546746,3.63093364106572e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,0.0660433078467381,0.00624179756845941,0.0538093846125577,0.0782772310809186,4.6241135718042e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42636,0.0403669195303729,0.00381508451637527,0.0328893538782773,0.0478444851824684,4.62818147531206e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTN6,Dynactin subunit 6,42311,0.0773042245548421,0.00731024361857298,0.0629761470624391,0.0916323020472451,4.96503460335535e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,0.0611567290906777,0.00578327666492193,0.0498215068274307,0.0724919513539247,5.1670310391483e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,0.11212254888442,0.0106325155100981,0.0912828184846276,0.132962279284212,7.05374974651629e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP5,Platelet glycoprotein V,40283,0.0387406726118802,0.00367447886964727,0.0315386940273715,0.0459426511963888,7.2395677364206e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP6,Platelet glycoprotein VI,42590,0.0932587804790382,0.00885346368256326,0.0759059916612142,0.110611569296862,7.63200228154776e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJC9,DnaJ homolog subfamily C member 9,40449,0.0822450108819892,0.00780484284555131,0.0669475189047086,0.0975425028592698,7.63842053290051e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RP2,Protein XRP2,42587,0.0449274571198482,0.00426891835521872,0.0365603771436195,0.0532945370960769,8.41574866263059e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFT20,Intraflagellar transport protein 20 homolog,40182,0.0460158637860265,0.00437660138919858,0.0374377250631973,0.0545940025088557,9.85782115117118e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,-0.12836477526041,0.0122220067782168,-0.152319908545715,-0.104409641975106,1.0575205919326e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42760,0.0357044578717595,0.00340059529888517,0.0290392910859445,0.0423696246575744,1.08975116114833e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIF1,Allograft inflammatory factor 1,42346,0.0555719981595193,0.00530529071667255,0.0451736283548411,0.0659703679641975,1.42143578163316e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLB,Beta-klotho,42311,-0.0796878798957912,0.00761526313082212,-0.0946137956322026,-0.0647619641593799,1.5892553334786e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAD23B,UV excision repair protein RAD23 homolog B,42346,0.0497051631609595,0.0047566249596858,0.0403821782399753,0.0590281480819437,1.84970025536599e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRI1,Methylthioribose-1-phosphate isomerase,40182,0.0732208620074869,0.00700443675177397,0.0594921659740099,0.0869495580409639,1.85887026961735e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.0561919663594119,0.00538030569509753,0.0456465671970207,0.0667373655218031,1.95443168906716e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,0.0804733000547653,0.00771897831269612,0.0653441025618809,0.0956024975476497,2.47639249145087e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT16,U8 snoRNA-decapping enzyme,40429,0.0916580979335267,0.00879910107914682,0.0744118598183989,0.108904336048654,2.71041574541247e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLNK,B-cell linker protein,40199,0.0432665384968202,0.00415798961962686,0.0351168788423516,0.0514161981512888,3.05955476123037e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC26,Anaphase-promoting complex subunit CDC26,40428,0.0732071358931291,0.00703888177596805,0.0594109276122317,0.0870033441740265,3.21348288944689e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL2,C-C motif chemokine 2,42475,0.0563485205273354,0.00542638730542804,0.0457128014086964,0.0669842396459743,3.6536629370115e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMOX2,Heme oxygenase 2,42311,0.0483015798574112,0.00465662944981996,0.0391745861357641,0.0574285735790583,4.1294996402891e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD276,CD276 antigen,42618,-0.0388011928626862,0.00374312454999377,-0.046137716980674,-0.0314646687446985,4.40256946315102e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,0.0460368472693757,0.00444461652253351,0.03732539888521,0.0547482956535414,5.01826510401987e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.0496747308256904,0.00480709653113925,0.0402528216246575,0.0590966400267233,6.41093251388109e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUOX,"Sulfite oxidase, mitochondrial",40482,0.0654380118246866,0.00633266960383833,0.0530259794011635,0.0778500442482098,6.42592849663192e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC5A,C-type lectin domain family 5 member A,42603,-0.0316553053398871,0.00307406111031078,-0.0376804651160962,-0.025630145563678,8.93864826241391e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB10,Ras-related protein Rab-10,40511,0.0560026155295899,0.00544169828787632,0.0453368868853523,0.0666683441738275,9.90356197434027e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APP,Amyloid-beta precursor protein,42592,0.0695097075074397,0.00676310620416548,0.0562540193472753,0.082765395667604,1.09601185810989e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL1,Growth-regulated alpha protein,42607,0.0999117565878354,0.00972310752704752,0.0808544658348222,0.118969047340848,1.11942119271144e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN9,Septin-9,42587,0.0297319031715205,0.0028979829102743,0.0240518566673829,0.0354119496756581,1.32253572387616e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.0688574265251093,0.0067211477215376,0.0556839769908956,0.082030876059323,1.53289811461826e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,0.124753834136737,0.0121864502089207,0.100868391727253,0.148639276546222,1.66459079285609e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,40511,0.0296420067904134,0.0028958802824578,0.0239660814367961,0.0353179321440307,1.7499153507252e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC3B,Tetranectin,40269,0.0218440108549091,0.00214284091360198,0.0176440426642492,0.026043979045569,2.70108560199485e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1RL,Complement C1r subcomponent-like protein,40519,0.0205942460293666,0.00202053806831528,0.0166339914154687,0.0245545006432646,2.7276896425793e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DYNLT3,Dynein light chain Tctex-type 3,40451,0.0450715253832512,0.0044234037944868,0.036401653946057,0.0537413968204453,2.82006810421061e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AK2,"Adenylate kinase 2, mitochondrial",40483,0.108998329903607,0.01073136341052,0.0879648576189879,0.130031802188226,3.91654720382382e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0532522198150964,0.00524376369131924,0.0429744429801107,0.0635299966500821,3.97888380515936e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,-0.0459054757019086,0.00452568256920253,-0.0547758135375455,-0.0370351378662716,4.32884030568928e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDT,D-dopachrome decarboxylase,40527,0.0429496468014774,0.00423391215838786,0.0346511789710372,0.0512481146319176,4.4556038766859e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMG3,Proteasome assembly chaperone 3,42594,0.0528022822146973,0.00521321814427067,0.0425843746519267,0.0630201897774678,5.03729675701088e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C7,Complement component C7,40251,-0.0340438692899079,0.00336306750714569,-0.0406354816039134,-0.0274522569759023,5.56394001720584e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,0.0456903468963179,0.00451443139542988,0.0368420613612753,0.0545386324313604,5.6677993924388e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.0893154734491928,0.00883295221209661,0.0720028871134835,0.106628059784902,5.9819812699865e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMP6,Bone morphogenetic protein 6,42342,0.0417654138301352,0.00413534570805995,0.0336601362423377,0.0498706914179327,6.77808936245028e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP2,Retinol-binding protein 2,42587,-0.0794642404988501,0.00787405584335521,-0.0948973899518263,-0.0640310910458738,7.30128346242544e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MIA,Melanoma-derived growth regulatory protein,42679,0.0387643646024441,0.00384395930309302,0.0312302043683818,0.0462985248365064,7.85939738101716e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP3R1,Calcineurin subunit B type 1,42495,0.0411687825855886,0.00408398916987549,0.0331641638126327,0.0491734013585446,8.20188232477432e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FADD,FAS-associated death domain protein,42636,0.0773735151758114,0.00767734520888868,0.0623259185663896,0.0924211117852332,8.3834713840604e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP2,"Fatty acid-binding protein, intestinal",42636,-0.0812300995846239,0.00806424145204468,-0.0970360128306315,-0.0654241863386164,8.84295246736134e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,0.0590038523509279,0.00586229918908855,0.0475137459403144,0.0704939587615415,9.56721359659152e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABCA2,ATP-binding cassette sub-family A member 2,40116,0.03710767165372,0.0036854442336076,0.0298842009558491,0.0443311423515909,9.64195517005789e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,0.0877059653123592,0.00871910625599329,0.0706165170506123,0.104795413574106,1.05451522698338e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OPLAH,5-oxoprolinase,40223,0.0692612531772157,0.00688799690871117,0.0557607792361418,0.0827617271182896,1.10042258224618e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF23,Fibroblast growth factor 23,42711,0.0557653594147927,0.00555076044838794,0.0448858689359523,0.066644849893633,1.15317371471808e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA13,Carbonic anhydrase 13,42483,0.104736587353143,0.0104446147969801,0.0842651423510624,0.125208032355224,1.39536649342419e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJC21,DnaJ homolog subfamily C member 21,40483,0.0390855100560834,0.00390294699282494,0.0314357339501465,0.0467352861620202,1.65209624886393e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSTN,Growth/differentiation factor 8,42357,0.0544047662774354,0.00543798628767493,0.0437463131535926,0.0650632194012783,1.76499824449655e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRD1,Natural killer cells antigen CD94,42754,0.0479744713180825,0.00479754613338135,0.038571280896655,0.0573776617395099,1.84136801715898e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS3BP,Galectin-3-binding protein,40539,0.0311717172104766,0.00312034981043874,0.0250558315820167,0.0372876028389366,2.10994597081101e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,0.0679997622173133,0.00681164168685438,0.0546489445110788,0.0813505799235479,2.26406252895717e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,40482,0.0387017545217732,0.00388034488853274,0.031096278540249,0.0463072305032974,2.4790470889942e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,40283,0.0388581927969763,0.00389758150253995,0.031218933051998,0.0464974525419546,2.58951163072873e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,0.0621318052043793,0.00624067809787481,0.0499000761325447,0.0743635342762139,2.86156188221342e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XCL1,Lymphotactin,42721,0.0569712368925,0.0057231110398573,0.0457539392543797,0.0681885345306203,2.89522249558634e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,0.028909351747728,0.00290478552762831,0.0232159721135765,0.0346027313818795,3.09376106647836e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMSB10,Thymosin beta-10,42611,0.0748880654870951,0.00754123733075185,0.0601072403188214,0.0896688906553687,3.68755451417231e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA12,Serpin A12,42249,0.104684392208968,0.010544510880435,0.0840171508833152,0.12535163353462,3.80415885298283e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOD1,Superoxide dismutase [Cu-Zn],42365,0.0484560084117874,0.00488865467752443,0.0388742452438395,0.0580377715797353,4.4495820270247e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEP1B,Meprin A subunit beta,42636,0.119205336299494,0.0120359401245018,0.0956148936554704,0.142795778943518,4.79093655255094e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BDNF,Brain-derived neurotrophic factor,40527,0.0846091764102853,0.00854229925242053,0.0678662698755411,0.10135208294503,4.92457937424539e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTX3,Pentraxin-related protein PTX3,42594,-0.0492892617681408,0.00499198485100497,-0.0590735520761106,-0.0395049714601711,6.48230177550281e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NBN,Nibrin,42370,0.0538876839566749,0.00545995220952098,0.0431861776260137,0.064589190287336,6.76832262891574e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNMT,Histamine N-methyltransferase,42439,0.0483607429661832,0.00490060174347428,0.0387555635489737,0.0579659223833928,6.8493285307489e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD84,SLAM family member 5,42594,0.0315247450810358,0.00319697905186239,0.0252586661393855,0.037790824022686,7.36398458910231e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SWAP70,Switch-associated protein 70,40449,0.0357560842503608,0.00363518897632857,0.0286311138567569,0.0428810546439648,9.71895802226382e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.0278793759197444,0.00283760484264265,0.0223176704281648,0.033441081411324,1.08993716031538e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSPN,Persephin,42594,0.0930724061418464,0.00950091006503029,0.074450622414387,0.111694189869306,1.39254322991698e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTC,Probetacellulin,42346,0.074616281889178,0.00762402649803083,0.0596731899530375,0.0895593738253184,1.52869355274548e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTNB,Dystrobrevin beta,40430,0.0426252637477753,0.0043565120912927,0.0340865000488416,0.051164027446709,1.61800091012144e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,0.036424882233708,0.00372784717844493,0.029118301763956,0.0437314627034601,1.78436586560465e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,0.0529883307759883,0.00542174721044132,0.0423617062435233,0.0636149553084533,1.80931122598325e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX9,Sorting nexin-9,42636,0.0665337131658022,0.00681290061073323,0.0531804279687651,0.0798869983628394,1.87389028247085e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,0.0584442508133292,0.00598465906841275,0.0467143190392403,0.0701741825874182,1.88032407079168e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,0.0626183497948923,0.00642358931096227,0.0500281147454062,0.0752085848443783,2.22738701857669e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,0.0523692097659661,0.00537291933410799,0.0418382878711145,0.0629001316608178,2.34128538485138e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,0.0723405652148643,0.00743128111874703,0.0577752542221201,0.0869058762076085,2.54881502124343e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,0.0423809898373831,0.00435616737943202,0.0338429017736963,0.0509190779010699,2.68584031940993e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL10RB,Interleukin-10 receptor subunit beta,42676,0.0297891809215698,0.00306793398606207,0.0237760303088881,0.0358023315342514,3.23663208117496e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAP25,Synaptosomal-associated protein 25,40136,0.0469452194579506,0.00483375801935841,0.0374710537400082,0.0564193851758931,3.29621196601464e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH7,Protocadherin-7,40449,0.0358701127830173,0.00370154064149754,0.0286150931256821,0.0431251324403525,4.0338144230188e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARFIP1,Arfaptin-1,40482,0.0674619179685431,0.0069628546997027,0.0538147227571258,0.0811091131799604,4.10095727628395e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,0.0865561077516158,0.00893650189920336,0.0690405640291772,0.104071651474054,4.11124715004446e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABHD14B,Protein ABHD14B,42460,0.0562627889495127,0.0058144947039632,0.0448663793297449,0.0676591985692806,4.49761740989456e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,42370,0.0649845290118874,0.00671585921339535,0.0518214449536325,0.0781476130701423,4.50361722698983e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,-0.0348224876825077,0.00360628692442263,-0.0418908100543761,-0.0277541653106394,5.66064367928321e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHRDL2,Chordin-like protein 2,42636,0.046466699450963,0.00481462701413366,0.0370300305032611,0.055903368398665,5.72717366117146e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX16,Syntaxin-16,42346,0.0569278466018197,0.00589992767171748,0.0453639883652535,0.068491704838386,5.87424005760043e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOF,Apolipoprotein F,40532,-0.023408454767548,0.00242692204942839,-0.0281652219844276,-0.0186516875506683,6.24538785632098e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARF2,Scavenger receptor class F member 2,42711,-0.0296586189791656,0.00309282591135316,-0.0357205577654178,-0.0235966801929134,1.03785609851278e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12A_IL12B,Interleukin-12,42587,0.080064300824338,0.00835036383986329,0.0636975876982059,0.09643101395047,1.05314869916728e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.0446035101153776,0.00465630830245892,0.0354771458425581,0.0537298743881971,1.18778581684947e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AFP,Alpha-fetoprotein,42459,0.0654534230284079,0.00684287468642348,0.0520413886430179,0.0788654574137979,1.31483800922051e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOE,Apolipoprotein E,40539,0.0708985779083061,0.007413527927974,0.0563680631694771,0.0854290926471352,1.37419666896146e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPM1F,Protein phosphatase 1F,40511,0.0506794392831216,0.00530152242108936,0.0402884553377864,0.0610704232284567,1.42848555489192e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB2B,Ras-related protein Rab-2B,40451,0.0588967269041914,0.00616424311995865,0.0468148103890724,0.0709786434193103,1.49773465943752e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGS10,Regulator of G-protein signaling 10,40482,0.0577579710049839,0.00604694837896311,0.0459059521822162,0.0696099898277516,1.5403927390291e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3BP1,SH3 domain-binding protein 1,40449,0.0465513194968816,0.00487442026957882,0.0369974557685071,0.056105183225256,1.56301694498121e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.0508033122439841,0.00532298604114157,0.0403702596033466,0.0612363648846216,1.61127455901425e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLF4,Krueppel-like factor 4,40136,0.0390544640256779,0.00409211142785651,0.0310339256270792,0.0470750024242767,1.66876337651544e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRP2,Neuropilin-2,42611,-0.0279548997946042,0.00293245420456053,-0.0337025100355428,-0.0222072895536656,1.78807024833046e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARAF,Serine/threonine-protein kinase A-Raf,40302,0.0665822432413933,0.00699014065950685,0.0528815675487598,0.0802829189340267,1.98923459725086e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,0.0341098730813422,0.00358282159992241,0.0270875427454943,0.0411322034171901,2.08594775075297e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL4,Angiopoietin-related protein 4,42654,-0.0434581718223653,0.00457031224335018,-0.0524159838193316,-0.0345003598253989,2.25104653722204e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CORO1A,Coronin-1A,42353,0.0863988176419943,0.00908867830437191,0.0685850081654253,0.104212627118563,2.31561923894782e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK7,Kallikrein-7,40009,0.0378982308998973,0.00398772208955501,0.0300822956043695,0.0457141661954251,2.45289104922806e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MENT,Protein MENT,40283,-0.0224081507785248,0.00236013498694871,-0.0270340153529443,-0.0177822862041053,2.66730937193893e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GDF2,Growth/differentiation factor 2,42636,0.0346643569418458,0.00365569287515367,0.0274991989065446,0.041829514977147,2.89879034631713e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PARD3,Partitioning defective 3 homolog,40302,0.0718320835921069,0.00757473462282547,0.056985603731369,0.0866785634528448,2.96971540422576e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMB1,Laminin subunit beta-1,40223,0.0293869244854641,0.00310126814431602,0.0233084389226047,0.0354654100483235,3.18847191915703e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,-0.0231854662130265,0.00245013619195206,-0.0279877331492526,-0.0183831992768005,3.48344107221474e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLMH,Bleomycin hydrolase,42794,0.0301750626337194,0.00318997600172558,0.0239227096703372,0.0364274155971015,3.5997693902738e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HRG,Histidine-rich glycoprotein,40479,0.0298041429887076,0.00314995346649175,0.0236302341943838,0.0359780517830314,3.62677180468411e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LONP1,"Lon protease homolog, mitochondrial",40223,0.0835786694034836,0.00883317188230734,0.0662656525141612,0.100891686292806,3.63720311225911e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,40511,0.0579812501654472,0.00613547422459823,0.0459557206852346,0.0700067796456597,4.04675989148385e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAP3,Cytosol aminopeptidase,42370,0.0466097328278319,0.00494206430755572,0.0369232867850227,0.0562961788706411,4.72227973396455e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLO1,Lactoylglutathione lyase,42357,0.0557169811266323,0.00590814638946883,0.0441370142032734,0.0672969480499912,4.75406798244472e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCRG1,Scrapie-responsive protein 1,40511,0.0274819817164663,0.00291345596149669,0.0217716080319328,0.0331923554009999,4.77118864318479e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD40LG,CD40 ligand,42754,0.0743774538195481,0.00789512019384799,0.0589030182396061,0.0898518893994902,5.19543875410346e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREML2,Trem-like transcript 2 protein,42611,0.0333641626242835,0.00354950400872004,0.0264071347671922,0.0403211904813748,6.34714325594259e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN4,CCN family member 4,42721,0.0383951368753897,0.0040848211073237,0.0303888875050352,0.0464013862457441,6.351700773681e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,0.0235078235184476,0.00250175253639972,0.0186043885471041,0.028411258489791,6.53957853439015e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARF1,Scavenger receptor class F member 1,42794,0.0400121835455035,0.00426168257628645,0.031659285695982,0.0483650813950249,7.01727746500857e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42711,0.0340122008960316,0.0036231699387319,0.026910787816117,0.0411136139759461,7.11738736415891e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD274,Programmed cell death 1 ligand 1,42495,0.033573161933526,0.00357671007764414,0.0265628101813435,0.0405835136857085,7.18900345851534e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMOTL2,Angiomotin-like protein 2,40404,0.0461960237899078,0.00492072200555427,0.0365514086590215,0.0558406389207942,7.2894462810031e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ING1,Inhibitor of growth protein 1,42292,0.0451208168307964,0.00481068067453709,0.0356918827087037,0.0545497509528891,7.71896026318007e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTRK3,NT-3 growth factor receptor,42711,-0.0208342386126643,0.00222234511578706,-0.025190035039607,-0.0164784421857217,8.00919481944356e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,0.0324664050381134,0.00346586922224475,0.0256733013625137,0.0392595087137131,8.60057178012649e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,0.0440234984907722,0.00469921555527588,0.0348130360024314,0.0532339609791129,8.77542018665142e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NID1,Nidogen-1,42652,0.0365935670524531,0.00390883284101501,0.0289322546840637,0.0442548794208425,9.06805035170413e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA4,Carbonic anhydrase 4,42794,-0.0229987096699251,0.0024610738935605,-0.0278224145013037,-0.0181750048385465,1.0600241068883e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSNL1,Visinin-like protein 1,40483,0.0365163341301526,0.00391535863771716,0.0288422312002269,0.0441904370600782,1.29848858699948e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAGED1,Melanoma-associated antigen D1,42346,0.0458543842530597,0.00492928945755223,0.0361929769162573,0.055515791589862,1.5868468926208e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTN2,Dynactin subunit 2,42587,0.0886767175642074,0.00953524314795509,0.0699876409942154,0.107365794134199,1.6207865996551e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,0.0485261973430442,0.00521927898322855,0.0382964105359162,0.0587559841501721,1.65630520219346e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VCAM1,Vascular cell adhesion protein 1,42663,-0.0265002276750814,0.00285365054569394,-0.0320933827446415,-0.0209070726055213,1.83640257695202e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX6,Peroxiredoxin-6,42721,-0.0574405401110841,0.00618951966108303,-0.0695719986468068,-0.0453090815753613,1.94350116205289e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPMT,Thiopurine S-methyltransferase,42346,0.0688304300024636,0.007424810272172,0.0542778018690065,0.0833830581359207,2.14105627615322e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,0.0395670504974374,0.00426756608098878,0.0312026209786994,0.0479314800161754,2.17317870349837e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP7,Matrilysin,42333,0.0476259924843194,0.0051489991493773,0.0375339541515399,0.0577180308170989,2.59778235644331e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCRN1,Secernin-1,42594,0.0518305629918907,0.00563336418894943,0.0407891691815498,0.0628719568022316,4.07764029945979e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCRIB,Protein scribble homolog,40223,0.0851160478394736,0.00925885145613566,0.0669686989854477,0.103263396693499,4.507678768088e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRLF1,Cytokine receptor-like factor 1,42676,0.0235475157730962,0.00256379078372578,0.0185224858369937,0.0285725457091987,4.72320764358122e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD164,Sialomucin core protein 24,42611,0.0256151302226623,0.00279101823991767,0.0201447344724237,0.031085525972901,5.03924995419429e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40980,-0.02982051584449,0.00324876430586183,-0.0361880938839792,-0.0234529378050008,5.07097413342763e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF2,Fibroblast growth factor 2,42594,0.0639592077111494,0.0069757345252314,0.0502867680416958,0.0776316473806029,5.47058979714023e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TST,Thiosulfate sulfurtransferase,42277,0.0696892140359088,0.00760266655526195,0.0547879875875954,0.0845904404842222,5.61088917560187e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LIPF,Gastric triacylglycerol lipase,40223,0.0580995034132898,0.00636154288515376,0.0456308793583884,0.0705681274681911,7.8292161614771e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,0.0376961072944317,0.00413095484085832,0.0295994358063494,0.045792778782514,8.41103696854289e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,0.0762737174277786,0.00837392749189127,0.0598608195436717,0.0926866153118854,9.75865725433284e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STXBP3,Syntaxin-binding protein 3,42346,0.0401935616433223,0.00441897954045148,0.0315323617440374,0.0488547615426072,1.07346692099069e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GDNF,Glial cell line-derived neurotrophic factor,42311,0.0354791791803863,0.00390216502732829,0.0278309357268229,0.0431274226339498,1.10864470931007e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,0.0299146242377182,0.00329263375012529,0.0234610620874726,0.0363681863879637,1.20583557290848e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGFL7,Epidermal growth factor-like protein 7,42346,0.0368509865816045,0.00406321539689942,0.0288870844036816,0.0448148887595273,1.36429632720104e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINT2,Kunitz-type protease inhibitor 2,42676,0.037211230130772,0.00411364468871634,0.029148486540888,0.045273973720656,1.68627676556859e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAP18,Chromatin complexes subunit BAP18,40483,0.0623734568022311,0.0069051661172046,0.04883933121251,0.0759075823919521,1.94352413232766e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCAM2,Neural cell adhesion molecule 2,42611,-0.0250498062445305,0.00277674479926641,-0.0304922260510926,-0.0196073864379683,2.10841828585214e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL24,C-C motif chemokine 24,42654,0.076129517448651,0.00843915722783942,0.0595887692820858,0.0926702656152163,2.11330413487281e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFASC,Neurofascin,42754,0.0267017244852388,0.00296051291667342,0.0208991191685589,0.0325043298019187,2.14409706921875e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FRZB,Secreted frizzled-related protein 3,42454,0.0228319124306285,0.00254615743781749,0.0178414438525063,0.0278223810087508,3.44433214362225e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPAG1,Sperm-associated antigen 1,40482,0.052405972851369,0.00584978562478471,0.040940393026791,0.0638715526759471,3.8027931876815e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR3,Toll-like receptor 3,42754,0.0557653977144884,0.00622695003557054,0.0435605756447702,0.0679702197842067,3.81750308666827e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC27A4,Long-chain fatty acid transport protein 4,42311,0.0607802878215337,0.00680161513706862,0.0474491221528792,0.0741114534901882,4.56170445440107e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF6,SLAM family member 6,42346,0.0353732854087456,0.00396313345018933,0.0276055438463745,0.0431410269711167,5.01455667491059e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD72,B-cell differentiation antigen CD72,40283,0.0403181747848042,0.00451609566590521,0.03146662727963,0.0491697222899784,5.0355311178414e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UNC79,Protein unc-79 homolog,40080,0.0506161177972526,0.00567663101224445,0.0394899210132535,0.0617423145812517,5.57680351495094e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,0.0364119826445589,0.00408645080320231,0.0284025390702823,0.0444214262188354,5.72465165496735e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,0.0366452274015684,0.00411147367768132,0.028586738993313,0.0447037158098238,5.75348813512643e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42706,0.0602383249587952,0.00676303793496245,0.0469827706062688,0.0734938793113216,5.9056697687594e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HPCAL1,Hippocalcin-like protein 1,42754,0.0656782037598509,0.00737534244501778,0.0512225325676161,0.0801338749520858,6.00385331429153e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42565,0.0392430129362095,0.00441174208328378,0.0305959984529733,0.0478900274194457,6.5760264513425e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DENR,Density-regulated protein,40199,0.0516991071114654,0.00581278139600926,0.0403060555752872,0.0630921586476435,6.81238935319765e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERI1,3'-5' exoribonuclease 1,40302,0.0311979392839073,0.00351189475185939,0.0243146255702629,0.0380812529975517,7.47465566357731e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH5,Cadherin-5,42794,-0.0273150174459464,0.00307617836854326,-0.0333443270482911,-0.0212857078436016,7.5455635959734e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAA10,N-alpha-acetyltransferase 10,40116,0.0465686399490331,0.00524924956312501,0.0362801108053081,0.0568571690927581,8.34119951537174e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.040008604996322,0.00451172820907086,0.0311656177065431,0.0488515922861009,8.61627230694556e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMPA1,Inositol monophosphatase 1,42495,0.0546894678925671,0.00617213911059489,0.0425920752358011,0.066786860549333,8.95023931613219e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,0.071400910139937,0.00808461786941243,0.0555550591158886,0.0872467611639854,1.18347526511087e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA6,Integrin alpha-6,42594,0.0457470732180411,0.00518858377884772,0.0355774490114995,0.0559166974245826,1.32072142688748e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,40511,0.0293588705679111,0.00333695695393442,0.0228184349381996,0.0358993061976225,1.59292897909298e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENO2,Gamma-enolase,42711,0.0577059029414011,0.00656711032091352,0.0448343667124106,0.0705774391703916,1.71763913740446e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL11,C-X-C motif chemokine 11,42711,0.0715020970230038,0.00813860262293738,0.0555504358820465,0.0874537581639611,1.74147301347682e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BGLAP,Osteocalcin,40527,0.0811008543195967,0.00924111083921717,0.0629882770747311,0.0992134315644624,1.93449545793857e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFB,Complement factor B,40344,0.0289544009541764,0.00330204672944953,0.0224823893644553,0.0354264125438975,2.07082313276928e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD1C,T-cell surface glycoprotein CD1c,42679,0.0225341249274959,0.00257189169452259,0.0174932172062316,0.0275750326487602,2.15062250324138e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD93,Complement component C1q receptor,42141,-0.0288761978861367,0.00329563433950359,-0.0353356411915637,-0.0224167545807096,2.15560507797323e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL6R,Interleukin-6 receptor subunit alpha,42582,0.0303623670021651,0.00347673527147936,0.0235479658700655,0.0371767681342646,2.77099908241449e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNM1,Dynamin-1,40449,0.101272230754603,0.0116167525933511,0.0785033956716348,0.124041065837571,3.2345692254931e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SF3B4,Splicing factor 3B subunit 4,42587,0.0644975676250033,0.00741036052648603,0.0499732609930907,0.0790218742569159,3.58411706808843e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTSL2,ADAMTS-like protein 2,40527,0.0302472162478696,0.00348674025301591,0.0234132053519584,0.0370812271437808,4.70167917315517e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.0775566691559914,0.00894717343792561,0.0600202092176572,0.0950931290943256,4.98650475193885e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB103A_DEFB103B,Beta-defensin 103,40135,0.0377296449705107,0.00435701179677972,0.0291899018488225,0.046269388092199,5.40210567578396e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPXM1,Probable carboxypeptidase X1,42679,0.0613302890205652,0.00708745056383493,0.0474388859154488,0.0752216921256817,5.56124975231886e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD2,Sushi domain-containing protein 2,42611,-0.0254704832089695,0.00294985997356527,-0.0312522087571574,-0.0196887576607815,6.55923876257781e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DGKZ,Diacylglycerol kinase zeta,42370,0.0307330807322312,0.00356357804684192,0.023748467760421,0.0377176937040414,7.1845131183166e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAP,Prolyl endopeptidase FAP,42794,0.0239396878358464,0.00278863849763512,0.0184739563804815,0.0294054192912112,1.00850613518163e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMS,Spermine synthase,40136,0.0558688138767555,0.00651197598510102,0.0431053409459575,0.0686322868075535,1.0824155131639e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,40283,0.0329890213810843,0.00384583051386376,0.0254511935739113,0.0405268491882573,1.09496371148031e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL18,C-C motif chemokine 18,42477,0.0609062566308155,0.00710593728029335,0.0469786195614406,0.0748338937001905,1.13651888552106e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC134,Coiled-coil domain-containing protein 134,40451,0.0426210565598207,0.00497153609771733,0.0328768458082948,0.0523652673113467,1.13967622792581e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRA1,GDNF family receptor alpha-1,42689,0.0259731171306558,0.00303273784385003,0.0200289509567098,0.0319172833046019,1.20465009307923e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPK1,Thiamin pyrophosphokinase 1,40511,0.0239248967726403,0.00279360004965899,0.0184494406753087,0.0294003528699719,1.22912919851709e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BOLA1,BolA-like protein 1,40136,0.0473366809752146,0.00553143858965474,0.0364950613394913,0.0581783006109379,1.30454027233464e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,0.0453842708166496,0.00531184172564224,0.0349730610343908,0.0557954805989084,1.43440966465073e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTR1,Endosome-associated-trafficking regulator 1,40223,0.0508805227662395,0.00596237120984159,0.03919427519495,0.0625667703375291,1.60415209010298e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42611,0.0261382649795731,0.00306716619722453,0.020126619233013,0.0321499107261331,1.73480371199042e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,0.0479111382217631,0.0056295084580169,0.0368773016440499,0.0589449747994762,1.94749817864357e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGR,Tyrosine-protein kinase Fgr,42311,0.0496941148627354,0.00584462207593976,0.0382386555938935,0.0611495741315773,2.05405425297734e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APRT,Adenine phosphoribosyltransferase,42480,0.0410642149738493,0.0048326571546046,0.0315922069508243,0.0505362229968744,2.14676956336453e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,0.0639597327178139,0.00752654363783779,0.0492077071876518,0.0787117582479759,2.17222730503171e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,0.05019264362841,0.00591239079279704,0.0386043576745278,0.0617809295822922,2.2978408091325e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,0.0839068469596421,0.00988659873137176,0.0645291134461534,0.103284580473131,2.3930087729519e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,42311,0.0451343083081009,0.00532440982389801,0.0346984650532609,0.055570151562941,2.55868111173802e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGH,Gamma-glutamyl hydrolase,42437,0.0295618541606684,0.00349124769061848,0.0227190086870561,0.0364046996342806,2.7710546038512e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12B,Interleukin-12 subunit beta,42754,0.0489949086215829,0.00578992314112189,0.037646659264984,0.0603431579781818,2.89302284545777e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,40329,0.0482386245361687,0.00569893794099595,0.0370687061718167,0.0594085429005208,2.89473981345785e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS27,Serine protease 27,42603,0.034793628316762,0.00411398404766474,0.0267302195833391,0.0428570370501849,3.01450467992193e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,0.0262018536481655,0.00309740436785396,0.0201309410871718,0.0322727662091593,3.02020694679084e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEK7,Serine/threonine-protein kinase Nek7,40302,0.0657557199944313,0.00777342082623321,0.0505198151750142,0.0809916248138484,3.03317710510472e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,42408,0.0414720489997458,0.00490466161165851,0.0318589122408952,0.0510851857585965,3.06462265931084e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRK5,G protein-coupled receptor kinase 5,42357,0.0438153192551323,0.00518452672341544,0.033653646877238,0.0539769916330266,3.18480357209195e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFRP1,Secreted frizzled-related protein 1,42457,0.0381605661467775,0.00451845526760664,0.0293043938222685,0.0470167384712865,3.34021452426118e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACRBP,Acrosin-binding protein,40451,0.0336812629583311,0.00399713257515507,0.0258468831110272,0.0415156428056351,3.99902546617633e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,0.0553825579578441,0.00657356044032879,0.0424983794947997,0.0682667364208886,4.05324609952812e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBLN4,Cerebellin-4,42721,0.0279543734099515,0.00332263976564723,0.0214419994692829,0.0344667473506201,4.38294702266554e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAL,Integrin alpha-L,40199,0.0382919394891202,0.0045548560163327,0.0293644216971081,0.0472194572811323,4.73095999110404e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0835052441658009,0.00994979285285823,0.0640036501741987,0.103006838157403,5.22229016683927e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPQ,Carboxypeptidase Q,40516,0.0306300839849912,0.00364907061209297,0.023477905585289,0.0377822623846934,5.25955709912871e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,-0.0168424215669207,0.00200815450268646,-0.0207784043921861,-0.0129064387416552,5.48140008605647e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOM3,Myomesin-3,40283,-0.0792658201203088,0.00944878906486466,-0.0977854466874435,-0.0607461935531741,5.49715486202177e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,0.0496889748640725,0.00592758854873281,0.0380709013085562,0.0613070484195888,5.78753112004483e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPL14,60S ribosomal protein L14,40223,0.0342392850971765,0.00408909533106965,0.02622465824828,0.042253911946073,6.27905016224612e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STK4,Serine/threonine-protein kinase 4,42636,0.0729328581205518,0.00872391688844508,0.0558339810191995,0.0900317352219042,6.87775758070245e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDA,Cytidine deaminase,40494,0.0399708799989336,0.00478839391012438,0.0305856279350898,0.0493561320627773,7.78655766410667e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFCAB2,Dynein regulatory complex protein 8,40302,0.0297046439734798,0.0035613833857353,0.0227243325374387,0.036684955409521,8.25273755625627e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPPK1,Epiplakin,40223,0.0615345665785396,0.00740737993275758,0.0470161019103347,0.0760530312467444,1.09448573328767e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL16,C-X-C motif chemokine 16,42778,0.0202106885940521,0.00243711041999789,0.0154339521708562,0.0249874250172479,1.20849050766777e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP1,Rho GTPase-activating protein 1,42346,0.0382244290430102,0.00461231247503682,0.0291842965919381,0.0472645614940824,1.26817031822683e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,0.0595321249994846,0.00718324997663356,0.0454529550452829,0.0736112949536864,1.28829079527023e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,0.0231986357184618,0.0028007371339498,0.0177091909359202,0.0286880805010034,1.34002350086656e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TF,Serotransferrin,40539,0.0180109847005862,0.00217547980894632,0.0137470442750515,0.022274925126121,1.38018659794018e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.0533428638828535,0.00645248598231651,0.0406959913575131,0.0659897364081938,1.52641535491024e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,0.0364439196893136,0.00441067430253214,0.0277989980563506,0.0450888413222766,1.58355090251313e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.0251667831800862,0.00304825549533054,0.0191922024092384,0.0311413639509341,1.64616338241334e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,42346,0.0316223851964001,0.00383570427416296,0.0241044048190407,0.0391403655737595,1.81911156943932e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDGF,Hepatoma-derived growth factor,42700,0.0778925479230221,0.00949089384486018,0.0592903959870961,0.096494699858948,2.47022947963626e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMARCA2,Probable global transcription activator SNF2L2,42311,0.0608798649957655,0.00742756736866263,0.0463218329531867,0.0754378970383442,2.70383283652161e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,0.0760271122698454,0.00927456690481447,0.057848961136409,0.0942052634032817,2.72676980097096e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C7orf50,Uncharacterized protein C7orf50,40483,0.0190303662515903,0.00232416557970573,0.0144750017153671,0.0235857307878135,2.94047179303934e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA2,Annexin A2,40054,0.0606796380892307,0.00741137630961368,0.0461533405223879,0.0752059356560736,2.96887767455437e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,40483,0.0271976599138594,0.00332519445017142,0.0206802787915234,0.0337150410361954,3.16129166597449e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLRX,Glutaredoxin-1,42546,0.0464505566546977,0.00571538670071889,0.0352483987212887,0.0576527145881068,4.77435822932929e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,0.0729381096046077,0.00897877282920163,0.0553397148593725,0.0905365043498429,5.01368516224924e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,0.0363279613995266,0.00447224037049146,0.0275623702733633,0.0450935525256899,5.03418658133193e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WAS,Wiskott-Aldrich syndrome protein,42370,0.0549931294059997,0.00677711218508835,0.0417099895232265,0.0682762692887728,5.30618306791436e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNGR2,Interferon gamma receptor 2,42495,0.0431741801041735,0.00532520751714108,0.032736773370577,0.0536115868377701,5.61603743532005e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DHPS,Deoxyhypusine synthase,40451,0.0334501667211069,0.00412760189364566,0.0253600670095614,0.0415402664326524,5.86653643688514e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,0.0593853642963532,0.00733321418936913,0.0450122644851897,0.0737584641075167,6.06381905344124e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASAH1,Acid ceramidase,40418,0.0377341651607609,0.00466467351769977,0.0285914050660694,0.0468769252554525,6.61545083077513e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDZD2,PDZ domain-containing protein 2,40116,0.0498051234031412,0.00617079531371067,0.0377103645882683,0.0618998822180141,7.69699212853996e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARSA,Arylsulfatase A,42611,0.0366579607705026,0.00454363628631719,0.0277524336493209,0.0455634878916843,7.75091700433239e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MET,Hepatocyte growth factor receptor,42654,-0.016307279374156,0.00202699008193017,-0.0202801799347391,-0.0123343788135728,9.33686779988221e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCOF1,Treacle protein,40511,0.0264418170357543,0.00328902242705875,0.0199953330787192,0.0328883009927895,9.9240173444337e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNAR1,Interferon alpha/beta receptor 1,40449,0.0210982260537301,0.00262447606981746,0.0159542529568878,0.0262421991505723,9.9607496098262e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,0.038555206710656,0.00479767008733406,0.0291517733394813,0.0479586400818308,1.01857188857631e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA9,Serpin A9,42538,0.0587363762552589,0.00731971347527604,0.0443897378437179,0.0730830146667999,1.10492483439911e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMPER,BMP-binding endothelial regulator protein,40283,0.0189822505518369,0.00236549785838224,0.0143458747494077,0.0236186263542661,1.12090947053552e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMM2,Phosphomannomutase 2,40116,0.0492335287174749,0.00613667587521132,0.0372056440020607,0.0612614134328891,1.13901935312312e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,0.0781581391665439,0.0097452592942503,0.0590574309498133,0.0972588473832745,1.14444155317823e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSE,Cathepsin E,40283,0.0418540301431552,0.00522545656327001,0.031612135279146,0.0520959250071645,1.26546763988659e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C5,Complement C5,40539,0.0123073870177864,0.00153721726141145,0.00929444118541996,0.0153203328501529,1.29756793440995e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BPIFA2,BPI fold-containing family A member 2,39838,-0.0925326447916365,0.0115584658544653,-0.115187237866388,-0.0698780517168845,1.31249170143674e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARA5,Scavenger receptor class A member 5,42711,0.025171761408842,0.00315104114163613,0.0189957207712352,0.0313478020464488,1.47711136682871e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OCLN,Occludin,40482,0.0367218000262684,0.00459587077188619,0.0277138933133715,0.0457297067391654,1.47843510725823e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPE,Ribulose-phosphate 3-epimerase,40302,0.0569420232062482,0.00712875023306939,0.0429696727494322,0.0709143736630642,1.51097171107631e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLIT2,Slit homolog 2 protein,42311,0.0428660896896085,0.00537263866911039,0.0323357178981522,0.0533964614810649,1.60242041992456e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NGRN,Neugrin,40483,0.0188727037687532,0.00236645439685331,0.0142344531509207,0.0235109543865857,1.66939916375667e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFNA4,Ephrin-A4,42475,0.0275965241427524,0.0034749088068313,0.020785702881363,0.0344073454041417,2.15469713283603e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSS,Cathepsin S,39872,0.0198662522673513,0.00250129194840278,0.0149637200484819,0.0247687844862208,2.18233568988145e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.0288253991833024,0.00363127214701845,-0.0359426925914585,-0.0217081057751462,2.2478141713773e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL26,C-C motif chemokine 26,42594,0.0754810429650734,0.00952754400463088,0.0568070567159969,0.0941550292141499,2.51255528871783e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPING1,Plasma protease C1 inhibitor,40516,0.0148013496000451,0.00186891959017917,0.0111382672032939,0.0184644319967962,2.60245971359531e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAM,Basal cell adhesion molecule,42611,-0.0199506980688461,0.00252053901025058,-0.0248909545289372,-0.015010441608755,2.66033354750883e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP9,Caspase-9,40199,0.0505330456653658,0.00638651118937563,0.0380154837341895,0.063050607596542,2.76526828273442e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0740946843351227,0.00936591245288442,0.0557374959274693,0.0924518727427762,2.78917265342574e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PVR,Poliovirus receptor,42711,0.0296608079978509,0.00375110470618352,0.0223086427737312,0.0370129732219706,2.83522482196191e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTSL4,ADAMTS-like protein 4,40223,0.0191934468365152,0.00242825273920529,0.0144340714676728,0.0239528222053575,2.95285087261498e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,0.0363392401318377,0.00459758771386891,0.0273279682126546,0.0453505120510208,2.95913244207001e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,0.0655639466214394,0.00831694965589555,0.0492627252958841,0.0818651679469947,3.43730518599493e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF7,SLAM family member 7,42594,-0.0478506906589116,0.00608261009201363,-0.0597726064392583,-0.0359287748785649,3.9157796632462e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APLP1,Amyloid-like protein 1,42636,-0.0414122219702857,0.00526710468706268,-0.0517357471569286,-0.0310886967836429,4.05349988128103e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX58,Antiviral innate immune response receptor RIG-I,42346,0.0453805388251497,0.0057779066354597,0.0340558418196487,0.0567052358306507,4.33597660412388e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UMOD,Uromodulin,42764,-0.0442867348401179,0.00563935061337027,-0.0553398620423236,-0.0332336076379121,4.36010632690684e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA4,Annexin A4,42584,0.0571067053790247,0.00727682356745459,0.0428441311868137,0.0713692795712357,4.55582762199077e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,0.0936780479907074,0.0119381644042984,0.0702792457582826,0.117076850223132,4.64887669498604e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPCAM,Epithelial cell adhesion molecule,42616,-0.0790409995563988,0.0100945801501239,-0.0988263766506416,-0.059255622462156,5.24144541433041e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,40527,-0.0264916151144701,0.0033891258774768,-0.0331343018343246,-0.0198489283946156,5.9043631966122e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100P,Protein S100-P,42357,0.0434835534142425,0.00556479388975456,0.0325765573903236,0.0543905494381615,5.95683948517797e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSTB,Cystatin-B,42437,0.0339293130036202,0.00434882587462512,0.025405614289355,0.0424530117178855,6.55103030945958e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AOC3,Membrane primary amine oxidase,42689,-0.0240666760518596,0.00308830079392377,-0.0301197456079502,-0.018013606495769,7.02869478229382e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSR,"Glutathione reductase, mitochondrial",40490,0.0178114084528713,0.00229591447630544,0.0133114160793127,0.02231140082643,9.37961095102811e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARB2,Lysosome membrane protein 2,42302,0.0277669737876305,0.00358141015995376,0.0207474098741211,0.0347865377011399,9.62840387207651e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPME1,Protein phosphatase methylesterase 1,42587,0.0469741925309908,0.00608142070231259,0.0350546079544582,0.0588937771075235,1.20520363685992e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,40428,0.0326931351426566,0.00423223910656791,0.0243979464937835,0.0409883237915297,1.21567675003484e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX6,Syntaxin-6,42346,0.0520703371720152,0.00675477061048631,0.0388309867754621,0.0653096875685684,1.36233063116264e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANSC1,MANSC domain-containing protein 1,42679,-0.0220475639306317,0.00287050223598504,-0.0276737483131624,-0.016421379548101,1.69056221302134e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,0.032647529778903,0.00425450678808265,0.024308696474261,0.0409863630835449,1.812890948881e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SBSN,Suprabasin,40511,-0.0274601009461948,0.00357964128298811,-0.0344761978608515,-0.0204440040315381,1.84383984730104e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.0196181021347799,0.00255832612963367,0.014603782920698,0.0246324213488619,1.86230102862072e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPA,Apolipoprotein(a),40324,-0.142027026745548,0.0185681052416696,-0.178420513019221,-0.105633540471876,2.19284763263259e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMIGO2,Amphoterin-induced protein 2,42587,0.0182563199414834,0.00239655527965429,0.013559071593361,0.0229535682896058,2.75457775530572e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLR2,Folate receptor beta,42711,-0.0230220608305699,0.00302580517986638,-0.028952638983108,-0.0170914826780317,2.95433021797715e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,0.0345740636106715,0.00454354517314058,0.0256687150713159,0.043479412150027,2.97652375630281e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP1,Interstitial collagenase,42136,0.0708920326821504,0.0093210438785992,0.052622786680096,0.0891612786842048,3.03156878996426e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLTA,Clathrin light chain A,42357,0.0370104060536268,0.00486695474949496,0.0274711747446167,0.0465496373626369,3.05538904597023e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,0.0272131489676129,0.00359237009639198,0.0201721035786846,0.0342541943565412,3.87137036925868e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RANBP1,Ran-specific GTPase-activating protein,40223,0.0405407183352131,0.00535330808163681,0.030048234495205,0.0510332021752213,3.93777411296506e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RARRES1,Retinoic acid receptor responder protein 1,42346,0.0255211178686676,0.00337107365007617,0.0189138135145183,0.0321284222228169,3.96162392547426e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNF,Tumor necrosis factor,42339,0.0297343999570052,0.00393018226103654,0.0220312427253736,0.0374375571886368,4.11541538359994e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.0219643968130841,0.00290673492318675,0.0162671963636381,0.0276615972625302,4.41022464526694e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX7,Syntaxin-7,40199,0.038478497704832,0.00510740440256919,0.0284679850757964,0.0484890103338676,5.31222759141451e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,40449,0.0868611242568434,0.0115465759383602,0.0642298354176574,0.109492413096029,5.77537254300266e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA11,Integrin alpha-11,42594,-0.0260635404233823,0.00346990493855352,-0.0328645541029472,-0.0192625267438174,6.2238458756076e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DMD,Dystrophin,40223,0.0395201832171111,0.00526444524750713,0.0292018705319972,0.0498384959022251,6.51628846719997e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEPH,Hephaestin,40511,0.0203058477548848,0.00270653670781755,0.0150010358075624,0.0256106597022072,6.72905218465055e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM3B,Protein FAM3B,42587,0.0269685993409493,0.00360197765208494,0.0199087231428628,0.0340284755390358,7.47717744581526e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP8,Caspase-8,42674,0.0466855624220808,0.00625313622562973,0.0344294154198466,0.0589417094243151,8.77759884294334e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIF22,Kinesin-like protein KIF22,40116,0.0952050862072316,0.0127675839450193,0.0701806216749937,0.120229550739469,9.53804587953298e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNLIP,Pancreatic triacylglycerol lipase,40532,0.0496647369013548,0.00666087673403474,0.0366094185026467,0.0627200553000628,9.5554609731128e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSCAM,Down syndrome cell adhesion molecule,40482,0.027545705637601,0.00369962385295524,0.0202944428858087,0.0347969683893932,1.0357552601898e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,0.0290686730067554,0.00391248722582531,0.0214001980441378,0.036737147969373,1.15413573880129e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,0.0519225201047631,0.00699483701925184,0.0382126395470295,0.0656324006624967,1.21421571271271e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FXN,"Frataxin, mitochondrial",42721,0.0553880725764826,0.00746270388360581,0.0407611729646152,0.07001497218835,1.22261464639165e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP1,Metalloproteinase inhibitor 1,42501,0.0221819399815536,0.00299038880557132,0.0163207779226338,0.0280431020404734,1.26342723765604e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBLIF,Cobalamin binding intrinsic factor,42613,0.0613018322679681,0.00826852794596055,0.0450955174938854,0.0775081470420508,1.30007172098715e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1F,V-type proton ATPase subunit F,42292,0.0503154108813039,0.00678839329868386,0.0370101600158836,0.0636206617467243,1.32062148279049e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,0.0176442166870389,0.00238030521106168,0.012978818473358,0.0223096149007198,1.32679756643068e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXN,Thioredoxin,40384,0.0336595904682199,0.00454286464754763,0.0247555757590265,0.0425636051774132,1.36079083989547e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSHB,Thyrotropin subunit beta,42636,0.059956722460717,0.00809880361356281,0.0440830673781339,0.0758303775433001,1.40886804176547e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSR1,Macrophage scavenger receptor types I and II,42711,0.0348230924786522,0.00470733604166789,0.0255967138369831,0.0440494711203212,1.46813118974589e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,0.0444463775588301,0.00601702780108953,0.0326530030686946,0.0562397520489656,1.59400564482585e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.0200709261715955,0.00272245440041457,0.0147349155467829,0.025406936796408,1.77360888074147e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.0504604656142122,0.00684918467565374,0.0370360636499309,0.0638848675784935,1.8658653251929e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTGES2,Prostaglandin E synthase 2,40102,0.0407957664871015,0.00555483865639436,0.0299082827205685,0.0516832502536344,2.2178254510178e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL2A1,Collagen alpha-1(II) chain,40223,0.0605640264326446,0.00825994636588566,0.0443745315555087,0.0767535213097805,2.42169245034824e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,0.0230511446896106,0.00315164854476636,0.0168739135418685,0.0292283758373527,2.73936344582253e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NID2,Nidogen-2,42611,0.0551780822443732,0.00755133011497367,0.0403774752190248,0.0699786892697216,2.8845733768809e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MATN2,Matrilin-2,42638,0.0220754378120896,0.00302142934235446,0.0161534363010748,0.0279974393231043,2.90093748049767e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPA2,Carboxypeptidase A2,42670,0.0492872274259833,0.00674691437205511,0.0360632752567553,0.0625111795952114,2.92513457624658e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADM,Pro-adrenomedullin,42721,0.020024441144628,0.00274128423597417,0.0146515240421186,0.0253973582471373,2.93287354865745e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C4BPB,C4b-binding protein beta chain,42679,0.030053579044879,0.00411524777555111,0.0219876934047988,0.0381194646849591,2.97240485282642e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMMT,MICOS complex subunit MIC60,40451,0.0336485712591587,0.00461222176685311,0.0246086165961266,0.0426885259221908,3.1749783790661e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.0231578906629888,0.00317656934848338,-0.0293839665860162,-0.0169318147399613,3.27108804698433e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDHB,Succinate dehydrogenase,40449,0.0493988808355785,0.00678383284721363,0.0361025684550398,0.0626951932161173,3.51231978738223e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPR,Nucleoprotein TPR,40116,0.0361344067373179,0.00496266384439521,0.0264075856023032,0.0458612278723325,3.53488557207408e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSNK1D,Casein kinase I isoform delta,40199,0.0466528487184918,0.00642362276023135,0.0340625481084384,0.0592431493285452,4.0507116838266e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,0.0490766208837358,0.0067652823392358,0.0358166674988336,0.0623365742686379,4.30551205861913e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LACRT,Extracellular glycoprotein lacritin,40419,0.0381474446511126,0.00527551813875531,0.0278074290991522,0.048487460203073,5.10507869474963e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17D,Interleukin-17D,42370,0.0254323799786799,0.00352599340057667,0.0185214329135496,0.0323433270438101,5.77949614635424e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRH,Corticoliberin,42322,0.063329404661617,0.00878697730933676,0.046106929135317,0.0805518801879171,6.02400227623847e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSDE1,Cold shock domain-containing protein E1,40116,0.0857937957406306,0.0119185861173278,0.0624333669506681,0.109154224530593,6.49624912007673e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,40332,0.0419059472485937,0.00582270911195339,0.0304934373891651,0.0533184571080224,6.55180488248763e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALB2,Calretinin,42311,0.0235773553182217,0.00327863611094925,0.0171512285407611,0.0300034820956822,6.77014805412622e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREML1,Trem-like transcript 1 protein,40532,0.0384761108079117,0.00535004397239839,0.0279900246220109,0.0489621969938125,6.80000452061021e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42636,0.0254301332192833,0.00354019938143618,0.0184913424316683,0.0323689240068982,7.16566831965958e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX5,Sorting nexin-5,40223,0.0213386195170363,0.00297048679215464,0.0155164654044132,0.0271607736296594,7.23077668521119e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0348441355529106,0.00485311262364637,-0.0443562362952575,-0.0253320348105638,7.35137776567775e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,0.0317364839376456,0.00442757251874579,0.0230584418009038,0.0404145260743873,8.02012808277028e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAPK2,Death-associated protein kinase 2,40199,0.0396286089291774,0.00553083965312111,0.02878816320906,0.0504690546492947,8.27458262267442e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM3C,Protein FAM3C,42613,0.0227466144398841,0.00317711710858366,0.0165194649070601,0.028973763972708,8.51756308500447e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTGR1,Prostaglandin reductase 1,40511,0.0613136768883918,0.00856268723082102,0.0445308099159826,0.078096543860801,8.53257640714682e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.0187068095359184,0.00261377872805165,0.0135838032289372,0.0238298158428997,8.75512872132585e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AK1,Adenylate kinase isoenzyme 1,42636,0.0459494506947765,0.00642751818076538,0.0333515150604763,0.0585473863290766,9.20162094562689e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.0348902169079659,0.00488064055836808,0.0253241614135645,0.0444562724023674,9.22300350342517e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.0499339476118611,0.00700068497867239,0.0362126050536632,0.063655290170059,1.03416057514772e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCF2,Neutrophil cytosol factor 2,42578,0.0603701543930356,0.00846543458873309,0.0437779025991188,0.0769624061869525,1.04476334713859e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDCP1,CUB domain-containing protein 1,42495,0.0396062562946968,0.00555766835162357,0.0287132263255146,0.050499286263879,1.08324252376386e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.0186628817038827,0.00262936681778564,0.0135093227410229,0.0238164406667426,1.33065950668438e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FST,Follistatin,42654,0.035605961488968,0.00501645406640349,0.0257737115188172,0.0454382114591188,1.33074373585193e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB8,Serpin B8,42754,0.0417398384255156,0.00589075620735431,0.0301939562591012,0.0532857205919301,1.45225404347336e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP6,Gastrotropin,42334,0.0425629508123061,0.00600709414715891,0.0307890462838746,0.0543368553407376,1.45660949422122e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY75,Lymphocyte antigen 75,42594,0.028207542895421,0.00398210110850575,0.0204026247227497,0.0360124610680922,1.4748609752673e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,0.0399212329018543,0.00564018179459909,0.0288664765844401,0.0509759892192685,1.55161703624982e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42587,0.0153343723583706,0.00216863745215002,0.0110838429521565,0.0195849017645846,1.61482201197593e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNC,Tenascin,42689,-0.0348508561088333,0.00493811917827037,-0.0445295696982433,-0.0251721425194234,1.77781491696018e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST5,Cystatin-D,42357,0.0412118163150839,0.005845417298995,0.0297547984090537,0.0526688342211141,1.87467474871042e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,0.0354230901469264,0.00502468516392533,0.0255747072256327,0.04527147306822,1.89646226292025e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRPX,Sushi repeat-containing protein SRPX,40511,-0.0266116579166702,0.00378456496722688,-0.0340294052524349,-0.0191939105809055,2.15895194657881e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VGF,Neurosecretory protein VGF,40482,0.0226683182472444,0.00322757941467171,0.0163422625944878,0.0289943739000009,2.29114030723474e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPP1,Tripeptidyl-peptidase 1,42545,0.0321408449494922,0.00460011630720698,0.0231246169873665,0.0411570729116179,2.94218115385089e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.0373033659357791,0.00534013451180686,0.0268367022926376,0.0477700295789205,2.9755508070672e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPP1,Osteopontin,42771,-0.033672766848359,0.00483175869764782,-0.0431430138957487,-0.0242025198009693,3.33809286440192e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKK4,Dickkopf-related protein 4,42477,0.0330736857855053,0.00474643884085609,0.0237706656574273,0.0423767059135832,3.36383896292417e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAS2,Growth arrest-specific protein 2,40302,0.0374759229160629,0.00538605200864354,0.0269192609791215,0.0480325848530042,3.64670628818975e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.0410859899406884,0.00590612800411957,-0.0526620008287628,-0.0295099790526141,3.65017785251474e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,0.0275701141286062,0.00397000195850291,0.0197889102899405,0.0353513179672719,4.00905718548955e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTN,Pleiotrophin,42357,0.0350735035390019,0.00505600113129959,0.0251637413216547,0.044983265756349,4.19221059041154e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFDC1,WAP four-disulfide core domain protein 1,40229,0.0399829066544608,0.0057627790008945,0.0286878598127076,0.051277953496214,4.19581677574913e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.0204043421343544,0.00295576168509032,-0.0261976350371314,-0.0146110492315773,5.31090264213051e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSAP,Prosaposin,40440,0.0204475374193097,0.0029629697537845,0.0146401167018921,0.0262549581367273,5.44033878513338e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42611,0.0683820773007919,0.009912319028424,0.0489539320050809,0.0878102225965029,5.48350049439585e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTA,Lymphotoxin-alpha,42594,0.0287374834100556,0.00417345939247507,0.0205575030008045,0.0369174638193067,6.00365543883153e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLITRK2,SLIT and NTRK-like protein 2,42721,0.0279268941503297,0.00405677008771849,0.0199756247784015,0.035878163522258,6.0751102126693e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECE1,Endothelin-converting enzyme 1,42311,0.0250680100733017,0.00364137795715957,0.017930909277269,0.0322051108693345,6.0752913368466e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,0.0320224517216173,0.00465694101613622,0.0228948473299904,0.0411500561132443,6.41574234762086e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,40511,0.0187655115114967,0.00273441113837293,0.0134060656802857,0.0241249573427076,7.10885853981656e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.0248869217923206,0.00363557677680476,-0.032012652274858,-0.0177611913097833,7.96509051746833e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDF1,Endothelial differentiation-related factor 1,40482,0.0467889085197576,0.00684517147780255,0.0333723724232646,0.0602054446162506,8.60421137122446e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,0.0266148918039274,0.00390223952004233,0.0189665023446444,0.0342632812632103,9.54931597283744e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.0165539825248752,0.00242874475429449,0.011793642806458,0.0213143222432924,9.77049313180399e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB8,DnaJ homolog subfamily B member 8,42357,0.0405344333948564,0.00594950172211077,0.0288734100195192,0.0521954567701935,9.96852977552105e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCT,Secretin,40182,0.0346815399708327,0.00511741927542772,0.0246513981909944,0.044711681750671,1.2884100266922e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACTN2,Alpha-actinin-2,40116,-0.0412911551262984,0.00609479385212023,-0.0532369510764541,-0.0293453591761428,1.30965428130954e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BGN,Biglycan,42328,-0.0832024363625935,0.0122882786871406,-0.107287462589389,-0.0591174101357979,1.33445586842963e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,0.0316418802014718,0.00468076333939103,0.0224675840562654,0.0408161763466782,1.45045307789749e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,0.0465489947239882,0.00688884182773552,0.0330468647416266,0.0600511247063498,1.4767042719882e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAM,Signal transducing adapter molecule 1,40451,0.0258243782055199,0.0038231570317577,0.0183309904232748,0.033317765987765,1.5015879193543e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRSF1,G-rich sequence factor 1,40014,0.0557117481252283,0.00824903033401169,0.0395436486705654,0.0718798475798912,1.51479556739581e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0273938670786433,0.00405971624569307,0.0194368232370849,0.0353509109202017,1.56454602034653e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRDT,Bromodomain testis-specific protein,40116,0.025651556542412,0.00380690077543622,0.018190031022557,0.033113082062267,1.68463720615245e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM4,Intercellular adhesion molecule 4,42594,-0.0362723043717438,0.00539629507420715,-0.0468490427171898,-0.0256955660262978,1.86877865896022e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN5,CCN family member 5,42611,0.0265455099871076,0.00394973913084751,0.0188040212906465,0.0342869986835687,1.87995582169757e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,0.0374000665382107,0.00557062083194862,0.0264816497075914,0.04831848336883,1.97253233309534e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,0.0490623958441114,0.00731141126114111,0.0347320297722748,0.063392761915948,2.02046310682366e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,0.0257958708925263,0.00385192968440338,0.0182460887110957,0.033345653073957,2.23070970406849e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHCHD6,MICOS complex subunit MIC25,40451,0.0197607548812018,0.00295223951113745,0.0139743654393724,0.0255471443230311,2.28281794052016e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,0.0374752154548726,0.00560004579228189,0.0264991257020001,0.0484513052077451,2.2897832574119e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD302,CD302 antigen,42587,0.0218989658021879,0.00327475696447413,0.0154804421518186,0.0283174894525571,2.36497998737423e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMOX1,Heme oxygenase 1,42500,-0.0330010400329373,0.00494030015765672,-0.0426840283419445,-0.0233180517239301,2.48497950074651e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.0249327759417843,0.00373772005209641,0.0176068446396753,0.0322587072438932,2.64667823199004e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,0.029527273951615,0.0044296598674633,0.0208451406113869,0.0382094072918431,2.73477273308002e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NADK,NAD kinase,42636,0.0372118526113804,0.00558257771323598,0.0262700002934379,0.048153704929323,2.7366133644572e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL3,Myosin light chain 3,40223,-0.0500094237397999,0.00751164307854331,-0.0647322441737447,-0.035286603305855,2.91577924696183e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,0.0295378441741656,0.00443954339872664,0.0208363391126614,0.0382393492356698,2.99785826762628e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RABEPK,Rab9 effector protein with kelch motifs,42346,0.039049348644534,0.00587842743094733,0.0275276308798773,0.0505710664091908,3.19840198143717e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPOCK1,Testican-1,42495,0.0175115922979486,0.00263741479490627,0.0123422592999323,0.0226809252959649,3.26567538980636e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42721,0.0362713826858061,0.00546319819910996,0.0255635142155506,0.0469792511560616,3.27375438109462e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,0.0328453040325622,0.00495616923364556,0.0231312123346169,0.0425593957305075,3.55611072445236e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42595,0.0218800602971162,0.00331132956074314,0.0153898543580596,0.0283702662361727,4.05263579834011e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSL5,Insulin-like peptide INSL5,40449,0.0666275668972624,0.0100826288630493,0.0468656143256858,0.086389519468839,4.0671234670408e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FES,Tyrosine-protein kinase Fes/Fps,42346,0.0321047139263263,0.00486061526538495,0.0225779080061718,0.0416315198464808,4.12605318539855e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGHMBP2,DNA-binding protein SMUBP-2,40116,0.037039712204791,0.00561781577201474,0.0260287932916421,0.0480506311179399,4.50129210436365e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS7_LGALS7B,Galectin-7,42524,0.0291897474365554,0.00443041750611604,0.0205061291245679,0.0378733657485428,4.61020849986924e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,0.0492682389648564,0.00747865489421202,0.0346100753722009,0.063926402557512,4.66420447348953e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.0254213027235884,0.00386537821285706,0.0178451614263886,0.0329974440207883,5.02360938889026e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.0183970512488266,0.00279742550999023,0.0129140972492458,0.0238800052484075,5.03248365025674e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWC2,Brorin,42456,0.0277022630818603,0.00421837559965516,0.0194342469065361,0.0359702792571844,5.3236270208221e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,42311,0.0420534734429314,0.00642471999819695,0.0294610222464653,0.0546459246393974,6.14724667836392e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,0.0328304749162048,0.00501816878709712,0.0229948640934945,0.0426660857389152,6.27645540186933e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GC,Vitamin D-binding protein,40539,0.0172777792280492,0.00264480646937195,0.0120939585480802,0.0224615999080182,6.73490981121773e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL19,C-C motif chemokine 19,42711,0.0874042546091474,0.0133950230290889,0.0611500094721332,0.113658499746162,7.03641742478e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,0.045035788120786,0.00690577621768698,0.0315004667341195,0.0585711095074525,7.21268401779138e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP1,Guanylate-binding protein 1,40466,0.0437045344175487,0.00670370251609267,0.0305652774860071,0.0568437913490904,7.35740684102064e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPT,Dermatopontin,42794,0.0168440204756615,0.00258507001819105,0.011777283240007,0.021910757711316,7.48068000767764e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.0142843475187349,0.00219265490261544,0.00998674390960863,0.0185819511278612,7.54585136081368e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINI2,Serpin I2,40449,0.0373148719804066,0.0057284470692043,0.0260871157247661,0.048542628236047,7.63162103476604e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMA4,Laminin subunit alpha-4,42676,0.0220123534583089,0.00338128026396578,0.015385044140936,0.0286396627756818,7.77778116899106e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42781,0.0394422133627002,0.00607218161798587,0.0275407373914479,0.0513436893339525,8.56057963504109e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,40223,0.0346125206705517,0.00533398326790487,0.0241579134654581,0.0450671278756452,9.0078183523814e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYM,Ketimine reductase mu-crystallin,40136,0.0502990040209795,0.00775512566571628,0.0350989577161756,0.0654990503257834,9.20053787567138e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.036895834733787,0.00570140869414007,0.0257210736932725,0.0480705957743016,1.00509206950971e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42555,0.0215922046713891,0.00334028290174019,0.0150452501839784,0.0281391591587999,1.05384543479741e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSL,Cathepsin L1,42636,0.01635620220659,0.00253375045186671,0.0113900513209313,0.0213223530922488,1.11689259632319e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAT,Catalase,40361,0.0356990701325774,0.00553952719484553,0.0248415968306801,0.0465565434344746,1.20817725409132e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA3,Protein disulfide-isomerase A3,40283,0.0162753299716308,0.00252553473579159,0.0113252818894793,0.0212253780537823,1.20943248689965e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYZL2,Lysozyme-like protein 2,40080,0.0237395131913468,0.00368703747161626,0.0165129197469789,0.0309661066357147,1.25623916526902e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS22,Brain-specific serine protease 4,40199,0.0240647152861768,0.00374123444156614,0.0167318957807071,0.0313975347916464,1.30907750893347e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA7,Thyroxine-binding globulin,40539,0.0121454799031234,0.00188834659016931,0.00844432058639157,0.0158466392198552,1.31166299431764e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OMD,Osteomodulin,42676,-0.0276965832680717,0.00431712832951852,-0.036158154793928,-0.0192350117422154,1.45039754094566e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX1,Peroxiredoxin-1,42261,-0.058784563905754,0.0091734691792272,-0.0767645634970393,-0.0408045643144687,1.52395398174698e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REN,Renin,42636,-0.0560002152787502,0.00874369673319587,-0.0731378608758141,-0.0388625696816863,1.55742366784105e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESAM,Endothelial cell-selective adhesion molecule,42794,0.0212122059150284,0.00331706996756042,0.01471074877861,0.0277136630514468,1.65944864042716e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNLY,Granulysin,42611,0.0349959466111429,0.0054781148137665,0.0242588415761606,0.0457330516461252,1.73254705310038e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XRCC4,DNA repair protein XRCC4,42311,0.0239952867575892,0.0037700223993527,0.0166060428548579,0.0313845306603205,2.02105311340281e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HGFAC,Hepatocyte growth factor activator,40428,0.0180563185986578,0.00283729855716918,0.0124952134266062,0.0236174237707093,2.04335987336997e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOA1,Apolipoprotein A-I,40539,-0.01794957441563,0.00282165034845888,-0.0234800090986094,-0.0124191397326506,2.07651532975993e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELOB,Elongin-B,40116,0.0260663665481621,0.00410497896134975,0.0180206077839166,0.0341121253124076,2.2395481440809e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,-0.0257435476153171,0.0040547381194322,-0.0336908343294042,-0.01779626090123,2.24998429930178e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.0547635842613551,0.00863288372473762,0.0378431321608693,0.0716840363618408,2.31825291575791e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,40383,0.0385814350851167,0.00608283347685772,0.0266590814704756,0.0505037886997578,2.34520423227061e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALM2,Paralemmin-2,40483,0.0244533466157158,0.00385834974215575,0.0168909811210906,0.0320157121103411,2.41993267402514e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.0379443808205611,0.00598757039690803,0.0262087428426214,0.0496800187985009,2.43139261228814e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CABP2,Calcium-binding protein 2,40182,0.0418480829062888,0.00661586240202867,0.0288809925983126,0.054815173214265,2.62367624815296e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN1,Tetraspanin-1,42357,0.0439229371504233,0.00694603170135732,0.030308715015763,0.0575371592850837,2.64040418270975e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,0.0232456062111387,0.00367791010014547,0.0160369024148536,0.0304543100074238,2.69245225722151e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PER3,Period circadian protein homolog 3,40199,0.0795057941402533,0.0125892089209539,0.0548309446551837,0.104180643625323,2.79869182505476e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD46,Membrane cofactor protein,42580,0.0186615006239838,0.00295564668037884,0.0128684331304413,0.0244545681175264,2.80779045508682e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLU,Clusterin,40539,0.0203340784874338,0.00322521570314118,0.0140126557092771,0.0266555012655906,2.9944031946483e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA2,Carbonic anhydrase 2,42573,0.0447436661386561,0.00710187325343736,0.0308239945619189,0.0586633377153933,3.06451102069101e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MILR1,Allergin-1,42370,-0.033202834091264,0.00527588282194525,-0.0435435644222767,-0.0228621037602513,3.2058526432475e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,0.0267007389518524,0.0042441628913686,0.0183821796847699,0.0350192982189348,3.24769801299175e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR15L,Protein GPR15L,40449,0.0388731761097389,0.00622320083517184,0.0266757024728021,0.0510706497466757,4.34921141997694e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,0.0379937320185508,0.00609212530400577,0.0260531664226995,0.0499342976144021,4.61051990960867e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CX3CL1,Fractalkine,42495,-0.0219681832680195,0.00352686295981061,-0.0288808346692483,-0.0150555318667907,4.84128173602625e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIMAP8,GTPase IMAP family member 8,40080,0.0335591531564972,0.00539332871858733,0.022988228868066,0.0441300774449284,5.07782322487672e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSME2,Proteasome activator complex subunit 2,42441,0.0230197090566442,0.0037017028417555,0.0157643714868034,0.0302750466264849,5.16418903250539e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIMAP7,GTPase IMAP family member 7,40283,-0.0201925315220161,0.00325325661656123,-0.0265689144904761,-0.0138161485535561,5.59820969686373e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.0336130341243526,0.00541956479446538,0.0229906871272005,0.0442353811215047,5.7360040938279e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGFR,Epidermal growth factor receptor,42794,0.010301331497083,0.00166644124557349,0.007035106655759,0.0135675563384071,6.52542486272718e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDM1,Nuclear protein MDM1,40182,0.0198129625347052,0.00320749811017619,0.0135262662387599,0.0260996588306506,6.7609168036811e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL1,Fc receptor-like protein 1,42636,0.0295766165225782,0.00480284564750243,0.0201630390534734,0.038990193991683,7.56990886149616e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPM3,Tropomyosin alpha-3 chain,40116,-0.027633728767972,0.00449294068151397,-0.0364398925037394,-0.0188275650322046,7.99529859135462e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,-0.026050436701045,0.00423708383530577,-0.0343551210182443,-0.0177457523838457,8.05939868390489e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,40482,0.0332339042059075,0.00541612688596971,0.0226182955094068,0.0438495129024081,8.74063216405363e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G15,Phospholipase A2 group XV,42679,0.016666068051198,0.0027165147839981,0.0113416990745617,0.0219904370278343,8.74911981655694e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHGA,Chromogranin-A,40527,-0.0614024200374858,0.0100245383289617,-0.0810505151622507,-0.041754324912721,9.3565705201969e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDK2,Protein sidekick-2,40283,0.0252839649837454,0.00413098044061937,0.0171872433201314,0.0333806866473594,9.63906978708324e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RCOR1,REST corepressor 1,42357,0.027724112242463,0.00453191308425929,0.0188415625973148,0.0366066618876112,9.77312952472717e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGF1R,Insulin-like growth factor 1 receptor,42587,0.0135442300110873,0.0022203163583928,0.00919240994863741,0.0178960500735372,1.08897884258935e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C2orf69,UPF0565 protein C2orf69,40182,0.0380695231962359,0.00624299748554661,0.0258332481245646,0.0503057982679073,1.11044468370503e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,0.021383576866574,0.00350917125703693,0.0145056012027816,0.0282615525303664,1.13409030337813e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,-0.0154606693035635,0.00253895719642253,-0.0204370254085517,-0.0104843131985754,1.1640315801119e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASS1,Argininosuccinate synthase,40116,0.0483936596343346,0.00795171017020443,0.032808307700734,0.0639790115679353,1.19693145547738e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.0568757651195244,0.00934647982740644,0.0385566646578077,0.075194865581241,1.20164437730687e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIT,Mast/stem cell growth factor receptor Kit,42663,-0.0186823721585144,0.00307830609279117,-0.024715852100385,-0.0126488922166437,1.32128296103742e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPC2,NPC intracellular cholesterol transporter 2,40367,0.0212285410343291,0.00349984171263942,0.0143688512775558,0.0280882307911023,1.35739727445251e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.0218265226563798,0.00359998646950243,0.0147705491761551,0.0288824961366046,1.37252141041556e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,0.0240922062417969,0.00397792477021198,0.0162954736921815,0.0318889387914124,1.42854316512925e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COPB2,Coatomer subunit beta',40116,0.0268726464937882,0.00443853118310274,0.0181731253749068,0.0355721676126696,1.45574378749308e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPM1A,Protein phosphatase 1A,42346,0.0197199672336106,0.00325897165935017,0.0133323827812843,0.026107551685937,1.47880767719187e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.0337945566606957,0.00559072728894097,0.0228367311743714,0.04475238214702,1.5449882259506e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASGR2,Asialoglycoprotein receptor 2,40532,0.0166449802224415,0.00275376872824433,0.0112475935150826,0.0220423669298003,1.5464760879492e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42668,-0.0188281480138724,0.00311856666167086,-0.0249405386707473,-0.0127157573569975,1.60697209051663e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFHR2,Complement factor H-related protein 2,40451,0.0356658597637561,0.00591504496636262,0.0240723716296853,0.0472593478978268,1.69432508133612e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADA,Adenosine deaminase,42754,0.0213096883259716,0.00354085978268051,0.0143696031519178,0.0282497735000254,1.80888232349021e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKD2,Serine/threonine-protein kinase D2,40116,0.0281212857628339,0.00467866741055094,0.0189510976381541,0.0372914738875138,1.90820286814632e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EBI3_IL27,Interleukin-27,42689,-0.0189614175779631,0.00315689091982544,-0.0251489237808209,-0.0127739113751052,1.94615437804236e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKK3,Dickkopf-related protein 3,42794,-0.0185255442598815,0.0030869460858266,-0.0245759585881016,-0.0124751299316613,2.00779249619726e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFC1,Cryptic protein,42346,0.0290468510798148,0.00484828966985564,0.0195442033268977,0.0385494988327319,2.13800964886455e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BOC,Brother of CDO,42357,-0.0143647460259786,0.00239843517963353,-0.0190656789780603,-0.00966381307389691,2.16352770605477e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,0.0513171340378331,0.00856820684717873,0.0345234486173628,0.0681108194583034,2.17450234464877e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CIT,Citron Rho-interacting kinase,40182,0.0277984733477572,0.00464191846744071,0.0187003131515734,0.036896633543941,2.18312129123848e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QA,Complement C1q subcomponent subunit A,42701,-0.0134841386944289,0.00225289309296189,-0.0178998091566342,-0.00906846823222354,2.21525462322507e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,0.0259857690303503,0.00434830870768565,0.0174630839632864,0.0345084540974141,2.34396949289864e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD248,Endosialin,40527,-0.0249416073936658,0.00417369138324061,-0.0331220425048174,-0.0167611722825143,2.35688935221247e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC14A,C-type lectin domain family 14 member A,42611,-0.020403798712469,0.00341505468684876,-0.0270973058986926,-0.0137102915262455,2.36407444153991e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,0.0188215855661056,0.00315266656551548,0.0126423590976953,0.025000812034516,2.43166374641438e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SV2A,Synaptic vesicle glycoprotein 2A,40182,0.038241405455288,0.00640582102233319,0.025685996251515,0.0507968146590611,2.44900735193596e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL15A1,Collagen alpha-1(XV) chain,40527,0.0170932913548371,0.00286722395303517,0.0114735324068882,0.022713050302786,2.57193767633669e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSTN3,Calsyntenin-3,40483,0.0187120181204111,0.00313930530531795,0.012558979721988,0.0248650565188343,2.58887255440158e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFIC,Nuclear factor 1 C-type,40482,0.0289011883603263,0.00486321244805252,0.0193692919621433,0.0384330847585092,2.88438413920382e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD83,CD83 antigen,42594,0.0213735311243814,0.00361301865654679,0.0142920145575497,0.0284550476912131,3.38529243411822e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOB,Apolipoprotein B-100,40532,0.0134762116522589,0.00228165878731602,0.0090041604291195,0.0179482628753983,3.59870045082216e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYGD,Gamma-crystallin D,40483,0.0587533465849838,0.00995711265950818,0.0392374057723478,0.0782692873976198,3.72490500224505e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXNB2,Plexin-B2,42743,0.0145534169915713,0.00246735543666319,0.00971740033571143,0.0193894336474311,3.75824500419928e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,0.0316392884443175,0.00536585891147608,0.0211222049778244,0.0421563719108106,3.80345814379063e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA6,Carbonic anhydrase 6,42581,-0.037714510238834,0.00639711944749924,-0.0502528643559325,-0.0251761561217355,3.82440846309913e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.0261001189514587,0.0044362626260788,0.0174050442043443,0.0347951936985732,4.13736753900548e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KITLG,Kit ligand,42636,-0.0225447811407846,0.00383441777927441,-0.0300602399881624,-0.0150293222934067,4.21060981122458e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAM,Integrin alpha-M,42611,-0.0190149092016237,0.00323773396028987,-0.0253608677637918,-0.0126689506394555,4.38356977240523e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RHOC,Rho-related GTP-binding protein RhoC,42443,0.0690259570071061,0.0117535227421514,0.0459890524324894,0.0920628615817229,4.38797809754306e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHCY,Adenosylhomocysteinase,42636,0.0400614409761517,0.00684851126859877,0.0266383588896981,0.0534845230626053,5.04047060399485e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.0604984216262548,0.0103477750678228,0.0402167824933221,0.0807800607591875,5.13760429168759e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,0.0293812865037002,0.0050261527677023,0.0195300270790036,0.0392325459283967,5.19117691025607e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENSA,Alpha-endosulfine,40451,0.0317092223323634,0.00543201433911627,0.0210624742276955,0.0423559704370312,5.44623025673008e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA1,Alpha-1-antitrypsin,40327,-0.00487680899315847,0.000838296564775912,-0.00651987026011925,-0.00323374772619768,6.13711723168591e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAFA5,Chemokine-like protein TAFA-5,42587,0.0229216031259262,0.00394386189486481,0.0151916338119912,0.0306515724398612,6.31476909273225e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THBD,Thrombomodulin,42636,0.0179170907889931,0.00308650415691516,0.0118675426414394,0.0239666389365468,6.58272462484876e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN4,Contactin-4,42611,-0.0142658755663465,0.00246210252996482,-0.0190915965250776,-0.00944015460761548,7.01953285735308e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,0.0242357661869162,0.00418377605291027,0.0160355651232121,0.0324359672506203,7.10778653333031e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,-0.0157093249334366,0.00271705195173743,-0.021034746758842,-0.0103839031080312,7.55745594690533e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOBR,Apolipoprotein B receptor,40223,-0.0252367159737977,0.00436465933740613,-0.0337914482751137,-0.0166819836724817,7.57948314477114e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,0.0294299221363378,0.00509171762464127,0.0194501555920409,0.0394096886806347,7.64136344396981e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A12,Protein S100-A12,42434,0.0443331318148106,0.00768166842852311,0.0292770616949053,0.0593892019347159,8.04294649340137e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PODXL,Podocalyxin,42587,0.00900403137961654,0.00156151563026376,0.00594346074429956,0.0120646020149335,8.2861687306986e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMOD1,Leiomodin-1,40482,-0.0211101153951564,0.00366220508142114,-0.0282880373547419,-0.013932193435571,8.4136140921017e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGMN,Legumain,42676,0.0209745471602277,0.00364274120493187,0.0138347743985613,0.0281143199218942,8.70219790606761e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.0181587780692118,0.00315355661723729,-0.0243397490389969,-0.0119778070994267,8.73211270038665e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOM2,Myomesin-2,40116,-0.0297233366069321,0.00516772433212281,-0.0398520762978928,-0.0195945969159714,9.07083953498673e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F3,Tissue factor,42636,-0.0160350625934421,0.00279272830853838,-0.0215088100781773,-0.0105613151087068,9.57462812479955e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTPN,Myotrophin,42357,0.0194973848407687,0.00339837083862724,0.0128365779970593,0.0261581916844781,9.83307537029934e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL7R,Interleukin-7 receptor subunit alpha,42611,-0.0308657203359141,0.00538586867336893,-0.0414220229357172,-0.0203094177361109,1.02064367816773e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD101,Immunoglobulin superfamily member 2,40449,0.0255364146440601,0.00446002798998703,0.0167947597836855,0.0342780695044347,1.0569474796102e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0228985803392627,0.00400231417503186,-0.0307431161223251,-0.0150540445562002,1.08378277712481e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALM,Paralemmin-1,40384,0.0184613260982989,0.00322726187371457,0.0121358928258184,0.0247867593707795,1.08979327204393e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB6,Integrin beta-6,42370,0.0182821395287609,0.00319840536843174,0.0120132650066347,0.0245510140508871,1.11413604936695e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEZ6L2,Seizure 6-like protein 2,42587,-0.0138788110798994,0.00242814410429282,-0.0186379735243133,-0.00911964863548545,1.11510128134736e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICOSLG,ICOS ligand,42587,0.0113021889186833,0.00197909824823636,0.00742315635214005,0.0151812214852266,1.14850744578389e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAGA,Alpha-N-acetylgalactosaminidase,40166,0.0326429581897798,0.00574056788554729,0.0213914451341071,0.0438944712454525,1.33088404723313e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,42357,0.031359996395854,0.00552581770452671,0.0205293936949816,0.0421905990967263,1.41467619588067e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTB,Lymphotoxin-beta,40451,0.0207583375612496,0.0036658307653483,0.0135733092611669,0.0279433658613323,1.52698369130001e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,42346,0.0302821803993012,0.00535517521409017,0.0197860369796845,0.0407783238189179,1.59321677649133e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.0264065792211231,0.00468346005307117,-0.0355861609251426,-0.0172269975171036,1.75200425061765e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,0.0199743514485987,0.00354282529117217,0.0130304138779013,0.0269182890192962,1.75496966951946e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL20,C-C motif chemokine 20,42754,0.0527987917829839,0.0093700354017393,0.0344335223955749,0.0711640611703929,1.78693654515592e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSC2,Desmocollin-2,42488,-0.0204323605942065,0.00362698786470244,-0.0275412568090233,-0.0133234643793897,1.80250911712661e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA12,Carbonic anhydrase 12,42587,-0.0190430566076528,0.00338561551277085,-0.0256788630126837,-0.012407250202622,1.89555207294625e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0375589233380735,0.00669286320271672,-0.0506769352153983,-0.0244409114607487,2.0415913353226e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,0.0391583234502265,0.00699957948673841,0.0254391476562192,0.0528774992442338,2.26698571734537e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH3,Cadherin-3,42711,0.021440639689095,0.00383706581880431,0.0139199906842385,0.0289612886939514,2.34449679956533e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPARCL1,SPARC-like protein 1,42644,-0.0158127821224569,0.00283208860290612,-0.0213636757841529,-0.0102618884607609,2.40380591918762e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC16A1,Monocarboxylate transporter 1,42311,0.0328155780360416,0.00588581467350632,0.0212793812759693,0.044351774796114,2.51886200856409e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSTN2,Calsyntenin-2,42754,-0.0226125580978738,0.0040574842872817,-0.0305652273009459,-0.0146598888948017,2.55092094824745e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CR1,Complement receptor type 1,40509,0.0206035173658941,0.00369683826420714,0.0133577143680482,0.0278493203637401,2.55708319597849e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,-0.0121957883038344,0.00219008343085233,-0.0164883518283049,-0.0079032247793638,2.61762166427055e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECI2,Enoyl-CoA delta isomerase 2,40116,0.0349864561340223,0.00630298372133068,0.0226326080402142,0.0473403042278305,2.9104306873153e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGBL1,Integrin beta-like protein 1,40527,0.0220943732629987,0.00398350934882317,0.0142866949393053,0.0299020515866921,2.98049130093069e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB1A1,Uteroglobin,42646,0.0315915711115525,0.00570034219472286,0.0204189004098957,0.0427642418132093,3.04576059286074e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COLEC12,Collectin-12,42618,0.0158268841635052,0.00286133635859888,0.0102186649006514,0.021435103426359,3.23827589414812e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX2,Sorting nexin-2,40451,0.046383942424704,0.00839584834095247,0.0299280796764372,0.0628398051729709,3.37523951382202e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HLA_E,,42594,0.0173938806190462,0.00315342487104001,0.0112131678718077,0.0235745933662846,3.5349134009004e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL1A1,Collagen alpha-1(I) chain,42794,-0.0141443231464223,0.0025658411815863,-0.0191733718623315,-0.00911527443051317,3.60117569996022e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFTPD,Pulmonary surfactant-associated protein D,42636,0.0382233737037734,0.00694440943233954,0.0246123312163879,0.0518344161911589,3.77656797719317e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDK,Midkine,42638,0.028706291569154,0.00521681358993268,0.018481336932886,0.0389312462054221,3.80973999511614e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECM1,Extracellular matrix protein 1,40269,0.0210144850747177,0.0038221360132115,0.0135230984888232,0.0285058716606123,3.92419807951931e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAG3,Lymphocyte activation gene 3 protein,42587,-0.0230770953074023,0.00419907677048531,-0.0313072857775535,-0.0148469048372511,3.96154770212567e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1R1,Interleukin-1 receptor type 1,42590,-0.0132533749138064,0.00241239134453919,-0.0179816619491032,-0.00852508787850961,4.00386734834475e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFD,Vascular endothelial growth factor D,42734,-0.020270365428324,0.00369059142159374,-0.0275039246146478,-0.0130368062420003,4.03560055842912e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH1,Protocadherin-1,42721,0.0121974609043119,0.00222122424221384,0.00784386138957282,0.0165510604190511,4.06129581980994e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.0190023908940223,0.00347546925739315,0.0121904711495317,0.0258143106385129,4.64324799938059e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRELP,Prolargin,42618,0.0136030109877256,0.00249039953688755,0.00872182789542596,0.0184841940800252,4.78696509014244e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,42292,0.0240261133782029,0.00440818356832261,0.0153860735842906,0.0326661531721153,5.11825189123543e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZBP1,Z-DNA-binding protein 1,40199,0.0222899074454777,0.00409490036145811,0.0142639027370198,0.0303159121539356,5.34149670613422e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECTIN2,Nectin-2,42613,0.0175414754937325,0.00322318449354353,0.0112240338863872,0.0238589171010779,5.35263120067798e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD6,Programmed cell death protein 6,42636,-0.039174643746677,0.00720419350068144,-0.0532948630080127,-0.0250544244853414,5.4898648733961e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,0.0360867084618062,0.00669111357524,0.0229721258543358,0.0492012910692766,7.06508574187616e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PVALB,Parvalbumin alpha,42654,0.0605308305705109,0.0112309318950578,0.0385182040561975,0.0825434570848242,7.17834626633535e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL8,Interleukin-8,42494,0.0383368121101768,0.00712549052550798,0.0243708506801812,0.0523027735401725,7.56490376192108e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA1,Carbonic anhydrase 1,42362,0.032869296415767,0.00615103089304123,0.0208132758654062,0.0449253169661278,9.25830910259134e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RALY,RNA-binding protein Raly,40451,0.0259097976305608,0.00484849305782141,0.0164067512372308,0.0354128440238908,9.27500897245785e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,0.0265613787032666,0.00497411727567135,0.0168121088429508,0.0363106485635825,9.4836019286522e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF16,Fibroblast growth factor 16,40199,0.0258457041392389,0.00485073792332156,0.0163382578095287,0.0353531504689492,1.01148698801742e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.00867667493674299,0.00163193539502476,0.00547808156249446,0.0118752683109915,1.07278111250977e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.0479579084790284,0.00902675332103122,0.0302654719698072,0.0656503449882496,1.09635629762299e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,0.0211163212759271,0.00398293437019646,0.0133097699103421,0.0289228726415122,1.16582331890661e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAA4,Serum amyloid A-4 protein,40539,0.017550443507241,0.0033140269809209,0.011054950624636,0.0240459363898459,1.20707788874498e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK6,Kallikrein-6,42656,0.0171668893825974,0.00324563049090432,0.010805453620425,0.0235283251447699,1.24755152736425e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFA,Protransforming growth factor alpha,42594,0.0256195545270501,0.00485075285180073,0.0161120789375207,0.0351270301165796,1.30090481679997e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN4B,Sodium channel subunit beta-4,40223,0.0238000710953016,0.00450752786310086,0.0149653164836239,0.0326348257069793,1.31588281706224e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL15,C-C motif chemokine 15,42794,0.0241292397568566,0.00457404325961461,0.015164114968012,0.0330943645457013,1.34606099416567e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH15,Cadherin-15,42692,0.0336367135734238,0.00638273768966007,0.0211265477016901,0.0461468794451576,1.38561368832592e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.0282659483380475,0.00537134983924888,0.0177381026531197,0.0387937940229753,1.44822266622748e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM1,Intercellular adhesion molecule 1,42595,0.0156865558891698,0.00298160191604009,0.00984261613373123,0.0215304956446084,1.4538918459618e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,0.031762570071047,0.00605222256602253,0.0199002138416429,0.0436249263004512,1.56036206263685e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AFAP1,Actin filament-associated protein 1,40283,0.0444977091788212,0.00848904677158928,0.0278591775065062,0.0611362408511362,1.61958461879755e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALPP,"Alkaline phosphatase, placental type",42587,0.0539576614842038,0.0103056558659054,0.0337585759870292,0.0741567469813783,1.66817691202872e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD109,CD109 antigen,42611,-0.0180354175374113,0.0034447666049447,-0.0247871600831029,-0.0112836749917197,1.66933711974256e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FSTL1,Follistatin-related protein 1,40223,-0.0121486409360134,0.00232018988815693,-0.016696213116801,-0.00760106875522585,1.67064047051737e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,40199,0.0198093938746374,0.00379005972329529,0.0123808768169786,0.0272379109322961,1.75750157774862e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.0126262020497435,0.00241746563805837,-0.0173644347003379,-0.00788796939914912,1.79343791533906e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHB4,Ephrin type-B receptor 4,42794,-0.0140819983473782,0.00270084634490243,-0.019375657183387,-0.00878833951136943,1.87600697311077e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL3,Fc receptor-like protein 3,42370,0.0300659265672529,0.00578427976443231,0.0187287382289656,0.0414031149055403,2.04600511488984e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,0.019777921941442,0.00383093809678195,0.0122692832717494,0.0272865606111346,2.47715793978046e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL14,C-C motif chemokine 14,42618,0.0212716485157069,0.00412322592358328,0.0131901257054837,0.0293531713259301,2.51834674255208e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLC,Galectin-10,42611,-0.0345204992195547,0.00673616755168814,-0.0477233876208635,-0.021317610818246,3.02232920812636e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFHR5,Complement factor H-related protein 5,40382,0.0221495449233219,0.00432561680251458,0.0136713359903933,0.0306277538562504,3.09708630933779e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENAH,Protein enabled homolog,42370,0.0247401393000696,0.00483253813212324,0.0152683645611081,0.0342119140390312,3.10677889513617e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AZU1,Azurocidin,42216,0.03999220087276,0.00781610249186651,0.0246726399887017,0.0553117617568184,3.1544865628431e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CENPF,Centromere protein F,40302,0.028546759985562,0.00558091914581546,0.0176081584597637,0.0394853615113603,3.18865362567714e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,0.0224737101655403,0.0044128716740607,0.0138244816843814,0.0311229386466993,3.57755798152542e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRK1,NKG2-D type II integral membrane protein,40483,0.0254604046501896,0.00500214615921702,0.0156561981781243,0.035264611122255,3.64026950812245e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSG3,Desmoglein-3,42651,0.0182654926971623,0.0035994509608409,0.0112105688139141,0.0253204165804105,3.93651025381119e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,0.0248595892252365,0.0049078251322782,0.0152402519659712,0.0344789264845017,4.14207694404392e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,42311,0.0216684664065675,0.00429187178097603,0.0132563977158545,0.0300805350972805,4.50741559769295e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGXT,Serine--pyruvate aminotransferase,42636,0.0387105449407948,0.00769394945211618,0.0236304040146471,0.0537906858669425,4.93463161855789e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL9A2,Collagen alpha-2(IX) chain,40302,0.023014080026581,0.00458354598853792,0.0140303298890467,0.0319978301641153,5.21951924580197e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL6A3,Collagen alpha-3(VI) chain,42794,0.0194639976653291,0.00388351692290601,0.0118523044964333,0.0270756908342249,5.45582392606831e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NXPH1,Neurexophilin-1,42311,0.0199591186904608,0.00398774602310124,0.0121431364851824,0.0277751008957392,5.65533545719378e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB6A,Ras-related protein Rab-6A,42594,0.0234515225257703,0.00469735622596533,0.0142447043228783,0.0326583407286624,6.03537929818089e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PZP,Pregnancy zone protein,40539,0.0260218928537713,0.00521426216885435,0.0158019390028168,0.0362418467047258,6.11096206871721e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFYA,Nuclear transcription factor Y subunit alpha,40116,0.0199888381986259,0.00400629280801776,0.0121365042949111,0.0278411721023407,6.15125916688588e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300LF,CMRF35-like molecule 1,42721,0.0310548815769613,0.00623529991381234,0.0188336937458891,0.0432760694080335,6.42040991442344e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300A,CMRF35-like molecule 8,40283,0.0158675069931713,0.00318576140474888,0.00962341463986349,0.0221115993464791,6.42899377385922e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGMB,RGM domain family member B,42711,0.0145153715557791,0.00291471990995731,0.00880252053226279,0.0202282225792954,6.43613338866357e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A14,Protein S100-A14,40482,0.0279760011855579,0.00561856473923177,0.0169636142966636,0.0389883880744521,6.47888276949526e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLIC5,Chloride intracellular channel protein 5,40182,-0.0161533636377761,0.00324580323261944,-0.0225151379737102,-0.00979158930184201,6.56604812134473e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD28,T-cell-specific surface glycoprotein CD28,42346,0.0192709684662034,0.00388709080004099,0.011652270498123,0.0268896664342837,7.222766276365e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTUS1,Microtubule-associated tumor suppressor 1,40302,0.028651646932631,0.0057794217064583,0.0173239803879727,0.0399793134772892,7.24501923960436e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.0168855582602778,0.0034086902641778,0.0102045253424893,0.0235665911780663,7.38757032195698e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRL,Prolactin,42711,-0.0379194082136407,0.00766088240939272,-0.0529347377360504,-0.0229040786912309,7.52066809863198e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,40449,0.0225885732101421,0.00457007067600799,0.0136312346851664,0.0315459117351178,7.81506986045943e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS3,Galectin-3,42669,0.0151100304352286,0.00305834859173694,0.0091156671954242,0.021104393675033,7.88235433730202e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM3,Intercellular adhesion molecule 3,42794,-0.0135964399415364,0.00275334145396293,-0.0189929891913037,-0.00819989069176905,7.97993225088615e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRN,Progranulin,42552,0.0123910611679493,0.00251255984589094,0.00746644387000304,0.0173156784658955,8.25191278267373e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.0168826590688777,0.00342846886590091,0.0101628600917119,0.0236024580460435,8.58841843341516e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEL1L,Protein sel-1 homolog 1,40223,0.0164474385701487,0.00334260065936836,0.00989594127778673,0.0229989358625107,8.75478750000827e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUSP3,Dual specificity protein phosphatase 3,42311,0.0430114777613835,0.00876900423550218,0.0258242294597993,0.0601987260629678,9.4574487206095e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,0.0174840178261089,0.00356462849237416,0.0104973459810555,0.0244706896711622,9.48295207740831e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,0.0292257039615547,0.00597941130116407,0.0175060578112732,0.0409453501118363,1.03188002748607e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,-0.0170864876479032,0.00349592479289282,-0.0239385002419731,-0.0102344750538333,1.03279594013403e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGER,Advanced glycosylation end product-specific receptor,42587,0.0209743230369065,0.00429551094583025,0.0125551215830793,0.0293935244907338,1.05771632136365e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,0.0215199180284645,0.00442269947451574,0.0128514270584137,0.0301884089985154,1.1532101333187e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSC,Dipeptidyl peptidase 1,42616,0.0218962921079229,0.00450157359240285,0.0130732078668133,0.0307193763490325,1.16258675230096e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,0.0204716970743254,0.00421217533272259,0.0122158334221891,0.0287275607264617,1.18890691354669e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.026264263259309,0.00540801125047975,-0.0368639653102493,-0.0156645612083687,1.20792756065734e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MARCO,Macrophage receptor MARCO,42636,0.013019792861917,0.00268100000948095,0.00776503284333435,0.0182745528804997,1.20933937998068e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,40182,0.0377856676734873,0.00780248901664414,0.0224927892008648,0.0530785461461098,1.29786980601828e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42705,-0.0100036408316488,0.00206807756349455,-0.0140570728560981,-0.00595020880719946,1.33154106177504e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,0.0192287131984717,0.00398131279752946,0.011425340115314,0.0270320862816295,1.3823294463344e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,0.0266780100262751,0.00553036426293702,0.0158384960709185,0.0375175239816316,1.42314193320265e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,40199,0.014839980856997,0.00308640737219897,0.00879062240748698,0.0208893393065069,1.54333113732779e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LUZP2,Leucine zipper protein 2,40451,0.0226226065085948,0.00470664743283943,0.0133975775402295,0.0318476354769601,1.55563818915214e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAX,Apoptosis regulator BAX,42292,0.0436469756111555,0.0090882919896941,0.0258339233113551,0.0614600279109559,1.58391687413303e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUCA2A,Guanylin,42563,-0.0178650590083377,0.0037314588262188,-0.0251787183077265,-0.0105513997089489,1.70521601431475e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,0.0205072890759813,0.00428532237794751,0.0121080572152041,0.0289065209367584,1.72748373012671e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTT2B,Glutathione S-transferase theta-2B,40483,0.117164231278775,0.0245626416635994,0.0690214536181207,0.16530700893943,1.86515736354253e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB37,Ras-related protein Rab-37,42370,0.0394459098061338,0.00828271095269278,0.0232117963388559,0.0556800232734116,1.93303861875097e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MST1,Hepatocyte growth factor-like protein,40370,0.031754865563769,0.0067006307002059,0.0186216293913654,0.0448881017361726,2.17331559490179e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.0279252268009306,0.00590851049386517,0.0163445462329549,0.0395059073689064,2.31049003678213e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSH,Pro-cathepsin H,42332,0.0360230393381392,0.00762606287595516,0.0210759561012671,0.0509701225750113,2.3401844607778e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,0.0220118926510808,0.00467942033618598,0.0128402287921563,0.0311835565100053,2.58175106984018e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.019342844737025,0.00411202946551207,0.0112832669846214,0.0274024224894287,2.58191523472757e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECTIN1,Nectin-1,40199,0.0157168541399515,0.00335179796426327,0.0091473301299955,0.0222863781499075,2.77732919984651e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAPG,Macrophage-capping protein,42461,0.0280479824599136,0.00598571837813723,0.0163159744387647,0.0397799904810626,2.81615809256993e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD209,CD209 antigen,42668,-0.0186232612974205,0.00397456672977041,-0.0264134120877705,-0.0108331105070705,2.81860596058616e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNG,Interferon gamma,42370,0.0542291802863854,0.0115744346174169,0.0315432884362483,0.0769150721365225,2.82407685352187e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP4,Guanylate-binding protein 4,42311,0.0236916833917386,0.00506027631110624,0.0137735418219704,0.0336098249615069,2.87082382358776e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,0.0166877871320719,0.00356567073772078,0.00969907248613914,0.0236765017780046,2.89479976517392e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,0.0174117773531673,0.00373111883257287,0.0100987844413245,0.0247247702650101,3.09782438567561e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWF,von Willebrand factor,42794,-0.034281050539574,0.00735362734160081,-0.0486941601291116,-0.0198679409500365,3.16453019047215e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSR,Insulin receptor,40199,0.00829394022995287,0.00177930418574691,0.00480650402588893,0.0117813764340168,3.17849612830763e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPA2,Replication protein A 32 kDa subunit,40199,0.0150499275746855,0.00324663689869938,0.00868651925323473,0.0214133358961363,3.60094435914009e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA14,Carbonic anhydrase 14,42721,-0.0170670514107905,0.00368226534083792,-0.0242842914788329,-0.00984981134274821,3.60390118346224e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFHR4,Complement factor H-related protein 4,40509,0.0353553230107587,0.00763384009510548,0.020392996424352,0.0503176495971655,3.67259649198993e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.0197678933803728,0.00426895572174591,-0.0281350465949948,-0.0114007401657508,3.68026479446982e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP2,Metalloproteinase inhibitor 2,40511,-0.0132016299444126,0.00285347777970695,-0.0187944463926382,-0.00760881349618697,3.76014691598443e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CR2,Complement receptor type 2,42689,0.0226861579644402,0.00490471334161633,0.0130729198148722,0.0322993961140082,3.77388432023727e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMBS,Porphobilinogen deaminase,42721,0.0204191133010132,0.00441775060912748,0.0117603221071234,0.0290779044949031,3.83458331664184e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYAR,Cell growth-regulating nucleolar protein,42346,0.0257051075534783,0.00556446665433074,0.0147987529109901,0.0366114621959666,3.8829769307057e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSB,Cathepsin B,42659,-0.0253331579789086,0.00549896971121858,-0.0361111386128971,-0.0145551773449202,4.12480862678139e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPHS1,Nephrin,40199,0.0158606959369977,0.00344351853617988,0.00911139960608511,0.0226099922679102,4.15181278791471e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROK1,Prokineticin-1,42594,0.0260375045313236,0.00565879720586555,0.0149462620078271,0.0371287470548201,4.23827639424899e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.0479458260655614,0.0104240575194158,0.0275146733275065,0.0683769788036163,4.28053466661369e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LXN,Latexin,42461,-0.0318697267348973,0.00694373002054,-0.0454794375751557,-0.0182600158946389,4.47928474659194e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,0.0185417292445869,0.00404852361719253,0.0106066229548896,0.0264768355342843,4.69448989877965e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNU13,NHP2-like protein 1,40116,0.0297498945071044,0.00649720153340921,0.0170153795016223,0.0424844095125865,4.72642813834813e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF5,Fibroblast growth factor 5,42370,-0.0154723329602999,0.00338817648283357,-0.0221131588666537,-0.00883150705394608,5.00269919175287e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,0.019691098621576,0.00431580898354551,0.0112321130138268,0.0281500842293252,5.09925902073091e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDO2,"Tryptophan 2,3-dioxygenase",40182,0.0181033051720742,0.00396836419123171,0.0103253113572601,0.0258812989868884,5.1240253484885e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP4,Dipeptidyl peptidase 4,42441,0.0131525804027041,0.0028868847855189,0.00749428622308708,0.0188108745823212,5.2608381818729e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,0.0166260431643276,0.00365314602836968,0.00946587694872302,0.0237862093799322,5.38151627082313e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRD1,Bromodomain-containing protein 1,40302,-0.0141880346699903,0.00313564473546462,-0.020333898351501,-0.00804217098847965,6.10921975322673e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP12,Macrophage metalloelastase,42592,0.0259426153940598,0.00573955404889726,0.0146930894582212,0.0371921413298984,6.23779825892376e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A13,Protein S100-A13,40199,0.0164399796106586,0.0036453530843976,0.00929508756523932,0.0235848716560779,6.554600211705e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA7,Carbonic anhydrase 7,40302,-0.0162464642236724,0.00361010776576406,-0.0233222754445699,-0.0091706530027748,6.85567410367555e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,0.0215998411157149,0.00480911973041105,0.0121739664441093,0.0310257157873206,7.13504075864978e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA5,Protein disulfide-isomerase A5,40080,0.0282017812154687,0.00628696238540852,0.0158793349400681,0.0405242274908694,7.3400194541377e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEK,Angiopoietin-1 receptor,42679,0.0100712866923474,0.00224564124248156,0.00566982985708358,0.0144727435276113,7.35797357384482e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN2,Ataxin-2,40136,0.0506077084180653,0.0113204023977429,0.0284197197184893,0.0727956971176413,7.88269739349296e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,0.0134409642609066,0.00301887106589476,0.0075239769717529,0.0193579515500603,8.56304008918443e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PI3,Elafin,42446,0.025857365332461,0.00582082404748267,0.014448550199395,0.037266180465527,8.97579564620809e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300C,CMRF35-like molecule 6,42711,0.0163150845620958,0.00367824089452355,0.0091057324088296,0.0235244367153619,9.25554039824747e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE3,Eosinophil cationic protein,42578,0.0497906992315286,0.0112318043156003,0.0277763627729519,0.0718050356901053,9.36661656238143e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VCAN,Versican core protein,42711,-0.0138547082433059,0.00312938230680356,-0.0199882975646408,-0.00772111892197088,9.61690297537229e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFB,Vascular endothelial growth factor B,40199,0.0133829954586491,0.00303034615163313,0.00744351700144816,0.01932247391585,1.01351156190496e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.0153047250894731,0.00346930731139371,-0.0221045674198048,-0.00850488275914143,1.0347538487037e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL5,Fc receptor-like protein 5,42611,-0.0266058017115572,0.00603933740552475,-0.0384429030263857,-0.0147687003967287,1.06398770532616e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM26,Tripartite motif-containing protein 26,40080,0.0253991796392809,0.00576825046795459,0.01409340872209,0.0367049505564719,1.07647457558802e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.0251063729153436,0.00570640760634319,0.0139218140069109,0.0362909318237762,1.09407418135736e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPR1,Atrial natriuretic peptide receptor 1,40116,-0.0185257739526196,0.00421117848431786,-0.0267796837818826,-0.0102718641233566,1.09685384293663e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,0.0136942676951014,0.00311350989242598,0.00759178830594648,0.0197967470842563,1.09930862410381e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROBO2,Roundabout homolog 2,42711,0.0105325755362635,0.00239641869049108,0.00583559490290102,0.0152295561696261,1.11549788317716e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUC16,Mucin-16,42587,0.0863107728606149,0.0196396690283468,0.0478170215650552,0.124804524156175,1.11770820794727e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLL4,Delta-like protein 4,40223,0.0385696408913661,0.00878918869251738,0.0213428310540321,0.0557964507287002,1.15299386726479e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,40116,0.0449692676063956,0.0102997438790229,0.0247817696035108,0.0651567656092804,1.27674184925987e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPC1,Glypican-1,42721,0.013354002086289,0.00306032768680639,0.0073557598201485,0.0193522443524295,1.28896146911942e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLASP1,CLIP-associating protein 1,40080,0.0324516995079937,0.00745304038355472,0.0178437403562264,0.0470596586597609,1.34801621359218e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSF,Cathepsin F,42679,0.0176341434046646,0.00405112165249473,0.0096939449657749,0.0255743418435542,1.35335587623881e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCC,Netrin receptor DCC,40182,0.0103483813330455,0.00237826828356275,0.00568697549726248,0.0150097871688284,1.36601534305866e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB44,Ras-related protein Rab-44,40451,0.0186513880658963,0.00429582281259008,0.0102315753532198,0.0270712007785729,1.42588133788793e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG1A,Lithostathine-1-alpha,42575,-0.0231850100141109,0.0053457969920153,-0.0336627721184609,-0.0127072479097609,1.45462270449467e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL14,C-X-C motif chemokine 14,42370,0.0250996845483969,0.00578809060600271,0.0137550269606316,0.0364443421361622,1.45887571461132e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.0118129733048899,0.00273381417852282,-0.0171712490947946,-0.00645469751498518,1.56635060338725e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRUNE2,Protein prune homolog 2,40302,0.0133036167207155,0.00308151220225586,0.00726385280429402,0.019343380637137,1.59364693564834e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK8,Kallikrein-8,42154,0.0165353402750128,0.00383142370287531,0.00902574981737719,0.0240449307326484,1.60265728753506e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC80,Coiled-coil domain-containing protein 80,42636,0.0165873571592688,0.00384577510838053,0.00904963794684292,0.0241250763716946,1.62102209494451e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBS,Cystathionine beta-synthase,40223,0.0226707906086465,0.0052581011452156,0.0123649123640239,0.0329766688532691,1.63491048611882e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GDF15,Growth/differentiation factor 15,42794,-0.0204060069029635,0.00473556105613842,-0.0296877065729948,-0.0111243072329322,1.65071858186027e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRTAP,Cartilage-associated protein,40182,0.0211594255133974,0.00491582283557041,0.0115244127556794,0.0307944382711154,1.68927392785126e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUCA1,Tissue alpha-L-fucosidase,42721,0.0370024881878831,0.00861131470262795,0.0201243113707323,0.0538806650050339,1.74365300317102e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPTLC1,Serine palmitoyltransferase 1,40483,0.0170323617707318,0.00396698212821727,0.00925707679942595,0.0248076467420376,1.77322383916075e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,0.0153272757399602,0.00357033560678083,0.00832941795066981,0.0223251335292507,1.77549499607348e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LIFR,Leukemia inhibitory factor receptor,42594,-0.0106116721029314,0.00247284745347356,-0.0154584531117396,-0.00576489109412324,1.78895929396206e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA7A,Semaphorin-7A,42760,0.0124642784890457,0.00291228224549894,0.00675620528786777,0.0181723516902236,1.88260069083381e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTX2,Neuronal pentraxin-2,40527,-0.0144019804978281,0.00336673714660725,-0.0210007853051783,-0.00780317569047789,1.90360798888526e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4D,C-type lectin domain family 4 member D,42594,0.0271776374100527,0.00637038553972471,0.0146916817521922,0.0396635930679131,2.00153311384785e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBC1D17,TBC1 domain family member 17,42311,0.0197888285162646,0.00464583355860133,0.010682994741406,0.0288946622911232,2.06332561616757e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN1,Contactin-1,42794,-0.0121314003330318,0.00284922399587939,-0.0177158793649555,-0.00654692130110824,2.07842524783967e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42689,-0.0156763283800805,0.00368446999392098,-0.0228978895681657,-0.00845476719199539,2.10737969415782e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FMR1,Synaptic functional regulator FMR1,42346,0.0154417161207562,0.00363125524548324,0.00832445583960907,0.0225589764019034,2.12909063869944e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOSB,Protein fosB,42311,0.0166687521870104,0.00393158382872033,0.00896284788271854,0.0243746564913022,2.25347153497048e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCN2,Transcobalamin-2,42771,-0.0133619397025423,0.00315833444281122,-0.0195522752104523,-0.00717160419463229,2.34502309153015e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WIF1,Wnt inhibitory factor 1,42721,-0.0149138685402676,0.00353048174759379,-0.0218336127655515,-0.00799412431498381,2.41237501473174e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROBO4,Roundabout homolog 4,40223,-0.00786770380126381,0.00186604354584357,-0.0115251491511172,-0.00421025845141042,2.50381209482199e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,0.0121453823029588,0.00288339151875167,0.00649393492620551,0.017796829679712,2.54553886095157e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLGN,Calmegin,40182,0.020073482292868,0.00476537974174648,0.0107333379990449,0.0294136265866911,2.54735692457624e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP5,Rho GTPase-activating protein 5,40080,0.0344350417544325,0.00818578613725777,0.0183909009254073,0.0504791825834578,2.61217761164543e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,0.0146637893171622,0.00349063121675555,0.00782215213232131,0.0215054265020031,2.67590461713779e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK4,Kallikrein-4,42721,-0.0273124233776516,0.00651082103696191,-0.0400736326100969,-0.0145512141452062,2.74699022533362e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42590,0.0356855420066915,0.00851754204383082,0.0189911596007831,0.0523799244125999,2.81172033415496e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.0121281474852766,0.0028962794252909,0.00645143981170647,0.0178048551588468,2.84245660058637e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A11,Protein S100-A11,42531,0.0194868463494486,0.00465658366025404,0.0103599423753507,0.0286137503235466,2.87252895969569e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL2,Fc receptor-like protein 2,42681,0.0224741937970492,0.00539007848089631,0.0119096399744924,0.0330387476196059,3.0711073605563e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGR2,Anterior gradient protein 2 homolog,42215,0.0431698044927826,0.0103846415176055,0.0228159071182758,0.0635237018672894,3.24401333168223e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,40302,0.0187514896798048,0.00451240885470943,0.00990716832457432,0.0275958110350353,3.26953913496747e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42602,-0.024229130285496,0.00583569451396041,-0.0356670915328584,-0.0127911690381336,3.3178791213919e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLPS,Colipase,42590,0.0309937885301977,0.00746606276412751,0.0163603055125078,0.0456272715478876,3.32652574849797e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.0328125551662685,0.00791740866969913,0.0172944341736582,0.0483306761588788,3.42904827370011e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,0.0157144409211862,0.00379154306033917,0.00828301652292143,0.023145865319451,3.42946445442406e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.0300032062563664,0.00724748612220927,-0.0442082790558966,-0.0157981334568362,3.50121722483791e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GZMB,Granzyme B,42594,0.028051439208744,0.00679705565178707,0.0147292101312413,0.0413736682862466,3.69751571098141e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMPD3,AMP deaminase 3,40483,0.029885259101488,0.00725266511421067,0.015670035477635,0.0441004827253409,3.80601680612069e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.017362457209947,0.00421514617004325,0.00910077071666222,0.0256241437032317,3.82741610136195e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.0182304946727086,0.00442878990370855,-0.0269109228839773,-0.00955006646143981,3.87689517906115e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX5,Syntaxin-5,40199,0.0173172590817067,0.0042073424178652,0.00907086794269093,0.0255636502207225,3.88380920120304e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROCR,Endothelial protein C receptor,40116,-0.0147485108970452,0.00358493486547567,-0.0217749832333775,-0.00772203856071284,3.91671981640251e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSH3,Protein phosphatase Slingshot homolog 3,40080,0.0121905008735773,0.00296874564768836,0.00637175940410813,0.0180092423430465,4.05020296633594e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD99,CD99 antigen,42611,-0.00849418282601335,0.00206976589730409,-0.0125509239847294,-0.00443744166729733,4.08585088116095e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C8B,Complement component C8 beta chain,40539,0.0127475459227785,0.00310895085627829,0.00665400224447302,0.0188410896010839,4.15540989285034e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XG,Glycoprotein Xg,42734,0.0144514304426305,0.00353035734645031,0.00753193004358788,0.0213709308416731,4.27421388824002e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,0.0451343909543798,0.0110266486971895,0.0235221595078883,0.0667466224008712,4.28484580119265e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOC,Myocilin,42611,-0.0187291579333613,0.00457855935810777,-0.0277031342752525,-0.00975518159147005,4.32729639054758e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,40223,0.0135697650628637,0.00332066022803783,0.00706127101590957,0.0200782591098179,4.41095122002489e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASET2,Ribonuclease T2,42749,0.0115563647241714,0.0028303629733698,0.00600885329636655,0.0171038761519762,4.47137164748023e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN10,Ataxin-10,42311,0.0301860998658705,0.00740060662097389,0.0156809108887616,0.0446912888429793,4.55228974740642e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UROS,Uroporphyrinogen-III synthase,40182,0.0283506707228758,0.00696195705615586,0.0147052348928104,0.0419961065529413,4.68923311105548e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPA2,Heat shock-related 70 kDa protein 2,40451,0.0142868452167474,0.00351590128211328,0.00739567870380536,0.0211780117296894,4.86717388791125e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,0.0181999294494749,0.00447954143722577,0.00942002823251237,0.0269798306664374,4.87481943523107e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSV,Cathepsin L2,42677,0.0174230663599277,0.00428890685048316,0.00901680893298071,0.0258293237868747,4.88549223314039e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERC2,ERC protein 2,40182,0.0315359985235431,0.00778763291186262,0.0162722380162924,0.0467997590307939,5.16801913108368e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIF1C,Kinesin-like protein KIF1C,40116,0.014918912188641,0.00368453852095944,0.00769721668756048,0.0221406076897215,5.17791576688363e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.020390505527086,0.00505172201444252,-0.0302918806753934,-0.0104891303787787,5.45904405240996e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGT,Angiotensinogen,40532,0.00985967485412811,0.00244454538875184,0.0050683658921745,0.0146509838160817,5.53507495248021e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.0153293161532213,0.00380231540222632,0.00787677796485769,0.0227818543415849,5.57163479996082e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTP1,Glutathione S-transferase P,42237,-0.0289612073663702,0.00719101450450506,-0.0430555957952001,-0.0148668189375403,5.6712558593984e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBA,Lysosomal acid glucosylceramidase,40182,0.0228740490249917,0.00568802384549369,0.011725522287824,0.0340225757621593,5.82301460312327e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LIF,Leukemia inhibitory factor,42311,0.0211218729784681,0.00527242684115835,0.0107879163697978,0.0314558295871385,6.2070017740394e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC10A,C-type lectin domain family 10 member A,42495,-0.0149477022013436,0.00373450518176799,-0.0222673323576089,-0.00762807204507836,6.29920290562683e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSL3,Insulin-like 3,40483,0.0320507202110042,0.00801623977428003,0.0163388902534154,0.0477625501685931,6.42259465015993e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.0201296457813728,0.00503717807980812,0.0102567767449489,0.0300025148177968,6.47861218524336e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.015677182769882,0.0039277625431706,0.00797876818526762,0.0233755973544964,6.61190306634883e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB2A2,Mammaglobin-A,40116,-0.013004042805056,0.00326223203116757,-0.0193980175861445,-0.00661006802396761,6.75651480645189e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH6,Cadherin-6,42636,-0.015759786187979,0.00396073193492635,-0.0235228207804346,-0.00799675159552333,6.95664671556335e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GZMH,Granzyme H,42357,0.0315743494545577,0.00794849998345725,0.0159952894869815,0.0471534094221339,7.15413466148571e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAST,Gastrin,40483,0.0590601900442972,0.0149021880442987,0.0298519014774717,0.0882684786111227,7.44105488425924e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFDN2,Prefoldin subunit 2,42311,0.0224883320376817,0.00567606369185504,0.0113632472016458,0.0336134168737176,7.47306724529381e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXADR,Coxsackievirus and adenovirus receptor,42594,0.0209684722869055,0.00530804748232833,0.0105646992215419,0.031372245352269,7.84474264417454e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4M,C-type lectin domain family 4 member M,40504,-0.0199113417524901,0.00506729568483715,-0.0298432412947709,-0.0099794422102093,8.56711055841433e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,0.0110961239842315,0.00282850780315484,0.00555224869004797,0.0166399992784149,8.79013064061399e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP7,Dipeptidyl peptidase 2,42551,0.0241113202070903,0.00615803403462498,0.0120415734992253,0.0361810669149553,9.06935613508148e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOD3,Extracellular superoxide dismutase,40532,-0.0234129254387438,0.00597951279369587,-0.0351327705143877,-0.0116930803630999,9.07364038525884e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42676,0.0112279196424274,0.00286798418908828,0.00560667063181437,0.0168491686530404,9.08803729294013e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SATB1,DNA-binding protein SATB1,40482,0.011711242811311,0.00300301624918286,0.00582533096291263,0.0175971546597094,9.68193016583037e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1B,Interleukin-1 beta,42293,0.0226900181561133,0.00582550994998735,0.0112720186541381,0.0341080176580885,9.87105389393639e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPB6,Heat shock protein beta-6,42721,0.0157199386921162,0.00403711339754669,0.00780719643292472,0.0236326809513077,9.91372857578153e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPL,Periplakin,40199,0.0132839665586387,0.00341259178320526,0.00659528666355634,0.019972646453721,9.97474294630553e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,0.0262951829014378,0.00677470735466737,0.0130167564862898,0.0395736093165859,0.000104460051729743
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPO,Myeloperoxidase,42611,0.0184589239673794,0.00475918197701588,0.00913092729242825,0.0277869206423305,0.00010556439526953
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX3,Syntaxin-3,40483,0.0154308549359423,0.00397834527624727,0.00763329819449763,0.0232284116773869,0.000105607046147667
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.0274640929489744,0.00708687021574675,0.0135738273261107,0.041354358571838,0.000107088670304283
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,0.015593727434525,0.00402447456467493,0.0077057572877621,0.0234816975812878,0.000107366365746099
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,0.0170365714002806,0.00439694515594265,0.00841855889463302,0.0256545839059282,0.000107386953787852
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0284612970559751,0.00734698143910191,-0.0428613806766148,-0.0140612134353353,0.000107721397629407
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.0115011997183663,0.00297562219213414,-0.0173334192149492,-0.00566898022178336,0.000111552593880634
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACE,Angiotensin-converting enzyme,40532,-0.0105942091975572,0.00274788565635846,-0.0159800650840197,-0.00520835331109457,0.000116176882046105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.0183196787626328,0.00476635607793294,-0.0276617366753814,-0.00897762084988426,0.000121827579087074
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMMD9,COMM domain-containing protein 9,40451,0.0156085666704249,0.004067786512946,0.00763570510505074,0.0235814282357991,0.000125168181718363
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BSG,Basigin,42746,0.0085293216412572,0.0022240184816464,0.00417024541723026,0.0128883978652841,0.000126084293931904
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,0.0421210962388704,0.0109958724186835,0.0205691862982508,0.06367300617949,0.000128403820548674
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.0100211234815073,0.00261745520047334,0.00489091128857955,0.015151335674435,0.000129472056090225
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG4,Regenerating islet-derived protein 4,42638,0.0206021663458019,0.00538639418579042,0.0100448337416527,0.0311594989499511,0.000131441428235782
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROBO1,Roundabout homolog 1,42638,0.00956277015467048,0.00250833794057823,0.00464642779113716,0.0144791125182038,0.000138242128588697
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.0097210616707739,0.00255560617661131,0.00471207356461572,0.0147300497769321,0.000143115721939109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2L15,Bcl-2-like protein 15,40199,0.0218999147335622,0.00576443792164274,0.0106016164071425,0.033198213059982,0.000145979952961101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPS10,40S ribosomal protein S10,40116,-0.0158658911121393,0.00417851917756851,-0.0240557887001736,-0.00767599352410507,0.000147242964165262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,0.0173609913543643,0.00457370413262377,0.00839653125442168,0.0263254514543069,0.00014794149516315
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.0153766385119836,0.00405398246267399,0.00743083288514256,0.0233224441388246,0.000149521737952941
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC38,Leucine-rich repeat-containing protein 38,40182,0.0187769105668447,0.00496258173347291,0.00905025036923783,0.0285035707644516,0.000155335757034051
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIL1,Nucleotide exchange factor SIL1,40223,0.0120070968897735,0.00317362140112305,0.00578679894357229,0.0182273948359747,0.000155515158469962
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCP1,Plastin-2,40527,0.0185153316546511,0.0049152202191704,0.00888150002507712,0.0281491632842251,0.00016609841726217
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSBP1,Heat shock factor-binding protein 1,40223,0.0364419886573199,0.00968511642048227,0.0174591604731746,0.0554248168414651,0.000168973400377738
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.0129081145510175,0.0034348528914905,0.00617580288369615,0.0196404262183389,0.000172172499815631
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.00759669783996564,0.00202457708226718,-0.0115648689212093,-0.00362852675872196,0.000176135365345589
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLYR1,Putative oxidoreductase GLYR1,40451,0.0226144619673354,0.00602700249679695,0.0108015370736133,0.0344273868610574,0.000176176458795954
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.0100529349464805,0.00268389054656279,-0.0153133604177436,-0.00479250947521743,0.000180850171600173
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST1,Cystatin-SN,39042,0.0421760735747842,0.0112860119952965,0.0200554900640031,0.0642966570855653,0.000187265758705008
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDI2,Protein DDI1 homolog 2,40283,0.0299005415894868,0.00801459059856024,0.0141919440163087,0.0456091391626649,0.000191852892687152
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSG4,Desmoglein-4,42543,0.0190394260338881,0.00512456200353065,0.00899528450696797,0.0290835675608081,0.000203768565420113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JCHAIN,Immunoglobulin J chain,42370,-0.0238083369524808,0.00642375538560825,-0.036398897508273,-0.0112177763966886,0.000211174047236131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD200,OX-2 membrane glycoprotein,42594,-0.0104103475449146,0.00281192388181487,-0.0159217183532717,-0.00489897673655743,0.000214582225504214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,0.0108391976656878,0.00292854024643924,0.00509925878266685,0.0165791365487087,0.000215405743454336
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNMA2,Paraneoplastic antigen Ma2,40136,0.0168646985463616,0.00455730683323993,0.0079323771532113,0.0257970199395118,0.000216158469436514
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRR3,Small proline-rich protein 3,40483,0.0265712448048385,0.00718198066684638,0.0124945626978196,0.0406479269118574,0.000216871161033829
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PADI4,Protein-arginine deiminase type-4,42292,0.0272408997780868,0.00736569983118813,0.0128041281089581,0.0416776714472156,0.000217896573525399
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALB1,Calbindin,42587,0.017249511460194,0.00466804535452659,0.00810014256532187,0.0263988803550661,0.000220561138130829
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,-0.0122916243832335,0.00333301295385534,-0.0188243297727899,-0.00575891899367701,0.000227261116326991
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMEM25,Transmembrane protein 25,40482,-0.0172051638840336,0.00467766874939774,-0.0263733946328532,-0.00803693313521407,0.000236024041473636
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL25,C-C motif chemokine 25,42754,0.0180195050081071,0.00490255326467438,0.00841050060934529,0.0276285094068689,0.000238267059000506
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARG1,Arginase-1,42488,0.0194595397235843,0.0053059753958669,0.00905982794768518,0.0298592514994834,0.000245911813028072
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPEP1,Dipeptidase 1,42476,-0.0187491698121658,0.00512491390403001,-0.0287940010640647,-0.00870433856026704,0.000254740826755498
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB39B,Ras-related protein Rab-39B,40116,0.034617417961051,0.00947358748774041,0.0160491864850798,0.0531856494370222,0.000259296829426697
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGA4,Pepsin A-4,40532,0.0300800720880083,0.00826009982760788,0.0138902764258968,0.0462698677501197,0.000272144225446487
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRISP3,Cysteine-rich secretory protein 3,40439,-0.0101568333768058,0.00279571007646004,-0.0156364251266675,-0.00467724162694417,0.000281385156584584
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,0.0111918754153217,0.00308506046770273,0.00514515689862435,0.017238593932019,0.000286970105616919
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX25,ATP-dependent RNA helicase DDX25,40182,-0.0140874124508473,0.0038907841238828,-0.0217133493336576,-0.00646147556803705,0.000295114246576383
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.016449925004269,0.00454907738893016,0.00753373332196592,0.0253661166865722,0.000300380502780858
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP13,Collagenase 3,42311,-0.0123554963141135,0.00342056675591963,-0.019059807155716,-0.00565118547251106,0.000304838690770515
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF21,Immunoglobulin superfamily member 21,40223,0.0146613506110318,0.00405914001376356,0.00670543618405525,0.0226172650380084,0.000305270595575513
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH1,Cadherin-1,42188,0.014668598522819,0.00407294021523291,0.00668563570096246,0.0226515613446754,0.000317594857894699
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF5,Eukaryotic translation initiation factor 5,40116,0.0162684124579995,0.00452044073679976,0.00740834861387201,0.0251284763021271,0.000321035218178194
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRR4,Proline-rich protein 4,40198,-0.0256022145967732,0.00712354759314682,-0.039564367879341,-0.0116400613142055,0.00032703035579343
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,0.0103408642740998,0.00287766937848069,0.00470063229227761,0.0159810962559219,0.000327478570919208
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VIT,Vitrin,40511,0.0141678962521869,0.00394822735178975,0.00642937064267901,0.0219064218616948,0.000334093956569608
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEG1,Protein LEG1 homolog,39926,-0.0256928223400924,0.00717308220568412,-0.0397520634632332,-0.0116335812169515,0.000342694132295766
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA1,Annexin A1,40235,0.015152823650893,0.00425310484574509,0.00681673815323265,0.0234889091485534,0.000368512513071134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FBLN2,Fibulin-2,40527,-0.0119066067638784,0.00334831057519798,-0.0184692954912664,-0.00534391803649036,0.000378073201072172
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDRG1,p53 and DNA damage-regulated protein 1,40182,0.0186976347881211,0.00525894704859299,0.0083900985728788,0.0290051710033633,0.000378997639364757
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMS1,PMS1 protein homolog 1,40182,0.0189456675880483,0.00533617641481629,0.00848676181500837,0.0294045733610882,0.000386225006956006
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,0.0133552563007733,0.00376543282853879,0.00597500795683726,0.0207355046447093,0.000391566849237786
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,-0.00986288344539992,0.00278297172970933,-0.0153175080356302,-0.00440825885516964,0.000395674897818193
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGFLAM,Pikachurin,40449,0.01120290235336,0.00317584626276051,0.00497824367834939,0.0174275610283706,0.00042112264150315
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHB6,Ephrin type-B receptor 6,42476,0.0121536729730723,0.0034467589513553,0.0053980254284159,0.0189093205177287,0.000423122967857072
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL34,Interleukin-34,42292,0.0132148361554895,0.00374960996414694,0.00586560062576148,0.0205640716852175,0.000426014841843795
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42794,-0.0113882079315375,0.00324523122998266,-0.0177488611423036,-0.00502755472077153,0.000450887601964546
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEO1,RNA polymerase-associated protein LEO1,40482,0.0116936754946874,0.00333514729070132,0.00515678680491283,0.018230564184462,0.000456327910949667
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VIM,Vimentin,42357,0.0416144269805527,0.0118717234780745,0.0183458489635266,0.0648830049975788,0.000457541511619403
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TK1,"Thymidine kinase, cytosolic",40302,0.0163116284519693,0.0046539300191212,0.00718992561449179,0.0254333312894469,0.000458553364457721
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TTN,Titin,40116,-0.0236027019425545,0.00673631133069491,-0.0368058721507165,-0.0103995317343925,0.000460502247467646
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD27,CD27 antigen,42679,-0.0158495197712239,0.00453407161177156,-0.0247363001302961,-0.00696273941215164,0.00047443131261348
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCG3,Secretogranin-3,42638,-0.0122268153610448,0.00349784558423381,-0.019082592706143,-0.0053710380159465,0.00047465061941313
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA9,Carbonic anhydrase 9,42721,-0.0173251728291997,0.00496444638899092,-0.0270554877516219,-0.00759485790677749,0.000484830602371765
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CENPJ,Centromere protein J,40302,0.0252341462929621,0.00726548702221467,0.0109937917294213,0.0394745008565028,0.000516341900212941
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,40136,-0.0115588400251376,0.00333169262771986,-0.0180889575754685,-0.00502872247480665,0.000523709790939828
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,40527,0.0225531052935699,0.00650164310716855,0.00980988480351953,0.0352963257836203,0.000524669495866767
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINI1,Neuroserpin,40267,0.0107082625187813,0.00309275015235659,0.00464647222016242,0.0167700528174003,0.000537451912134163
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADA2,Adenosine deaminase 2,42572,-0.0157317337493419,0.00454448072624986,-0.0246389159727916,-0.00682455152589213,0.000538405657779787
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHRM1,Muscarinic acetylcholine receptor M1,40182,-0.0131943888007597,0.00381808578429984,-0.0206778369379874,-0.00571094066353203,0.000550817270091398
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHNAK2,Protein AHNAK2,40223,0.0107056758526339,0.00309847417034693,0.00463266647875391,0.0167786852265139,0.000552067635784743
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPE,Carboxypeptidase E,42588,-0.0136574679721771,0.00395347204286572,-0.021406273176194,-0.00590866276816033,0.000552917874022656
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA11,Serpin A11,42794,-0.0144480445801659,0.00418542555942478,-0.0226514786766384,-0.00624461048369331,0.000558161564576587
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH12,Protocadherin-12,40482,0.00906872546970973,0.00264543622704941,0.00388367046469289,0.0142537804747266,0.000610071811510777
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STC2,Stanniocalcin-2,42591,0.00872135676197089,0.00254806023501498,0.00372715870134152,0.0137155548226003,0.000621779083386438
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0240323581561529,0.00707123551334471,0.0101727365499972,0.0378919797623085,0.000679283901174928
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,-0.0136936951308163,0.00403417892717373,-0.0216006858280769,-0.00578670443355581,0.000689736362337111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,40302,0.0234908632026346,0.0069222007398133,0.00992334975260049,0.0370583766526686,0.000692329718272269
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,0.018814979366756,0.00554494283564115,0.00794689140889936,0.0296830673246127,0.000693240884060202
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1D,V-type proton ATPase subunit D,42587,0.00907538641531349,0.00267599618320947,0.00383043389622293,0.014320338934404,0.00069736301115917
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD14,Monocyte differentiation antigen CD14,42416,0.0144699969761934,0.00427353628148356,0.00609386586448566,0.0228461280879012,0.000711377373903041
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.0142396795613098,0.00421141748418657,-0.0224940578303155,-0.00598530129230412,0.000723720626551344
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG3G,Regenerating islet-derived protein 3-gamma,40451,0.0141514763193302,0.00420095582063616,0.00591760291088332,0.0223853497277771,0.000757954871565017
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEO1,Neogenin,40482,0.00759837055708382,0.00227905898219276,0.003131414951986,0.0120653261621816,0.000858838961288494
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42636,0.0249052054366121,0.00747063919122207,0.0102627526218168,0.0395476582514073,0.00085916747064286
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDS,Iduronate 2-sulfatase,42754,0.00297863595623741,0.000894366063143071,0.00122567847247699,0.00473159343999783,0.000869390681296347
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNPY2,Protein canopy homolog 2,42357,0.0210307335528561,0.00632158923603136,0.0086404186502346,0.0334210484554775,0.000880864446440102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YY1,Transcriptional repressor protein YY1,40199,0.00961113211762863,0.00289095585174343,0.00394485864821151,0.0152774055870457,0.00088850209037397
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.0129111353430634,0.00388555037825617,-0.0205268140844454,-0.00529545660168127,0.000893386166714738
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLL1,Delta-like protein 1,42679,-0.0106907882880012,0.00322246771691989,-0.0170068250131642,-0.00437475156283822,0.000910417520985823
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRTG,Protogenin,42721,0.0084521149367659,0.00254890099532988,0.00345626898591933,0.0134479608876125,0.000915614717827599
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSAP,Gamma-secretase-activating protein,42346,0.0290006022860402,0.0087762985255198,0.0117990571760214,0.046202147396059,0.000954265231273757
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBR2,TGF-beta receptor type-2,42679,0.0121202644374413,0.00367274814817204,0.00492167806702411,0.0193188508078585,0.000969172550514214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,0.0128233534947078,0.00388582532021056,0.00520713586709506,0.0204395711223204,0.000969736096229188
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DGCR6,Protein DGCR6,40136,0.0149937801837777,0.00454558048469449,0.00608444243377647,0.0239031179337789,0.000974991928906252
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA4C,Semaphorin-4C,42587,-0.00938116485664566,0.00284700319622583,-0.0149612911212483,-0.00380103859204303,0.000986416508843657
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,0.0222256352307442,0.0067558728400497,0.00898412446424674,0.0354671459972416,0.00100557949769122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42611,-0.0150777945293633,0.00459460385581291,-0.0240832180867566,-0.00607237097197,0.00103472140420638
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTA4H,Leukotriene A-4 hydrolase,42721,-0.0195855144331872,0.0059904732290697,-0.0313268419621638,-0.00784418690421062,0.00108028438768122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD59,CD59 glycoprotein,42130,0.00834641979038632,0.00256006091573731,0.00332870039554119,0.0133641391852314,0.00111604749103375
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,0.00942358213992784,0.00289192947595451,0.00375540036705701,0.0150917639127987,0.00112248744341495
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,42311,0.0498704183352216,0.0153098134430786,0.0198631839867875,0.0798776526836558,0.00112717628503267
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHAD,Chondroadherin,40283,0.0172649129558298,0.00531654778486447,0.00684447929749539,0.0276853466141641,0.00116814235535151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEDD9,Enhancer of filamentation 1,40199,0.0110843104969289,0.00341332887471461,0.00439418590248823,0.0177744350913695,0.0011682952481488
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EXTL1,Exostosin-like 1,40116,0.0157390049387254,0.00485833273145403,0.00621667278507552,0.0252613370923753,0.00120059889323496
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RCC1,Regulator of chromosome condensation,40451,0.0174000685311789,0.00537913947721371,0.00685695515584007,0.0279431819065178,0.00122108887545867
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,0.0113015503282745,0.00350488533694759,0.00443197506785721,0.0181711255886918,0.00126486424358261
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM171B,Protein FAM171B,40451,0.00872751504581933,0.00270778693877527,0.00342025264581981,0.0140347774458189,0.00127164780050593
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CILP,Cartilage intermediate layer protein 1,40527,0.0182275328496511,0.00565640793219763,0.00714097330254379,0.0293140923967585,0.00127455438239682
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAL,Galanin peptides,42676,0.0211629943209912,0.00657481375936554,0.0082763593526347,0.0340496292893476,0.00129033945250302
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,0.0179425447997041,0.00557577922990178,0.00701401750909661,0.0288710720903116,0.00129477615708138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PREB,Prolactin regulatory element-binding protein,42370,0.00970858450403009,0.00302271706930223,0.00378405904819772,0.0156331099598625,0.00132189245295655
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OPTC,Opticin,42587,-0.0152287807022766,0.00474220360164433,-0.0245234997614995,-0.00593406164305377,0.00132434139394834
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDRG1,Protein NDRG1,42311,0.0214411868004426,0.00667899564843858,0.00835035532950297,0.0345320182713822,0.001329430515603
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,-0.0230442346501179,0.00722671679998437,-0.0372085995780873,-0.00887986972214855,0.00143277842342755
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,0.0114999261665826,0.00360743581542395,0.00442935196835167,0.0185705003648135,0.00143669579771152
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNXB,Tenascin-X,42611,-0.00842299322185569,0.00264503819742346,-0.0136072680888057,-0.00323871835490571,0.00145360567312748
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,0.0211159348382125,0.00663807445773063,0.00810530890106042,0.0341265607753645,0.00147157298264405
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.0105947693581543,0.00333086170454838,-0.0171232582990691,-0.00406628041723948,0.00147278878244242
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL6,Fc receptor-like protein 6,42594,0.0228005234623712,0.00717921055980839,0.00872927076514677,0.0368717761595957,0.00149705949150554
NMR metabolomics,X23508.Triglycerides in Medium VLDL,QSOX1,Sulfhydryl oxidase 1,40342,0.014058993583639,0.0044410643985483,0.00535450736248433,0.0227634798047937,0.00155136784535907
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA1549,UPF0606 protein KIAA1549,40302,0.0228657157697748,0.00726047700162601,0.00863518084658781,0.0370962506929618,0.00164073008346131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EP300,Histone acetyltransferase p300,40199,0.00998763783343209,0.00317467347079505,0.00376527783067379,0.0162099978361904,0.00165940537072612
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ULBP2,UL16-binding protein 2,42495,0.0128937980903779,0.00409905122886516,0.00485965768180218,0.0209279384989536,0.00166136315076301
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.018260527321896,0.00580565890948989,0.00688143585929583,0.0296396187844962,0.00166287349730222
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN3,Neuronal-specific septin-3,40482,-0.0241603563221603,0.0076842230634619,-0.0392214335265456,-0.00909927911777496,0.00167001370466712
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRPB1,Signal-regulatory protein beta-1,42600,0.0154924258199719,0.0049291682937936,0.00583125596413645,0.0251535956758073,0.00167584538283201
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAFB2,Scaffold attachment factor B2,40482,0.00884149209287072,0.00281719486152765,0.00331979016427652,0.0143631940214649,0.00170308708480625
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,0.00962810000851383,0.00306978026022241,0.00361133069847791,0.0156448693185498,0.00171404982964125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,40199,0.0113858220671339,0.00363486873419235,0.00426147934811693,0.0185101647861509,0.0017384484787864
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEPACAM2,HEPACAM family member 2,40483,-0.0134996993983668,0.00432070834404822,-0.0219682877527013,-0.00503111104403227,0.00178608342345875
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,-0.00925977019016163,0.00296489054663251,-0.0150709556615614,-0.00344858471876192,0.00179307797811031
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDHB15,Protocadherin beta-15,40451,-0.0128712185603388,0.00412998352239828,-0.0209659862642395,-0.0047764508564382,0.00183453415378129
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPESP1,Sperm equatorial segment protein 1,40511,0.0101415097423606,0.0032564084100006,0.00375894925875943,0.0165240702259618,0.00184827432966989
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NLGN2,Neuroligin-2,40136,-0.0153633279561689,0.00493310873384094,-0.0250322210744971,-0.00569443483784062,0.00184839320031668
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,-0.0124517692396932,0.00400421352031578,-0.0203000277395121,-0.00460351073987423,0.00187780485436758
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF3,Granulocyte colony-stimulating factor,42370,0.0155517984424382,0.00500917477341329,0.00573381588654816,0.0253697809983282,0.00190899907899168
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYTL1,Cytokine-like protein 1,40527,0.00813857853516428,0.00262166594010439,0.00300011329255969,0.0132770437777689,0.00191165033397958
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.0152272151392989,0.00490590083277674,-0.0248427807715414,-0.00561164950705654,0.00191408646978814
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGMA,Repulsive guidance molecule A,42711,-0.0101404550673374,0.00328099418076583,-0.0165712036616384,-0.00370970647303636,0.00200114452369997
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEZ6,Seizure protein 6 homolog,40182,-0.00994374518953274,0.0032218202420769,-0.0162585128640035,-0.00362897751506202,0.0020311722646552
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.0129167802775352,0.00418731073872118,-0.0211239093254288,-0.00470965122964174,0.00204236558734919
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA1549L,UPF0606 protein KIAA1549L,40302,-0.00913520624174805,0.00297112308408434,-0.0149586074865534,-0.00331180499694274,0.00211250995527725
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL10RA,Interleukin-10 receptor subunit alpha,42370,0.0182843244935384,0.00594993219805726,0.00662245738534614,0.0299461916017306,0.00212329298290978
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.0137317410659959,0.0044854759092888,-0.0225232738482019,-0.00494020828378983,0.00220756424726343
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIF20B,Kinesin-like protein KIF20B,40136,0.024502736622262,0.00803069654096427,0.00876257140197206,0.040242901842552,0.00228524365591953
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGA,Glycoprotein hormones alpha chain,42611,-0.0196597782913603,0.0064565262147125,-0.0323145696721968,-0.00700498691052377,0.0023317271797639
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.0570057154247238,0.0187469088628419,0.0202617740535536,0.0937496567958939,0.0023640225393201
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MB,Myoglobin,42794,-0.0164004360167245,0.00543605455877132,-0.0270551029519163,-0.00574576908153276,0.00255783697323083
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPT2,Angiopoietin-2,42721,-0.0116452741970357,0.0038698477108838,-0.019230175710368,-0.00406037268370348,0.0026239036936494
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,0.00823466288516274,0.00273646923269271,0.00287118318908503,0.0135981425812404,0.00262402832187601
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,-0.0084522544645604,0.0028188827810617,-0.0139772647154413,-0.00292724421367948,0.0027185507139609
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HLA_DRA,,42549,-0.0113415549175775,0.00378461330330718,-0.0187593969920596,-0.00392371284309546,0.00273372209881389
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHX2,Bifunctional epoxide hydrolase 2,42357,0.0190474372990011,0.0063774939017464,0.00654754925157815,0.0315473253464241,0.00282558010371927
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCAM1,Neural cell adhesion molecule 1,42689,-0.0092438557116189,0.00309579483920947,-0.0153116135964695,-0.00317609782676835,0.00283215993805161
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NGF,Beta-nerve growth factor,42495,0.0036727277739362,0.00123127652469775,0.00125942578552862,0.00608602976234378,0.00286084825334295
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOA4,Apolipoprotein A-IV,40539,0.0110022740269033,0.00369501424782057,0.00376004610117494,0.0182445019526316,0.00291128832324617
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHI3L1,Chitinase-3-like protein 1,42416,0.0249989806008376,0.00844112080736274,0.00845438381840659,0.0415435773832686,0.00306617760379257
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM5,Intercellular adhesion molecule 5,42636,0.0138961675794027,0.00469396545104124,0.0046959952953619,0.0230963398634436,0.0030774389827577
NMR metabolomics,X23508.Triglycerides in Medium VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42681,0.00827207922326386,0.00279529437320356,0.00279330225178489,0.0137508561947428,0.00308887297781373
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.00913463256442144,0.00308876991374428,0.00308064353348265,0.0151886215953602,0.00310936829829961
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TG,Thyroglobulin,40451,-0.0348623352351826,0.0118074472233725,-0.0580049317929927,-0.0117197386773725,0.00315789591445374
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,40199,0.0073601810349537,0.00249509682105646,0.00246979126568304,0.0122505708042244,0.00318589446187015
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRAL,GDNF family receptor alpha-like,40109,-0.018957860564881,0.00645159710286407,-0.0316029908864946,-0.00631273024326738,0.00330520972105206
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA6C,Semaphorin-6C,40199,0.0079075624508893,0.00269172365927928,0.00263178407870191,0.0131833408230767,0.00331308503433421
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST6,Cystatin-M,42332,0.0152413494752763,0.00519611766280547,0.00505695885617758,0.025425740094375,0.00336046987321503
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPO,Erythropoietin,42594,0.0221920469568035,0.00757100291424595,0.00735288124488141,0.0370312126687255,0.00338236783740514
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ODAM,Odontogenic ameloblast-associated protein,42292,0.0169069727604687,0.00577075390096145,0.00559629511458423,0.0282176504063531,0.00339799899813594
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,0.00852674961410381,0.00291070086540681,0.00282177591790647,0.0142317233103012,0.00340241394472335
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,0.0100357931566854,0.00343167491302821,0.00330971032715013,0.0167618759862207,0.00345759285087201
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD1,Programmed cell death protein 1,42689,0.0134326066147198,0.00461285284671573,0.00439141503515697,0.0224737981942826,0.00359716041131227
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OLFM4,Olfactomedin-4,39870,0.0367689498817374,0.0126475506738062,0.0119797505610773,0.0615581492023976,0.00365431412308974
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX18,Sorting nexin-18,40449,0.0130593700892126,0.00449260430144714,0.00425386565837617,0.021864874520049,0.0036578940369811
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G1B,Phospholipase A2,42782,-0.0135642063878172,0.00467088144157273,-0.0227191340132997,-0.00440927876233464,0.00369029909319877
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.0169228367699144,0.00582942724680508,0.00549715936617645,0.0283485141736524,0.00370217815277468
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC1A,C-type lectin domain family 1 member A,42357,-0.0104380607323556,0.00359795927125696,-0.0174900609040192,-0.00338606056069192,0.00372464197208984
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.025005310991146,0.00863113567442532,0.00808828506927235,0.0419223369130196,0.00377366720058323
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,0.0151117954764242,0.00523445679175096,0.0048522601645923,0.0253713307882561,0.00389693769702519
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTF4,Neurotrophin-4,42346,0.0115263656008518,0.0040017883257461,0.00368286048238949,0.0193698707193142,0.00397933987014582
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRD3,Bromodomain-containing protein 3,40116,0.0146868432549719,0.00510503897905234,0.00468096685602928,0.0246927196539144,0.00402341556304957
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP112,Centrosomal protein of 112 kDa,40116,0.0132387426300829,0.00460534439929118,0.00421226760747215,0.0222652176526936,0.00405259702046385
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRTN,Neurturin,42370,0.0145042133988041,0.00504758144121456,0.00461095377402357,0.0243974730235847,0.00406602986160599
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,40302,0.0167628474676801,0.00587709365427314,0.00524374390530476,0.0282819510300555,0.00434932347286649
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,-0.00613411969375967,0.00215368341712724,-0.0103553391913291,-0.00191290019619028,0.00440486930227075
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUK1,Guanylate kinase,40116,-0.0112185497353497,0.0039441598065668,-0.0189491029562206,-0.00348799651447879,0.00445855938183361
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.0143454737952659,0.00505266209193918,-0.0242486914954667,-0.00444225609506511,0.00452957606711201
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSC1,Hamartin,40199,0.0213185837459972,0.00752784323721231,0.0065640110010611,0.0360731564909334,0.00463469997484101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,0.00868417592124895,0.003077177541345,0.00265290794021275,0.0147154439022851,0.00477765462805493
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.0156247007158621,0.00554493835038371,-0.0264927798826141,-0.00475662154910999,0.00484359145445318
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,0.025276372557211,0.00900167190970273,0.00763309561419371,0.0429196495002284,0.00499446251475958
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.0080626110973503,0.0028762369078145,-0.0137000354366667,-0.00242518675803388,0.00506743139796236
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE1,Ribonuclease pancreatic,40532,0.00756968866073531,0.00270580227741708,0.00226631619699783,0.0128730611244728,0.00515744003565522
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.0113280030415407,0.00405843868603482,0.00337346321691246,0.0192825428661689,0.00525853564682819
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAYN,Layilin,42476,-0.0108174312500484,0.00388432790304214,-0.018430713940011,-0.00320414856008578,0.00536214721644414
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL9A1,Collagen alpha-1(IX) chain,42594,0.0138211649052726,0.00497998100197871,0.00406040214139434,0.0235819276691509,0.00552196288008344
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.0149337552236303,0.00538085163889226,0.00438728601140151,0.0254802244358592,0.00552358407232796
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP9,Fatty acid-binding protein 9,42594,0.0161213709781892,0.00581810442646495,0.00471788630231791,0.0275248556540605,0.00559790628944985
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP1,Caspase-1,42311,0.019593461572455,0.00708721757360546,0.00570251512818831,0.0334844080167217,0.00570687688919244
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42495,0.0066728096785238,0.00241955410752957,0.00193048362776585,0.0114151357292817,0.00582591892257025
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.0201492635954707,0.00730783538081463,0.00582590624907399,0.0344726209418673,0.00583744818774655
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.0242694353801248,0.00880834147489008,-0.0415337846709093,-0.00700508608934021,0.00587239235124372
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17A,Interleukin-17A,42347,-0.0121537342004815,0.00442850952059545,-0.0208336128608486,-0.00347385554011439,0.00606983045880907
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRP15,RRP15-like protein,40136,-0.0258538075228227,0.00942707413268211,-0.0443308728228797,-0.0073767422227658,0.00610714991936581
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDK1,Cyclin-dependent kinase 1,40080,0.0103717849341391,0.00378394161424912,0.00295525937021082,0.0177883104980674,0.00613523966293647
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JAM2,Junctional adhesion molecule B,42711,0.00797664565965995,0.0029118685984988,0.0022693832066023,0.0136839081127176,0.00616403228768883
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL21,C-C motif chemokine 21,42676,0.0117923821444789,0.00431868224980363,0.00332776493486378,0.020256999354094,0.00633107041473687
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.013943473851717,0.00512390212140358,-0.023986322009668,-0.00390062569376601,0.00651358619715133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS11D,Transmembrane protease serine 11D,40470,0.0113977559214432,0.00420275552234221,0.00316035509765249,0.019635156745234,0.00669856086663467
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNW1,Interferon omega-1,40116,-0.0102448773860234,0.00378429656993473,-0.0176620986630955,-0.00282765610895132,0.00679572915065966
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLAU,Urokinase-type plasminogen activator,42611,-0.00817502826724598,0.00302001153363702,-0.0140942508731745,-0.00225580566131742,0.00679898760718388
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC12A2,Solute carrier family 12 member 2,40116,-0.00753950526294584,0.00279631937331428,-0.0130202912346418,-0.00205871929124984,0.00702378440174022
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.0105785207535252,0.00392524138082303,-0.0182719938599383,-0.00288504764711205,0.00704765672125687
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QL2,Complement C1q-like protein 2,40199,0.0121710439708128,0.00451989135498397,0.00331205691504419,0.0210300310265814,0.00709676765684421
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,40080,0.0163122792692121,0.00606572880611476,0.00442345080922721,0.0282011077291971,0.00717212380150967
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRK1,Protein BRICK1,42311,0.012385724010975,0.00460705892823277,0.00335588851163881,0.0214155595103113,0.00718810259068832
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,0.0144275820042104,0.00536890666419675,0.00390452494238481,0.0249506390660361,0.0072150796654489
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLVRB,Flavin reductase,42611,0.0180661241592923,0.00673226858355178,0.0048708777355308,0.0312613705830538,0.00729427113760742
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP164,Centrosomal protein of 164 kDa,42370,0.0181665744867331,0.00677140945062168,0.00489461196351459,0.0314385370099516,0.00730920987992737
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBPMS,RNA-binding protein with multiple splicing,40199,0.0175528116484815,0.00654612566609482,0.00472240534293566,0.0303832179540274,0.00734231550527276
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,0.0137318444020346,0.0051239906710558,0.00368882268676526,0.023774866117304,0.00737486647085736
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.0192496929189067,0.00719645393006158,0.00514464321598604,0.0333547426218274,0.00748441265926734
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOX9,Transcription factor SOX-9,40182,0.00759566012634758,0.00284400081039864,0.00202141853796625,0.0131699017147289,0.00757898759117171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,40182,0.0176084791479841,0.00660124786769262,0.00467003332730652,0.0305469249686616,0.00765419883699597
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PON1,Serum paraoxonase/arylesterase 1,40532,-0.00745330267548827,0.00279796245747054,-0.0129373090921305,-0.00196929625884601,0.00773653127622147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,0.00785171251755192,0.00295535777728184,0.0020592112740795,0.0136442137610243,0.00790040168841591
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,0.0126796574774593,0.00478834027301298,0.00329451054235384,0.0220648044125647,0.00810757785384042
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL25,Interleukin-25,40036,0.00949664641879897,0.00359015074850402,0.00245995095173109,0.0165333418858668,0.00817617471601742
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KEL,Kell blood group glycoprotein,42311,0.00983124355346523,0.00371876885889622,0.00254245659002863,0.0171200305169018,0.00821071267312407
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,-0.0166784419898647,0.00632457022559529,-0.0290745996320315,-0.00428228434769793,0.00837395599708887
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL9,C-X-C motif chemokine 9,42676,0.0182243826196721,0.00693256254208814,0.00463656003717934,0.0318122052021648,0.00857816576515814
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCB,Calcitonin gene-related peptide 2,40483,0.011036093976935,0.00420640420990875,0.00279154172551383,0.0192806462283561,0.00871124773359018
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00703189887980087,0.0026802557922789,-0.0122852002326675,-0.00177859752693424,0.0087124849902962
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,-0.0129408732201075,0.00495188863499026,-0.0226465749446884,-0.00323517149552656,0.00897884886067056
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP152,Centrosomal protein of 152 kDa,40080,0.0111502474490056,0.00427955214509048,0.00276232524462826,0.0195381696533829,0.00918729835999213
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.00988430885167384,0.00380246692279189,0.00243147368300173,0.0173371440203459,0.00934986480819079
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00958973223914494,0.00370126433245699,0.00233525414752924,0.0168442103307606,0.00958214722689277
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,0.0118934414819239,0.0045903232297636,0.00289640795158724,0.0208904750122605,0.00958299483596505
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSN,Gelsolin,40488,-0.00514097822487416,0.0019869893177035,-0.00903547728757302,-0.00124647916217529,0.00968493182637226
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PXDNL,Peroxidasin-like protein,40451,-0.0147850483537467,0.00571500885674647,-0.0259864657129698,-0.00358363099452365,0.00969240413995248
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBH,Dopamine beta-hydroxylase,40515,0.0290430963867156,0.0112273376043053,0.00703751468227726,0.051048678091154,0.00969898511170152
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MKI67,Proliferation marker protein Ki-67,40199,0.0102615182229514,0.00397139879506676,0.00247757658462053,0.0180454598612822,0.00978305589280713
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRR5,Proline-rich protein 5,40199,0.0126457339688785,0.00490243990340532,0.00303695175820404,0.0222545161795529,0.0099078393973302
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTNAP2,Contactin-associated protein-like 2,42594,-0.0110593716915634,0.00428811121380413,-0.0194640696706195,-0.00265467371250727,0.00991701320391157
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.0162163958382114,0.00630923332088208,-0.0285824931471403,-0.00385029852928255,0.0101751336872109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTO1,Protein LTO1 homolog,42370,0.0110862276438729,0.00431925929511729,0.00262047942544306,0.0195519758623028,0.0102781868638577
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL1,Angiopoietin-related protein 1,42439,0.00761270633323887,0.00297491349902088,0.00178187587515794,0.0134435367913198,0.0105093744270577
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.00896430930494765,0.0035036787651072,0.00209709892533754,0.0158315196845578,0.010522121859849
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,0.0138415779001574,0.00542844701592195,0.00320182174895043,0.0244813340513645,0.0107890406664805
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPA4,Carboxypeptidase A4,40060,0.0115257234787582,0.00452462035497716,0.00265746758300295,0.0203939793745134,0.0108685770078342
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK11,Kallikrein-11,42543,0.00852484905779729,0.00335307313460126,0.00195282571397882,0.0150968724016158,0.0110206459622291
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGLON5,IgLON family member 5,40080,-0.0247248709187013,0.00973174547938597,-0.0437990920582978,-0.00565064977910483,0.0110787161726244
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,0.0216246778981998,0.00853921275995768,0.00488782088868276,0.0383615349077169,0.0113423436223986
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00665643435923921,0.00262954059457223,-0.0118103339246008,-0.00150253479387764,0.0113744052526905
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY96,Lymphocyte antigen 96,42495,-0.00923765076908452,0.00366300513074877,-0.0164171408253521,-0.00205816071281694,0.0116846084605391
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDA1,DET1- and DDB1-associated protein 1,40116,0.0103923804940222,0.00413346943685636,0.00229078039778377,0.0184939805902607,0.011944437319345
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,-0.0100114908574019,0.00398925551530779,-0.0178304316674052,-0.00219255004739865,0.0121006756433239
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD80,T-lymphocyte activation antigen CD80,40511,0.00896414735284932,0.00357284297942542,0.00196137511317549,0.0159669195925231,0.0121223205716231
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REXO2,"Oligoribonuclease, mitochondrial",40116,-0.012292037956818,0.00492032945104405,-0.0219358836808644,-0.00264819223277172,0.0124966510575408
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPSAB1,Tryptase alpha/beta-1,42741,0.0134069395540877,0.00536683243221114,0.0028879479869539,0.0239259311212216,0.0124974918716853
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACRV1,Acrosomal protein SP-10,40199,0.0205374855474166,0.00822204443963994,0.00442227844572232,0.0366526926491109,0.0125091641964945
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFAP,Glial fibrillary acidic protein,42326,0.0124950598207673,0.00501490319560301,0.00266584955738543,0.0223242700841492,0.0127296797971538
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BABAM1,BRISC and BRCA1-A complex member 1,40199,0.00741913948640767,0.00298367695391934,0.00157113265672577,0.0132671463160896,0.0129126135538323
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMP4,Bone morphogenetic protein 4,42475,-0.0118623557612687,0.00477872941730026,-0.0212286654191772,-0.00249604610336023,0.013065107310796
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSM,Oncostatin-M,42534,0.0177263435952959,0.00716490481269084,0.00368313016242191,0.03176955702817,0.0133713914162276
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.0253817390722978,0.0102611223727704,-0.0454935389229278,-0.00526993922166775,0.0133916605551632
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.00815034894289587,0.00329638438683486,0.00168943554469954,0.0146112623410922,0.0134313191409425
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASPN,Asporin,40511,0.00712094223600024,0.00288147844111895,0.00147324449140711,0.0127686399805934,0.0134776187245719
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,-0.0100098166884854,0.00406334673631902,-0.0179739762916707,-0.00204565708530013,0.0137761920349041
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE6,Ribonuclease K6,40468,0.00858450868259074,0.00348482070665902,0.00175426009753907,0.0154147572676424,0.0137774389113821
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.0191593779247475,0.00782300353549331,0.00382629099518056,0.0344924648543143,0.0143365137804524
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B2M,Beta-2-microglobulin,40539,0.00787175803895072,0.0032147306932195,0.00157088588024049,0.0141726301976609,0.0143542045076522
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.00884788579601938,0.00362000358573191,0.00175267876798483,0.0159430928240539,0.0145343745443879
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUC2,Mucin-2,40527,0.0233010443907919,0.00953412322878057,0.00461416286238194,0.0419879259192018,0.0145420560686111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FSTL3,Follistatin-related protein 3,42574,0.00845651016320161,0.00346487630483698,0.00166535260572113,0.0152476677206821,0.0146742068444198
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGLC2,Immunoglobulin lambda constant 2,40519,-0.00633145637658689,0.0025952277225171,-0.0114181027127204,-0.00124481004045337,0.0147165932502918
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD5,Sushi domain-containing protein 5,40235,-0.00866611039438421,0.00356263081933596,-0.0156488668002827,-0.00168335398848573,0.0150106425632354
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.00733162597623632,0.00301502061840027,-0.0132410663883008,-0.00142218556417179,0.0150435319372504
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK14,Kallikrein-14,42721,-0.0117209236592924,0.00483047366894147,-0.0211886520504177,-0.00225319526816715,0.0152601506412678
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL28,C-C motif chemokine 28,42538,0.0145686670961565,0.00601609180644642,0.00277712715552152,0.0263602070367915,0.0154648900687891
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00535933326306186,0.00221465241192584,0.00101861453568722,0.0097000519904365,0.015536177449275
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX2,Peroxiredoxin-2,40333,0.0154788589554946,0.00640495624683803,0.00292514471169206,0.0280325731992971,0.0156778769642537
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP1,"Fatty acid-binding protein, liver",42618,-0.0232948921408284,0.00964849800324933,-0.0422059482271971,-0.00438383605445974,0.0157764160282591
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.00936255622702509,0.00388477387394631,0.00174839943409033,0.0169767130199599,0.0159630549892231
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKAP12,A-kinase anchor protein 12,40283,-0.00543531955609652,0.0022565189577244,-0.00985809671323636,-0.00101254239895669,0.0160248322992651
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD7,T-cell antigen CD7,40166,0.011006120968886,0.00458163114769467,0.0020261239194044,0.0199861180183675,0.0163120773925918
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITM2A,Integral membrane protein 2A,42594,-0.015126554951979,0.00632543436948407,-0.0275244063161678,-0.00272870358779025,0.0167986051880002
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.00457817335857601,0.00191890903238743,0.000817111655096645,0.00833923506205537,0.0170573506441346
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42794,-0.007677654716332,0.00322006314981848,-0.0139889784899762,-0.00136633094268778,0.0171244332781167
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKCQ,Protein kinase C theta type,42370,0.0107095330866588,0.00449463564549886,0.001900047221481,0.0195190189518365,0.0171985757337172
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,42351,0.0133892136694923,0.00563559097372303,0.00234345536099514,0.0244349719779894,0.0175236991252737
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.00541423901800364,0.00227987257279936,0.000945688775316891,0.0098827892606904,0.0175724918772731
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMNB2,Lamin-B2,40483,0.00697503642170052,0.00293893697342877,0.00121471995378012,0.0127353528896209,0.0176456499259917
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,0.0176351077818453,0.00743215471712517,0.00306808453627998,0.0322021310274107,0.0176698891508624
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMOD4,Tropomodulin-4,40080,-0.0100443944049077,0.00423655135825714,-0.0183480350670917,-0.00174075374272373,0.0177626544158556
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2,Apoptosis regulator Bcl-2,40449,0.0138927672016044,0.00586435089903968,0.00239863943948664,0.0253868949637222,0.0178520489573723
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PEPD,Xaa-Pro dipeptidase,40532,0.00640632583048044,0.00270635616547393,0.00110186774615153,0.0117107839148094,0.0179428136907949
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,0.0209441675793826,0.00885743692897604,0.00358359119858957,0.0383047439601756,0.0180673533214682
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,-0.00800286257291639,0.0033853472452018,-0.0146381431735119,-0.00136758197232087,0.0180943680509995
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRA2,GDNF family receptor alpha-2,42587,0.00514972528827669,0.00218032327186923,0.000876291675412995,0.00942315890114039,0.0181953272843853
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMRK2,Nicotinamide riboside kinase 2,40080,-0.0102810864767666,0.0043598507555334,-0.018826393957612,-0.00173577899592108,0.0183849378335677
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRXN3,Neurexin-3,40182,0.00860412234993142,0.00365114339091305,0.00144788130374184,0.015760363396121,0.0184627600385068
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP73,Tumor protein p73,40182,0.0083648870140987,0.00355093894336832,0.00140504668509679,0.0153247273431006,0.0185061522688701
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,0.0156665371587753,0.0066846472447977,0.00256462855897181,0.0287684457585788,0.0191131291055515
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRG3,Proteoglycan 3,40527,-0.0118961749231484,0.00510899877610941,-0.0219098125243229,-0.001882537321974,0.0199044039263474
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CKAP4,Cytoskeleton-associated protein 4,42713,0.00689599298744954,0.0029632367664522,0.00108804892520322,0.0127039370496959,0.0199702404565276
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECTIN4,Nectin-4,42679,-0.00821717261076628,0.00353678077188559,-0.015149262923662,-0.00128508229787052,0.0201752579582664
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELAVL4,ELAV-like protein 4,40136,0.0201943949721702,0.00871888442455094,0.00310538150005041,0.0372834084442901,0.0205675213666668
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTTG1,Securin,40302,0.00967655770725984,0.00420230974119199,0.00144003061452355,0.0179130847999961,0.0213154734939631
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP2,Guanylate-binding protein 2,42370,0.0143335604983178,0.00622747716437997,0.00212770525613301,0.0265394157405025,0.0213696470054897
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,0.008171852167462,0.00356458384690211,0.00118526782753386,0.0151584365073901,0.0218916818390848
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,0.0181637826332959,0.00792644350812006,0.0026279533573806,0.0336996119092112,0.0219478260488405
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,40136,-0.0120597475719192,0.00527320077415832,-0.0223952210892695,-0.00172427405456893,0.0222155208423637
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17C,Interleukin-17C,42370,-0.0175240200900981,0.00766321651105717,-0.0325439244517701,-0.00250411572842602,0.0222249881615956
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMNB1,Lamin-B1,40434,0.0140002563899924,0.00612411391428087,0.00199699311800188,0.0260035196619829,0.0222676966649927
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD5L,CD5 antigen-like,40479,0.0111737430440935,0.00489101273106224,0.00158735809121148,0.0207601279969754,0.0223579460126439
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.00988132458330979,0.00432838219181069,0.00139769548736084,0.0183649536792587,0.0224509248698367
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.0148791433678123,0.00651934379858377,-0.0276570572130365,-0.00210122952258815,0.0224901034410197
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.0287055312764285,0.0125910206327836,0.00402713083617265,0.0533839317166844,0.0226330280691109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,0.0150481642401647,0.00660558463933246,0.00210121834707308,0.0279951101332563,0.02273986698086
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WNT9A,Protein Wnt-9a,42370,-0.00693129515314233,0.00304563220624799,-0.0129007342773884,-0.000961856028896266,0.0228730693039656
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.0331058979524503,0.0145660604151138,-0.0616553763660734,-0.0045564195388273,0.0230562288837421
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOH,Beta-2-glycoprotein 1,42611,-0.0084175911337908,0.0037326172776412,-0.0157335209979676,-0.00110166126961405,0.0241403109643233
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.00808283823475307,0.00358917419701363,-0.0151176196608998,-0.00104805680860637,0.0243379763278583
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAMP5,Vesicle-associated membrane protein 5,42357,0.0127898268969876,0.00568372408932031,0.00164972768191981,0.0239299261120554,0.0244492239630925
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.00559311733457189,0.00248661450280798,0.00071935290906826,0.0104668817600755,0.0245101190609605
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKD1,Polycystin-1,40511,0.00616957330423042,0.00275076906983815,0.000778065927347635,0.0115610806811132,0.0249255089514797
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C9orf40,Uncharacterized protein C9orf40,40449,0.0186361831073236,0.00833170673402966,0.00230603790862548,0.0349663283060217,0.0253203211484558
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALCAM,CD166 antigen,42794,0.00449977380823073,0.00201261279238687,0.000555052735152467,0.00844449488130899,0.0253818761291134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR4,Toll-like receptor 4,40199,0.00671995854506296,0.00300579707752587,0.000828596273112248,0.0126113208170137,0.0253936249519144
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFNA1,Ephrin-A1,42590,0.00694117814413316,0.00310521348784937,0.000854959707948393,0.0130273965803179,0.0254120775376198
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TERF1,Telomeric repeat-binding factor 1,40199,-0.00677375582543481,0.00303325170690788,-0.0127189291709743,-0.00082858247989536,0.0255579964284196
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NME1,Nucleoside diphosphate kinase A,40199,-0.00501272171715593,0.0022578555881672,-0.00943811866996365,-0.000587324764348212,0.0264305758541242
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEF,Thyrotroph embryonic factor,40116,0.00987928950012709,0.00446001071652124,0.00113766849574546,0.0186209105045087,0.0267749900555269
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN8,Tetraspanin-8,40449,0.0231233256535641,0.0105022092328114,0.00253899555725367,0.0437076557498744,0.0277026051446545
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA6,Corticosteroid-binding globulin,40539,0.00353680928169532,0.00160816844387413,0.000384799131702022,0.00668881943168861,0.0278782731752081
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,0.0195120797174194,0.00889027433195165,0.00208714202679421,0.0369370174080447,0.0282013686271354
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACTA2,"Actin, aortic smooth muscle",42357,-0.00988352300388895,0.00450603543663649,-0.0187153524596965,-0.00105169354808143,0.0282962413696046
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.00770906811590726,0.00352034749959406,-0.0146089492151116,-0.000809187016702895,0.0285517254771063
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENO1,Alpha-enolase,42588,0.0176039409371117,0.00804891055499596,0.00182807624931965,0.0333798056249038,0.0287509275769189
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFB2,Transforming growth factor beta-2 proprotein,40451,0.011690267477777,0.00534509288984704,0.00121388541367681,0.0221666495418772,0.0287555265796803
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.00707403058384102,0.00325648153169715,-0.0134567343859674,-0.000691326781714601,0.0298549112055891
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF1,Macrophage colony-stimulating factor 1,42676,0.00618623272826586,0.00284854600781243,0.000603082552953496,0.0117693829035782,0.0298944720534241
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.00791201533087984,0.00364372369729627,0.000770316884179157,0.0150537137775805,0.0299177152475717
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B4,Protein ATP1B4,40080,-0.00942646828606774,0.00434198526575964,-0.0179367594069566,-0.000916177165178835,0.0299523881773884
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN7,Septin-7,40302,0.0121166904055097,0.0055821375332194,0.00117570084039967,0.0230576799706197,0.0299811417823639
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD58,Lymphocyte function-associated antigen 3,42600,-0.00394207607795307,0.00181647112721919,-0.00750235948730268,-0.000381792668603468,0.0300104298959074
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS5,Transmembrane protease serine 5,42438,-0.00847757061228799,0.00390709713240945,-0.0161354809918105,-0.000819660232765473,0.0300406660944396
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,-0.0109311391154593,0.00503897968433298,-0.020807539296752,-0.00105473893416669,0.0300761482565609
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LHB,Lutropin subunit beta,42346,0.0186976591855253,0.00863857726275995,0.00176604775051581,0.0356292706205348,0.0304487352700216
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MBL2,Mannose-binding protein C,40379,-0.0241267242137524,0.0111555721818044,-0.045991645690089,-0.00226180273741572,0.0305814630679337
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTM4,Glutathione S-transferase Mu 4,40116,-0.0165298159940338,0.0076480415785585,-0.0315199774880085,-0.00153965450005917,0.0306927859460117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN2B,Sodium channel subunit beta-2,40182,-0.00645400480546456,0.00299246053484785,-0.0123192274537663,-0.000588782157162782,0.0310463654791519
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOS1,"Nitric oxide synthase, brain",42311,-0.0120013709135581,0.00556555234559069,-0.0229098535109159,-0.00109288831620036,0.0310731729876996
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB118,Beta-defensin 118,40136,0.01260246816042,0.00585347281308754,0.00112966144676846,0.0240752748740716,0.0313412565574108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.006849233071657,0.00318530005562938,0.000606044962623422,0.0130924211806906,0.0315561301849132
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,-0.00749809977661292,0.00349269218370568,-0.014343776456676,-0.000652423096549793,0.0318313894176725
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UNG,Uracil-DNA glycosylase,40451,0.00750138621428545,0.00349846236744585,0.000644399974091579,0.0143583724544793,0.0320385999110221
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH17,Cadherin-17,42636,-0.0151840517568809,0.00711744150436461,-0.0291342371054355,-0.00123386640832627,0.0329134138943652
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.0162737419217045,0.00763517472827849,-0.0312386843891304,-0.0013087994542787,0.0330770156630979
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOM1,Myomesin-1,40136,0.0105238926527093,0.00494121261385135,0.000839115929560671,0.020208669375858,0.0332087415422827
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK1,Kallikrein-1,42505,-0.0282300906742133,0.0132851544853492,-0.0542689934654978,-0.00219118788292878,0.0336104015893798
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,0.00940401315372522,0.00442816723623656,0.000724805370701556,0.0180832209367489,0.0337149950029781
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUOX2,Dual oxidase 2,42357,0.0154799708853123,0.00733119994935686,0.00111081898457283,0.0298491227860517,0.0347464886374543
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIF1L,Allograft inflammatory factor 1-like,40223,0.0120273440734219,0.0057098757809222,0.000835987542814378,0.0232187006040294,0.0351912149663708
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST7,Cystatin-F,42642,0.020160501473972,0.00959123018384678,0.00136169031363235,0.0389593126343117,0.0355742392614272
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,0.00463279135075223,0.00220717351884325,0.00030673125381945,0.008958851447685,0.0358417511409145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,-0.00745461431973804,0.00355370569456382,-0.0144198774810831,-0.000489351158392947,0.0359499939842377
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THBS4,Thrombospondin-4,42652,0.00981148087120842,0.0046852961757396,0.000628300366758809,0.018994661375658,0.0362696908803728
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOX2,Transcription factor SOX-2,40461,0.00513612517304473,0.00245583247331533,0.000322693525346696,0.00994955682074277,0.0365146642752544
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MERTK,Tyrosine-protein kinase Mer,42754,-0.00546557612609875,0.00261553298323134,-0.0105920207732322,-0.000339131478965336,0.0366668891090751
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALY,Neuron-specific vesicular protein calcyon,40116,-0.00840029257615873,0.00402123980270342,-0.0162819225894574,-0.000518662562860017,0.0367325450212098
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSLN,Mesothelin,42553,0.0127399191792402,0.00610154634828462,0.000780888336602293,0.024698950021878,0.0368183481077738
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHISA5,Protein shisa-5,40527,0.0059565870156555,0.00285354901573016,0.000363630944824382,0.0115495430864866,0.0368714624530046
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.00567345150593855,0.00271970476927922,0.000342830158151274,0.0110040728537258,0.0369969827679689
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,0.0124235298582661,0.00596237239343445,0.00073727996713454,0.0241097797493976,0.0372147858210432
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.00805213383450987,0.00386587043407515,-0.0156292398852972,-0.000475027783722565,0.0372812986860501
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ID4,DNA-binding protein inhibitor ID-4,40302,-0.00927196660459128,0.00445563193275369,-0.0180050051927885,-0.000538928016394047,0.0374609396875909
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN3,CCN family member 3,42779,0.00756029920796577,0.00363442690606896,0.000436822472070613,0.0146837759438609,0.0375267898541695
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBR1,T-box brain protein 1,40182,0.0103370745554346,0.00498385513316439,0.000568718494432425,0.0201054306164368,0.0380921278640447
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.0111439380940143,0.0053931655701708,0.000573333576479564,0.0217145426115491,0.0388225865372597
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300E,CMRF35-like molecule 2,42677,0.00911700133092668,0.00442751281391628,0.00043907621565077,0.0177949264462026,0.0394971215297538
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANPEP,Aminopeptidase N,42666,-0.00583550708796824,0.00284180227894454,-0.0114054395546995,-0.000265574621236953,0.0400479370242912
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPK13,Mitogen-activated protein kinase 13,40080,0.0087870905238399,0.0042916158206223,0.000375523515420185,0.0171986575322596,0.0406328023688574
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP290,Centrosomal protein of 290 kDa,40302,0.0114551278306139,0.00559474241349887,0.00048943270015612,0.0224208229610717,0.0406343675778521
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RSPO1,R-spondin-1,42495,0.00710444072646357,0.00347979333661928,0.000284045786689784,0.0139248356662373,0.0412082135534389
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM2,Intercellular adhesion molecule 2,42794,-0.00676814561612002,0.00332137214804775,-0.0132780350262936,-0.000258256205946441,0.041593665170926
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18BP,Interleukin-18-binding protein,42689,0.00674395086156127,0.00331009794310367,0.000256158893078075,0.0132317428300445,0.0416307331003476
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNL1,Thioredoxin-like protein 1,40124,0.0206135672207575,0.0101233965569449,0.000771709969145544,0.0404554244723694,0.0417512887037461
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.00766100802696211,0.00376494921383586,-0.0150403084860804,-0.000281707567843827,0.0418882307556157
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0141767030445808,0.00697677894395526,-0.0278511897747331,-0.000502216314428457,0.0421749811295902
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAPRT,Nicotinate phosphoribosyltransferase,40483,0.0070590484708888,0.00347425609591767,0.000249506522890166,0.0138685904188874,0.0421956757965839
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENOPH1,Enolase-phosphatase E1,40451,0.0114427313310227,0.00563841155109784,0.000391444690870891,0.0224940179711744,0.0424385357479599
NMR metabolomics,X23508.Triglycerides in Medium VLDL,METAP1,Methionine aminopeptidase 1,42311,0.00607942368152497,0.00299573699597517,0.000207779169413632,0.0119510681936363,0.0424419609034238
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SULT1A1,Sulfotransferase 1A1,42711,-0.0264077537724766,0.0130526247267319,-0.0519908982368711,-0.000824609308082216,0.0430746743406186
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FRMD7,FERM domain-containing protein 7,40182,0.00693621909874512,0.00343801150579054,0.000197716547395655,0.0136747216500946,0.043666688957088
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENDOU,Poly(U)-specific endoribonuclease,39633,0.0113299539953996,0.00561834466705628,0.000317998447969304,0.0223419095428299,0.0437628279115532
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDHR1,Cadherin-related family member 1,42311,0.00883446514206499,0.00439057734467647,0.00022893354649911,0.0174399967376309,0.0442253737858288
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RSPO3,R-spondin-3,42721,0.00612079639657581,0.00304566574172799,0.000151291542788948,0.0120903012503627,0.0444854851628142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPM1B,Protein phosphatase 1B,40199,0.0125697646501228,0.00625797691688349,0.000304129893031127,0.0248353994072144,0.0446040861088349
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHRDL1,Chordin-like protein 1,42654,0.00663128667928374,0.00330886426159315,0.000145912726561175,0.0131166606320063,0.045079613539016
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBM19,Probable RNA-binding protein 19,40116,-0.00992688665981894,0.00495758751830311,-0.019643758195693,-0.000210015123944848,0.0452704499974351
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACAN,Aggrecan core protein,42488,0.00568682748485439,0.00284374505669146,0.000113087173739123,0.0112605677959697,0.0455457414675593
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.00816940929996092,0.00409613773819237,0.000140979333103869,0.016197839266818,0.0461304410969014
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.00773480701205504,0.00389478667167612,-0.0153685888885402,-0.00010102513556984,0.0470650598980263
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00483371766839022,0.00243559556939834,-0.00960748498441097,-5.99503523694631e-05,0.0472115767937234
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,0.00659994376499017,0.00332857978193701,7.59273923936219e-05,0.0131239601375867,0.0474135386610066
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.010329527319247,0.00521122725579967,0.000115521897879646,0.0205435327406143,0.047481288293833
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYB5A,Cytochrome b5,40080,0.0148500104913861,0.00750660686596037,0.00013706103410375,0.0295629599486684,0.0479246981520277
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3GL3,Endophilin-A3,40250,0.0172708258577956,0.00875516218862859,0.000110707968083594,0.0344309437475077,0.0485609121724911
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFR4,Fibroblast growth factor receptor 4,40283,0.0107184090537726,0.0054390096241599,5.79501904191815e-05,0.021378867917126,0.048788237292453
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAPS,Calcyphosin,40483,0.0208810198359673,0.0106215642874531,6.27538325592737e-05,0.0416992858393753,0.0493336912909575
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC12A,C-type lectin domain family 12 member A,40199,0.0041678006629932,0.00212383770968703,5.07875200661881e-06,0.00833052257397977,0.0497421026967412
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.00545714471153561,0.00278867034083888,-8.64915650859287e-06,0.0109229385795798,0.0503840213624726
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGA,Fibrinogen alpha chain,40284,0.00618552383459061,0.00317102497396823,-2.96851143871254e-05,0.0124007327835684,0.0511252005464675
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS53,Serine protease 53,40483,0.00745200710274578,0.00382736351001573,-4.96253768850442e-05,0.0149536395823766,0.0515554168729739
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA2013,Uncharacterized protein KIAA2013,40451,0.0107145404933102,0.00550515089889984,-7.55552685334747e-05,0.0215046362551539,0.0516464983069105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFF3,Trefoil factor 3,42613,-0.0085827421857412,0.00441295012292072,-0.0172321244266658,6.66400551834079e-05,0.0518079996092343
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PI16,Peptidase inhibitor 16,40532,-0.00500051908710533,0.00257136660214785,-0.0100403976273151,3.93594531044577e-05,0.0518366110182609
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,0.0127745402637127,0.00657608121068108,-0.000114578909222207,0.0256636594366476,0.0520921921540647
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL20RB,Interleukin-20 receptor subunit beta,40199,0.00818430475733849,0.00421467150409374,-7.64513906852376e-05,0.0164450609053622,0.0521794572883188
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP350,Centrosome-associated protein 350,40080,0.00757032492437372,0.00390427285482889,-8.20498710908972e-05,0.0152226997198383,0.0525290231278316
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.0102430725035028,0.00528947558990554,-0.000124299652712092,0.0206104446597176,0.0528322707745441
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFDC2,WAP four-disulfide core domain protein 2,41948,0.00865696985978144,0.00448776912427875,-0.000139057623804921,0.0174529973433678,0.0537512748308336
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAT1,Diamine acetyltransferase 1,40116,-0.0100946410619791,0.00527615225576383,-0.0204358994832762,0.000246617359318047,0.0557411352055968
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.0101743534894881,0.00534404065228704,-0.0206486731679707,0.000299966188994465,0.0569536217975297
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKKL1,Dickkopf-like protein 1,42587,-0.0171032656853396,0.00900173303695855,-0.0347466624377784,0.000540131067099169,0.0574549712604555
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIGR,Polymeric immunoglobulin receptor,42464,0.00695880037928688,0.00366926933254394,-0.000232967512499238,0.014150568271073,0.0579145376388732
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD4,Sushi domain-containing protein 4,40451,-0.00815776332073157,0.00430425317545102,-0.0165940995446156,0.000278572903152433,0.0580809608068353
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEX101,Testis-expressed protein 101,40182,0.0102900341375284,0.00543539254053204,-0.000363335241914437,0.0209434035169712,0.0583636677434962
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP3,"Fatty acid-binding protein, heart",40511,0.010180116862733,0.00537762751227247,-0.000360033061321036,0.0207202667867871,0.0583767317939874
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.0120021762927683,0.00634715181072529,-0.00043824125625325,0.0244425938417899,0.0586567892299287
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,0.00794368780438824,0.00420885386395086,-0.000305665768955438,0.0161930413777319,0.0591353639429318
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNPEP,Aspartyl aminopeptidase,40483,0.0109791744819641,0.00585562351635226,-0.000497847610086304,0.0224561965740145,0.0608213294963731
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,-0.00397898386640231,0.00213325672603516,-0.00816016704943122,0.0002021993166266,0.0621779743993099
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.00763333123177432,0.00410508277798734,-0.0156792934766295,0.00041263101308086,0.0629855903595792
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF2RB,Cytokine receptor common subunit beta,40199,-0.00828595226629491,0.0044639689887531,-0.017035331484251,0.000463426951661168,0.0634539033474626
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GID8,Glucose-induced degradation protein 8 homolog,40482,0.00650278993642768,0.00351487228028552,-0.00038635973293193,0.0133919396057873,0.0643283399096802
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRISP2,Cysteine-rich secretory protein 2,42721,0.0112002294616275,0.00608450155863196,-0.000725393593291124,0.0231258525165462,0.0656756761649685
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.00737583401027468,0.00401564837336228,-0.000494836801515395,0.0152465048220647,0.0662655789017476
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH23,Cadherin-23,40483,-0.00488051543233906,0.00267936881711669,-0.0101320783138878,0.000371047449209651,0.0685547806269478
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.00608768992423337,0.00334439377066209,-0.000467321866264318,0.0126427017147311,0.0687456957549364
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00674014749765013,0.00372645578894742,-0.000563705848686809,0.0140440008439871,0.0705204861196927
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD160,CD160 antigen,42754,0.00907878495927213,0.00502348085815608,-0.000767237522713789,0.018924807441258,0.0707423845985569
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TJP3,Tight junction protein ZO-3,40136,-0.00779769530278068,0.00431979452378699,-0.0162644925694032,0.000669101963841809,0.0710852739865767
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OTOA,Otoancorin,40136,-0.0100996583356957,0.00561015231480211,-0.0210955568727078,0.000896240201316413,0.0718492200514946
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAG,Myelin-associated glycoprotein,40182,0.00906607256552248,0.00503941580177442,-0.000811182405955381,0.0189433275370003,0.0720409766177749
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OBP2B,Odorant-binding protein 2b,42462,-0.0113056508150868,0.00629958808800707,-0.0236528434675807,0.00104154183740703,0.0727298303791338
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLH1,Glutamate carboxypeptidase 2,40199,0.0186890514895246,0.0104217434497218,-0.00173756567193005,0.0391156686509792,0.0729564186221969
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DENND2B,DENN domain-containing protein 2B,40116,-0.00915856415564403,0.00512895803587556,-0.0192113219059601,0.000894193594672065,0.0741824114348882
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.00578291934487116,0.00326736349604902,-0.0121869517971272,0.000621113107384909,0.0767663185460231
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF9,Fibroblast growth factor 9,40065,0.00747119550339546,0.00423138901009705,-0.000822326956394761,0.0157647179631857,0.0774809269984514
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JUN,Transcription factor AP-1,42370,0.00867506167648622,0.00491344457914378,-0.000955289698635581,0.018305413051608,0.0774901035080043
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,0.00637344588978221,0.00361532812631442,-0.000712597237794052,0.0134594890173585,0.0779408975379794
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,-0.00875625051395315,0.00496982062692667,-0.0184970989427294,0.000984597914823132,0.0781167654184476
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42587,0.0146079164260989,0.00830676813968274,-0.00167334912767922,0.0308891819798771,0.0786757986800859
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,-0.00512761912390682,0.00291672378602342,-0.0108443977445127,0.000589159496699076,0.0787690484891681
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMG4,Proteasome assembly chaperone 4,40199,0.0102593020522023,0.00583935622872938,-0.00118583615610724,0.0217044402605119,0.0789586593602897
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOCK9,Dedicator of cytokinesis protein 9,40136,0.0217386693127539,0.0123919441685443,-0.0025495412575929,0.0460268798831007,0.0794142701120692
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAMDC2,MAM domain-containing protein 2,40511,-0.00656035859838149,0.00374420741169944,-0.0138990051253124,0.000778287928549418,0.079777598564705
NMR metabolomics,X23508.Triglycerides in Medium VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,0.00718480679561209,0.00410249532932361,-0.00085608404986218,0.0152256976410864,0.0799175649094284
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,0.0126658824838569,0.00725391907783801,-0.00155179890870558,0.0268835638764194,0.0808256663857812
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTR,Methionine synthase,40116,0.0118870553138065,0.00681396268628528,-0.00146831155131263,0.0252424221789257,0.0810975790746987
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP6,Guanylate-binding protein 6,40116,-0.00824431821958253,0.00473737396706614,-0.0175295711950322,0.00104093475586711,0.0818394716352244
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.0100111076072474,0.00575800517551769,-0.00127458253676725,0.0212967977512621,0.0821251605839591
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,0.00719660233311197,0.0041614945891899,-0.000959927061700242,0.0153531317279242,0.0837770582153171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.00575375681475032,0.00332760459619356,-0.0122758618232897,0.000768348193789066,0.0838144288407339
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.0103009087795605,0.00595846131717335,-0.00137767540209927,0.0219794929612203,0.0838754820176031
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTF3,Neurotrophin-3,42594,0.00634679089334806,0.00367703622750074,-0.000860200112553388,0.0135537818992495,0.0843593892430748
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.0163258420042788,0.00948953545147874,-0.00227364748061953,0.0349253314891771,0.0853873101835124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTNNA1,Catenin alpha-1,40136,-0.0061881531526185,0.00361112598954642,-0.0132659600921295,0.00088965378689249,0.0866240407935478
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NXPH3,Neurexophilin-3,40199,0.0053907839694749,0.00315242083248507,-0.000787960862195846,0.0115695288011456,0.0872855938881253
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.0126088768066075,0.00739881897672598,-0.00189280838777544,0.0271105620009904,0.0883760589210732
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42618,0.0516476331319372,0.0303672861250085,-0.00787224767307943,0.111167513936954,0.0890101877481035
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.00870899465049366,0.00512724608150892,-0.00134040766926382,0.0187583969702511,0.0894283583792399
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHGB,Secretogranin-1,42664,-0.00744177017735517,0.00440631929851542,-0.0160781560024454,0.00119461564773505,0.0912644584445408
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100G,Protein S100-G,40482,-0.00834691772863833,0.0049499713659916,-0.0180488616059819,0.00135502614870521,0.0917741829606206
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,0.00853117133575412,0.00507196213297329,-0.00140987444487353,0.0184722171163818,0.0925914902513744
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUMF1,Formylglycine-generating enzyme,40199,0.0110698858529289,0.00658277349043273,-0.00183235018831923,0.0239721218941771,0.0926661393019827
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELENOP,Selenoprotein P,40539,0.00395002945544962,0.00235810498360513,-0.000671856312416429,0.00857191522331566,0.0939448515241675
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC50,Coiled-coil domain-containing protein 50,40482,0.0129564088440159,0.00774362540936891,-0.00222109695834715,0.028133914646379,0.0943213626433348
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG1B,Lithostathine-1-beta,42794,-0.0100365347871593,0.005999067692915,-0.0217947074652727,0.00172163789095413,0.094347193147085
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOP1,DNA topoisomerase 1,40449,0.0191942168977601,0.0115092182618937,-0.00336385089555164,0.0417522846910718,0.0953980481328454
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBM25,RNA-binding protein 25,40080,-0.00812377317745357,0.00487528139763091,-0.0176793247168101,0.00143177836190301,0.0956786985710833
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,-0.0088916189999531,0.00533652713030208,-0.0193512121753452,0.00156797417543899,0.0957009572840595
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.00938195531729457,0.00563574940414668,-0.0204280241494221,0.00166411351483292,0.0959968873718008
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GM2A,Ganglioside GM2 activator,40269,0.00694681199888373,0.00419307422092553,-0.00127161347413031,0.0151652374718978,0.0976014295607964
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMA1,Laminin subunit alpha-1,40116,-0.0091723033511406,0.00553636883519043,-0.0200235862681138,0.00167897956583263,0.0976015190236362
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.0101897434570572,0.00615717742916251,-0.0222578112182157,0.00187832430410133,0.0979659203632838
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.0100599977804307,0.00607886746745523,-0.00185458245578156,0.0219745780166429,0.0979708460132214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,-0.00864146885278313,0.00522676312503171,-0.0188859245778453,0.00160298687227902,0.0982961737930784
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.0149188082626348,0.00903439399458076,-0.00278860396674348,0.0326262204920131,0.0986989999737305
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANSC4,MANSC domain-containing protein 4,40116,0.0120781201171519,0.00735136373283576,-0.00233055279920617,0.02648679303351,0.10041651728183
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.0100337834359814,0.00613981747350324,-0.00200025881208497,0.0220678256840477,0.102237572323398
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHPK,Sedoheptulokinase,40302,-0.00686157730696547,0.00421419325875957,-0.0151213960941342,0.00139824148020328,0.103509443814175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNPO1,Transportin-1,40302,0.00590623754268991,0.00363586067674599,-0.00122004938373223,0.013032524469112,0.104310306728569
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOS2,"Nitric oxide synthase, inducible",40116,-0.00662448056867123,0.0040903501489588,-0.0146415668606305,0.00139260572328803,0.105360267168884
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAD51,DNA repair protein RAD51 homolog 1,40302,0.00901253741526514,0.00557117904248972,-0.00190697350801471,0.019932048338545,0.105754069531464
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFHD1,EF-hand domain-containing protein D1,40482,0.00598217654194429,0.00370299397049299,-0.00127569164022197,0.0132400447241106,0.106231004301896
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,0.018884029734528,0.0116933976347876,-0.00403502962965572,0.0418030890987117,0.106349593022477
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,-0.0101546979951196,0.00629366670621109,-0.0224902847392933,0.00218088874905414,0.106664573844396
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN7,Tetraspanin-7,40136,-0.0155569143073227,0.00967737154532388,-0.0345245625361575,0.0034107339215121,0.1079613617142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRTN3,Myeloblastin,42276,-0.00803845089247594,0.00500259216033745,-0.0178435315267373,0.00176662974178547,0.10810984608293
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMCN2,Hemicentin-2,40269,-0.00958807932664237,0.00598884099595746,-0.021326207678719,0.00215004902543426,0.109407478646949
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYO6,Unconventional myosin-VI,40482,0.00595340108549593,0.00372995746200108,-0.00135731554002619,0.0132641177110181,0.110493505627479
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HCG22,Protein PBMUCL2,40116,-0.00930105222772219,0.005853213186759,-0.0207733500737698,0.00217124561832544,0.112077902142335
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPEP2,Dipeptidase 2,42587,-0.00480004713423475,0.00302180792438308,-0.0107227906660256,0.00112269639755609,0.112204011171334
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCL2,Phosducin-like protein 2,40080,0.00865429465067498,0.00544886885021342,-0.00202548829574331,0.0193340775970933,0.112253521539439
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.0087325568701906,0.00550211497972461,-0.00205158849006963,0.0195167022304508,0.112512711520071
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.0104196625967776,0.00657444984414392,-0.00246625909774454,0.0233055842912996,0.113024427351045
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY9,T-lymphocyte surface antigen Ly-9,42443,0.00496953735712882,0.0031401738715195,-0.00118520343104939,0.011124278145307,0.113543927228909
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPN1,Epsin-1,40302,0.00720315734016189,0.00456713905499814,-0.00174843520763447,0.0161547498879583,0.114784757180859
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLIN3,Perilipin-3,42636,0.00676566083269889,0.0043033838036902,-0.00166897142253391,0.0152002930879317,0.115934132306892
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,40527,-0.00341534001721359,0.00217742292581915,-0.00768308895181913,0.000852408917391952,0.116786822494068
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.010249540210201,0.00653471747951171,-0.00255850604964195,0.0230575864700439,0.116798454913091
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFPI2,Tissue factor pathway inhibitor 2,42635,0.00603599285684585,0.00385407795884624,-0.00151799994249278,0.0135899856561845,0.117341378448869
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.00646706528177754,0.00413513437503516,-0.0145719286568465,0.00163779809329137,0.117858003123311
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YAP1,Transcriptional coactivator YAP1,40483,0.00459405062818863,0.00294931035403139,-0.00118659766571291,0.0103746989220902,0.119339658576411
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSAPL1,Proactivator polypeptide-like 1,40449,-0.00814293720893237,0.00523845003572439,-0.0184102992789522,0.00212442486108743,0.120103932194487
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLNS1A,Methylosome subunit pICln,40182,0.00532410250729243,0.00342584703297876,-0.00139055767734594,0.0120387626919308,0.120189808516871
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJA1,DnaJ homolog subfamily A member 1,40080,-0.00759805624568327,0.00489593589677104,-0.0171940906033545,0.00199797811198796,0.120712616149561
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GKN1,Gastrokine-1,42017,0.00447003809236913,0.00288292152375708,-0.00118048809419474,0.010120564278933,0.121040552747372
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00679687618559817,0.00439796138968491,-0.00182312813818426,0.0154168805093806,0.122263682843012
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.0104018986782069,0.00673542291326031,-0.00279953023178334,0.0236033275881971,0.122525953344121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL36G,Interleukin-36 gamma,40154,0.0108387798589521,0.00706309135410898,-0.00300487919510148,0.0246824389130057,0.124919334002351
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL6ST,Interleukin-6 receptor subunit beta,42636,-0.0027456510334224,0.0017912918050421,-0.00625658297130492,0.000765280904460105,0.125354321936895
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTRC,Chymotrypsin-C,42626,0.0103683790009146,0.00677725930174245,-0.00291504923050061,0.0236518072323298,0.126070511598122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL5,Interleukin-5,42370,0.0218273712160774,0.0143055447693224,-0.00621149653179444,0.0498662389639492,0.127084187569308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,0.0235134382352636,0.0154597100989164,-0.0067875935586125,0.0538144700291396,0.128296107387667
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,-0.00719318612460384,0.00473430273863663,-0.0164724194923316,0.00208604724312395,0.12869664234087
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIRREL1,Kin of IRRE-like protein 1,40136,-0.00889760676453257,0.00590823623992999,-0.0204777497947954,0.00268253626573021,0.13210460010834
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.0102869653985543,0.00684297444965736,-0.00312526452277414,0.0236991953198827,0.132788973947557
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALPI,Intestinal-type alkaline phosphatase,40199,0.0193033457471264,0.0128606340459329,-0.00590349698290207,0.0445101884771548,0.133393621723726
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC13A1,Solute carrier family 13 member 1,40451,0.00962162561213893,0.00641667593265234,-0.00295505921585967,0.0221983104401375,0.133779281542664
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FDX2,"Ferredoxin-2, mitochondrial",40116,0.00866711607109608,0.00579583513135232,-0.00269272078635447,0.0200269529285466,0.134837882714569
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA11,Carbonic anhydrase-related protein 11,42346,0.00497330367709832,0.00333090842082249,-0.00155527682771377,0.0115018841819104,0.135440947281295
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCAN,Neurocan core protein,42711,0.00580701813094405,0.00389256942479036,-0.00182241794164506,0.0134364542035332,0.13576932521109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,0.00772744163482,0.00519593264952091,-0.00245658635824099,0.017911469627881,0.136983397573
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP3,Microfibril-associated glycoprotein 3,42357,0.00738693419664267,0.00497804721284798,-0.00237003834053936,0.0171439067338247,0.137858865817929
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF8,SLAM family member 8,42346,0.00841674519137623,0.00567318349089125,-0.00270269445077062,0.0195361848335231,0.137938556597011
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGBL2,Cytosolic carboxypeptidase 2,40136,0.0138164868389431,0.0093272483870823,-0.00446491999973819,0.0320978936776244,0.138554477853165
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,0.0145438807308322,0.00990916755284767,-0.00487808767274924,0.0339658491344136,0.142208307479491
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,0.0130391218381471,0.0088919427556683,-0.0043890859629628,0.0304673296392569,0.142563517150425
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCN15,Lipocalin-15,40482,-0.00939202596395492,0.00642356507637668,-0.0219822135136532,0.00319816158574338,0.143736039804756
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,0.00421175397545434,0.00289711460026783,-0.0014665906410706,0.00989009859197928,0.146032087553029
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGN,Mimecan,42611,0.00660296475548884,0.004542616743444,-0.0023005640616614,0.0155064935726391,0.146091798078746
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AXL,Tyrosine-protein kinase receptor UFO,42689,-0.00411246772766376,0.00283679311671284,-0.00967258223642093,0.00144764678109341,0.147168507686437
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTLA,B- and T-lymphocyte attenuator,40080,0.0130845249043439,0.00904525594988023,-0.0046441767574213,0.0308132265661092,0.148048384788461
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,0.00897455702425855,0.00621718773997249,-0.00321113094608752,0.0211602449946046,0.148906194394536
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC51B,Organic solute transporter subunit beta,40116,-0.0113859664327694,0.00791183944513459,-0.0268931717452332,0.0041212388796944,0.150149477939583
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,0.00397263614259521,0.00276261078716673,-0.00144208100025159,0.00938735328544201,0.15046261151971
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT8,"Keratin, type II cytoskeletal 8",40136,0.0119441421956676,0.00832066508242171,-0.00436436136587899,0.0282526457572141,0.151179156959046
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD2,T-cell surface antigen CD2,40116,0.0056489608783641,0.00395571555395813,-0.00210424160739384,0.013402163364122,0.153305966978454
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,0.00659455165755742,0.00464815141585071,-0.00251582511750998,0.0157049284326248,0.15599617114823
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,0.0108365116522702,0.00764061799498329,-0.00413909961789703,0.0258121229224375,0.156133165132917
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,0.00472276003859187,0.00333364169177504,-0.0018111776772872,0.0112566977544709,0.15659914338104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSL4,Early placenta insulin-like peptide,40451,-0.00707189054214094,0.00499393147379212,-0.0168599962307735,0.00271621514649163,0.156774823595104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTSL5,ADAMTS-like protein 5,40511,-0.00571792887480269,0.00404816277531029,-0.0136523279144109,0.00221647016480547,0.15783763328672
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MN1,Transcriptional activator MN1,40182,-0.00855892598398526,0.00609089063174006,-0.0204970716221958,0.00337921965422526,0.159989769435178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL13,Interleukin-13,42370,-0.00682717824136596,0.00487268236319623,-0.0163776356732306,0.00272327919049864,0.161203858829819
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.012098817922554,0.00863576191165991,-0.00482727542429946,0.0290249112694074,0.161238315011944
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC1,Sialoadhesin,42676,-0.00618402828860296,0.00442224155850094,-0.0148516217432648,0.00248356516605888,0.162018312489622
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.00958468949291571,0.00686066036185178,-0.00386220481631377,0.0230315838021452,0.162421996141863
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.00696591226344047,0.004994123077154,-0.0167543934946623,0.00282256896778136,0.163097916757128
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CORO6,Coronin-6,40136,-0.00531326977740771,0.0038205025426455,-0.0128014547609929,0.00217491520617748,0.164337005751277
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP3L,Microfibrillar-associated protein 3-like,40182,0.00961577844399715,0.00693315033440684,-0.00397319621144025,0.0232047530994346,0.165491934990767
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TUBB3,Tubulin beta-3 chain,40136,-0.00398655534296004,0.00288816354361409,-0.00964735588844364,0.00167424520252357,0.167520020027104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.0113541597432437,0.00825496289456759,-0.0275338870165962,0.00482556753010874,0.169020242934052
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPEP,Glutamyl aminopeptidase,40116,-0.00671889178470524,0.00489827601612977,-0.0163195127763196,0.00288172920690911,0.170189692798801
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.00389686664442058,0.00284195852196217,-0.00167337205862527,0.00946710534746643,0.170338941391533
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.00682520496052567,0.00499321290702761,-0.0166119022582998,0.00296149233724845,0.171685900742956
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA4,Ephrin type-A receptor 4,40283,0.00407899747629071,0.00298557626135135,-0.00177273199595794,0.00993072694853935,0.171893056693574
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MELTF,Melanotransferrin,40511,0.00421108539628361,0.00309530378312244,-0.00185571001863638,0.0102778808112036,0.173706551724583
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARTN,Artemin,42370,0.00623992034848772,0.00458789483557353,-0.0027523535292364,0.0152321942262118,0.173826751864672
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.00674692048617296,0.00496379196903928,-0.01647595274549,0.00298211177314403,0.174098008820218
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.00572306931049589,0.0042146212987512,-0.00253758843505646,0.0139837270560482,0.174515306104123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BST2,Bone marrow stromal antigen 2,42711,0.00709350046760389,0.00523672546146869,-0.00317048143687474,0.0173574823720825,0.175577891543961
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HLA_A,,40482,-0.00460768391499801,0.00340443281041049,-0.0112803722234026,0.00206500439340656,0.175943297401667
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB5,Serpin B5,42357,0.00673806737285456,0.00499076775879475,-0.00304383743438316,0.0165199721800923,0.17700507740089
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MATN3,Matrilin-3,42475,-0.00450439008240023,0.00335963139528242,-0.0110892676171538,0.0020804874523533,0.180028018399094
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR158,Probable G-protein coupled receptor 158,40482,0.00495494323337671,0.00369584639661987,-0.00228891570399824,0.0121988021707517,0.180051711607518
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR1,Toll-like receptor 1,40199,0.00367921323314334,0.00274646284894018,-0.00170385395077942,0.00906228041706609,0.1803969748319
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A3,Protein S100-A3,40451,0.0059769606843152,0.00446307860402591,-0.00277067337957558,0.014724594748206,0.180532187217922
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,0.00671105898525596,0.00502044179433073,-0.00312900693163227,0.0165511249021442,0.18132843654693
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00420047969768759,0.00314856646605122,-0.0019707105757728,0.010371669971148,0.182196541412165
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,-0.00514032749350279,0.00386243536492977,-0.0127107008087651,0.00243004582175956,0.183261400135834
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RALB,Ras-related protein Ral-B,40199,0.00408817890400446,0.00307506170858422,-0.00193894204482061,0.0101152998528295,0.183723021764339
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRC1,Protein regulator of cytokinesis 1,40451,0.00606452407101572,0.00456635201947615,-0.00288552588715754,0.015014574029189,0.184175475209717
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCN,Decorin,42357,-0.00326876287484885,0.00246448301216354,-0.00809914957868939,0.00156162382899169,0.184747364135643
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLR1,Folate receptor alpha,42600,0.00412158457520764,0.003110310399656,-0.00197462380811811,0.0102177929585334,0.185148600561118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP30,Rho GTPase-activating protein 30,40302,0.00518319662891524,0.00391165863927688,-0.00248365430406745,0.0128500475618979,0.185177300359744
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRTAC1,Cartilage acidic protein 1,42794,0.00405205746304458,0.00306008353653521,-0.00194570626856444,0.0100498211946536,0.185470294233491
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHD,SH2 domain-containing adapter protein D,40083,-0.0118898357096331,0.00902468022531042,-0.0295782089512416,0.00579853753197531,0.187705500159759
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD70,CD70 antigen,42594,-0.00583155766094613,0.00443728068572729,-0.0145286278049716,0.00286551248307936,0.18879508197827
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCP2,Non-specific lipid-transfer protein,42346,0.00995679313989054,0.00758373067012495,-0.00490731897355436,0.0248209052533354,0.1892345264618
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS11B,Transmembrane protease serine 11B,40136,0.0104880887169076,0.00800065557783766,-0.00519319621565423,0.0261693736494694,0.189917823660514
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD177,CD177 antigen,42595,-0.0176816555565405,0.0135093966678517,-0.0441600730255299,0.00879676191244888,0.190610576106295
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD55,Complement decay-accelerating factor,42201,0.00364652448217814,0.00279182005182964,-0.00182544281940795,0.00911849178376422,0.191526023117855
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGN,Secretagogin,42370,-0.00605870265703779,0.00464021162442336,-0.0151535174409076,0.003036112126832,0.191678982684847
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXDC2,Plexin domain-containing protein 2,40483,-0.00365514371551123,0.00280052936073999,-0.0091441812625616,0.00183389383153915,0.191864387161136
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA3G,Semaphorin-3G,40283,0.00595530316548912,0.00458329689920274,-0.00302795875694825,0.0149385650879265,0.19385112931547
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00746087889953927,0.00574770800891243,-0.0187263865970076,0.0038046287979291,0.194293423337984
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSP90B1,Endoplasmin,42247,-0.0088689984570962,0.00684431268731799,-0.0222838513242395,0.00454585441004706,0.195060358907229
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL4,Interleukin-4,42370,0.0124395055080617,0.00961225952800248,-0.00640052316682313,0.0312795341829466,0.195643486976274
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00498201730853003,0.00386373183563023,-0.00259089708930522,0.0125549317063653,0.197274439828915
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA10,Ephrin type-A receptor 10,42311,-0.00873715374963092,0.0068728893230362,-0.0222080168227819,0.00473370932352004,0.20366261783937
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,-0.00564577282937598,0.00444722627584223,-0.0143623363300267,0.00307079067127478,0.204288310979084
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOC2B,Double C2-like domain-containing protein beta,40182,0.00471259861654459,0.00371901186310099,-0.00257666463513335,0.0120018618682225,0.205123446558997
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMP10,Bone morphogenetic protein 10,40283,-0.0037303134396257,0.00294387927476745,-0.00950031681816991,0.0020396899389185,0.205131086164466
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZPR1,Zinc finger protein ZPR1,40136,0.012668568811342,0.0100107568991735,-0.00695251471103795,0.032289652333722,0.20572067074458
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.00525828118053769,0.00415786816055474,-0.0028911404141496,0.013407702775225,0.206020488786377
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL9,Interleukin-9,40302,0.00729200205578972,0.00577157523114666,-0.00402028539725773,0.0186042895088372,0.206459912523993
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC44A4,Choline transporter-like protein 4,40182,-0.00923010234017148,0.00732598498022739,-0.0235890329014172,0.00512882822107421,0.20772757438935
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSLNL,Mesothelin-like protein,40182,-0.00508563274987573,0.00404366700910596,-0.0130112200877234,0.00283995458797195,0.208534806147865
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UPK3BL1,Uroplakin-3b-like protein 1,40281,-0.00702275233483154,0.00558999559781449,-0.0179791437065479,0.00393363903688485,0.209031042883925
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EVI2B,Protein EVI2B,40080,-0.00523704397818318,0.00420530982034543,-0.0134794512260602,0.00300536326969386,0.213033301708912
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PODXL2,Podocalyxin-like protein 2,42679,-0.00359817967873937,0.00289824453175879,-0.0092787389609866,0.00208237960350786,0.214441533970215
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAN,Brevican core protein,42495,0.00439675510789389,0.00355340428528777,-0.00256791729127015,0.0113614275070579,0.215984204592878
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH17,Protocadherin-17,42636,0.00469432198462596,0.00381281015859684,-0.00277878592622384,0.0121674298954758,0.218270581186811
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFL4,Insulin growth factor-like family member 4,40199,0.00927247690719972,0.00755234685229608,-0.00553012292330059,0.0240750767377,0.21956296042295
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42636,-0.00339552214531136,0.0027696394111769,-0.00882401539121808,0.00203297110059537,0.220227730279081
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMCH,Pro-MCH,40116,-0.0106545082183468,0.0087017738070997,-0.0277099848802622,0.00640096844356861,0.220825335588179
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00423570362669837,0.00348521259470057,-0.0110667203123115,0.00259531305891475,0.224264314233735
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL21R,Interleukin-21 receptor,40199,0.00697498756901372,0.00574095969269545,-0.00427729342866937,0.0182272685666968,0.224410657324937
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL31,Interleukin-31,40199,0.00702043115066162,0.00578184164505106,-0.00431197847363845,0.0183528407749617,0.22468955625413
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,0.00457185464571593,0.00378031251815187,-0.00283755788986174,0.0119812671812936,0.226540566427305
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPHS2,Podocin,40199,-0.0130081286165422,0.0107768531006191,-0.0341307606937556,0.00811450346067113,0.227441402071531
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHH,Sonic hedgehog protein,40199,-0.00521781557634898,0.00433392555850408,-0.013712309671017,0.00327667851831901,0.228636056751925
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENG,Endoglin,42794,-0.00214373930673254,0.00178122486327752,-0.00563494003875648,0.00134746142529141,0.228796200653418
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SKIV2L,Helicase SKI2W,40116,-0.00492055448587867,0.00408847269400228,-0.0129339609661231,0.00309285199436579,0.228801635739829
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD48,CD48 antigen,42654,0.00380509180845347,0.003175780242287,-0.00241943746642905,0.010029621083336,0.230875959030705
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.0103915162587516,0.00868721718002725,-0.027418461931605,0.00663542941410179,0.231650543579972
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNL2,Interferon lambda-2,40136,0.00758617855220839,0.00635663205678058,-0.00487282027908155,0.0200451773834983,0.232727923440658
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAGE2A,G antigen 2A,40080,0.0081435950417836,0.00684708587058944,-0.00527669326457171,0.0215638833481389,0.234327134878312
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.00870604094420581,0.00732201066561978,-0.00564509996040895,0.0230571818488206,0.234456211099584
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,0.00392832520656784,0.00331045666471445,-0.00256016985627248,0.0104168202694082,0.23539007661413
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,-0.00608656835516944,0.00514887085630226,-0.0161783552335219,0.00400521852318299,0.237184573240651
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,0.00941381660017026,0.00798209974656305,-0.00623109890309331,0.0250587321034338,0.238278264028102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,0.00404891822272573,0.00343875581962766,-0.00269104318374448,0.0107888796291959,0.239046549852598
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,0.00482757267167407,0.00410223562960957,-0.00321280916236068,0.0128679545057088,0.239294821892778
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,-0.00495333330445076,0.00421065165196435,-0.0132062105423009,0.00329954393339937,0.23946788890941
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRING1,SREBP regulating gene protein,40080,0.00710715758557284,0.00607716737522917,-0.00480409046987633,0.019018405641022,0.242233787319571
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL12,Stromal cell-derived factor 1,42370,0.00481719430071295,0.00412429169552546,-0.00326641742251696,0.0129008060239429,0.242825786384166
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,-0.00489081457590691,0.00419087827910985,-0.0131049360029622,0.00332330685114839,0.243229276365993
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOP56,Nucleolar protein 56,40116,0.0134006404419387,0.0114909673953298,-0.0091216556529077,0.0359229365367851,0.243563479649611
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.00787280752160319,0.0067765310664547,-0.00540919336864803,0.0211548084118544,0.245347386661114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.0100929599796859,0.00870012888407079,-0.0271452125924647,0.00695929263309281,0.246035992049182
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,42311,0.00600502017744034,0.00518004975442656,-0.00414787734123572,0.0161579176961164,0.246371661851392
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAP18,Histone deacetylase complex subunit SAP18,40302,-0.00877370681702671,0.00759883080335987,-0.023667415191612,0.00612000155755864,0.248273887629659
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMBN,Ameloblastin,42370,-0.00339018439262222,0.00294002122963167,-0.0091526260027003,0.00237225721745586,0.24888385065566
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL11,Interleukin-11,42370,0.00740979161153795,0.00643096782753276,-0.00519490533042627,0.0200144885535022,0.249257855093765
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR2,Toll-like receptor 2,40302,0.00274915531093554,0.00240284484585895,-0.001960420586948,0.00745873120881909,0.252596377014419
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00659674119876994,0.00576970173771638,-0.00471187420715418,0.0179053566046941,0.2529217180576
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00684760974961064,0.00600391125850873,-0.0186152758162877,0.00492005631706646,0.254092685036635
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.00588700702865773,0.00516472585158718,-0.00423585564045315,0.0160098696977686,0.254374211764009
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,0.00471026245029921,0.00413504107380247,-0.00339441805435364,0.0128149429549521,0.254677833802037
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMI,N-myc-interactor,40421,0.00838392729517775,0.00737262136124683,-0.00606641057286604,0.0228342651632215,0.255491298763708
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSTN,Osteocrin,40182,-0.00487045371777133,0.00429766813631147,-0.0132938832649418,0.00355297582939915,0.257122159202848
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYH7B,Myosin-7B,40080,-0.00520780686856366,0.00460719937925732,-0.014237917651908,0.00382230391478069,0.258348279060185
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,40302,0.00623682131249309,0.00554627938957934,-0.00463388629108242,0.0171075289160686,0.26082296530766
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRR1B,Cornifin-B,40302,-0.00947564313283999,0.00852290184080467,-0.0261805307408171,0.00722924447513715,0.266254225251274
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00793438955137128,0.00714265289648452,-0.0219339892284809,0.00606521012573839,0.266658966471384
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERCC1,DNA excision repair protein ERCC-1,40080,0.0038960882777104,0.00350956350226462,-0.00298265618672826,0.0107748327421491,0.266965500926324
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD164L2,CD164 sialomucin-like 2 protein,40182,-0.00414773968109751,0.00374435572745317,-0.0114866769069057,0.00319119754471071,0.268002165982978
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42566,0.00438716378815973,0.00396650072957885,-0.00338717764181481,0.0121615052181343,0.268723068244494
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.00426996977525909,0.00388206690157195,-0.00333888135182194,0.0118788209023401,0.27139046471686
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.00718259069799497,0.00653064088057546,-0.00561746542793293,0.0199826468239229,0.271430304367814
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DRAXIN,Draxin,42495,0.00492655943800267,0.00449890421403225,-0.00389129282150054,0.0137444116975059,0.273511212789685
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUCL3,Mucin-like protein 3,40080,-0.00476939465660491,0.00437254848891171,-0.0133395896948719,0.00380080038166205,0.275403281058797
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VASN,Vasorin,42449,-0.00307148780802491,0.00281980832882848,-0.00859831213252873,0.00245533651647892,0.276061646639648
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,-0.00305811360885355,0.00280806995002162,-0.00856193071089592,0.00244570349318882,0.276153485096405
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCARE,Photoreceptor cilium actin regulator,40136,0.00937923876403388,0.00863093330084275,-0.0075373905056179,0.0262958680336857,0.277193170448929
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMOD2,Leiomodin-2,40136,0.0069431982525078,0.00640503811025988,-0.00561067644360157,0.0194970729486172,0.278379204041486
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALM3,Paralemmin-3,40116,0.00795972754579893,0.0073470084434102,-0.00644040900328507,0.0223598640948829,0.278656124076881
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTX1,Neuronal pentraxin-1,42611,-0.00441701260858162,0.00410762063157929,-0.012467949046477,0.0036339238293138,0.282250168601673
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN5,Contactin-5,42640,-0.00418828582071132,0.00390453091206267,-0.0118411664083542,0.00346459476693152,0.283437002462439
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUP50,Nuclear pore complex protein Nup50,40116,-0.00382369176634734,0.00356480959234908,-0.0108107185673515,0.00316333503465686,0.28346462836015
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.00347016039365723,0.00323990052769072,-0.00982036542793104,0.00288004464061658,0.284161682804131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH4,Cadherin-4,40136,0.0054509011158892,0.00510782397172752,-0.00456043386869674,0.0154622361004751,0.285919981759413
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FBN2,Fibrillin-2,40182,0.00664960053188241,0.00625541870849286,-0.0056110201367636,0.0189102212005284,0.287798755619822
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,0.00408927781338726,0.00389803486565135,-0.00355087052328939,0.0117294261500639,0.294172329778059
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.0136096851367897,0.0130131447459295,-0.0118960785652321,0.0391154488388116,0.295653497502636
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.00373088570864273,0.00357329903034987,-0.0107345518081285,0.00327278039084302,0.296457306445226
NMR metabolomics,X23508.Triglycerides in Medium VLDL,H2AP,Huntingtin-interacting protein M,40080,-0.00559769391565321,0.00540998372955204,-0.0162012620255752,0.0050058741942688,0.300833423592077
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.0125808151404328,0.0121640473151725,-0.0364223478781708,0.0112607175973052,0.301032213251884
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMY2B,Alpha-amylase 2B,41779,-0.00530549506767118,0.00515441139948807,-0.0154081414106678,0.00479715127532543,0.303353089916978
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA10,Annexin A10,42311,-0.00910226712873462,0.00885242349066989,-0.0264530171704476,0.00824848291297836,0.303863811696319
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLI2,Zinc finger protein GLI2,40199,-0.00338539422805759,0.00329266487443939,-0.0098390173819588,0.00306822892584362,0.303896037782311
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLK,STE20-like serine/threonine-protein kinase,40302,0.00839763354982548,0.00819878833576589,-0.00767199158827566,0.0244672586879266,0.30573809575702
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY6D,Lymphocyte antigen 6D,42548,0.00425350206777846,0.00417989457574894,-0.00393909130068946,0.0124460954362464,0.308881820058652
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,0.00554891277044325,0.00550439662099319,-0.00523970460670341,0.0163375301475899,0.313434679293185
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEB,Nebulin,40116,-0.00395387064169537,0.00394331603813559,-0.0116827700764411,0.00377502879305038,0.316039146164985
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP9,Matrix metalloproteinase-9,42594,-0.00617339394390955,0.00615730978610968,-0.0182417211246845,0.00589493323686542,0.316066108802362
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRND,Prion-like protein doppel,40483,-0.0053788072058421,0.00537101715978413,-0.015906000839019,0.0051483864273348,0.316630579950847
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT14,"Keratin, type I cytoskeletal 14",41948,0.00300761521814851,0.0030045149317245,-0.00288123404803151,0.00889646448432853,0.316830389345647
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HYAL1,Hyaluronidase-1,42544,-0.00237463555847718,0.00237634023384293,-0.00703226241680932,0.00228299129985496,0.317675901148449
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STEAP4,Metalloreductase STEAP4,40136,0.00746020217919438,0.00747747761442055,-0.0071956539450699,0.0221160583034587,0.318451925780109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,-0.00273577135860018,0.00274902690862722,-0.00812386409950954,0.00265232138230917,0.31967098616704
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,0.00792622908678455,0.00797161046636768,-0.0076981274272961,0.0235505856008652,0.320091645191823
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HBQ1,Hemoglobin subunit theta-1,42721,-0.00613700255498563,0.00617448504457604,-0.0182389932423547,0.00596498813238342,0.320274991899162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00598850859602394,0.00603035734852155,-0.0058309918070783,0.0178080089991262,0.320702632260061
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL20RA,Interleukin-20 receptor subunit alpha,42370,0.0045763480556506,0.00461394144482039,-0.00446697717619736,0.0136196732874986,0.321287834607196
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,-0.00461272533226942,0.00465105244760449,-0.0137287881295742,0.00450333746503539,0.321336129023844
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.00398857571745764,0.00402306142703466,-0.0118737761144456,0.0038966246795303,0.321498600057278
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK15,Kallikrein-15,40429,0.00542541695631298,0.00547379899278064,-0.00530322906953708,0.016154062982163,0.321628238462153
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTK7,Inactive tyrosine-protein kinase 7,42311,0.00385987280852986,0.00391955322928693,-0.00382245152087253,0.0115421971379322,0.324753421679687
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJA4,DnaJ homolog subfamily A member 4,40483,0.00713614350337827,0.0072516942186056,-0.0070771771650887,0.0213494641718452,0.325104302842088
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAPPA,Pappalysin-1,42370,0.00470541875867712,0.00479486051707929,-0.00469250785479829,0.0141033453721525,0.326440002825587
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC6A,C-type lectin domain family 6 member A,42346,0.00477916270787771,0.00487635685364028,-0.00477849672525723,0.0143368221410127,0.327070439489698
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINT1,Kunitz-type protease inhibitor 1,42565,-0.00262653690748199,0.00268032335767317,-0.00787997068852141,0.00262689687355743,0.327136995795646
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HIP1,Huntingtin-interacting protein 1,40116,0.00335469285019145,0.00343115586764243,-0.00337037265038771,0.0100797583507706,0.328236913794187
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC123,Cell division cycle protein 123 homolog,40080,0.00628533780164332,0.00648507448153178,-0.00642540818215896,0.0189960837854456,0.332466665589082
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX1,ATP-dependent RNA helicase DDX1,40449,0.00496436847202166,0.00513155905702195,-0.00509348727974137,0.0150222242237847,0.333355330633733
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.00653004590131214,0.00675247825166151,-0.00670481147194442,0.0197649032745687,0.333535517533943
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,0.00289427639161445,0.00300305080224729,-0.00299170318079023,0.00878025596401914,0.335174249606757
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,0.00394716808969329,0.00410286837159638,-0.00409445391863562,0.0119887900980222,0.336041379578191
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GH2,Growth hormone variant,42346,0.0163080230426254,0.0171111319544002,-0.0172297955879991,0.0498458416732498,0.340574592198685
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAV,Integrin alpha-V,42721,0.00159357516387218,0.00167845448385096,-0.00169619562447571,0.00488334595222006,0.3424188827818
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK12,Kallikrein-12,42346,0.0135056122955574,0.0143201234757666,-0.0145618297169451,0.0415730543080598,0.345636227677481
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDNRB,Endothelin receptor type B,40199,0.00430549394446667,0.00457434608579708,-0.00466022438369561,0.0132712122726289,0.346609661817474
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DIPK1C,Divergent protein kinase domain 1C,40182,0.00405998545246669,0.00431737893358924,-0.00440207725736821,0.0125220481623016,0.347042321908019
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.0067951465376584,0.00722933125718734,-0.0209646358017456,0.00737434272642879,0.347264688778997
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.00609401412721499,0.00650337544361663,-0.0188406299967036,0.00665260174227361,0.34875114175852
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17RA,Interleukin-17 receptor A,42611,0.00421547906436887,0.00450905500025215,-0.00462226873612534,0.0130532268648631,0.349860829345087
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB5,Integrin beta-5,42679,-0.00355295864394276,0.00380994086265918,-0.0110204427347547,0.00391452544686923,0.351069286893937
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPLA2,Acyl-protein thioesterase 2,40136,0.0106680596445988,0.0115009823047844,-0.0118738656727786,0.0332099849619763,0.353646906821394
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH22,Cadherin-22,40302,-0.00267169351939803,0.00288387847412247,-0.00832409532867806,0.00298070828988201,0.354245931819145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42711,0.00221037065224691,0.00238629942110299,-0.00246677621311494,0.00688751751760877,0.354319370285273
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,0.00447416363233084,0.00484193169873874,-0.00501602249719709,0.0139643497618588,0.355483054977331
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RLN1,Prorelaxin H1,40482,0.00455887595253138,0.0049690941729885,-0.00518054862652607,0.0142983005315888,0.358928538500581
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,-0.00278239515807084,0.00304688563314731,-0.00875429099903957,0.00318950068289788,0.361160514789498
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACTN4,Alpha-actinin-4,42370,0.00304023467299291,0.00335994135833022,-0.00354525038933431,0.00962571973532014,0.365562706407267
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRLB,Fc receptor-like B,42346,0.00602681192188651,0.0066625183122519,-0.00703172397012722,0.0190853478139002,0.365702029599591
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OMP,Olfactory marker protein,40136,-0.00467002072720452,0.00516730365337083,-0.0147979358878113,0.0054578944334023,0.366140686074437
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42611,-0.00318793567028361,0.00353153056541824,-0.0101097355785034,0.00373386423793614,0.366697880163859
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.0044466328769927,0.00493209638800758,-0.00522027604350215,0.0141135417974875,0.36730491875784
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT17,"Keratin, type I cytoskeletal 17",40116,0.00364686569264413,0.00404824945212494,-0.00428770323352076,0.011581434618809,0.367687919003086
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42737,0.00286276164871537,0.00319213137899285,-0.00339381585411061,0.00911933915154135,0.369831853854546
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNGR1,Interferon gamma receptor 1,42676,0.00200884065277535,0.00224247263453472,-0.0023864057109127,0.00640408701646341,0.370367563940402
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RYR1,Ryanodine receptor 1,40116,-0.0031720794117251,0.00354198333445815,-0.0101143667472631,0.00377020792381288,0.370504403535181
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAG,S-arrestin,40136,-0.00477154313583982,0.00538035170006781,-0.0153170324679727,0.0057739461962931,0.375181333930646
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1A,Interleukin-1 alpha,42370,0.00528989027506108,0.00598291542674404,-0.00643662396135723,0.0170164045114794,0.376622753637515
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.0104549888974846,0.0118281029075203,-0.0127280928012551,0.0336380705962243,0.376763146650609
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN3B,Sodium channel subunit beta-3,40136,0.00435091027028979,0.0049439469607517,-0.00533922577278353,0.0140410463133631,0.378852674613839
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYH4,Myosin-4,40116,-0.00409734191861661,0.00465671239325663,-0.0132244982093996,0.00502981437216639,0.378944398380995
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTF,Ciliary neurotrophic factor,40136,-0.00309490807478513,0.00352905749786475,-0.0100118607706,0.00382204462102978,0.380517488843401
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,-0.00571027421726457,0.00651368311433691,-0.0184770931213649,0.00705654468683577,0.380691440300892
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPSG1,Tryptase gamma,40199,0.00237212401379024,0.00272788753561607,-0.00297453555601726,0.00771878358359774,0.384547419514339
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,-0.00529981484582799,0.00615152897739136,-0.017356811641515,0.00675718194985907,0.388957236551495
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PYDC1,Pyrin domain-containing protein 1,40223,-0.00377897348723456,0.00439112345894349,-0.0123855754667638,0.00482762849229469,0.389480526405079
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAX,Integrin alpha-X,40302,0.0047942229305404,0.00558504265594326,-0.00615246067510839,0.0157409065361892,0.39068794401144
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPO,Lactoperoxidase,42134,-0.00535253184173146,0.0062471578549154,-0.0175969612373656,0.00689189755390272,0.391574212818294
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42594,0.00605748935924774,0.00711027165985735,-0.00787864309407266,0.0199936218125681,0.394265389029214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFRC,Transferrin receptor protein 1,42673,-0.00329240925165909,0.00387554296681071,-0.0108884734666081,0.00430365496328991,0.395598772011366
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL5A1,Collagen alpha-1(V) chain,40283,-0.00358729151503268,0.00422852810504337,-0.0118752066009177,0.00470062357085232,0.396258797822462
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FZD10,Frizzled-10,40182,0.0052722033806282,0.0062337549393113,-0.00694595630042195,0.0174903630616784,0.397710180193525
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,0.00245149988492986,0.00291734092694128,-0.00326648833187505,0.00816948810173476,0.400747254764256
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.00426152928948475,0.00507482932674313,-0.0142081947699013,0.00568513619093178,0.401073255137538
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.00392517099580241,0.00467967128010645,-0.00524698471320623,0.013097326704811,0.401613299646257
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTKN2,Rhotekin-2,40116,-0.00444471087856046,0.00529929558442731,-0.014831330224038,0.00594190846691707,0.401635732602594
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELL,L-selectin,40539,0.00204540625370076,0.00244469323688612,-0.00274619249059604,0.00683700499799756,0.402794613666807
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAGLN3,Transgelin-3,40080,0.00526226936462723,0.00629618920872618,-0.00707826148447607,0.0176028002137305,0.403293417866309
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PITHD1,PITH domain-containing protein 1,40065,-0.00692601140351009,0.00829147067870914,-0.02317729393378,0.00932527112675983,0.403557266866026
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC39A14,Zinc transporter ZIP14,42311,-0.00295497210498373,0.0035419516875524,-0.00989719741258644,0.00398725320261897,0.404139581166109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.00774886111982894,0.00929109867860251,-0.0259594145298899,0.010461692290232,0.404293536160412
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.00402974264264542,0.00487881705496839,-0.0135922240703835,0.00553273878509261,0.408837301812441
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PADI2,Protein-arginine deiminase type-2,42370,0.00471353249731057,0.00571558912824052,-0.00648902219404085,0.015916087188662,0.409568172966767
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX1B,Syntaxin-1B,40182,0.00341856543296228,0.00416793004718758,-0.00475057745952538,0.0115877083254499,0.412115899509743
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17F,Interleukin-17F,42370,0.00631134414287825,0.00775626801452841,-0.00889094116559742,0.0215136294513539,0.415826451291215
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RETN,Resistin,42598,0.00360823642740042,0.00444618724614732,-0.00510629057504833,0.0123227634298492,0.417072930133504
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB6B,Ras-related protein Rab-6B,42311,0.00410089180062769,0.00505675388302717,-0.00581034581010557,0.0140121294113609,0.41739578426265
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA2,Protein disulfide-isomerase A2,40080,-0.00350178545102816,0.00432868255144627,-0.0119860032518629,0.00498243234980653,0.418548603748287
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00440343963369267,0.00548157645516628,-0.00634045021843325,0.0151473294858186,0.421809429139064
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN8,Septin-8,40470,0.00267210459913348,0.0033285083498276,-0.00385177176652862,0.00919598096479557,0.422111066488803
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCND2,G1/S-specific cyclin-D2,40302,0.00303467238970486,0.00378708206760765,-0.00438800846280614,0.0104573532422159,0.42296236533643
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM3D,Protein FAM3D,40449,0.00702328411459601,0.00879442489021394,-0.0102137886702233,0.0242603568994153,0.424535518879654
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00281842055592026,0.00354150772419199,-0.00412293458349604,0.00975977569533656,0.426147620517006
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC2L,C-type lectin domain family 2 member L,40182,0.00400824125144043,0.0050611883340231,-0.00591168788324484,0.0139281703861257,0.428403107974922
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIRREL2,Kin of IRRE-like protein 2,42311,0.00325592071331478,0.00414635838789639,-0.00487094172696214,0.0113827831535917,0.432322207112443
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPON1,Spondin-1,42638,0.00272369241399167,0.00347128052769128,-0.00408001742028323,0.00952740224826657,0.432680715781836
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRNN,Cornulin,42209,0.00555196630532357,0.00709262127882675,-0.00834957140117685,0.019453504011824,0.433770206892885
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,0.00483418793634365,0.00619469130105094,-0.0073074070137162,0.0169757828864035,0.435186547728509
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCLRE1C,Protein artemis,40080,0.00250291969704949,0.00320987892939024,-0.00378844300455538,0.00879428239865436,0.435551949178298
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP8,Neutrophil collagenase,42681,0.00582794936450617,0.00747789013802543,-0.00882871530602368,0.020484614035036,0.435782858165287
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHP1,Calcineurin B homologous protein 1,40136,0.00591095685493145,0.00761066640892451,-0.00900594930656059,0.0208278630164235,0.437371785652334
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.00421487042023489,0.0054330409163852,-0.0148636306163499,0.00643388977588011,0.437892372977648
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF1,Signaling lymphocytic activation molecule,42370,-0.00481707607589219,0.00621580939566155,-0.0170000624913888,0.00736591033960444,0.438370317847433
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,-0.00230468563502932,0.00297991790430279,-0.00814532472746279,0.00353595345740414,0.439298997002704
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDAC8,Histone deacetylase 8,40199,0.0046787429396296,0.00606419588064209,-0.00720708098642889,0.0165645668656881,0.440406101895954
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.00432960697706934,0.00562453125433722,-0.0153536882355703,0.00669447428143162,0.441451641809806
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,-0.00452232385216226,0.00589285156475589,-0.0160723129190838,0.00702766521475928,0.442842082621671
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00290266250939211,0.00378692530171604,-0.00451971108197133,0.0103250361007555,0.443397789758403
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNNI3,"Troponin I, cardiac muscle",42357,0.00661449871828778,0.00864728790771416,-0.010334185580832,0.0235631830174075,0.444331846585511
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BSND,Barttin,40080,0.00267775929421679,0.00350672282491091,-0.00419541744260859,0.00955093603104216,0.445117821562189
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCNE1,G1/S-specific cyclin-E1,40199,0.0069416474349673,0.00909247888845288,-0.0108796111864003,0.0247629060563349,0.44521180177025
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL4,Myosin light chain 4,40223,-0.00407247084851533,0.00535258157320523,-0.0145635307319976,0.00641858903496693,0.446767489805384
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.00241190746874881,0.00317030519998076,-0.0086257056607111,0.00380189072321348,0.446803915162109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSCA,Prostate stem cell antigen,40449,0.0207427871992422,0.0273051953838911,-0.0327753957531844,0.0742609701516688,0.447471073356496
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESR1,Estrogen receptor,40199,-0.00431077224570456,0.00567470411920248,-0.0154331923193414,0.00681164782793229,0.447481858788235
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF7,Fibroblast growth factor 7,40080,-0.0061701551194044,0.00814391926180763,-0.0221322368725474,0.00979192663373855,0.448683211199205
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,40136,0.00545800100716026,0.00720504224220364,-0.00866388178755889,0.0195798838018794,0.448751591802621
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,-0.00503659238947122,0.00666068282919909,-0.0180915307347014,0.008018345955759,0.449561959896275
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INHBB,Inhibin beta B chain,40283,0.00421716558821467,0.0055851842990528,-0.00672979563792882,0.0151641268143582,0.450227263855079
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARB1,Scavenger receptor class B member 1,42311,0.00450351090104973,0.00596711238480436,-0.0071920293731668,0.0161990511752663,0.450429362283973
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00379044546449246,0.00502404358881455,-0.00605667996958405,0.013637570898569,0.450588537096983
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLINT1,Clathrin interactor 1,40080,0.00357579499975567,0.00474473203090471,-0.00572387978081757,0.0128754697803289,0.451084863604063
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUSP29,Dual specificity phosphatase 29,40182,-0.00520543136412117,0.00691851519035884,-0.0187657211372245,0.00835485840898216,0.451831831074331
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMY2A,Pancreatic alpha-amylase,42114,-0.00373855571591837,0.00502202292768714,-0.0135817206541852,0.00610460922234842,0.456628567241742
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.00348052869298024,0.00467878651214874,-0.0126509502567918,0.00568989287083129,0.456952665333831
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,0.00277928687987216,0.00375841170581954,-0.00458720006353414,0.0101457738232785,0.45962607426497
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FSHB,Follitropin subunit beta,40223,-0.00410487316221225,0.00555480729349601,-0.0149922954574644,0.00678254913303993,0.459936871999115
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMMR,Hyaluronan mediated motility receptor,40059,0.00377030934445774,0.00510431837082689,-0.00623415466236297,0.0137747733512784,0.460134964722531
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HRAS,GTPase Hras,40286,0.00755045381414303,0.0102265786909177,-0.0124936404200557,0.0275945480483418,0.460337642162321
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAEP,Glycodelin,42495,-0.00679283737208629,0.0092437305842165,-0.0249105493171506,0.011324874572978,0.462438407753026
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00509218792785202,0.00694132083117262,-0.0186971767569503,0.00851280090124631,0.463205236095814
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.00313479919409172,0.00427791330875266,-0.0115195092792469,0.00524991089106349,0.463703967950025
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSTN1,Calsyntenin-1,42311,-0.00398783522676806,0.00545348096023429,-0.0146766579088273,0.00670098745529115,0.464642071907841
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,40116,-0.00360986041853762,0.00495199436579266,-0.0133157693754912,0.00609604853841598,0.46603501612381
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,0.00248293841862385,0.00343427790731659,-0.00424824627971667,0.00921412311696437,0.469700692323223
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD82,CD82 antigen,40302,-0.00301489929755318,0.00420350637364673,-0.0112537717899008,0.00522397319479441,0.473244568948111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPGN,Epigen,40451,0.00334010131752192,0.00466729657670711,-0.00580779997282402,0.0124880026078679,0.474228882274241
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIPC2,PDZ domain-containing protein GIPC2,40483,0.00227116275191418,0.00317588230606924,-0.00395356656798153,0.0084958920718099,0.474544666603687
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMP,Cartilage oligomeric matrix protein,42511,-0.00245756948880812,0.00344775967826775,-0.00921517845821292,0.00430003948059667,0.475980867722548
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NELL2,Protein kinase C-binding protein NELL2,42676,0.0021122105248772,0.00296558520648686,-0.00370033647983704,0.00792475752959144,0.476328054192966
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,-0.00327437523969542,0.00460470246784041,-0.0122995920766626,0.00575084159727178,0.477040863374715
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ISM2,Isthmin-2,40527,0.00315949617815351,0.00444596293533155,-0.00555459117509634,0.0118735835314034,0.477319592009465
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZP3,Zona pellucida sperm-binding protein 3,40223,0.0196490103858821,0.0278007927758715,-0.034840543454826,0.0741385642265902,0.479718895361765
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPT1,Palmitoyl-protein thioesterase 1,40182,0.00555542235913667,0.00791558206326284,-0.00995911848485849,0.0210699632031318,0.482797735752184
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL20,Interleukin-20,42370,-0.00353933463724465,0.00504628514541041,-0.0134300535222491,0.00635138424775976,0.483081852450161
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.00579166931104191,0.00826827825306587,-0.021997494687051,0.0104141560649672,0.483649377601995
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL3A1,Collagen alpha-1(III) chain,40527,0.00166516943354335,0.00239525776959373,-0.00302953579486037,0.00635987466194707,0.486947827347002
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNN,Tenascin-N,40527,0.00313441580294723,0.00452038054890931,-0.00572553007291502,0.0119943616788095,0.488075002828635
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.0036223237572936,0.00523347984871507,-0.00663529674618793,0.0138799442607751,0.488861278052611
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTPP1,dCTP pyrophosphatase 1,42636,-0.00223236775940188,0.00324206518959912,-0.00858681553101616,0.00412208001221239,0.491109879213042
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.00242691213296192,0.00352615851994468,-0.00448435856612966,0.0093381828320535,0.49130400038796
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,40482,-0.00280666528712574,0.00412091788611845,-0.0108836643439179,0.00527033376966642,0.495836295894834
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRCAM,Neuronal cell adhesion molecule,42636,0.00201708232865909,0.00297555856420558,-0.00381501245718386,0.00784917711450203,0.497857171875191
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.00257556371749027,0.0038092558857309,-0.0100417052535228,0.00489057781854229,0.498970040859319
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.00414232785675574,0.00614327101765408,-0.00789848333784625,0.0161831390513577,0.500140627817274
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAD2,Glutamate decarboxylase 2,40199,-0.00316753370404419,0.0047310547637938,-0.01244040104108,0.00610533363299166,0.503178153623718
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00488510708100706,0.00731118849249384,-0.019215036526295,0.00944482236428086,0.504040026236885
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA5,Annexin A5,42261,-0.00208672392873317,0.00314758037242579,-0.00825598145868773,0.00408253360122139,0.507367043549714
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL6,Interleukin-6,42587,-0.00518780836112244,0.00787193136553243,-0.020616793837566,0.0102411771153211,0.509890327833272
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYT1,Synaptotagmin-1,40483,0.00286018705725908,0.00434756647868565,-0.0056610432409648,0.0113814173554829,0.510627176047655
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALMS1,Alstrom syndrome protein 1,40302,-0.00300793533333193,0.00457639029029615,-0.0119776603023124,0.00596178963564853,0.511019355339601
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCUN1D1,DCN1-like protein 1,40136,-0.00505366918851041,0.0076949319571189,-0.0201357358244635,0.0100283974474426,0.51135359984005
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RELB,Transcription factor RelB,40199,0.00334032275962087,0.00509786460388454,-0.00665149186399282,0.0133321373832346,0.512327198294107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLHL41,Kelch-like protein 41,40482,-0.00320492426677207,0.00491780155886418,-0.0128438153221459,0.00643396678860173,0.514608910200164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,0.00167002627739008,0.00259318726407884,-0.00341262076020443,0.0067526733149846,0.519585046040589
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.00250568006467523,0.00389908469530943,-0.00513652593813124,0.0101478860674817,0.520475751036747
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS4,Galectin-4,42618,-0.00371249661582832,0.00578561308678424,-0.0150522982659254,0.00762730503426878,0.521093683682553
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFDN6,Prefoldin subunit 6,40182,0.00417932890979523,0.00665553731917408,-0.00886552423578596,0.0172241820553764,0.530051295369801
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRC1,Macrophage mannose receptor 1,40532,-0.00187803425046921,0.00299119796753821,-0.00774078226684409,0.00398471376590568,0.530112529994543
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA3,Alpha-1-antichymotrypsin,40502,-0.000972993612698453,0.00155735999267638,-0.00402541919834415,0.00207943197294725,0.53213386579433
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,40182,-0.00238157349551433,0.00381215215236675,-0.00985339171415316,0.00509024472312451,0.53215992917119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00256918327291652,0.00417168300151659,-0.00560731541005599,0.010745681955889,0.537998059623258
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSLP,Thymic stromal lymphopoietin,42357,0.00383422935805184,0.00625849342372825,-0.00843241775245554,0.0161008764685592,0.540122245146917
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFD,Complement factor D,40539,0.00130690150410386,0.00214828756166254,-0.00290374211675472,0.00551754512496244,0.54297039474247
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.00296598444324614,0.00488629344223108,-0.00661115070352678,0.0125431195900191,0.543862942631034
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FH,"Fumarate hydratase, mitochondrial",40136,0.00532364835277406,0.00878947572227125,-0.0119037240628776,0.0225510207684257,0.544736905954566
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,-0.00187226306938834,0.00309899187036214,-0.00794628713529814,0.00420176099652146,0.545754915593904
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,0.0046004090405651,0.00763897667384052,-0.0103719852401623,0.0195728033212925,0.547034149441675
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBR1,TGF-beta receptor type-1,40199,0.00133254770845741,0.00221737736864078,-0.00301351193407851,0.00567860735099334,0.547881226763757
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.00317109937633723,0.00529686761907091,-0.0135529599097162,0.00721076115704176,0.549402382680207
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FDX1,"Adrenodoxin, mitochondrial",40116,0.00380389273567602,0.0063603118043482,-0.00866231840084645,0.0162701038721985,0.549807614907793
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACHE,Acetylcholinesterase,40283,0.00203307279896089,0.00340555570586986,-0.00464181638454403,0.00870796198246582,0.550528186601423
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRD2,Bromodomain-containing protein 2,40136,0.00218347402827188,0.00367198003737261,-0.00501360684497843,0.00938055490152219,0.552102290838638
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00477422524886167,0.00807234183663701,-0.0110475647509469,0.0205960152486702,0.554244501314525
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KDM3A,Lysine-specific demethylase 3A,40199,-0.00531762166046622,0.00899114201390745,-0.0229402600077248,0.0123050166867924,0.554245197008135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HTR1A,5-hydroxytryptamine receptor 1A,40136,-0.00475891932403438,0.00805562728853631,-0.0205479488095655,0.0110301101614968,0.554695358905348
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42521,-0.00348121398610943,0.00592257511766094,-0.0150894612167249,0.00812703324450602,0.556685079807523
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,-0.00298110473364505,0.00508795131056456,-0.0129534893023516,0.00699127983506149,0.557945041866044
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,-0.00396411168522676,0.00677888758381234,-0.017250731349499,0.00932250797904543,0.558712356046259
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR101,Probable G-protein coupled receptor 101,40136,-0.00360150054719735,0.00620185852830459,-0.0157571432626743,0.00855414216827964,0.561445784779039
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00182541270883857,0.00314967522094099,-0.00434795072420578,0.00799877614188291,0.562224098229297
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL3,Interleukin-3,40080,0.00366170095861488,0.00634725332346971,-0.00877891555538574,0.0161023174726155,0.564022077627149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAPN3,Calpain-3,40451,-0.00225192269553144,0.00392120607439499,-0.00993748660134563,0.00543364121028275,0.565780762360008
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.00263782005534385,0.00459541393177944,-0.00636919125094386,0.0116448313616316,0.565971513570646
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHIT1,Chitotriosidase-1,42699,-0.00905933457851784,0.0158115752657974,-0.0400500220994808,0.0219313529424451,0.566684125417212
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCUN1D2,DCN1-like protein 2,40080,0.00469985705937064,0.00823179714230202,-0.0114344653395413,0.0208341794582826,0.568052528985242
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC1A4,Neutral amino acid transporter A,40182,0.00305552446794233,0.00535368182028602,-0.00743769189981826,0.0135487408357029,0.568192116570419
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00252867505238387,0.00444018630286565,-0.0112314402060005,0.0061740901012328,0.569030249283609
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00419207816594295,0.00736686108275677,-0.0102469695562603,0.0186311258881462,0.569336983839066
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAP1A,Ras-related protein Rap-1A,40199,0.00414462056226169,0.00728471175924088,-0.0101334144858504,0.0184226556103738,0.569403191366576
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCP11,T-complex protein 11 homolog,40302,0.00345272237967443,0.00607473050420241,-0.0084537494085623,0.0153591941679112,0.569792138947492
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP15,Matrix metalloproteinase-15,40511,0.00283226464435225,0.00501005922797217,-0.00698745144247321,0.0126519807311777,0.57187032560353
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42676,0.00163834815209358,0.00290143752758405,-0.00404846940197116,0.00732516570615832,0.572309179620548
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,40136,-0.00422107453387829,0.00753130236662312,-0.0189824271724596,0.010540278104703,0.575169874254767
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRN1,Neuritin,40482,0.00206966322380476,0.00373350976782307,-0.00524801592112846,0.00938734236873797,0.579351770596568
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB2,Integrin beta-2,42569,-0.00162570958191895,0.00293363843658163,-0.00737564091761894,0.00412422175378105,0.579477564407574
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.00209592848785501,0.0037922940760451,-0.00533696790119338,0.0095288248769034,0.58049283739144
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POF1B,Protein POF1B,40199,-0.00264267156802127,0.0047856184631839,-0.0120224837558617,0.00673714061981919,0.580814954005832
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00399209503008729,0.00723504534847209,-0.010188593852918,0.0181727839130926,0.581115712059883
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK3,Prostate-specific antigen,40527,0.00555133383695557,0.0100740209227768,-0.0141937471716869,0.025296414845598,0.581607227174745
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPVL,Probable serine carboxypeptidase CPVL,42698,0.00228595977532948,0.0042360784751342,-0.00601675403593356,0.0105886735865925,0.589453834558482
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.00163759357292927,0.00305376264549969,-0.00434778121225011,0.00762296835810866,0.591791812595367
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCAR,Immunoglobulin alpha Fc receptor,42594,-0.00268004302386466,0.0049993347410958,-0.0124787391164124,0.00711865306868312,0.591912207684858
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42587,-0.0017417354169758,0.00326294944160538,-0.00813711632252235,0.00465364548857075,0.593494497135159
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKLR,Pyruvate kinase PKLR,42636,0.00355946123424063,0.00667593615408989,-0.00952537362777554,0.0166442960962568,0.593919292988092
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TYMP,Thymidine phosphorylase,42563,0.003528996300891,0.00664464503828604,-0.00949450797414965,0.0165525005759316,0.595355666655685
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.00157132381497805,0.00302352290988806,-0.00749742871835864,0.00435478108840254,0.603283117458653
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFF2,Trefoil factor 2,42654,0.00309248681332257,0.00596248161892028,-0.00859397715976119,0.0147789507864063,0.604008012855422
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,0.00206382284317174,0.0040091900949355,-0.00579418974290183,0.00992183542924531,0.606722066248492
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEBP1,Heme-binding protein 1,42357,0.00277284598447559,0.00540780154269016,-0.00782644503919713,0.0133721370081483,0.608135364091406
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPSD1,Tryptase delta,40482,-0.00199237373275306,0.00394128252803158,-0.00971728748769496,0.00573254002218884,0.613207696005683
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,-0.00418074214890387,0.00832490185526759,-0.0204975497852283,0.0121360654874206,0.615538788280658
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,-0.00314697301512384,0.00629418657035753,-0.0154835786930246,0.00918963266277691,0.617098604826572
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00153869441632243,0.00308317817169328,-0.0045043348001964,0.00758172363284126,0.617745998813056
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,0.00218203051019087,0.00441202846702173,-0.00646554528517173,0.0108296063055535,0.620916006754215
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REST,RE1-silencing transcription factor,40080,-0.00172602471217606,0.00352360561011557,-0.00863229170800258,0.00518024228365045,0.624252628043267
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2,Interleukin-2,42370,-0.00159932437375553,0.00329263402407368,-0.00805288706093995,0.00485423831342889,0.627168141276399
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALLD,Palladin,40199,-0.00193658536187747,0.00399878547716519,-0.00977420489712124,0.0059010341733663,0.628187306201958
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGS8,Regulator of G-protein signaling 8,42370,0.00319503062069532,0.0066174463533987,-0.00977516423196613,0.0161652254733568,0.629232088347065
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.00241938465637428,0.00502280338404283,-0.00742530997634967,0.0122640792890982,0.630042761706382
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGN,Cingulin,40182,0.00203338729460026,0.00423382676905092,-0.00626491317273954,0.0103316877619401,0.631043750774258
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF3,Fibroblast growth factor 3,40199,0.00142517010019813,0.00298532771324025,-0.00442607221775277,0.00727641241814903,0.633092840359916
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERVV_1,,40116,-0.00213731675716549,0.00448176185981018,-0.0109215700023934,0.00664693648806247,0.633448509720229
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,-0.00204819882207014,0.00430446923871389,-0.0104849585299494,0.00638856088580908,0.634204461055966
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THBS2,Thrombospondin-2,42611,0.00188709142484221,0.00397862403470415,-0.00591101168317793,0.00968519453286235,0.635288326058667
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDAN1,Codanin-1,40483,0.00110018505274768,0.00232109595870827,-0.00344916302632052,0.00564953313181589,0.635513507964383
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF12,Fibroblast growth factor 12,40199,0.00227061712536665,0.00480427002009833,-0.00714575211402608,0.0116869863647594,0.636490263147923
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GJA8,Gap junction alpha-8 protein,40080,0.0031557016964069,0.00670291135568935,-0.00998200456074422,0.016293407953558,0.637796084321522
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,-0.00344305717490395,0.00734537767957866,-0.0178399974268781,0.0109538830770702,0.639264546929375
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESPL1,Separin,40080,0.00274067586747629,0.00590847438561581,-0.00883993392833071,0.0143212856632833,0.642760851491537
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NINJ1,Ninjurin-1,42346,0.00256050670507456,0.00553546660583038,-0.00828900784235299,0.0134100212525021,0.643684683096913
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,-0.0016471333207674,0.00356742197828581,-0.00863928039820759,0.00534501375667279,0.644292965890275
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC4A1,Band 3 anion transport protein,40527,-0.00220154140241455,0.00481093893168377,-0.0116309817085147,0.00722789890368563,0.64724028957985
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UPK3A,Uroplakin-3a,40136,0.00239606662969305,0.00524862273839453,-0.00789123393756023,0.0126833671969463,0.648029895956068
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RANGAP1,Ran GTPase-activating protein 1,42346,-0.0022606014308432,0.00495408452457875,-0.0119706070990176,0.00744940423733115,0.648174155824223
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA8,Carbonic anhydrase-related protein,40199,0.00133681752622284,0.00293837828386622,-0.00442240391015496,0.00709603896260064,0.649153615326715
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,0.00212068025176631,0.00466548969074989,-0.00702367954210347,0.0112650400456361,0.649444684743926
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,40302,-0.00312603977281801,0.00687871653029581,-0.0166083241721978,0.0103562446265618,0.649513114729675
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,0.00267972263924393,0.00596201564471659,-0.0090058280244006,0.0143652733028885,0.65310285931732
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCNA,Proliferating cell nuclear antigen,40080,-0.00288460697479416,0.00642441668109063,-0.0154764636697318,0.00970724972014348,0.653435666990235
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NLGN1,Neuroligin-1,40182,-0.00321577044087438,0.00717903541326998,-0.0172866798508835,0.0108551389691348,0.654206002271301
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.00328558724967294,0.00736005096440646,-0.0111401126405637,0.0177112871399096,0.655311246414865
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDSN,Corneodesmosin,42710,-0.00202947062050724,0.00456254878005928,-0.0109720662294234,0.00691312498840894,0.656463667368691
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLMP,CXADR-like membrane protein,42721,0.000981968410686602,0.00225021455285902,-0.00342845211291707,0.00539238893429028,0.662561634017001
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL33,Interleukin-33,42370,0.00173172405675798,0.00397738063390531,-0.00606394198569642,0.00952739009921238,0.663284254677926
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18RAP,Interleukin-18 receptor accessory protein,42425,-0.00768663617380545,0.01768048902176,-0.0423403946564551,0.0269671223088442,0.663749202619872
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL4A4,Collagen alpha-4(IV) chain,40284,-0.00237734685460818,0.0054899792365658,-0.0131377061582771,0.00838301244906078,0.664998598639141
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMA1,Proteasome subunit alpha type-1,42346,0.00204854003645862,0.00474186971001868,-0.00724552459517798,0.0113426046680952,0.665740475875258
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2RG,Cytokine receptor common subunit gamma,40451,0.00162096353819243,0.00375505864874728,-0.00573895141335223,0.0089808784897371,0.665986178800066
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNR,Tenascin-R,42495,-0.00187593218995825,0.00434898054713841,-0.0103999340623495,0.00664806968243304,0.666220985647429
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLR3,Folate receptor gamma,42629,-0.00819109100177318,0.0190066655552566,-0.0454441554900762,0.0290619734865298,0.666505195077113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,0.00198255134002132,0.00464529768087934,-0.0071222321145022,0.0110873347945448,0.669543123108558
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-0.00147305876601996,0.00345627932158249,-0.00824736623632163,0.00530124870428173,0.66997209349705
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCLN,Nicalin,42370,-0.00224829096485656,0.00532080196711419,-0.0126770628204004,0.00818048089068725,0.67263241565391
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,0.00256783290647954,0.00608030307743549,-0.00934956112529402,0.0144852269382531,0.672799842439507
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,-0.00244227267209314,0.00584850012815592,-0.0139053329232787,0.00902078757909247,0.676255415043963
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,-0.00190095013089548,0.0045936820249047,-0.0109045668997087,0.00710266663791773,0.679013691000917
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.00467939567452068,0.0113203682067362,-0.0175085260106823,0.0268673173597237,0.679350456357698
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HK2,Hexokinase-2,42357,0.00114975982463338,0.00282971911085722,-0.00439648963264677,0.00669600928191353,0.684517120563499
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL10,Interleukin-10,42370,0.00353506108098072,0.00871668390324697,-0.0135496393693833,0.0206197615313448,0.685079021527532
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,0.00122727400462921,0.00303397828210034,-0.00471932342828747,0.00717387143754588,0.685845503767986
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,-0.00250544373464051,0.00619902095020046,-0.0146555247970334,0.0096446373277524,0.68609589422351
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,0.00153516613133077,0.00381421813609541,-0.00594070141541624,0.00901103367807777,0.687334765221276
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSMB,Beta-microseminoprotein,42559,-0.00291444061155215,0.00742022149420204,-0.0174580747401881,0.0116291935170838,0.694495606745209
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPBGL,Trophoblast glycoprotein-like,40182,-0.00169485141068106,0.00431561623983891,-0.0101534592407653,0.0067637564194032,0.694530046915257
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00116850239915614,0.0030072532974871,-0.00472571406391858,0.00706271886223086,0.697608179686222
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,-0.00142072418443431,0.00372324543063085,-0.00871828522847077,0.00587683685960215,0.702778711899014
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFNB2,Ephrin-B2,40182,0.00210685590822121,0.00560543345347666,-0.00887979366059305,0.0130935054770355,0.707028541364833
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP7,Retinoid-binding protein 7,40449,0.00230742100993678,0.00615389044603613,-0.00975420426429402,0.0143690462841676,0.707702326063293
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL24,Interleukin-24,42370,0.00192994787846281,0.00518700885632604,-0.00823658947993622,0.0120964852368618,0.709844204709745
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,-0.00212463839413976,0.00572822530899428,-0.0133519599997685,0.00910268321148902,0.710714055951026
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.00185636106760618,0.00502888799054344,-0.0117129815290713,0.00800025939385897,0.712030946811748
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF6,Fibroblast growth factor 6,40199,-0.00156464265340787,0.00425528552508358,-0.00990500228257168,0.00677571697575594,0.713108539000477
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CADPS,Calcium-dependent secretion activator 1,40182,0.00160710953898013,0.00440037417173152,-0.00701762383761365,0.0102318429155739,0.7149533911743
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP1,Retinol-binding protein 1,40182,0.00255731604142523,0.00702079547193931,-0.0112034430835758,0.0163180751664263,0.715679268224781
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTXR,Neuronal pentraxin receptor,42636,0.00126516882148321,0.00347919853959373,-0.0055540603161205,0.00808439795908691,0.71613406060319
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFF1,Trefoil factor 1,42556,-0.00309073078634274,0.00850222816820561,-0.0197550979960257,0.0135736364233403,0.716222155921314
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBLN1,Cerebellin-1,40136,0.003508507041556,0.0097445714038995,-0.015590852910087,0.022607866993199,0.718818678902087
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,-0.00110902626920202,0.0030804448257875,-0.00714669812774553,0.00492864558934148,0.718836745918187
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00277335272545241,0.00776420798861752,-0.0124444949322379,0.0179912003831428,0.720951131079669
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,40199,0.00225874087476759,0.0063723124046619,-0.0102309914383697,0.0147484731879049,0.72299967172806
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPNMB,Transmembrane glycoprotein NMB,42315,0.00105606334768263,0.0029830477398357,-0.00479071022239535,0.00690283691776061,0.723328380791934
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMEM132A,Transmembrane protein 132A,40223,0.00226423611486599,0.00642984744811258,-0.0103382648834347,0.0148667371131667,0.724736543437112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COPE,Coatomer subunit epsilon,42311,0.00170098607412229,0.00486849263397866,-0.00784125948847589,0.0112432316367205,0.726804702789097
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.00274405208237263,0.00785904047878304,-0.0126596672560421,0.0181477714207874,0.726976726879129
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANK2,Ankyrin-2,40116,-0.00263496001815777,0.00756123869977533,-0.0174549878697174,0.0121850678334019,0.727484506061951
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPT1,Translationally-controlled tumor protein,42370,-0.00226643535305943,0.00670758744649921,-0.0154133067481979,0.010880436042079,0.735450497046087
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBX2,Chromobox protein homolog 2,40116,-0.00139197165859591,0.00412209797050958,-0.0094712836807947,0.00668734036360288,0.735606885520446
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,-0.00313768766158398,0.00929271389101723,-0.0213514068879778,0.0150760315648098,0.735633169705977
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.00113868605115643,0.00341024659055778,-0.00554539726633681,0.00782276936864967,0.738459295598909
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNLZ,DNL-type zinc finger protein,40136,0.00310364348296741,0.00934800059373383,-0.0152184376807509,0.0214257246466857,0.739886952101705
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORN4,MORN repeat-containing protein 4,40080,-0.00260434905788132,0.00789787314723196,-0.018084180426456,0.0128754823106933,0.741592785893327
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42794,-0.000763281624053663,0.00233080973613908,-0.00533166870688626,0.00380510545877893,0.743313784539176
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,0.000951526839340779,0.00291502111034585,-0.00476191453693709,0.00666496821561865,0.744111349052515
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,-0.00178459794009745,0.00552961694105365,-0.0126226471445626,0.00905345126436771,0.746902518276104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDC1,Syndecan-1,42636,0.00134083360654491,0.00416274982010572,-0.0068181560408623,0.00949982325395211,0.747379783562277
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF20,Fibroblast growth factor 20,40199,-0.00146155180757916,0.00463033930111249,-0.0105370168377596,0.00761391322260132,0.752276592542843
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFAP2A,Transcription factor AP-2-alpha,40136,0.0019669017134568,0.00626376412610522,-0.0103100759737094,0.014243879400623,0.75351735167815
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDN1,Endothelin-1,40223,0.000978292792260961,0.00312085172303797,-0.00513857658489346,0.00709516216941538,0.753929682831641
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN2,Contactin-2,42721,-0.00142135295208772,0.00456938037512357,-0.0103773384873299,0.00753463258315448,0.755759553865086
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORF4L2,Mortality factor 4-like protein 2,40080,-0.00116929283519605,0.00377567323400273,-0.0085696123738414,0.0062310267034493,0.756801710853013
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRRT3,Proline-rich transmembrane protein 3,40223,-0.00123094273326966,0.00410394352133193,-0.00927467203508024,0.00681278656854091,0.76422747609745
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4C,C-type lectin domain family 4 member C,42594,0.00145850495866821,0.00491581217369417,-0.00817648690177236,0.0110934968191088,0.766702720310863
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAP1,Antigen peptide transporter 1,40302,-0.00187097049036234,0.00632252297454633,-0.0142631155204731,0.0105211745397485,0.767295562116291
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSB,Lupus La protein,42311,-0.00174858486266033,0.00597706677823334,-0.0134636357479977,0.00996646602267702,0.769871534128222
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53BP1,TP53-binding protein 1,40199,-0.00258379282203363,0.00890661955918126,-0.0200407671580289,0.0148731815139616,0.771746705663384
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.00192860687830159,0.00671019614230854,-0.0150805913172263,0.0112233775606232,0.773799460364243
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NXPE4,NXPE family member 4,40116,0.000994438960188158,0.00346194578760445,-0.00579097478351657,0.00777985270389289,0.773927452135873
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPLX2,Complexin-2,40080,-0.000919883381967569,0.0032617093175505,-0.00731283364436654,0.00547306688043141,0.777929746280986
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMIGO1,Amphoterin-induced protein 1,40182,0.00145245746109526,0.00519476444821422,-0.00872928085740462,0.0116341957795951,0.779789474614616
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPT,Microtubule-associated protein tau,42311,-0.00151210742921592,0.00546304718006882,-0.0122196799021508,0.00919546504371896,0.781947042655646
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLITRK1,SLIT and NTRK-like protein 1,40199,-0.000915554571811902,0.00336597349280903,-0.00751286261771761,0.0056817534740938,0.785624887435288
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.000793193494146613,0.00292017288213372,-0.00651673234312871,0.00493034535483548,0.785914915908995
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,40080,-0.000685233602424302,0.00259017040647048,-0.00576196759910644,0.00439150039425784,0.791359954439764
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANKRA2,Ankyrin repeat family A protein 2,40080,-0.00155943929803972,0.00589677861288559,-0.0131171253792955,0.00999824678321603,0.791433465334313
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAND5,DAN domain family member 5,40199,0.00148645743039635,0.00568712470177825,-0.00966030698508902,0.0126332218458817,0.793810230471829
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42737,-0.00113440923677744,0.00436237482513404,-0.00968466389404015,0.00741584542048528,0.794833815476889
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEFL,Neurofilament light polypeptide,42262,0.00123193824066196,0.00474539189019886,-0.00806902986412781,0.0105329063454517,0.795170816319138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGR,Progesterone receptor,40199,0.00259919422393044,0.0100356172596041,-0.0170706156048936,0.0222690040527545,0.795642440735911
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,-0.00184761842219371,0.00716758198846286,-0.0158960791195809,0.0122008422751935,0.796585875964019
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.00136254527885191,0.005321932534288,-0.0117935330460564,0.00906844248835258,0.79793668843399
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,40199,0.0010285091395426,0.00411710482840883,-0.00704101632413871,0.00909803460322391,0.802736096827933
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDAC9,Histone deacetylase 9,40136,-0.0016822938826702,0.00673869337945703,-0.014890132906406,0.0115255451410656,0.80286511537303
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.000701396910259016,0.00282110795112298,-0.00482797467394202,0.00623076849446005,0.803654943577137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,-0.00076829068706535,0.00309432735021991,-0.00683317229349638,0.00529659091936568,0.803913811029186
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RUVBL1,RuvB-like 1,42346,0.00263127821681088,0.0108404646174514,-0.0186160324333938,0.0238785888670156,0.808220334610979
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAGEA3,Melanoma-associated antigen 3,40302,-0.00215980676643623,0.00890933202299886,-0.019622097531514,0.0153024839986415,0.808458649256612
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOS,Proto-oncogene c-Fos,40065,-0.000888428919348641,0.00366988950725011,-0.00808141235355885,0.00630455451486157,0.808718082334983
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00143229733113236,0.00592380134222927,-0.010178353299637,0.0130429479619017,0.808949874654659
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HBZ,Hemoglobin subunit zeta,40511,0.0026211128096319,0.0109085984399905,-0.0187597401327495,0.0240019657520133,0.810117921901474
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THY1,Thy-1 membrane glycoprotein,42711,0.000736530836922062,0.00308622142833268,-0.00531246316260999,0.00678552483645412,0.811379580066978
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,-0.00152631024551809,0.00645781866877953,-0.014183634836326,0.0111310143452898,0.813164872092289
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MLLT1,Protein ENL,40080,0.001601789121723,0.00681900000389935,-0.0117634508859197,0.0149670291293657,0.814290082348107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB116,Beta-defensin 116,40136,-0.00184699379239263,0.00790696921363786,-0.0173446534511228,0.0136506658663376,0.815307185004022
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABO,Histo-blood group ABO system transferase,40532,-0.00342075526909091,0.0148818517478072,-0.0325891846947931,0.0257476741566112,0.818204036312164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEZ6L,Seizure 6-like protein,42679,-0.000654237137632781,0.00287590564635536,-0.00629101220448929,0.00498253792922373,0.820046906150934
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.00133510630990698,0.00588503696991368,-0.0101995661511238,0.0128697787709378,0.820533308075999
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.00134896688430152,0.00594802136484351,-0.0103091549907918,0.0130070887593948,0.820589321777991
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC11A,C-type lectin domain family 11 member A,42592,-0.00113601490334629,0.00503094671058461,-0.0109966704560921,0.00872464064939953,0.821356226008273
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN15,Tetraspanin-15,40116,0.00113060943361646,0.00535178023310265,-0.00935887982326474,0.0116200986904977,0.832689451909114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL19,Interleukin-19,42261,-0.00155856879927945,0.00740223161717028,-0.0160669427689332,0.0129498051703743,0.833238664578216
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TET2,Methylcytosine dioxygenase TET2,40286,0.00220276759525387,0.0105023231085735,-0.0183817856975501,0.0227873208880578,0.833873687463768
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA2,Ephrin type-A receptor 2,42125,0.000723265565787025,0.00344971795005218,-0.00603818161631524,0.00748471274788929,0.833936870195982
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ART5,Ecto-ADP-ribosyltransferase 5,40136,-0.00138020678778212,0.00660820527548225,-0.0143322891277273,0.0115718755521631,0.834559406359805
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,-0.000708435293288628,0.00341562816640857,-0.00740306649944943,0.00598619591287217,0.835693566362319
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FZD8,Frizzled-8,40136,0.000971147455560974,0.00469838836637854,-0.00823769374254096,0.0101799886536629,0.836249569239153
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP2BP,LRP2-binding protein,40182,0.00180149192379235,0.0088656712881831,-0.0155752238010465,0.0191782076486312,0.838983575774298
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDDM3B,Epididymal secretory protein E3-beta,40451,0.0010848647719873,0.00540428434746756,-0.00950753254904911,0.0116772620930237,0.840904243907042
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHC1,SHC-transforming protein 1,40080,-0.0024022890936423,0.012134839580089,-0.0261865746706167,0.0213819964833321,0.84307513986016
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNL1,Interferon lambda-1,42311,0.000922064036828029,0.00469871124784074,-0.00828741000893983,0.0101315380825959,0.84442720320874
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTNL10,Butyrophilin-like protein 10,40080,-0.000859597333965474,0.00438072698750845,-0.00944582222948204,0.00772662756155109,0.844439656931341
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNF75D,Zinc finger protein 75D,40302,0.00123338817729108,0.00629586272835222,-0.0111065027702793,0.0135732791248614,0.844688456563697
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCNIP4,Kv channel-interacting protein 4,42311,0.000983625848354674,0.00506156510355338,-0.00893704175460995,0.0109042934513193,0.845918665139777
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLGAP5,Disks large-associated protein 5,40482,0.0010127487791338,0.00521469056092797,-0.00920804472028503,0.0112335422785526,0.846014388513824
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GHRHR,Growth hormone-releasing hormone receptor,42311,-0.00110593580995268,0.00577066861276276,-0.0124164462909677,0.0102045746710623,0.848021082119609
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.00342411325177208,0.017970115438134,-0.0317973130069705,0.0386455395105146,0.848885625172621
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.000971919820280183,0.00519275069829641,-0.00920587154838078,0.0111497111889412,0.851531940169347
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RASA1,Ras GTPase-activating protein 1,42311,0.000618426454105923,0.00332400853433673,-0.00589663027319406,0.00713348318140591,0.852409686687517
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRX,Cone-rod homeobox protein,42357,-0.00199343428292867,0.0108993270304974,-0.0233561152627036,0.0193692466968463,0.854883088592319
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYTH3,Cytohesin-3,40080,-0.00138990221858127,0.00767235513174494,-0.0164277182768014,0.0136479138396388,0.856247576510044
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NME3,Nucleoside diphosphate kinase 3,42638,-0.000442390579430243,0.00245335859462144,-0.00525097342488827,0.00436619226602779,0.856903766730106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,0.000949070100902438,0.00527040283923922,-0.00938091946400643,0.0112790596658113,0.857096770602799
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,-0.00258223380046521,0.0147196604638557,-0.0314327683096224,0.026268300708692,0.86074696638624
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGM2,Phosphoglucomutase-2,40182,0.00105783418107486,0.00614270864669562,-0.0109818747664486,0.0130975431285983,0.863275822342696
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DHODH,Dihydroorotate dehydrogenase,40116,0.000844992171189756,0.00499458365975517,-0.00894439180193039,0.0106343761443099,0.865656853976583
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP10,Inactive dipeptidyl peptidase 10,42594,-0.000617245143995001,0.0036830579220479,-0.00783603867120888,0.00660154838321888,0.866908054447007
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLB1,"Phospholipase B1, membrane-associated",40483,0.0010279993573709,0.00616624962761482,-0.0110578499127541,0.0131138486274959,0.867598175032078
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UNC5D,Netrin receptor UNC5D,40199,0.000447349147788796,0.00268428693377867,-0.00481385324241739,0.00570855153799498,0.867644779402521
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00107073695281338,0.00650487048700835,-0.011678809201723,0.0138202831073497,0.869257619318831
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EXOSC10,Exosome component 10,40116,0.00101672596193109,0.00620256358718602,-0.0111402986689535,0.0131737505928157,0.869796934754901
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VNN2,Vascular non-inflammatory molecule 2,42587,0.000751918705522223,0.00466065882668772,-0.00838297259478571,0.00988681000583016,0.871833459623052
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,-0.00101382944544766,0.00633693933040826,-0.0134342305330479,0.0114065716421525,0.872893553643641
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPHA2,Glycoprotein hormone alpha-2,40449,-0.000763502574343998,0.00477768692599962,-0.0101277689493033,0.00860076380061526,0.873036841446422
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCIN,Adseverin,40136,-0.00119356966021331,0.00748782094219386,-0.0158696987069133,0.0134825593864867,0.873355523410916
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD86,T-lymphocyte activation antigen CD86,40449,0.000492333003265898,0.00311377257810297,-0.00561066124981592,0.00659532725634772,0.874369308089671
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPA33,Cell surface A33 antigen,42587,-0.00222522823833629,0.0142214506493902,-0.030099271511141,0.0256488150344684,0.875665041757586
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,0.000435844834870884,0.00278992188114021,-0.00503240205216393,0.0059040917219057,0.875861478909233
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UGDH,UDP-glucose 6-dehydrogenase,40116,-0.00151290492119406,0.00982288122755439,-0.0207657521272007,0.0177399422848125,0.877598035388626
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFDN4,Prefoldin subunit 4,40080,-0.000820155980054299,0.00539388024425581,-0.0113921612587957,0.00975184929868709,0.879147906492004
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.00106752835522882,0.0071792839414971,-0.0151389248805631,0.0130038681701055,0.881796532109971
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,-0.000783587602525969,0.00533738927300358,-0.011244870577613,0.00967769537256105,0.883283890081799
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD33,Myeloid cell surface antigen CD33,42679,0.00118841998737801,0.00821212597627419,-0.0149073469261194,0.0172841869008754,0.884937848943828
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNF174,Zinc finger protein 174,40199,0.000555532046418745,0.00384114762263586,-0.00697311729394754,0.00808418138678503,0.885008357943042
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCN1,Transcobalamin-1,40337,0.000496206618129785,0.00350003268357949,-0.00636385744168602,0.00735627067794559,0.887262667853271
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.000636550096160419,0.00457982051165743,-0.00961299829900898,0.00833989810668814,0.889460463558208
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,-0.00108771087555701,0.00809758488039558,-0.0169589772411323,0.0147835554900183,0.893147773298804
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNF830,Zinc finger protein 830,40451,-0.00106466856193995,0.0079529781867373,-0.0166525058079451,0.0145231686840652,0.893507431055143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC25A,M-phase inducer phosphatase 1,40080,-0.000533731681015959,0.00400435620793289,-0.00838226984856443,0.00731480648653251,0.893968268694746
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC7A,C-type lectin domain family 7 member A,42754,0.000827093715340082,0.00622967178965538,-0.0113830629923845,0.0130372504230646,0.894379765535203
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,0.000350855789808071,0.00265626977421162,-0.00485543296764671,0.00555714454726285,0.894918779622492
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NENF,Neudesin,40451,-0.00146727727873662,0.0112879090810403,-0.0235915790775756,0.0206570245201023,0.896579325941658
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2RB,Interleukin-2 receptor subunit beta,42370,-0.000492165498763201,0.00402900243086199,-0.0083890102632527,0.0074046792657263,0.902777595153069
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTN,Neuroplastin,42346,-0.000978825584848167,0.00806733875816315,-0.0167908095508479,0.0148331583811516,0.903430003229671
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BEX3,Protein BEX3,40080,-0.000581880759762065,0.00491077477882226,-0.0102069993262537,0.00904323780672956,0.90568111126902
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,-0.000774344529419737,0.0065495354671096,-0.0136114340449545,0.0120627449861151,0.905888443003114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASQ2,Calsequestrin-2,40116,-0.000594869986322395,0.00504307804206918,-0.010479302948778,0.00928956297613319,0.906103327783407
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAMT,Guanidinoacetate N-methyltransferase,40116,0.000451020376572183,0.00389127728721104,-0.00717588310636145,0.00807792385950581,0.907729580409395
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXDC1,Plexin domain-containing protein 1,42346,0.00035744747608001,0.00323411927163422,-0.00598142629632307,0.00669632124848309,0.911995582648509
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP4,Caspase-4,40302,0.00193624233494123,0.0177257671601822,-0.0328062612990159,0.0366787459688984,0.913019498250239
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRA3,GDNF family receptor alpha-3,42474,-0.000319610297230731,0.00295297943888116,-0.00610744999743781,0.00546822940297635,0.913812376396557
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSPN,Claspin,42292,-0.000387889507695406,0.00359989043978605,-0.00744367476967607,0.00666789575428526,0.91419536717898
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IKZF2,Zinc finger protein Helios,42346,0.000964350468093021,0.00902322789580112,-0.0167211762076772,0.0186498771438632,0.914890393385922
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.000463475306170302,0.00435633005936809,-0.00807493161019116,0.00900188222253177,0.915273891524745
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPB41L5,Band 4.1-like protein 5,40182,0.000666197431396593,0.00629559716501393,-0.0116731730120307,0.0130055678748239,0.91572743513711
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL3RA,Interleukin-3 receptor subunit alpha,42370,0.000351885332151501,0.00335933941532978,-0.00623241992189486,0.00693619058619786,0.916577072762445
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EVPL,Envoplakin,40302,-0.000373273128235514,0.00361193407674324,-0.00745266391865226,0.00670611766218123,0.917691510726217
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.000389078407050951,0.00386332424318256,-0.00718303710958686,0.00796119392368877,0.919781872510984
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORF4L1,Mortality factor 4-like protein 1,40302,-0.000410187453471783,0.00409788115344588,-0.00844203451422571,0.00762165960728215,0.920268766257376
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEX33,Testis-expressed protein 33,40302,-0.000389195785037878,0.00391515953739542,-0.00806290847833289,0.00728451690825714,0.920816610511649
NMR metabolomics,X23508.Triglycerides in Medium VLDL,L1CAM,Neural cell adhesion molecule L1,42679,0.000295467714055147,0.00299917874319573,-0.00558292262260848,0.00617385805071877,0.921523867458623
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYBB2,Beta-crystallin B2,40483,-0.000781900324428596,0.00837912079514406,-0.017204977082911,0.0156411764340538,0.925654718855028
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL36A,Interleukin-36 alpha,40199,-0.000543843369730669,0.00590672109259794,-0.0121210167112226,0.0110333299717613,0.92664254481941
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,0.000444474359238556,0.00485839236433646,-0.0090779746748609,0.00996692339333801,0.927108165425643
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINT3,Kunitz-type protease inhibitor 3,40449,-0.00135820422356034,0.0152450637841674,-0.0312385292405285,0.0285221207934078,0.92901084947927
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.000286919710813078,0.00324379978065499,-0.00607092785927071,0.00664476728089686,0.929518991302613
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM171A2,Protein FAM171A2,40482,0.00139162610344181,0.0164134991667741,-0.0307788322634353,0.033562084470319,0.9324334554652
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,-0.000733469102062694,0.00988934577111875,-0.0201165868134554,0.0186496486093301,0.940878384124395
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL6B,Myosin light chain 6B,40182,-0.000670111562995129,0.00934478158456035,-0.0189858834687334,0.0176456603427432,0.942834234931658
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.000247835113119634,0.00355301970302301,-0.00721175373104474,0.00671608350480547,0.944391239897688
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DIPK2B,Divergent protein kinase domain 2B,40283,0.000197862257728134,0.00285649859144657,-0.00540087498150715,0.00579659949696341,0.944778015803638
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,-0.000394926376160883,0.0057036572404948,-0.0115740945675307,0.0107842418152089,0.944799137311183
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB1,Integrin beta-1,42638,-0.000147133845237191,0.00218949230579961,-0.00443853876460443,0.00414427107413005,0.946423498131319
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.000239429669884711,0.00387519169039379,-0.00783480538305654,0.00735594604328711,0.950734983970193
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,-0.000192875828859509,0.00325016857510661,-0.00656320623606847,0.00617745457834945,0.952679732638967
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.000373636055638318,0.00642813785706706,-0.0129727862554897,0.0122255141442131,0.953650055071332
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORC3,MORC family CW-type zinc finger protein 3,40483,0.000156090724592907,0.00290284931932431,-0.00553349394128274,0.00584567539046855,0.957118123261917
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NELL1,Protein kinase C-binding protein NELL1,42679,-0.000240895651230049,0.00448003662100977,-0.0090217674284092,0.00853997612594911,0.957118482018284
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL22,Interleukin-22,40451,-0.000382027943517783,0.00717943699308639,-0.0144537244499671,0.0136896685629315,0.957564411274178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA3,Carbonic anhydrase 3,42770,0.000319038045711674,0.00610252768073929,-0.0116419162085373,0.0122799922999607,0.95830663277063
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.000162016555440979,0.0032178937559813,-0.00614505520628238,0.00646908831716434,0.95984545919426
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXK,Tyrosine-protein kinase TXK,40302,-0.000362500644988854,0.0076996814287914,-0.01545387624542,0.0147288749554423,0.962450350628381
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL15,Interleukin-15,42594,0.000149376388922802,0.00340082166479082,-0.0065162340740672,0.0068149868519128,0.964965944139638
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,40302,0.000194354097616435,0.00450410720180927,-0.00863369601792974,0.00902240421316261,0.965582406451064
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.000185400675837595,0.00450650733436368,-0.00864735369951521,0.0090181550511904,0.967184491577672
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KHDC3L,KH domain-containing protein 3,40080,0.000284224190948023,0.00708980183815138,-0.0136117874118287,0.0141802357937247,0.968022780129809
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,-0.00015781400555229,0.00419903124863044,-0.00838791525286794,0.00807228724176336,0.970020389840103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMC3,Structural maintenance of chromosomes protein 3,40080,-0.000206607705551445,0.00570676471118156,-0.0113918665394673,0.0109786511283644,0.97112036092523
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMC3,26S proteasome regulatory subunit 6A,40080,-0.00010946709455492,0.00314584310375681,-0.00627531957791827,0.00605638538880844,0.972241948666379
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL15RA,Interleukin-15 receptor subunit alpha,42370,0.000116114037064774,0.00371110343918848,-0.00715764870374464,0.00738987677787419,0.975040112324091
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB7,Integrin beta-7,42721,0.000133838195193253,0.00472185603011593,-0.00912099962383398,0.00938867601422048,0.977387883635063
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AREG,Amphiregulin,42587,-0.000119828899351386,0.00435882022878541,-0.00866311654777078,0.00842345874906801,0.978068422944494
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTNAP4,Contactin-associated protein-like 4,40182,-0.000239531920673959,0.0105696316008449,-0.0209560098583299,0.020476946016982,0.981920078079712
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,40429,8.75673225178614e-05,0.0040469362305211,-0.0078444276893035,0.00801956233433922,0.982737161167139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.000101167716229969,0.00489933196870239,-0.00970385837488665,0.00950152294242672,0.983525801239874
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARG2,"Arginase-2, mitochondrial",40451,8.57042264263678e-05,0.0043820735303241,-0.00850315989300886,0.0086745683458616,0.984396382120802
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,5.48478448725001e-05,0.00290672685738485,-0.00564233679560181,0.00575203248534681,0.984945665714844
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAD1,Glutamate decarboxylase 1,40080,-4.64539064198379e-05,0.00268835826487512,-0.00531563610557507,0.00522272829273539,0.986213831893118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBQLN3,Ubiquilin-3,40116,-9.56692452158094e-05,0.00557124359037457,-0.01101530668235,0.0108239681919183,0.986299734755767
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A16,Protein S100-A16,42292,4.61631699527696e-05,0.00623152740464271,-0.0121676305431469,0.0122599568830525,0.994089436141769
